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Abstract
Cellular stress conditions, e. g. hyperosmolality or hypothermia, may occur in micro-environments
of non-ideally mixed large scale bioreactors (1,000 - 20,000 L) during biopharmaceutical manufac-
turing. Although cell growth is inhibited by stress conditions, it has been shown that specific product
formation rates (qP) ofChinesehamsterovary (CHO)producer cell linesenhanceduponcellular stress.
This thesis deciphers the reasons behind the aforementioned phenomenon based on a hyper-
osmotically stressed antibody producing CHO DP-12 cell line and utilizes the gained knowledge in
order to identify potential cell line engineering strategies to further improve cellular performance.
Characterization of the phenotype of the CHO DP-12 cell line upon osmotic upshift (+ 100/
+ 150 mOsmol kg-1) exhibited well-known effects like reduced cell growth due to cell cycle arrest, in-
creased cell specific consumption of the substrate glucose or formation of the by-product lactate as
well as enhanced qP. Considering the energy demand of recombinant protein production, this
thesis particularly focused on intracellular adenine nucleotide pools and ATP formation rates (qATP)
as ameasureof cellular energetic capacity. Thereby, itwas shownthathyperosmotically stressedCHO
DP-12 cells do not exhibit reduced mitochondrial activity, disproving a previous hypothesis that was
made on basis of significantly decreased antibody-mediatedmitochondrial fluorescence intensities.
Noteworthy, 20 - 39% increased qATP at 390 mOsmol kg-1 or 140 - 176% enhanced qATP at
430 mOsmol kg-1 and significantly elevated intracellular ATP pools mirrored improved ATP supply
uponhyperosmotic stimuluswherebyadenylateenergychargesandADP/ATPratioswerenotaffected
at all. This picturewas refined by a compartment specificmetabolomics approach showing that both
cytosolic andmitochondrial ATP pools increased in response to osmotic upshift.
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Abstract
Next generation sequencing for analysis of mRNA and miRNA expression dynamics linked
hyperosmolalitymediated G1-arrest and enhanced qP to the immediate and long term upregulation
of the gene encoding cyclin dependent kinase inhibitor protein 1A (CDK1A). The significantly upreg-
ulated miRNAs miR-132, miR-194 and miR-215 may play decisive roles in the aforementioned con-
text as overexpression of these miRNAs correlated with increased CDK1A expression in independent
cancer studies. With respect to the results of a previous independent CHO study, the hyperosmoti-
cally induced upregulation ofmiR-183 seemed as well to contribute to cell cycle arrest and enhanced
qP.
Concluding, improved ATP supply in combination with a presumably decreased energy demand
of arrested CHO cells was anticipated to result in increased qP. Accordingly, enhancement of ATP
supplywas the central focus for the identification of potential cell line engineering targets to improve
productivity of CHO cells. Strikingly, several genes encoding glycosylated proteins with strictly tissue
related function exhibited significantly elevated expression levels upon hyperosmotic
stimulus. Therefore, deletion of genes with presumably dispensable function in suspension cultures
may contribute to an improvement of qP of CHOproducer cell lines by enhancedATP supply. Further-
more, miR-132, miR-183, miR-194 and miR-215 are hypothesized to be suitable targets to increase qP
by stable overexpression as these miRNAs were associated with CDK1A-dependent or independent
cell cycle arrest. TherebymiR-183may be themost promising target due to the fact that a qP enhanc-
ing function has already been described for a transient expression of humanmiR-183 in an antibody
producing CHO cell line.
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Zusammenfassung
Stressbedingungen,wiebeispielsweiseHyperosmolalität oderHypothermie, können imRahmender
Herstellung von Biopharmazeutika inMikroumgebungen nicht-ideal durchmischter, großvolumiger
Bioreaktoren (1.000 -20.000L) auftreten.ObwohldasZellwachstumdurchdiese Stressbedingungen
inhibiertwird, zeigtenausdenOvariendes chinesischenHamsters stammendeProduktionszelllinien
(CHO-Zellen) infolge des zellulären Stresses verbesserte spezifische Produktbildungsraten (qP).
IndieserArbeitwerdendieUrsachen fürdaszuvorbeschriebenePhänomenaufBasis einerhyper-
osmotisch gestressten Antikörper produzierenden CHO DP-12 Zelllinie aufgeklärt. Die gewonnenen
Erkenntnisse werden außerdem zur Identifizierung potentieller Strategien für die Zelllinienentwick-
lung herangezogen, umMöglichkeiten für eine weitere Steigerung der zellulären Leistungsfähigkeit
aufzuzeigen. Die phänotypische Charakterisierung der Zelllinie CHO DP-12 zeigte bei Erhöhung der
Osmolalität (+ 100/+ 150mOsmol kg-1) bereits bekannte Effekte, wie verringertes Zellwachstum auf-
grund von Zellzyklusarrest, erhöhter zellspezifischer Verbrauch des Substrats Glucose und erhöhte
Bildung des Nebenprodukts Laktat, sowie eine verbesserte qP. In Anbetracht des Energiebedarfs der
Produktion rekombinanter Proteine, lag das Augenmerk dieser Arbeit insbesondere auf den intra-
zellulären Gehalten an Adenin-Nukleotiden, sowie auf den ATP-Bildungsraten (qATP) als Maß für das
energetische LeistungsvermögenderZellen.Dadurchwurdegezeigt, dasshyperosmotischgestresste
CHODP-12 Zellen keine verringerte mitochondriale Aktivtät aufweisen, womit eine auf einer verrin-
gerten Antikörper-vermittelten mitochondrialen Fluoreszenzintensität basierende vorangegangene
Hypothesewiderlegtwurde.Erstaunlicherweise, spiegelten20-39%erhöhteqATPbei390mOsmolkg-1
beziehungsweise140-176%verstärkteqATPbei430mOsmolkg-1undsignifikanterhöhte intrazelluläre
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ATP-Gehalte eine verbesserte ATP-Bereitstellung infolge des hyperosmolalen Stimulus wider, wobei
Energieladung undADP/ATPVerhältnisse unverändert blieben. Anhand eines kompartimentspezifi-
schenMetabolomik-Ansatzeswurdedieses Bild näher charakterisiert,wobei gezeigtwurde, dass sich
sowohl die cytosolischen als auch die mitochondrialen ATP-Gehalte im Zuge des hyperosmotischen
Stimulus erhöhten.
Die mittels einer Sequenzierungstechnologie der nächsten Generation analysierten mRNA und
miRNA Expressionsdynamiken verknüpften den durch Hyperosmolalität induzierten G1-Arrest und
die gesteigerte qP mit der unmittelbaren und langfristigen Hochregulierung des Gens CDK1A,
welches einen Inhibitor Cyclin-abhängiger Kinasen codiert. Die signifikant hochreguliertenmiRNAs
miR-132, miR-194 und miR-215 könnten eine entscheidende Rolle im zuvor erwähnten Kontext
spielen, da diese miRNAs in unabhängigen Krebsstudien mit einer erhöhten CDK1A-Expression
korrelierten. Unter Berücksichtigung der Ergebnisse eines vorangegangenen, unabhängigen CHO-
Forschungsprojekts, schiendiehyperosmotisch induzierteHochregulationdermiR-183ebenfalls zum
Zellzyklusarrest und der Erhöhung der qP beizutragen.
Abschließend wurde angenommen, dass die verstärkte ATP-Bereitstellung in Kombination mit
einem wahrscheinlich verminderten Energiebedarf arretierter CHO-Zellen zu den erhöhten qP
führte. Dementsprechend lag der zentrale Fokus für die Identifizierung potentieller Ansatzpunkte
für die Zelllinienentwicklung auf einer Verstärkung der ATP-Bereitstellung, um dadurch die Produk-
tivität von CHO-Zellen zu vebessern. Auffälligerweise, führte der hyperosmotische Stimulus zu einer
signifikant erhöhten Expression vonGenen,welche glycosylierte Proteinemit grundsätzlich gewebe-
spezifischer Funktion codieren. Daher könnte die Deletion von Genen mit vermutlich überflüssiger
Funktion inSuspensionskulturenzueiner verstärktenBereitstellungvonATPbeitragenundsomitdie
qP erhöhen.DesWeiterenkönntenenmiR-132,miR-183,miR-194undmiR-215 geeigneteAnsatzpunk-
te für eine Erhöhung der qP durch stabile Überexpression sein, da diese miRNAs mit einem CDK1A-
abhängigen oder -unabhängigen Zellzyklusarrest assoziert wurden. Dabei wird angenommen, dass
miR-183 die vielversprechendste miRNA ist, da in einer unabhängigen Studie bereits gezeigt
wurde, dass eine transiente Expression der humanen miR-183 in einer Antikörper produzierenden
CHO-Zelllinie zu einer Erhöhung der qP führte.
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The biotechnological production of therapeutic proteins for the treatment of diseases, e. g. cancer
or autoimmune diseases, is a steadily increasingmarket. From $94 billion in 2007, the global annual
sales increased7 - 12%per year and reached$140billion in2013 (Walsh, 2010a, 2014). Thereof∼ 50%
werecommonlyapportionedontheUnitedStates (US)biotechmarket (Aggarwal,2014;Walsh,2014).
Biopharmaceutical products encompass the categories monoclonal antibodies (mAbs), hormones,
fusion proteins, cytokines, therapeutic enzymes, blood factors, recombinant vaccines and anti-
coagulants in the order of declining USmarket volume (Aggarwal, 2014). These biopharmaceuticals
areproducedbymammalian,microbial and insect cell lines. Escherichia coli (E. coli) is thepredominant
microbial expression systemwhichwasused for theproductionof three (Lantus,Neulasta andLucen-
tis) of the 10 top-selling biopharmaceutical products in 2013 (Tab. 1.1). Besides E. coli, biopharmaceu-
ticals aremainly produced bymammalian cell cultures (∼ 70%). This percentage is steadily increas-
ing asmore andmore products require complex post-translationalmodifications (e. g. glycosylation)
which are insufficient in prokaryoticmicroorganisms like E. coli (Walsh, 2014). Cells fromhuman em-
bryo kidney (HEK293),murinemyeloma (NS0, SP2/0), baby hamster kidney (BHK) and fromChinese
hamster ovary (CHO) are typicalmammalian host cell lines (Jayapal et al., 2007). Seven of the 10 top-
selling biopharmaceutical products in 2013were produced bymammalian cells, predominantly CHO
cell lines (6 of 7).
Research activities continually focus on the enhancement of cellular productivity. Since the ap-
provalof the firstproductexpressedbyaCHOcell line (tissueplasminogenactivator, 1987,Genentech)
specific product formation rates (qP) improved from less than 10 pg cell-1 d-1 to∼ 40 - 100 pg cell-1 d-1
(Seth et al., 2006; Tabuchi and Sugiyama, 2013; Wurm, 2004). In addition, product titers increased
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by more than 100-fold (cP, > 5 g L-1) (Schaub et al., 2012; Wurm, 2004). Enhancements in qP and cP
were achieved by e. g. process optimization, cell line engineering and by improved cultivation me-
dia and feeding supplements (Jayapal et al., 2007; Schaub et al., 2012; Seth et al., 2006; Tabuchi and
Sugiyama, 2013;Wurm, 2004).
Table 1.1: The 10 top-selling biopharmaceutical products in 2013. With changes toWalsh (2014). TNF = tumor
necrosis factor, VEGF = vascular endothelial growth factor.
Sales Year first
ranking product [$ billions]a approved company
1 Humira 11.00 2002 AbbVie& Eisai
(adalimumab; anti-TNF)
2 Enbrel 8.76 1998 Amgen, Pfizer,
(etanercept; anti-TNF) Takeda Pharmaceuticals
3 Remicade 8.37 1998 J&J,Merck&Mitsubishi,
(infliximab; anti-TNF) Tanabe Pharma
4 Lantus 7.95 2000 Sanofi
(insulin glargine)
5 Rituxan/MabThera 7.91 1997 Biogen-IDEC, Roche
(rituximab; antiCD20)
6 Avastin 6.97 2004 Roche/Genentech
(bevacizumab; anti-VEGF)
7 Herceptin (anti-HER2) 6.91 1998 Roche/Genentech
8 Neulasta (pegfilgrastim) 4.39 2002 Amgen
9 Lucentis 4.27 2006 Roche/Genentech, Novartis
(ranibizumab; anti-VEGF)
10 Epogen/Procrit/Eprex/ESPO 3.35 1989 Amgen, J&J, KHK
(epoetin alfa)
aFinancial data from LaMerie Business Intelligence. J&J, Johnson& Johnson
However, optimization strategies intensified culture conditions, thus facilitating the occurrence
of cellular stress. Strikingly, stress conditions, e. g. low culture temperature or hyperosmolality, were
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shown to enhance qP (Fox et al., 2004; Furukawa andOhsuye, 1998;Han et al., 2009; Kaufmann et al.,
1999; Lee et al., 2003a; Ryu et al., 2000; Shen et al., 2010). Deciphering the fundamentals of the qP
enhancing effect of hyperosmotic culture conditions is expected to reveal potential strategies for a
further improvement of cellular performance. As a consequence this research project focuses on the
effects of hyperosmotic culture conditions on energetic capacity and transcriptomic response of an
antibodyproducingCHOcell line toelucidate theunderlying reason for theqP and to identify suitable
cell line engineering strategies.
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2 Theoretical Background
2.1 ChineseHamsterOvary Cells
Thepredominantlyusedmammalianhostcell lines forheterologousproteinexpression inthebiotech
industry are CHO cells. These cells date back to the year 1957 when Puck et al. isolated cells from
different organs (kidney, lung, ovary and spleen) ofCricetulus griseus (Chinesehamster) and cultivated
them in vitro. Surprisingly, the cellularmorphology and growth rate of CHO cells were not affected by
a long-term in vitro cultivation of∼ 10 months (Puck et al., 1958). For about two decades CHO cells
weremainly used to investigate the cell cycle and the effects ofmutagenesis on cellular functions and
structure, until in the 1980s Urlaub et al. generated two dihydrofolate reductase (DHFR) lacking cell
lines (CHODXB11, CHODG44) which later became themain parental hosts of today's industrial pro-
duction cell lines (UrlaubandChasin, 1980;Urlaubetal., 1983, 1986). CHODXB11andCHODG44were
generated by mutagenesis of CHO K1 and CHO pro-3 which had both been isolated by Puck et al.
in 1957. While both DHFR loci were deleted in CHO DG44, CHO DXB11 cells still possess one inac-
tive DHFR locus (Urlaub and Chasin, 1980; Urlaub et al., 1983, 1986; Wurm and Hacker, 2011). DHFR
catalyzes the reduction of folate to dihydrofolate and finally to tetrahydrofolate which is an
important carbon-carrier. As a cofactor tetrahydrofolate provides one-carbon-groups, e. g. methyl,
methylene or formyl groups, for the synthesis of amino acids, purines or pyrimidines (e. g. hypo-
xanthine, thymidine) (Berg et al., 2003; Hamlin andMa, 1990).
The DHFR deficiency of CHO DXB11 and CHO DG44 established the basis for a widely applied
selection system (2.5) for the isolation of strains with high expression of recombinant protein.
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2.2 Cell Cycle andGenome
Mammalian cell cycle is a defined and highly regulated chronology of cellular processes that finally
result in the division of one cell into two identical daughter cells (Fig 2.1). In cell culture, this process
ofmultiplying by cell division is commonly defined as cell growth and is the basis of biotechnological
production.
Cell Cycle
Cell cycle is divided into four phases - gap phase 1 (G1), DNA-synthesis (S), gap phase 2 (G2) and
mitosis (M) (Fig. 2.1-A). Extracellular mitogenic stimuli (e. g. growth factors) are required for the in-
duction of the highly regulated process of cell cycle (Fig. 2.1). At the beginning of each cycle, cells
enter G1-phase and prepare for the subsequent DNA replication in S-phase until they finally reach
a checkpoint ("restriction point") that decides on commitment of further cell cycle progression or en-
tering of cells into a quiescent/arrested state (G0/G1) (Bertoli et al., 2013; Malumbres and Barbacid,
2005; Poon, 2016; Zetterberg et al., 1995). As part of positive and negative feedback loops, complexes
of cyclin and cyclin-dependent kinases (cyclin D/CDK 4/6, cyclin E/CDK 2, cyclin A/CDK 2) inactivate
transcription factors or associated inhibitors (pRb) and corepressors (p107, p130) by phosphorylation,
thereby enabling transcriptionof S-phase specific genes andpassageof the "restrictionpoint" (Bertoli
et al., 2013;Malumbres andBarbacid, 2005; Poon, 2016). Thereafter, cells are committed for cell cycle
progression and continuewith semi-conservative replication of chromosomalDNA (Alexandrowand
Hamlin, 2004; Dimitrova et al., 1999;Masai et al., 2010; Poon, 2016).
The further progression in cell cycle after DNA replication is dependent on a second checkpoint
at the end of G2-phase. Cyclin B/CDK 1 is amajor complex of the G2-M regulatory systemwhereby its
phosphorylated, inactive formmediates cell cyclearrest inG2-phase (MalumbresandBarbacid,2005;
Poon, 2016; Stark and Taylor, 2006). G2-M transition is therefore based on the functional interaction
of G2 checkpoint kinases and phosphatases with CDK 1 (Malumbres and Barbacid, 2005; Poon, 2016;
StarkandTaylor, 2006). Furthermore,CDK1 in turn is capableof regulating theactivityof itsactivators
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or repressors via a feedback loop (Ma and Poon, 2011; Poon, 2016; Stark and Taylor, 2006).
The final M-phase is characterized by the equal separation of chromosomes and other cellular
components to two daughter cells. This involves themitotic processes spindle assembly, nuclear en-
velope breakdown and chromosomemovement which are regulated by a variety of kinases (Ma and
Poon, 2011; Nigg, 2001; Poon, 2016).
Figure2.1: Cell cyclephases (A) andpositive (B) andnegative feedback loop (C) duringG1-S transition. A)An
exemplary cell with two chromosomes enters a new round of cell cycle. In gap phase 1 (G1) the cell prepares for
the subsequent DNA replication and either passes the "restriction point" (R) or enters an arrested or quiescent
state (G0). Further cell cycle progression leads toDNA replication and a second gapphase (G2). Another check-
point (C) inG2-phase regulateswhether thecell entersmitosisorarrests inG2-phase. Mitosis is characterizedby
equaldistributionofcellular components to twodaughter cells. B-C)pRb inhibits the transcription factorsE2F1-
3while p107 andp130 are corepressors of E2F4. pRb, p107 andp130 are inactivatedbyphosphorylationwhich is
mediated by cyclin/cyclin-dependent kinase (CDK) complexes. Cyclin D/CDK 4/6 is specific for G1-phase while
cyclin E/CDK 2 and cyclin A/CDK 2 are related to S-phase. Passing of the "restriction point" is regulated by pos-
itive and negative feedback loops. Cyclin D/CDK 4/6 inactivates pRb, p107 and p130 and enables transcription
of S-phase specific genes. Cyclin E/CDK2 itself stimulates transcription by phosphorylating pRb, p107 andp130
(positive feedback). This complex further targets p27 for degradation and thereby the inactivation of E2F1-3 by
cyclin A/CDK 2 is enhanced. This leads to a decreased transcription of cyclin E/A and the transcription factors
E2F6-8 (negative feedback). (Poon, 2016). B) and C) withmodifications to Bertoli et al. (2013).
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DNADamageCheckpoints
DNAdamage is a commonly occurring cellular effect upon exposure of cells to stress conditions, e. g.
hyperosmolalityandradiation (Bertoli et al., 2013;Burgetal., 2007;Hanetal., 2010; LeungandSharp,
2010; Sieck et al., 2013). Specific DNA damage checkpoints in G1- and G2-phase of cell cycle can
induce cell cycle arrest in order to provide time for DNA repair mechanisms. DNA damage activates
the protein kinases ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3 related
(ATR)which activate the subsequent checkpoint kinases 1 and 2 (CHK1/2) (Bertoli et al., 2013;Ma and
Poon, 2011; Poon, 2016). CHK1/2 induce transcriptional activity of tumor suppressor protein 53 (p53)
by hampering the binding to its regulator MDM2, thus inducing either cell cycle arrest or
p53-mediated apoptosis (Poon, 2016). p53 is a transcriptional activator of the CDK-inhibitor CDK1A/
p21 which induces G1-arrest by inhibiting cyclin A/E/CDK 2 and cyclin D/CDK 4 (Fig. 2.1B/C) (He et al.,
2005; Poon, 2016).
Genome
Cell cycle includes the replication of the cellular genome in S-phase. In general the Chinese hamster
genome is characterized by a small but highly variable chromosome set of 2n = 19 - 23 chromosomes
(Cao et al., 2012; Derouazi et al., 2006; Puck et al., 1958; Worton et al., 1977). Derouazi et al. (2006)
analyzed the karyotype of 16 recombinant CHODG44 cell lines thereby showing thatmore than half
of the cell lines contained chromosomal aberrations, e. g. rearrangements, aneuploidy or deletions.
Nevertheless, the comparison of chromosomal sequences of the primary Chinese hamster cells CHO
K1 and CHODG44 by Cao et al. (2012) revealed the conservation of eight of 20 chromosomes.
Although the preparation of CHO expressed sequencing tag (EST) libraries (Kantardjieff et al.,
2009; Wlaschin et al., 2005), CHO-specific gene sequences (Birzele et al., 2010) and CHO cDNA
microarrays (Nissometal., 2006; Schaubetal., 2010)hadbeendescribed in literature, almostnoCHO
sequence informationwaspublicly availableuntilXuet al. (2011) publishedadraft genomic sequence
comprising 24,383 predicted genes for the cell line CHO K1. In general, a variety of next generation
sequencing (NGS) and Sanger-based sequencing studies for Chinese hamster, CHO K1, CHO DXB11
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andCHODG44cell linespredictedgene/transcriptnumbersbetween∼24,000and∼29,000(Becker
et al., 2011; Kantardjieff et al., 2009; Le et al., 2015; Lewis et al., 2013; Rupp et al., 2014; Xu et al., 2011).
While in the past, gene annotation was commonly performed by mapping CHO sequencing data to
reference genomes ofHomo sapiens,Musmusculus and Rattus norvegicus (Hammond et al., 2011; Kan-
tardjieff et al., 2009; Wlaschin and Hu, 2006; Wlaschin et al., 2005; Xu et al., 2011), this approach
was rejected by the public availability of Chinese hamster genomes (Hammond et al., 2012; Le et al.,
2015; Lewis et al., 2013; Rupp et al., 2014). Besides the protein encoding segments, the CHO genome
containssmallnon-codingmicroRNAs(miRNAs)whichare involved inmessengerRNA(mRNA)degra-
dation and silencing ofmRNA translation (2.7). Based onNGS of small cDNA libraries from different
CHO cell lines, Hackl et al. (2011) identified 387 and Johnson et al. (2011) 350 mature miRNAs. For
319 of these previously determined mature miRNAs distinct genomic loci were identified by map-
ping miRNA sequences to CHO reference genomes (Hackl et al., 2012). Recently, Diendorfer et al.
(2015) identified another 71 novel CHOmiRNAsbyNGSof cDNA libraries fromparental and recombi-
nant CHOK1 and CHODXB11 cell lines. Nevertheless, the publicmiRNAdatabase "miRBase" (release
21) (Kozomara andGriffiths-Jones, 2011) currently contains 307mature and200precursormiRNAs of
Chinese hamster.
2.3 Mitochondria
Mammalian cells are eukaryotic organisms which are characterized by a complex subcellular
compartmentalization (Fig. 2.2). Several distinct cell organelles, e. g. nucleus, endoplasmic reticu-
lum (ER) andmitochondria, provide appropriate conditions for various cellular processes.
The metabolic pathways tricarboxylic acid (TCA) cycle, electron transport chain, oxidative phos-
phorylation (2.4) and β-oxidation of fatty acids are located in the mitochondrial compartment and
provide precursor metabolites and energy for anabolic processes. The latter therefore gives rise to
the fact that mitochondria are commonly defined as cellular "powerhouses". Furthermore, these cell
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organellesplayacentral role inaminoacidmetabolism, ionhomeostasisandprogrammedcelldeath.
(Friedman andNunnari, 2014; Hock and Kralli, 2009; Scheffler, 2001; Shi, 2001)
Figure 2.2: Schematic drawing of mammalian cell. The nucleus, host of genetic information, is the cell
organelle where DNA replication and transcription of DNA occur. A small genome is as well found in mito-
chondria where important metabolic pathways, e.g. TCA cycle, oxidative phosphorylation and β-oxidation,
take place. A variety of acid hydrolases enables the degradation of all kinds of macromolecules in the cell's
lysosomes. The degradation of hydrogen peroxide and β-oxidation of fatty acids occurs in the peroxisomes.
The rough endoplasmic reticulum (studdedwith ribosomes) represents the site for protein synthesis, process-
ing and translocation, while the smooth endoplasmic reticulum is often involved in assembly of vesicles for
transport to theGolgi apparatus. Glycosyltransferases, kinases and proteasesmodify proteins or lipids on their
way through the Golgi apparatus until they are finally delivered to their cellular destinations. With modifica-
tion to Pfizenmaier and Takors (2016).
According to the endosymbiotic theory, mitochondria originate from the uptake of an
α-proteobacterium by a proto-eukaryotic cell (Pernas and Scorrano, 2016; Scheffler, 2001). This
theory was supported by the discovery of mitochondrial DNA byNass andNass (1963). However, the
16,284 bp circular mitochondrial genome of CHO cells was shown to encode only 13 of the∼ 1,100
to 1,500mitochondrial proteins as well as two ribosomal RNAs (rRNA) and 22 transfer RNAs (tRNA)
(Hock and Kralli, 2009; Partridge et al., 2007;Wenz et al., 2015).
Apart from 13 proteins of the electron transport chain, e. g. cytochrome c oxidase and ATP
synthase, the majority of mitochondrial proteins is nuclear encoded and synthesized in the form of
preproteins in the cytosol. Thesemitochondrial precursor proteins contain eitherN-terminal prepep-
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tides or internal targeting sequences which direct them to their predestinedmitochondrial location.
(Endo and Kohda, 2002; Neupert andHerrmann, 2007;Wenz et al., 2015)
Mitochondrial Transport -Nuclear EncodedProteins,Metabolites and Ions
The mitochondrial morphology is characterized by an extensively folded and protein-rich inner
mitochondrial membrane (IMM) surrounded by a smooth outer mitochondrial membrane (OMM)
(Bauer et al., 2015; Passarella et al., 2003; Pernas and Scorrano, 2016; Scheffler, 2001). The charac-
teristic invaginations of the IMMare commonly defined as cristae and extend into the IMMenclosed
space which is defined as mitochondrial matrix (Cogliati et al., 2013; Passarella et al., 2003; Pernas
and Scorrano, 2016; Scheffler, 2001). Concluding,mitochondrial proteins can be located in theOMM,
in the IMM, in thematrix or in the intermembrane space (IMS)which forms between IMMandOMM.
The precursors of nuclear encoded proteins of the mitochondrial matrix, e. g. enzymes of the TCA
cycle, possessN-terminal targeting sequences of about 10 - 80 amino acidswhich are capable to form
amphipathic α-helices. These targeting sequences are commonly cleaved from the preproteins by
the mitochondrial processing peptidase upon entry into the mitochondrial matrix. In contrast to
the preproteins of themitochondrialmatrix, nuclear encodedproteins of theOMM, IMMor the inter-
membrane spaceusually contain internal targeting sequenceswhichare individually specific for their
final mitochondrial location, e. g. precursors of the OMM proteins TOM5 and BCL-2 possess positive
charges at the N-terminus and signal-anchor domains withmoderate hydrophobicity. Furthermore,
heat shock proteins (e. g. HSP70, HSP90) associate with the cytosolic precursor proteins and keep
them in an unfolded import-capable state. (Bauer et al., 2015; Endo and Kohda, 2002; Hartl et al.,
1989; Neupert andHerrmann, 2007;Wenz et al., 2015)
The transport of nuclear encoded mitochondrial preproteins from the cytosol to their final
location is mediated by several translocases. The translocase of the outer mitochondrial membrane
(TOM) complex represents the entry gate for almost all nuclear encodedmitochondrial proteins (Aht-
ing et al., 1999; Neupert and Herrmann, 2007; Pfanner et al., 1998; Schmitt et al., 2005; Wenz et al.,
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2015; Yanoet al., 2000). Componentsof theOMM,e. g. β-barrel proteins/porins, enter the IMSvia the
TOMcomplexandare then transferred to the topogenesisofmitochondrial outermembraneβ-barrel
proteins (TOB) complex, also named sorting and assembly machinery (SAM) complex, which medi-
ates folding of theOMMproteins aswell as their integration into theOMM. (Neupert andHerrmann,
2007; Wenz et al., 2015; Wiedemann et al., 2003). The transport of IMM proteins is either mediated
by theTOMand theTIM22 complex (e. g. carrier proteins) or by theTOMand theTIM23 complex (e. g.
proteinswith only one transmembrane span)whereby small TIMproteins in the IMS assist in protein
transport from the TOM to the TIM22 complex (Moro et al., 1999; Neupert and Herrmann, 2007; Sir-
renberg et al., 1996; Wenz et al., 2015). The protein transport from the IMS into the mitochondrial
matrix is an energy-consuming process and is also dependent on the mitochondrial membrane po-
tential (2.4) (Bauer et al., 1996;Moro et al., 1999; Neupert andHerrmann, 2007;Wenz et al., 2015).
Porins in the OMM and carriers in the IMM enable the exchange of metabolites and ions between
the cytosol and themitochondrial matrix which is of utmost importance for the cellular metabolism
(2.4). While the OMM is permeable for molecules with low molecular weight (< 5 kDa), the IMM
functions as a selective permeability barrier, thus requiring a variety of different carriers formetabo-
liteand ionexchange (LaNoueandSchoolwerth, 1979;Mannella, 1992;Mitchell, 1966;Passarellaetal.,
2003). Exemplary mitochondrial transporters are pyruvate carriers (MPC1/MPC2) transporting the
product of the Embden-Meyerhof-Parnas pathway of glycolysis from the cytosol into the mitochon-
drialmatrix (Fig. 2.3) (Bricker et al., 2012) or theATP/ADP carrierwhich exchangesmitochondrial ATP
with cytosolic ADP (Klingenberg and Rottenberg, 1977; Passarella et al., 2003).
Mitochondrial Dynamics
The mitochondrial compartment is a dynamic network which continuously changes its shape by
fusion and fission thereby forming a continuous reticulum or discrete isolated cell organelles
(Campello and Scorrano, 2010; Hoitzing et al., 2015; Pernas and Scorrano, 2016; Scheffler, 2001).
Morphological changes and the cytosolic localization are characteristic for the cellular needs. For ex-
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ample, mitochondria accumulate at locations where high amounts of ATP are required and cristae
folds proliferate in order to increase the surface area for oxidative phosphorylation (Campello and
Scorrano, 2010; Cogliati et al., 2013; Pernas and Scorrano, 2016). Furthermore, mitochondria may
formhyperfused networks to regulate calcium signaling or fragment and release cytochrome c as re-
sponse to apoptotic stimuli (Mitra et al., 2009; Pernas and Scorrano, 2016). Investigations on mito-
chondrial mass and number are highly related to morphological changes and were studied likewise
on basis of electronmicroscopy and fluorescent labeling of mitochondria in combination with laser-
scanning confocalmicroscopy (Dewey and Fuhr, 1976; Lee et al., 2007, 2002b;McClatchey et al., 2015;
Mitra et al., 2009; Ross andMel, 1972; Santel and Fuller, 2001).
Mitochondrial Pathway ofApoptosis
The programmed cell death, named apoptosis, is characterized by cell shrinkage, chromatin conden-
sation, nuclear DNA fragmentation, blebbing of cytoplasmic membrane, cell fragmentation
(apoptotic bodies) and phagocytosis of apoptotic bodies by adjacent cells (Fulda and Debatin, 2006;
Shi, 2001). Induction of the apoptotic pathway is either mediated by death receptors of the tumor
necrosis factor (TNF) receptor superfamily , e. g. TNF-related apoptosis-inducing ligand (TRAIL) or
CD95, (extrinsicpathway)orbymitochondria (intrinsicpathway) (FuldaandDebatin,2006;Shi,2001).
BCL-2 familymembersplayan important role in controllingmitochondria-mediatedapoptosis as
this group includes interacting proteins of pro- (e. g. BAX, BAK, BID) or anti-apoptotic function (e. g.
BCL-2, BCL-XL) (Bhola and Letai, 2016; Gross et al., 1999). While anti-apoptoticmembers of the BCL-2
family are commonly located in the membrane of cell organelles, e. g. mitochondria, ER and
nucleus, pro-apoptotic members are usually found in the cytosol or attached to cell organelles via
BCL-2 unless apoptotic stimuli are absent (Gross et al., 1999; Wolter et al., 1997). However, upon in-
duction of apoptosis by e. g. DNA damage (2.2), lack in growth factors or starvation, BAX and BAK
were showntobeactivatedbyBIDandBIMresulting in the formationofmultimericpores in theOMM
(Bhola and Letai, 2016; Kuwana et al., 2002; Shi, 2001). Bellot et al. (2007) and Renault et al. (2012)
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elucidatedthatTOM22is requiredas receptor forBAXinorder tobe integrated in theOMM.OMMper-
meabilization by BAX and BAK causes release of the apoptogenic IMS proteins cytochrome c,
apoptosis induction factor (AIF), endonuclease G and secondmitochondrial apoptotic factor (SMAC)
(Bhola and Letai, 2016; Fulda andDebatin, 2006; Gross et al., 1999; Kuwana et al., 2002; Shi, 2001).
Apoptosis is mediated by an intracellular proteolytic cascade, named caspase cascade which is
activatedby the release of apoptogenic IMSproteins. Upon entry into the cytosol, cytochrome cbinds
to the C-terminal region of the apoptotic protease activating factor 1 (APAF1), thus facilitating dATP/
ATP-association and the formation of a sevenfold symmetric, wheel-like complex called apoptosome
(Acehan et al., 2002; Saelens et al., 2004; Srinivasula et al., 1998; Zou et al., 1999). Central N-terminal
caspase-recruitment domains (CARDs) enable binding and activation of procaspase-9 which then in
turn activates effector caspase-3 and -7, thus inducing the characteristic effects of apoptosis by cleav-
age of specific cellular substrates (Lavrik et al., 2005; Saelens et al., 2004; Srinivasula et al., 1998).
The caspase cascade can also be activated by SMAC-mediated inhibition of the inhibitor of apoptosis
protein (IAP) which normally inhibits caspase-3 as well as caspase-9-mediated activation of effector
caspases (Du et al., 2000; Shi, 2001).
In addition to the caspase-dependent apoptotic pathway, nuclear DNA damage can be induced
by the IMS proteins AIF and endonuclease G via a caspase-independent process (Candé et al., 2004;
Saelens et al., 2004).
2.4 Metabolism
CHO cells grow aerobically on the common main substrates glucose and glutamine which are
fueled into Emden-Meyerhof-Parnas pathway of glycolysis and tricarboxylic acid cycle (TCA),
respectively (Fig. 2.3). In conjunctionwith further catabolic pathways, e. g. pentose-phosphate path-
way, anaplerotic pathways, oxidative phosphorylation and β-oxidation, glycolysis and TCA provide
12 precursormetabolites: glucose-6-phosphate, fructose-6-phosphate, glyceraldehyde-3-phosphate,
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3-phosphoglycerate, phosphoenolpyruvate, pyruvate, ribose-5-phosphate, erythrose-4-phosphate,
acetyl-CoA, α-ketoglutarate, succinyl-CoA and oxaloacetate. Precursor metabolites serve as
substrates for biosynthesis of e. g. nucleotides and amino acids which are essential building blocks
for the synthesis ofmacromolecules (e. g. proteins,DNA,RNA). (Nielsenand Jewett, 2008; Seth et al.,
2006)
Central CarbonMetabolism
Glucose uptake is based on facilitated diffusion via glucose transporter 1 (GLUT1)which is also known
as solute carrier family 2 member 1 (SLC2A1) (Baldwin, 1993; Mulukutla et al., 2010). Cellular uptake
of glutamine ismediatedby two types of transporters: alanine serine cysteine transporter (ASCT, SLC1
genefamily)andsodium-coupledneutralaminoacid transporter (SNAT,SLC38genefamily) (Shotwell
et al., 1981; Zander et al., 2015). SNAT2 is a symporter and transports glutamine together with one
sodium ion (Na+) whereas ASCT1 and 2 are amino acid antiporters. Glutamine andNa+ are imported
in exchange for a cytosolic amino acid (Shotwell et al., 1981; Zander et al., 2015). In mitochondria,
glutamine is deamidated by glutaminase to form glutamate which in turn is converted to
α-ketoglutaratebyeither oxidativedeamination (glutamatedehydrogenase) or transaminationwith
oxaloacetate (glutamic-oxaloacetic transaminase) (Lane and Fan, 2015). α-ketoglutarate is fueled
into TCA cycle and converted tomalate. Oxidative decarboxylation ofmalate to form pyruvatemight
occur in combination with the previous α-ketoglutarate formation by oxidative deamination of
glutamate (Glacken, 1988). Thereby pyruvate can either be converted to lactate or refueled into TCA
cycle via acetyl-CoA. Themetabolization of glutamine is defined as "glutaminolysis" (Glacken, 1988).
Cytosolic glucose is phosphorylated by hexokinase and resulting glucose-6-phosphate is either
metabolized in Embden-Meyerhof-Parnas pathwayof glycolysis or in pentose-phosphatepathway. In
glycolysis (Fig.2.3), glucose-6-phosphate is isomerizedtofructose-6-phosphate (glucose-6-phosphate
isomerase)which is subsequentlyphosphorylated(phosphofructokinase). Fructose-1,6-bisphosphate
is then cleaved (aldolase) to produce the triose phosphate isomers glyceraldehyde-3-phosphate and
dihydroxyacetone-phosphatewhich can be interconverted by triose phosphate isomerase.
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Figure 2.3: Central carbon metabolism of CHO cells. CHO cells grow on glucose and glutamine
which are fueled into Emden-Meyerhof-Parnas pathway of glycolysis and tricarboxylic acid
cycle (TCA), respectively. Exchange of metabolites between cytosol and mitochondrial matrix or
cytosol and extracellular matrix requires specific transporters. Grey shaded ellipses symbolize the
gene names of corresponding enzymes for each reaction. CoA = coenzyme A, P = (ortho)phosphate.
HK: hexokinase, GPI: glucose-6-phosphate isomerase, PFK: phosphofructokinase, ALDO: aldolase,
GAPDH: glyceraldehyde-3-phosphate dehydrogenase, PGK: phosphoglycerate kinase, PGAM: phospho-
glycerate mutase, ENO: enolase, PK: pyruvate kinase, LDH: lactate dehydrogenase, GLS: glutaminase,
GLUL: glutamate-ammonia ligase, GLUD: glutamate dehydrogenase, PDH: pyruvate dehydrogenase,DLAT: di-
hydrolipoamide S-acetyltransferase, CS: citrate synthase, ACO: aconitase, IDH: isocitrate dehydrogenase,
OGDH:α-ketoglutarate dehydrogenase, DLST: dihydrolipoamide S-succinyltransferase, SUCLG: succinate-CoA
ligase, SDH: succinate dehydrogenase, FH: fumarate hydratase, MDH: malate dehydrogenase ME: malic
enzyme. Withmodifications toMulukutla et al. (2012) and KEGG pathway cge00010.
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In the subsequent reactions of glycolysis, glyceraldehyde-3-phosphate is converted to pyruvate
and twomolecules of ATP are produced by substrate-level phosphorylation. Altogether themetabo-
lization of one glucosemolecule by glycolysis generates a net energy yield of two ATPmolecules and
leads to the reduction of onemolecule of NAD+ (oxidized nicotinamide adenine dinucleotide). (Berg
et al., 2003; Klempnauer et al., 2011)
A substantial amount of produced pyruvate is not transported into mitochondrial matrix for
further metabolization in TCA cycle but is instead converted to lactate, thereby regenerating NADH
(reduced nicotinamide adenine dinucleotide) to NAD+. This lactate formation is known as the
"Warburg Effect" and is part of "aerobic glycolysis". Cell cultures were shown to metabolize the
accumulated lactate after entering glucose and glutamine depletion. (Mulukutla et al., 2010; Seth
et al., 2006; Vander Heiden et al., 2009)
Nevertheless, pyruvate is primarily metabolized in TCA cycle (Fig. 2.3) and therefore mitochon-
drial pyruvate uptake ismediated by a heterodimer ofmitochondrial pyruvate carriers (MPC1/MPC2)
(Bricker et al., 2012). Pyruvate dehydrogenase and dihydrolipoamide S-acetyltransferase mediate
oxidative decarboxylation of pyruvate and thus acetyl-CoA formation. Thereafter citrate synthase
uses thesubstratesoxaloacetateandacetyl-CoAfor citrate formation. Aconitase isomerizes citratevia
cis-aconitate to isocitrate. Two subsequent oxidative decarboxylation steps convert citrate to
α-ketoglutarate (isocitrate dehydrogenase) and then to succinyl-CoA (α-ketoglutarate dehydro-
genase, dihydrolipoamide S-succinyltransferase). α-ketoglutarate is the entry point for metaboli-
zation of glutamine by TCA cycle. Succinate-CoA ligase cleaves the energy-rich thioester bond of
succinyl-CoA, thus phosphorylating guanine diphosphate (GDP) to form the energy-rich guanine
triphosphate (GTP). Succinate is oxidized by succinate dehydrogenase to form fumarate which is
subsequently hydrated by fumarate hydratase to form malate. Oxaloacetate is finally regenerated
by oxidation ofmalate (malate dehydrogenase). (Berg et al., 2003; Klempnauer et al., 2011)
Altogether one round of TCA cycle generates one molecule of GTP, two molecules of carbon
dioxide (CO2) and reduces three molecules of NAD+ to NADH during oxidation and oxidative
decarboxylation steps. In addition, one molecule of FAD (oxidized flavin adenine dinucleotide) is
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reduced (FADH2) during oxidation of succinate to form fumarate. The acetyl-CoA formation by
oxidative decarboxylation of pyruvate, upstream of TCA cycle, generates another NADH and CO2
molecule. (Berg et al., 2003; Klempnauer et al., 2011)
Electron Transport Chain andOxidative Phosphorylation
The regeneration of reducing equivalents NADH and FADH2 to NAD+ and FAD is a function of the
electron-transport chain which is coupled to oxidative phosphorylation. The transfer of cytosolic
NADH to mitochondrial matrix is mediated by the glycerol 3-phosphate shuttle and the malate-
aspartate shuttle (Mulukutla et al., 2010; Passarella et al., 2003). The interaction of five complexes
of the IMM (NADHdehydrogenase, succinate dehydrogenase, cytochrome bc1 complex, cytochrome
c oxidase andATP synthase)mediates regeneration of reducing equivalents, reduction of oxygen and
ATP-synthesis (Fig. 2.4).
NADH binds to NADH dehydrogenase (complex I) and is regenerated to NAD+, thereby trans-
ferring two electrons via the prosthetic groups flavin mononucleotide and iron-sulfur cluster to the
hydrophobic molecule ubiquinone (UQ). Likewise complex II bound FADH2 transfers two electrons
via iron-sulfur complex to UQ, thus regenerating FAD. The reduced state of UQ takes up two protons
(H+) fromthemitochondrialmatrix to formubiquinol (UQH2). Dueto itshydrophobic characterUQH2
diffuses within the IMM to cytochrome bc1 complex (complex III). UQH2 binds to a distinct binding
site of complex III and transfers one of its two electrons via iron-sulfur cluster and cytochrome c1 to
oxidized cytochrome c. The other electron reduces a complex III bound UQmolecule to form a semi-
ubiquinone anion (UQ•-). This electron transfer is mediated by cytochrome b. The resulting UQ is
replaced by another UQH2 molecule which again transfers one electron to cytochrome c and one
electron to UQ•- to form UQH2 by uptake of two H+ from the mitochondrial matrix. During the re-
generation of NADH toNAD+ andUQH2 to UQ the releasedH+ are pumped into the IMS by complex
I and complex III, respectively. The electron transfer to UQ and via cytochrome c1 to cytochrome c in
combinationwith theH+ transport isdefinedas "Qcycle" (BrandtandTrumpower, 1994;Mitchell, 1975;
Trumpower, 1990).
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Figure 2.4: Electron-transport chain and oxidative phosphorylation. Complex I-IV build the electron trans-
port chain which finally reduces oxygen (O2) to water (H2O). Electrons from NADH (complex I) and FADH2
(complex II) are transferred to complex III via ubiquinone (UQ). Thus UQ is reduced to ubiquinol (UQH2).
UQH2 transfers electrons to cytochrome b (cyt b) and through cytochrome c1 (cyt c1) to cytochrome c (cyt c).
Cytochrome c oxidase oxidizes the reduced cyt c and reduces O2 to H2O. Electron transport leads to the
transfer of protons (H+) from mitochondrial matrix to IMS, thus forming a H+-gradient across the IMM. The
resulting protonmotive force is utilized for oxidative phosphorylation byATP synthase, thereby producingATP.
(Berg et al., 2003). Withmodifications to KEGG pathway cge00190.
Cytochrome c oxidase (complex IV) oxidizes cytochrome c molecules and transfers the released
electrons via complex bound copper ions (CuA/CuA, CuB) and heme groups (heme a, heme a3) to
oxygen to form water. Thereby two H+ per two oxidized cytochrome c molecules and one reduced
oxygenatom, respectively, are transported frommitochondrialmatrix to intermembranespace. (Berg
et al., 2003)
The H+-pumping function of complex I, III and IV was described to create a pH gradient and a
mitochondrial membrane potential, thus generating a proton motive force. According to the
"chemiosmotic theory" of Mitchell (1966), electron-transport chain and ATP synthesis are linked by
this proton-motive force: oxidative phosphorylation. (Berg et al., 2003; Nath and Villadsen, 2015)
Mitochondrial ATP synthase (complex V) catalyzes the phosphorylation of ADP to form ATP and
consists of the F0 domain (subunits: c-ring, a, b, d, f, A6L, F6 and oligomycin sensitivity-conferring
protein (OSCP)) which is located mainly in the inner mitochondrial membrane and the F1 domain
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(subunits: α, β, γ, δ, ) in the mitochondrial matrix. A hexameric ring of alternating α and β sub-
units in association with subunits a, b, d, F6 and OSCP build the so called "stator" of ATP synthase,
whereas the "rotor" is composed of c-ring, γ, δ and . H+ flux through subunit a and c-ring into the
mitochondrialmatrix induces rotation of theγ subunit, thus changing the conformations of catalytic
β sites of ATP synthesis. Rotation enables switching betweenADP and orthophosphate binding, ATP
synthesis and ATP release. (Berg et al., 2003; Jonckheere et al., 2012)
The coupling efficiency of electron-transport chain and oxidative phosphorylation is quantita-
tively described by the P/O ratio which defines the number of produced ATP molecules per reduced
oxygen atom (Hinkle, 2005). The P/O ratio varies depending on the type of regenerated reducing
equivalent. P/O ratios of 2.5 and 1.5 werementioned in literature for NADH and FADH2, respectively
(Hinkle, 2005; Nath and Villadsen, 2015;Wahl et al., 2008).
EnergyYield
CHO cells catabolize glucose in part to lactate via "aerobic glycolysis" and in part to CO2 via glycoly-
sis and TCA cycle. The energy yield of glucose metabolization to lactate is 2 ATP molecules whereas
a complete metabolization via TCA in combination with subsequent oxidative phosphorylation the-
oretically yields 36 ATP molecules (Berg et al., 2003; Klempnauer et al., 2011; Vander Heiden et al.,
2009). Glacken (1988) and Altamirano et al. (2013) described a theoretical energy yield of 24 - 27 ATP
molecules for complete oxidation of glutamine to carbon dioxide. This energy yield can be achieved
via oxidative deamination of glutamate toα-ketoglutarate, conversion ofα-ketoglutarate tomalate
in TCA, subsequent oxidative decarboxylation ofmalate to pyruvate and fueling of pyruvate into TCA
cycle via conversion to acetyl-CoA (Glacken, 1988). In contrast an energy yield of 9 ATP was stated if
pyruvatewas catabolized to lactateor for the transaminasemediatedmetabolizationof glutamineas
this pathway requires further TCA intermediates, e. g. oxaloacetate (Altamirano et al., 2013; Glacken,
1988).
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Biosynthesis of PurineNucleotides
Nucleotides of thepurinebases adenine (A) andguanine (G) arebuildingblocks ofDNAandRNAand
therefore substantial amounts of purine nucleotides are required during DNA replication and tran-
scription. Further, purine nucleoside triphosphates (ATP, GTP) are important cellular energy sources
with ATP being the most abundant form, even in its own de novo biosynthesis pathway (Fig. 2.5).
This elucidates the high energy requirement of the de novo purine nucleotide biosynthesis. Salvage
pathways provide an opportunity to avoid de novo synthesis by recycling of purine bases (Berg et al.,
2003). Adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase
catalyze the formation of adenine monophosphate and guanine monophosphate, respectively.
Enzymes catalyze the conversion of purine base and 5-phosphoribosyl-1-pyrophosphate to purine
nucleosidemonophosphate and pyrophosphate (Berg et al., 2003).
Figure 2.5: De novo biosynthesis of purine nucleotides. Grey shaded ellipses symbolize the gene names of
corresponding enzymes for each reaction. P = (ortho)phosphate, PP = pyrophosphate, THF = tetrahydrofolate.
G6PD: glucose-6-phosphate dehydrogenase, PGLS: 6-phosphogluconolactonase, PGD: phosphogluconate
dehydrogenase, RPIA: ribose 5-phosphate isomerase A, PRPS: phosphoribosyl pyrophosphate synthetase,
PPAT: phosphoribosyl pyrophosphate amidotransferase , GART: phosphoribosylglycinamide formyltrans-
ferase, PFAS: phosphoribosylformylglycinamidine synthase, PAICS: phosphoribosylaminoimidazole carboxy-
lase,ADSL: adenylosuccinate lyase ,ATIC: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase,
ADSS: adenylosuccinate synthase. Withmodifications to KEGG pathway cge00030 and cge00230.
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De novo biosynthesis of purine nucleotides is located in the cytosol and includes the synthesis of
ribose-5-phosphate, an important precursor of purine nucleotide synthesis, via pentose-phosphate
pathway. Glucose-6-phosphate is converted to ribulose-5-phosphate by the enzymes glucose-6-
phosphate dehydrogenase, 6-phosphogluconolactonase and phosphogluconate dehydrogenase.
Ribulose-5-phosphate is isomerizedtoribose-5-phosphatebyribose-5-phosphate isomeraseandsub-
sequentlyphosphorylatedbyphosphoribosylpyrophosphate synthetase to form5-phosphoribosyl-1-
pyrophosphate (PRPP). PRPP is a centralmetabolite of purinenucleotide synthesis as thepurinebase
ringstructure isgraduallyconstructeddirectlyonPRPP.Avarietyofenzymes (Fig.2.5)builtupthebase
ring structure and thereby convert PRPP to inosine monophosphate (IMP). The required
nitrogen atoms are provided by amino/amido groups of glutamine, glycine and aspartate while
10-formyl-tetrahydrofolate, glycine and CO2 provide carbon groups. Synthesis of AMP is
finallymediatedbyadenylosuccinatesynthaseandlyaseandrequiresGTPandaspartateassubstrates.
In subsequent reactions adenylate kinases can transfer phosphate groups fromATP to AMPandADP,
respectively. Altogether the de novo synthesis of AMP from glucose requires 7 molecules of ATP,
1 molecule of GTP, 2 molecules of oxidized nicotinamide adenine dinucleotide phosphate (NADP+)
and a variety of nitrogen and carbon donors. (Berg et al., 2003; Lane and Fan, 2015)
Regulation ofMetabolismbyAdenineNucleotides
Regulation at the level of enzymes is a common property of metabolic pathways. In this context,
adeninenucleotidesallostericallyactivate (AMP,ADP)or inhibit (ATP)avarietyofenzymesofcatabolic
pathways. Further, metabolic enzymes are inactivated by kinase mediated phosphorylation. There-
fore cellular ratiosof adeninenucleotides, e. g. ADP/ATP ratioorenergy charge, havean impacton the
metabolization of the main cellular substrates glucose and glutamine (Fig. 2.3). The glycolytic
enzymes phosphofructokinase (PFK) and pyruvate kinase (PK) are targets for allosteric inhibition by
ATP (Berg et al., 2003; Brüser et al., 2012; Fenton andHutchinson, 2009;Martínez-Costa et al., 2012).
In addition, highATP levels contribute inactivationofpyruvate kinasebyphosphorylation (Berg et al.,
26
2 Theoretical Background
2003; Fenton andHutchinson, 2009), whereas binding of AMP and ADP to allosteric sites stimulates
phosphofructokinase. High energy charges, which correspond to high ATP levels, induce phosphory-
lation of pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (OGDH), thereby
inactivating these enzymes of TCA cycle. The oxidative deamination of glutamate by glutamate de-
hydrogenase (GLUD) to formα-ketoglutarate is activated by high ADP levels and inactivated by high
ATP levels (Fang et al., 2002).
In addition to the regulatory effect on the catabolic pathways glycolysis and TCA cycle, adenine
nucleotide levels also influence their de novo biosynthesis pathway (Fig. 2.5). AMP, ADP and ATP are
feedback inhibitors of PRPP amidotransferase (PPAT), where AMP also inhibits the enzymes PRPP
synthetase (PRPS) and adenylosuccinate synthase (ADSS) (Lane and Fan, 2015; Van der Weyden and
Kelly, 1974;Wyngaarden, 1976).
AMP/ATP ratio is a trigger of the AMP-activated protein kinase (AMPK) mediated regulation of
catabolic and anabolic pathways (Carling, 2004; Corton et al., 1994; Mulukutla et al., 2010). AMPK,
which is also defined as energy sensor, is activated by allosterical binding of AMP and a subsequent
phosphorylation. High ATP levels hamper the binding of AMP to AMPK, thus inhibiting enzyme
activity (Carling, 2004). In its active state, AMPK inactivates ATP-consuming anabolic pathways,
stimulates ATP-producing catabolic pathways, e. g. by activation of glucose transporters, hexokinase
andphosphofructokinase 2, and induces p53-mediated cell cycle arrest (2.2) (Barnes et al., 2002; Car-
ling, 2004; Jones et al., 2005; Mulukutla et al., 2010). Stress conditions, e. g. heat shock, arsenite
treatment or sorbitol induced hyperosmolality, were shown to activate the AMPK cascade indepen-
dent from changes in AMP/ATP ratios (Carling, 2004; Corton et al., 1994; Fryer et al., 2002).
2.5 Industrial Relevance of CHOCells
Theapprovalofmorethan100biopharmaceuticalsproduced inCHOcells (ButlerandMeneses-Acosta,
2012) illustrates the industrial relevance of these cells asmammalian host cell lines.
27
2 Theoretical Background
Several important cellular characteristics benefited this trend. CHO cells have the ability to grow in
suspension in chemically defined culture medium without fetal calf serum reaching high cell den-
sities in large scale bioreactors of up tp 20,000 L (Birch and Racher, 2006; Chu and Robinson, 2001;
Jayapal et al., 2007; Kim et al., 2012; Li et al., 2010). In addition, suitable expression systems (2.5) are
available for insertionof thegeneof interest (GOI) into thehost cell genome, for cell line selectionand
for amplification of the inserted genes (2.5) (Jayapal et al., 2007; Kim et al., 2012;Wurm, 2004).
Since the approval of the first biotherapeutic product in 1986, CHO cells have proven to be safe hosts
showing high viral resistance and producing therapeutic proteins with low human immunogenicity
(Butler and Meneses-Acosta, 2012; Jayapal et al., 2007; Kim et al., 2012). The immunogenicity is
mediated by the post-translational modification (2.5) of a therapeutic protein. Therefore a low
immunogenicity represents a high similarity of the humanandCHOpost-translationalmodification.
This similarity is also responsible for thegoodbioactivityofCHOproducts for the treatmentofhuman
diseases.
The aforementioned characteristics contribute to the fact that CHO cells became the industry's
"mammalianworkhorse" (Jayapal et al., 2007; Kim et al., 2012).
Cell LineDevelopment
The biotechnological production of therapeutic proteins requires cell lines which stably express a
defined gene of interest (GOI) - the product. The development of such cell lines is a time consuming
process which can take more than six months (Jayapal et al., 2007). The use of a host cell line which
hadbeenpre-adapted to the later cultivationconditions, e. g. growth in suspension, reduced this time
span significantly (Birch and Racher, 2006). At first a CHOhost cell line is transfectedwith an expres-
sionvectorusingelectroporation, nucleofectionor lipofection (Jayapal et al., 2007; Lattenmayer et al.,
2007; Li et al., 2010).
Two common expression systems are described in CHO literature; the glutamine
synthetase (GS) and the DHFR expression system where the DHFR system is the one which is most
frequently used in CHO cell line development (Jayapal et al., 2007; Kim et al., 2012;Wurm, 2004).
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The DHFR expression vector (Fig. 2.6) usually contains genetic information for the replication of
the vector in bacteria (e. g. E. coli) and for the expression of the GOI in combination with DHFR as
selectionmarker forgeneamplification. Thevectormightaswell containasecondaryantibiotic selec-
tionmarker (e.g. aminoglycosidephosphotransferasegene,blasticidindeaminase,hydromycinphos-
photransferase) in order to facilitate clone selection (Jayapal et al., 2007; Li et al., 2010). The gene of
interest and the selection marker can be under the control of one promoter but usually their
expression is controlled by individual promoters. While strong viral promoters (e. g. from human
cytomegalovirus) are used to control the expression of the gene of interest, selection markers are
commonly under the control of weak promoters (e. g. SV40) (Birch and Racher, 2006; Boshart et al.,
1985).
Figure2.6:VectordesignforDHFR(dihydrofolatereductase)expressionsystem. ori =originof replication for
E. coli, selection markers represent genes mediating antibiotic resistance, poly(A) = 3’ poly-adenine tail. With
modifications to Jayapal et al. (2007)
The DHFR expression system is used in combination with DHFR deficient cell lines like CHO DXB11
and CHO DG44. Due to their deficiency of DHFR, the aforementioned cell lines are not able to syn-
thesize glycine, hypoxanthine and thymidine (2.1). This auxotrophy is utilized in the cell selection
process.
After transfection, the expression vector can enter the nucleus of the host cell line and random
integration of the genetic information into the host cell genome might occur. In a subsequent
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selection step transfected cells are grown in the presence of low concentrations of the folic acid
analogmethotrexate (MTX)which competitively inhibits DHFR (Jayapal et al., 2007). In addition the
cultivation medium is free of glycine, hypoxanthine and thymidine thereby selecting for cells show-
ing stable expression of DHFR due to vector integration. The surviving cells of the previous selection
step are exposed to high concentrations of MTX and have to adapt to this intense selection pressure
in order to survive. The cells most likely cope with this situation by amplifying the integration site of
theDHFRgeneorbygenomic rearrangements. Thegeneof interest is supposed tobe simultaneously
amplified with the DHFR gene so that the amplification step results in cell clones often containing
several hundreds of gene copies (Jayapal et al., 2007).
The resulting cell pool is screened for clones with high growth rate (µ), qP and product quality.
Pre-cultures of the resulting clones (∼ 10 -30) are generated during several passages of cultivation
and are finally used as inoculum for scale-down processes of the final industrial production process.
The cell clone showing the best performance under this culture conditions is chosen for the gener-
ation of a cell bank of cryo cultures (Jayapal et al., 2007). The cell line development with the GS ex-
pression system proceeds in accordance to the previously described steps for the DHFR expression
system. In contrast to the DHFR system, the GS expression vector contains DNA encoding for
glutamine synthetase instead ofDHFR. GS synthesizes glutamine fromglutamate and ammonia and
enables cell lineswhichare auxotrophic for glutamine to survive inglutamine-freemedium. CHOcell
lines commonly require a glutamine supplemented cultivationmediumdue to their lowendogenous
GS activity but GS-knockout CHO cell lines are utilized as well. Cells transfectedwith a GS expression
vector can integrate the GS gene into their genome andmay overcome this auxotrophy. Methionine
sulphoximine (MSX), a competitive inhibitor of GS, can be applied to enforce the selection pressure.
Selection and amplification step are therefore performed in glutamine-free cultivationmedium sup-
plementedwith low or high concentrations ofMSX.
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Post-translationalModification
Several therapeuticproteinspossesspost-translationalmodifications (PTM,e.g. glycosylation)which
are necessary for their bioactivity. A high similarity between the PTM pattern of biotechnologically
produced therapeutics and thepatternof theorganismundergoingmedical treatment (e. g. humans)
is important for ahighbioactivity anda low immunogenicity. ThereforePTMisan importantproperty
of product quality.
The PTM of a therapeutic protein depends on the post-translational machinery of the host cell
line. CHO cells have a highly similar post-translational machinery compared to humans and thus
synthesize therapeutically applicable products (Butler and Meneses-Acosta, 2012; Walsh, 2010a,b).
Butler and Meneses-Acosta (2012) mentioned that ∼ 99% of the genes encoding glycosylating
enzymes in the human genome had a CHO homolog. Böhm et al. (2015) analyzed the impact of the
type of mammalian host cell line (BHK, CHO, HEK293) on qP, cP and the glycosylation pattern. In
conclusion, CHO cells were shown to own the best properties in terms of formation, stability and
bioactivity of the product.
The main types of PTMs associated with therapeutic proteins are amidation, sulfation, disulfide
bond formation, γ-carboxylation, β-hydroxylation and glycosylation (Walsh, 2010b; Walsh and Jef-
feris, 2006). Disulfide bond formation affects the folding process and therefore the tertiary and
quaternary structure of proteins. This folding process is located in the endoplasmic reticulum (ER)
where covalent linkages between inter- or intramolecular cysteine residues of proteins are favored
due to oxidizing conditions (Feige andHendershot, 2011;Wittrup, 1995). This process ismediated by
disulfide isomerases whereby a subsequent quality control mechanism in the ER ensures that only
correctly folded proteins are passed on in the secretory pathway. Human IgG1 antibodies are exam-
ples for proteins requiring disulfide bond formation for a proper folding (Fig. 2.7).
Another important PTM of antibodies (Fig. 2.7) is glycosylation and in general it is the most
complex and with∼ 40% of all approved biopharmaceutical products being glycosylated the most
abundant type of PTM (Walsh, 2010a,b). Walsh (2010b) summarized cell- and protein-specific
processes that were described to be affected by glycosylation. This involved serum half-life, folding,
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targeting/trafficking and the stability and bioactivity of a protein. Two types of glycosylation are
described in literature, O-linked and N-linked glycosylation. The O-linked glycosylation defines the
attachment of a glycan structure to a protein's serine or threonine residue via the oxygen atom. This
type of glycosylation occurs either in the ER or the Golgi and requires no consensus sequence. The
more abundant N-linked glycosylation is located in the ER where an oligosaccharide is transferred
from the donor molecule dolichol phosphate to an asparagine residue of a protein via the nitrogen
atom (Fig. 2.8). The consensus sequence Asn-X-Ser/Thr, where X can be any amino acid but proline,
determines the asparagine residues that can functionas glycan recipients (Hossler et al., 2009;Walsh
and Jefferis, 2006).
Figure 2.7: Structure of a human IgG1 antibody. White = domains of immunoglobulin heavy chain (H),
grey = domains of immunoglobulin light chain (L), C = constant region, V = variable region, star = Fc-terminal
glycosylation at asparagine residue 297 (Asn297). The antibody consists of two heavy and two light chains and
is divided in twoFabandone Fc region. A flexible linker connects the Fc regionwith the twoFab regions (hinge).
The heavy chains are covalently linked by disulfide bonds. The constant domains of a Fab region are also con-
nected by a disulfide bond. The antigen binding site is formed by the Fab domains VH and VL.WithModifica-
tions toNatsume et al. (2009).
IgGantibodies arebuilt upby two identical heavy and two identical light chains forming twoanti-
genbinding fragments (Fab) anda Fcmoiety for the inductionof effectormechanisms, e .g. antibody-
dependent cellular cytotoxicity (ADCC), phagocytosis or complement-dependent cellular cytotoxicity
(Fig. 2.7) (Walshand Jefferis, 2006). TheFc regionpossesses conservedsites forN-linkedglycosylation
at asparagine residue 297 (Asn297) of each heavy chain (Fig. 2.7). Fab regions show as well N-linked
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glycosylation but in a non-conserved manner and with a low frequency of∼ 15 - 20% (Dwek et al.,
1995;Mimura et al., 2007).
Figure 2.8: Glycosylation of proteins in the endoplasmic reticulum and the Golgi network. An Oligosac-
charyltransferase transfers a glycan structure from the donor dolichol phosphate (Dol-P-P) to an asparagine
residue of a protein via the nitrogen atom. Therefore this type of glycosylation is called N-linked
glycosylation. Glucosidases and α-mannosidases (α-Man) trim the glycan structure in the ER thereby remov-
ing glucose and mannose molecules. The resulting glycoprotein (type mannose-5) is transported to the Golgi
network where the glycan structure can be further modified by the enzymes galactosyl-, sialyl-, fucosyl- and
mannosyl-glycoprotein N-acetylglucosaminyltransferase. Examples for the different types of N-linked glycan
structures (complex, hybrid, high mannose) are shown. All glycan structures possess a pentasaccharide core
structure (GlcNAc2Man3). Withmodifications toHossler et al. (2009).
The N-linked glycosylation of proteins is located in the ER and is followed by themodification of
theglycanstructurebygalactosyl-, sialyl-, fucosyl-andmannosyl-glycoproteinN-acetylglucosaminyl-
transferases in the Golgi network. The modification of glycan structures leads to the formation of
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representative typesofN-linkedglycosylation-highmannose,hybridandcomplextype(Hossleretal.,
2009). A pentasaccharide core structure (GlcNAc2Man3) is specific for all types of N-linked
glycosylation. The conserved N-linked glycan structures of IgG antibodies are assigned to the
complex diantennary type (Fig. 2.7) (Dwek et al., 1995; Jefferis, 2009;Walsh and Jefferis, 2006).
Culture conditions, e. g. temperature, dissolved oxygen (DO) level and/or composition of cultivation
media, can cause alterations of the glycan structure (2.6). In the field of glycoengineering, targeted
modifications of the glycan structure are utilized for the improvement of antibody properties, e. g.
bioactivity or half-life (Ceaglio et al., 2008; Elliott et al., 2003).
Cell Culture Processes
Thebiotech industry utilizes recombinant cell lines as "cell factories" for theproductionof therapeutic
proteins. The manufacturing process of these biotherapeutics is subdivided into the main sectors
upstream processing and downstream processing. While the focus of downstream processing is
placed on the isolation, purification and sometimes modification of the biotechnological product,
upstreamprocessing ismorediversified (Butler andMeneses-Acosta, 2012;Walsh, 2010b). It includes
thedevelopmentof cell lines (2.5),mediaandprocess strategies, the realizationof the final cultivation
process and the separation of the cells from the cultivation medium. Therefore various possibilities
for the improvement of specific product formation rates and product titers are available but likewise
complicate an optimization in the sector of upstreamprocessing.
Important issues of upstreamprocessing are summarized in the following sections.
Cell Growth
All cell culture processes are based on a tremendous amount of viable cells. This biomass is
generated from a cryo culture and scaled-up during a series of bioreactor processes defined as "seed
train" and "inoculum train" (Li et al., 2010). The knowledge of the different phases of cell growth
(Fig. 2.9) occurring during a bioprocess is essential for the production of large amounts of viable,
metabolically active cells as inoculum for the production of therapeutic proteins.
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Figure2.9:Phasesof cell growthduringabatch cultivation. 1: during "lagphase" cells showalmost nogrowth
as theyadapt tonewcultureconditionsafterbeing inoculated into freshmedium,2: in "accelerationphase" cells
start growingwith a steadily increasing growth rate, 3: amaximal and constant growth rate is characteristic for
cells in the "exponential growth phase", 4: substrate limitation in "decelerating phase" causes a decline of cell
growth, 5: no cell growth occurs in "stationary phase" due to complete substrate consumption, 6: in "declining
phase" substrate deficiency hampersmaintenance of important cellular functions and causes cell death. With
modifications to Katoh et al. (2015)
Each bioprocess starts with the inoculation of cells into fresh cultivation medium. Commonly,
cells requirechanges ingene/proteinexpression inorder toadapt tothenewcultureconditions. There-
fore they show almost no growth in this so called "lag phase" whose length depends for example on
the type andnumber of the inoculated cells and the culture conditions. In the following "acceleration
phase" cells start growing with a steadily increasing growth rate (µ) until they enter the
"exponential growth phase" where cell growth is constant and maximal (µmax). Cell growth
subsequently declines ("deceleration phase") due to limitation of substrate (e. g. glucose (Glc),
glutamine (Gln)) and stopswhen substrate is completely consumed in the "stationary phase". Finally,
substrate deficiency hampers themaintenance of important cellular functions and causes cell death
("declining phase"). (Katoh et al., 2015)
ProcessModes
Most mammalian production processes are either performed in fed batch or perfusion mode
(Fig. 2.10). The simplest form of cultivation is a batch process where cells are inoculated into fresh
medium and incubatedwithout furthermanipulation (Fig. 2.10-A). Therefore batch cultures contain
relativelyhighsubstrateconcentrations (e.g. cGlc, cGln)at thebeginningof thecultivation(cS,0), thereby
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facilitatingtheproductionofby-products. Accumulationof thecommonby-products lactate (Lac)and
ammonium (NH4+) was shown to be linked to inhibition of cell growth and impaired qP and product
quality (Lao and Toth, 1997; Yang and Butler, 2002). Despite the relatively high substrate level, high
cell densities and product titers are hampered by substrate limitation occurring during the time of
batch cultivation (Wlaschin and Hu, 2006). Lower cS,0 in combination with the supply of substrates
as required, limits the formation of by-products and prevents substrate limitations. This is realized in
fed batch and perfusion mode thereby enabling high cell densities (> 107 cells mL-1) and high prod-
uct titers (Howaldt et al., 2011; Wlaschin and Hu, 2006). A fed batch process is based on a batch
process with low cS,0. Cells are grown without further manipulation until substrate concentrations
approach limitation, thus thesupplyofconcentratedsubstratesolutions (feeding) is started (Fig.2.10-
B) (Wlaschin andHu, 2006).
Inorder topreventby-product formation, theavailability of the substrates glucose andglutamine
is limited by controlled feeding strategies. The simple periodic feeding strategy is based on the
addition of concentrated substrate solutions once or twice a day. The required volume for each
interval can be calculated according to cGlc and cGln in the bioreactor and the cell specific
consumption of thesemetabolites. Although final substrate concentrations commonly show a wide
range of variety, the simplicity of periodic feeding is still the reason for its application in large scale
production (Li et al., 2010). A more precise adjustment of the availability of substrates can be real-
izedby continuous feeding. Thereby feeding is executed as a function of an on-linemeasuredprocess
parameter (e. g. cGlc, oxygen uptake rate) (Wlaschin andHu, 2006).
The performance of a fed batch process relies not only on the feeding strategy but as well on the
compositionof the feed solution. A commonapproach for thepreparationof feed solutions is touse a
10- to 15-fold concentrated versionof the cultivationmedium (Li et al., 2010;Wlaschin andHu, 2006).
As this most likely leads to a surplus (e. g. inorganic ions) or limitation (e. g. Mg2+ and vitamins) of
certain nutrients, special feeding solutions are developed. Another important aspect of feed solution
design is to reduce the feeding-mediated increase in culture osmolality as high osmotic conditions
inhibit cell growth (> 350mOsmol kg-1) or even cause cell death (> 450mOsmol kg-1) (Han et al., 2010;
Kim and Lee, 2002; Lee et al., 2003a; Ryu et al., 2000; Shen et al., 2010).
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Figure 2.10: Bioreactor setups for batch (A), fed batch (B) and perfusionmode (C). Bioreactors are agitated
(M), aerated (FIRC) and possess control modules for the adjustment of temperature (TIRC), pH and dissolved
oxygen (DO). In batchmode (A), cells are inoculated into cultivationmediumand incubated at defined growth
conditionswithout furthermanipulations. A fedbatchprocess (B) is anextension to thebatchmodewhere con-
centrated nutrient solutions (feed) are added during the time of cultivation. Thus the accumulation of growth
inhibiting amounts of by-products (e. g. ammonium, lactate) is limited. In perfusion mode (C) the system is
suppliedwith concentrated nutrient solutionswhile an equal volume of cell suspension is withdrawn from the
bioreactor (V = constant). Cells are subsequently separated from the cultivation broth (harvest) by an exter-
nal cell retention device and are finally returned into the bioreactor. V = working volume of the bioreactor [L],
Fin = influx [L h-1], Fout = efflux [L h-1], const. = constant. (Birch and Racher, 2006; Howaldt et al., 2011)
Continuous cultivations are characterized by withdrawal of the same amount of cell suspension
as added by feeding. Thereby the equal influx and efflux lead to a constant working volume in the
bioreactor. Perfusionmode (Fig. 2.10-C) is a special form of continuous cultivation where cells of the
withdrawn cell suspension are aseptically separated from the culture broth and are returned into the
bioreactor. Thus veryhigh cell densities (¥ 108 cellsmL-1) canbeachievedunderdefinedand constant
culture conditions. The steady replacement of cell suspension by freshmediumprovides appropriate
conditions for high µ , qP and product quality by preventing the accumulation of by-products.
A variety of cell retention systems, namely spin filters, centrifuges, alternating tangential filter
systems (ATF), hydroclones and acoustic or gravity settlers, has been described in literature
(Voisardetal., 2003;WarnockandAl-Rubeai, 2006). The retentionof cells is eitherbasedon filtration,
sedimentation or centrifugation and therefore cell size and density are important criteria for cell
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separation. All of these systems, except spin filters, can only be used as external systems so that cells
reside outside the bioreactor for a certain amount of time. Ideal cell retention devices show high
perfusion rates (in L d-1), high retention efficiencies, low residence times outside the bioreactor and a
high robustness. In general, perfusionmode enables the cultivation of cells at defined and constant
conditions for several months. Therefore the long-term stability of cell lines regarding µ and qP is of
utmost importance. Spin filters, centrifuges, gravity settlers and ATF are commonly applied for large
scale biomanufacturing ofmAbs, enzymes and blood factors (Ozturk, 2015).
In conclusion, fed batch mode is the most frequently used process strategy for industrial
production as it yields high product titers, shows high robustness in large scale and as less time is re-
quired for process development and validation compared to perfusion mode (Howaldt et al., 2011).
However, perfusion mode is utilized for the production of some biopharmaceuticals, e. g. for the
rather instable blood coagulation factor VIII (Chu and Robinson, 2001; Howaldt et al., 2011).
ProcessDevelopment
Process performance, in terms of cell growth, product formation and product quality, relies not only
on the selected cell line but as well on culture conditions (Fig. 2.11). These depend on process mode,
compositionofmediaandonoperatingparameters (e.g. pH,agitation (N), temperature (T),dissolved
oxygen (DO)). The synergy of this operational properties is investigated during process development
in order to identify a process strategy that provides appropriate culture conditions for a selected cell
line. Since 2009 the application of the quality by design (QbD) approach has been recommended
for process development by the EMA and the FDA. The major purpose of this approach is the com-
prehensive understanding of biotechnological production processes and the identification of critical
parameters and sources of variation in order to ensure that therapeutic products consistently meet
predefined quality standards (EMA, Gronemeyer et al. (2014)). A multidimensional "design space"
finally specifies the limits that a process must observe (Howaldt et al., 2011). The required
experiments for process analysis are frequently planned on basis of the design of experiments (DOE)
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approach (Castro et al., 1992; Fisher, 1935; Gronemeyer et al., 2014; Hammett et al., 2007; Horvath
et al., 2010; Legmann et al., 2009; Li et al., 2010). Thus the number of experiments is reduced to an
essential minimum and the financial burden and duration can be decreased as well. QbD is highly
connected with Process Analytical Technology (PAT), an FDA initiative for the implementation of
modern measurement devices with the objective of a better understanding of the influence of
process parameters on product quality (Gnoth et al., 2007). PAT and QbD often apply multivariate
data analysis (e. g. principle component analysis) for investigating the synergy of operational
properties and the effect on product quality (Gnoth et al., 2007; Horvath et al., 2010; Schaub et al.,
2012).
Figure 2.11: Correlation between operating parameters and process performance. DO = dissolved oxygen,
pCO2 = dissolved carbon dioxide level. Withmodifications to Li et al. (2010).
Stirred tank bioreactors (STRs) aremost frequently applied during large scale biomanufacturing
(1,000 - 20,000 L) and process development (Birch and Racher, 2006; Chu and Robinson, 2001; Li
et al., 2010; Wurm, 2004). Usually STRs are equipped with sensors and devices that allow
39
2 Theoretical Background
measurement and adjustment of pH, T, N and DO. This enables a high grade of experimental
reproducibility which is important during process optimization. Microscale (10 - 15 mL), benchtop
scale (1 - 5 L) and pilot scale (80 - 100 L) STRs are standard cultivation vessels for industrial process
development. Due to the low amount of required resources,microscale bioreactors are often utilized
forscreeningexperimentsduringdevelopmentofcultivationmediaandparameter testing(Chenetal.,
2009; Janakiraman et al., 2015; Legmann et al., 2009). Janakiraman et al. (2015) described a high
consistencybetweenthe resultsof themicroscaleambr15TM systemandbenchtopscaleSTRsandeven
claimed that microscale STRs might replace benchtop scale STRs as traditional scale-down models.
But at the moment the main experiments during process development are still performed in 1 - 2 L
STRs (Li et al., 2010;Wurm,2004). Pilot scale STRs are commonly applied at late stage inorder to vali-
date the developed process strategy at a larger scale and to provide higher quantities of cell
suspension for the optimization of downstreamprocesses.
Process development involves the optimization of operational properties that can in part be ad-
justed by specific control strategies during cultivation (Fig. 2.11). Common parameter set points for
mammalian cell cultures are a culture osmolality of 270 - 330 mOsmol kg-1, T = 37°C, 20 - 50% DO
and pH 7.0. Most cell culturemedia are based on the bicarbonate buffering system and therefore pH
can be reduced by carbon dioxide (CO2) sparging while pH is increased by base titration. STRs are
equipped with cooling devices which are utilized for temperature control. DO depends on agitation,
the typeof aeration, gas flow rateand the compositionofgas. Usually the typeof aerationandstirring
device has been predetermined in accordance with the equipment of themanufacturing STRs and is
therefore not changed during process development. Gas mixing modules enable the possibility to
mix air, O2, N2 and CO2 as required during a cultivation process. (Li et al., 2010)
Control strategies do not only regulate the targeted parameter but also influence other opera-
tionalproperties. Osmolalitymainlydependsontheosmolalityof cultivationmediumbut it isusually
increasedbybase titrationand theadditionof feedsolutions in fedbatchmode. ADOcontrol strategy
that involves changes in agitation speed will most likely influence the mixing of cell culture, bubble
size and shear forces while changes in gas flow rate and composition affect the dissolved CO2 level
(pCO2). In addition, pCO2 is influenced by pH control as CO2 sparging and base titration influence the
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balance between dissolved CO2 and bicarbonate (HCO3-). The solubility of gasses, e. g. O2, CO2, is
further increased by decreasing culture temperature and increasing pressure in the STR.
Asprocess strategiesaredeveloped for largescaleSTRs, typical scale-upcriteriahave tobeconsidered.
Volume-independent operating parameters (e. g. DO, T, pH) can be maintained whereas volume-
dependent parameters (e. g. agitation, aeration, feed volume) need to be scaled up (Li et al., 2010).
Workingvolumeand feedvolumecanproportionallybe increasedbutdue todifferences inbioreactor
setup (e. g. geometry, control capability, volume to surface ratio) this is not suitable for agitation and
aeration. The intensity of shear forces and the accumulation of pCO2would significantly be increased
by a linear scale-up of agitation speed and gas flow rate, thus causing cell disruption and inhibition
of cell growth and product formation (DeZengotita et al., 2002; Kimura andMiller, 1996; Lara et al.,
2006; Zhu et al., 2005). Commonly applied scale-up criteria for agitation and aeration are a sufficient
oxygensupply,mixingof cultureandstrippingofCO2. The resulting cell compatible volumetricpower
inputsareusually lowand interferewithhomogeneousmixingof the cell suspension. Local variations
of process parameters, e. g. pH, osmolality, pCO2 andT, are therefore commonproperties of large scale
cell culture processes (Fig 3.1) andwere described to influence the cellular performance (2.6).
2.6 Hyperosmolality
The separation of two solutionswith different solute concentrations by a semipermeablemembrane
activates a process called osmosis. While solvent molecules are able to pass the semipermeable
membrane, solutemolecules are not. The differences in solute concentration cause a flow of solvent
molecules across the semipermeable membrane. Although solvent molecules can pass the mem-
brane in both directions, the flow rate from the less concentrated solution to the higher concentrated
solution is significantly higher. This compensation process causes an increase in pressure on the side
of the originally higher concentrated solution. A characteristic property in this context is the osmotic
pressure which defines the pressure that would be required in order to stop the solvent flow across
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the semipermeablemembrane. (Florence and Attwood, 2016;Mortimer andMüller, 2003)
In 1887 Jacobus van't Hoff claimed that molecules of an ideal dilute solution behaved like the
molecules of an ideal gas in a defined space (Mortimer and Müller, 2003). Therefore the van't Hoff
equation for osmotic pressure of ideal dilute solutions equals the gas law,
pi  csolute,i  R T (2.1)
wherepi is theosmoticpressure, csolute,i represents themolal concentrationof solute i, R is the ideal
gas constant and T the absolute temperature (Florence and Attwood, 2016; Mortimer and Müller,
2003). Eq.2.1 was extended by factor ν and ω in order to consider the fact that solutions are com-
monly non ideal andmay containmolecules that ionizewhen dissolved. In this context,ω represents
the osmotic coefficient and ν the number of ions (e. g. ν = 2 for NaCl). (Florence and Attwood, 2016)
pi  ωi  νi  csolute,i  R T (2.2)
The osmolality of a solution is defined as themass of osmotically active particles in 1 kg of water
andhas the correspondingunitmilliosmoleper kg (mOsmolkg-1) (Costanzo, 2014). Eq. 2.3 shows that
osmolality equals the ratio of the osmotic pressure of a solution and the osmotic pressure of a 1molal
ideal unionized solutionwith νideal  ωideal  1 (Florence and Attwood, 2016).
ξ 
pi
piideal

ωi  νi  csolute,i  R T
ωideal  νideal  csolute,ideal  R T
 ωi  νi  csolute,i (2.3)
As cellmembranespossess semipermeableproperties, osmosis canoccurbetweenthecultivation
medium and cytoplasm (Mortimer andMüller, 2003). An important aspect in this context is the dif-
ference in osmolality of cultivationmediumand cytoplasmbecause this triggers osmosis. Cultivation
mediawith similar osmolality (isotonic) as the cytoplasm (∼29020mOsmol kg-1 ) prevent osmosis
whereas cells exposed to cultivationmedia with significantly higher osmolality (hyperosmotic) have
to copewith this phenomenon (Costanzo, 2014; Kiehl et al., 2011; Mortimer andMüller, 2003).
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Cellular ResponseUponHyperosmotic Culture Conditions
In general, independent osmolality studies investigated the cellular response in a range of approxi-
mately 290 - 610mOsmol kg-1. Significant effects were commonly described above 350mOsmol kg-1
which can be defined as the osmolality level where hyperosmotic stress begins. Characteristic
phenomena of hyperosmotic conditions are a dose-dependent decrease in µ and themaximal viable
cell density (DeZengotita et al., 2002;Han et al., 2010; Kiehl et al., 2011; Kimand Lee, 2002; Lee et al.,
2003a; Ryu et al., 2000, 2001; Shen et al., 2010; Zhang et al., 2010; Zhu et al., 2005). This inhibition
of cell growth was shown to be associated with DNA damage, thus inducing cell cycle arrest or even
apoptosis (Cherlet andMarc, 1999; Han et al., 2010; Kim and Lee, 2002; Ryu et al., 2001). Specifically,
p53-mediated arrest of CHO, murine hybridoma and renal inner medullary cells in G1-phase of cell
cycle (Cherlet andMarc, 1999;Dmitrieva et al., 2001; Ryu et al., 2001) and arrest ofmurine hybridoma
in S-phase (Sun et al., 2004) were described in literature. Hyperosmolality studies of Kim and Lee
(2002) and Han et al. (2010) revealed that osmolalities ∼ 500 mOsmol kg-1 or higher activate
caspase-3 and -7, thus mediating apoptosis (2.3) including fragmentation of chromosomal DNA via
the caspase cascade.
Analysis of the cell metabolism of hyperosmotically stressed CHO cells highlighted an enhanced
metabolic activity(Ryu et al., 2000; Shen et al., 2010; Zhu et al., 2005). In concurrencewith increased
consumption ofmetabolites andproduction of by-products, hyperosmotically stressed antibody pro-
ducing CHO cells showed a dose-dependent increase in qP (Kiehl et al., 2011; Kim and Lee, 2002; Lee
et al., 2003a; Ryu et al., 2000, 2001; Shen et al., 2010). However, the combination of cell growth inhi-
bition and increased qP commonly hampered a significant enhancement of final cP (Han et al., 2010;
Kiehletal., 2011;KimandLee,2002;Leeetal., 2003a;Ryuetal., 2000;Shenetal., 2010). The influence
of hyperosmotic culture conditions on product quality is another important aspect as
variations inPTMmaycausee. g. decreaseofbioactivity or increaseof immunogenicity (Hossler et al.,
2009; Pacis et al., 2011;Walsh, 2010b). Pacis et al. (2011) revealed an increased number of antibodies
withmannose-5 glycoform (2.8) at hyperosmotic culture conditionswhich is unusual for human IgGs.
Therefore hyperosmolalitymay negatively affect the functional properties of the producedmAbs.
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Cultivation of CHO cells in hyperosmotic cultivation medium exposes the cells to the process of
osmosis. Kiehl et al. (2011) described a rapid and dose-dependent decrease in cell size of IgG
producing CHO cells followed by an increase in cell size above the initial. This phenomenon had
already been described and reviewed for other mammalian cells, thereby exhibiting that efflux of
water resulted in a decrease in cell size within minutes whereas a long-term process called regula-
tory volume increase (RVI) caused the subsequent increase in cell size (Alfieri and Petronini, 2007;
Burg et al., 2007; Kiehl et al., 2011; Lang et al., 1998). Ion transporters in the cytoplasmic membrane,
e. g. sodium (Na+)/hydrogen (H+) exchanger, chloride (Cl-)/hydrogen carbonate (HCO3-) exchanger
andNa+-potassium (K+)-2Cl- co-transporter, enable an accumulation of Na+, K+ and Cl- in the cytosol
in combination with an influx of water, thus causing RVI. The resulting increased intracellular ionic
strength is then compensated by an accumulation of organic osmolytes, e. g. glycine, sorbitol,myo-
inositol, taurine and betaine. This synthesis or influx of osmolytes together with the increased
synthesisof chaperones isan importantadaptationprocess inorder topreventapoptosisasosmolytes
and chaperones stabilizemacromolecules. (Alfieri and Petronini, 2007; Lang et al., 1998)
The effect of hyperosmolality on the transcriptomewill be described in section 2.7.
2.7 Transcriptomics
Thegenomeofmammaliancells consistsofproteinencodingandnon-codingsequences (Eddy,2001).
The expression patterns of both protein encoding (mRNA) and non-coding genomic sequences (e. g.
miRNAs, transfer RNAs (tRNA) and ribosomal RNAs (rRNA)) are characteristic for a cell cultivated
at defined conditions due to a process of adaptation. The research field of transcriptomics investi-
gates changes inexpressionpatterns, thereby focusingonchanges inmRNAandmiRNAexpression in
relation to product formation, cell growth, apoptosis and variations of process parameters,(Clarke
et al., 2011, 2012;Doolan et al., 2013; Fischer et al., 2014; Gammell et al., 2007;Hammondet al., 2012;
Harreither et al., 2015; Hernández Bort et al., 2012; Kelly et al., 2015b; Schaub et al., 2012, 2010; Shen
et al., 2010; Vishwanathan et al., 2015;Wong et al., 2006; Yee et al., 2009). In terms of cell culture, re-
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search resultsmay contribute to an optimization of cell lines and production processes (Barron et al.,
2011a; Datta et al., 2013; Fischer et al., 2014, 2015b,c; Fomina-Yadlin et al., 2015; Jadhav et al., 2014;
Jamnikaretal.,2015;Kellyetal.,2015a;Lewisetal., 2016;Linetal., 2011; Lohetal., 2014;Vishwanathan
et al., 2014). Commonmethods in transcriptomics are 'quantitative real time polymerase chain reac-
tion’ (qRT-PCR), microarrays and RNA sequencing, where especially CHO studies were hampered by
the lack of a publicly available CHO genome (Datta et al., 2013; Wuest et al., 2012). Before Xu et al.
(2011) published the draft genomic sequence for CHOK1, cross species approaches applying genomic
information fromHomosapiens,MusmusculusorRattusnorvegicusandcustom-madeCHOcDNAmicro-
arrayswerecommonlyappliedto investigate theCHOtranscriptome. (Clarkeetal., 2011,2012;Doolan
etal., 2013;Druzetal., 2011;Harreitheretal., 2015;HernándezBortetal., 2012; Linetal., 2011;Melville
et al., 2011; Nissom et al., 2006; Schaub et al., 2010; Yee et al., 2009).
The Link betweenmiRNAandmRNA
Lee et al. (1993) discovered a genomic sequence which did not encode a protein but two transcripts
of∼ 22 and 61 nucleotides (nt). LIN-4was described as a negative regulator of LIN-14mRNA, thereby
playing an important role in postembryonic development of the nematode Caenorhabditis elegans
(C. elegans) . As LIN-4 transcripts and the 3'untranslated region (UTR) of LIN-14 mRNA revealed se-
quence complementarity, the negative regulationwas suggested to bemediated by an interaction of
the two RNAs. Wightman et al. (1993) confirmed this hypothesis, thereby revealing a functional con-
servation of seven elements in the LIN-14 3'UTR among C. elegans and C. briggsae. Seven years after
the identification of LIN-4, Reinhart et al. (2000) described another short RNA (21 nt) which showed
sequence complementarity to the 3'UTR of several mRNAs . This 21 nt RNA, named LET-7, was there-
fore hypothesized to control target mRNAs and to regulate the transition of C. elegans from the
late-larval to the adult stage (Reinhart et al., 2000). An evenmore important discovery wasmade by
Pasquinelli et al. (2000) who detected LET-7 among a variety of different organisms includingHomo
sapiens, Mus musculus and Drosophila melanogaster, thereby revealing sequence conservation. More
small RNAs with similarity to LIN-4 and LET-7 were identified and the group of these∼ 22 nt short
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RNAswas finally termedmiRNAs (Lau et al., 2001; Lee and Ambros, 2001).
Sequence information for a variety of different miRNAs from 223 species, including vertebrates,
viruses and plants, are currently deposited at the public miRNA database "miRBase" (http://www.
mirbase.org) andmay be used as reference sequences for the assignment of newmiRNAs (Griffiths-
Jones, 2004; Griffiths-Jones et al., 2006; Kozomara andGriffiths-Jones, 2011, 2014). Among these are
306 sequences from Chinese hamster which are based on an NGS study by Hackl et al. (2011). How-
ever, as mentioned in section 2.2 evenmore CHO-specific miRNAs have been described in literature
(Diendorfer et al., 2015; Hackl et al., 2012, 2011; Johnson et al., 2011).
miRNAProcessingPathway
miRNA encoding genomic sequences are embedded in both non-coding and protein encoding
transcripts, where both intronic and exonic localization ofmiRNA genes were described in literature
(Barron et al., 2011b; Kim et al., 2009; Lagos-Quintana et al., 2001; Lau et al., 2001; Lee et al., 2002b).
However, the majority of miRNAs is encoded in form of single miRNA genes or miRNA clusters in
intronic regionsof thegenome(Barronetal., 2011b;Kimetal., 2009; Leeetal., 2002b). Formostof the
poly- and monocistronically encoded miRNAs a RNA polymerase II mediated transcription
process was described in literature (Fig. 2.12) (Lee et al., 2004).
In this context theresultingprimarymiRNAtranscripts (pri-miRNA)arecharacterizedbyahairpin
stem-loop structure with a cap motif at the 5’ end and a polyadenylated tail at the 3’ end (Lee et al.,
2004). In addition to the RNA polymerase II mediated transcription, research studies revealed RNA
polymerase III mediated transcription for a small group of human miRNAs which are associated to
repetitive genomic elements (e. g. Alu) (Borchert et al., 2006).
The Microprocessor complex, including the RNase III enzyme Drosha and the double-stranded
RNA binding protein DGCR8 (DiGeorge syndrome critical region 8), mediates cleavage nearby the
stem structure of pri-miRNAs, thus forming ∼ 70 nt hairpin precursor miRNAs (pre-miRNAs) with
a∼ 22 nt stem and a two nucleotide overhang at the 3’ end (Denli et al., 2004; Gregory et al., 2004;
Lee et al., 2003b). While pri-miRNAs are located in the nucleus (Lee et al., 2002b), pre-miRNAs are
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exportedtothecytoplasmbytheRan-GTP-dependent importin-β-relatedtransport receptorexportin-
5 (Bartel, 2004; Kim, 2004; Lee et al., 2002b; Lund et al., 2004). In the cytoplasm, pre-miRNAs are
recognized and further processed to∼ 22 ntmiRNAduplexes (miRNA:miRNA*) by another RNase III
enzyme called Dicer (Barron et al., 2011b; Hutvágner et al., 2001; Kim et al., 2009).
Figure 2.12: Biogenesis of miRNAs. miRNAs are encoded either mono- or polycistronically in the cellular
genome. Commonly, miRNA genes are transcribed by RNA polymerase II (RNA PolII) so that the resulting
hairpin stem-loop primary-miRNA transcripts (pri-miRNA) possess a 5’-cap and a polyadenylated 3’ end. The
Microprocessor complex which consists of the RNAse III Drosha and the double-stranded RNA binding pro-
teinDGCR8 (DiGeorge syndrome critical region 8)mediates the processing of pri-miRNA into a∼ 70 nt precur-
sormiRNA (pre-miRNA). Exportin-5 enables the transport of pre-miRNA into the cytoplasmwhere the RNAse
III enzyme Dicer cleaves the terminal loop, thus forming a miRNA duplex. The assembly of the RNA-induced
silencing complex (RISC), mediating mRNA degradation or repression of translation, is facilitated by Dicer,
TRBP (TAR RNA-binding protein) and Ago (Argonaute). One of the strains of the miRNA duplex is loaded
into RISC, thus being able to bind to complementary regions of target mRNAs. The other strain (miRNA*) is
degraded. Withmodifications to Barron et al. (2011b); Jadhav et al. (2013); Kim et al. (2009); Sun et al. (2010).
In general, both strands of the miRNA duplex are capable of being assembled into the RNA-
induced silencing complex (RISC) (Bartel, 2004; Khvorova et al., 2003; Kimet al., 2009; Schwarz et al.,
2003). However, Schwarz et al. (2003) and Khvorova et al. (2003) revealed that the RNA strand with
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thermodynamically less stable base pairing at the 5’ end is commonly themiRNA that is part of RISC
while the other RNA strand, designated as miRNA*, is degraded. The miRNA loading process is
mediatedbythemiRNAloadingcomplexconsistingofanArgonauteprotein (Ago)andtransactivating
response RNA-binding protein (TRBP) in association with Dicer (Chendrimada et al., 2005; Gregory
etal.,2005;ManiatakiandMourelatos,2005). TherebyTRBPrecruits theendonucleaseAgotomiRNA,
thus forming the catalytic engine of RISC where the miRNA targets complementary mRNA regions
and Ago is capable of cleaving the targetmRNA in an ATP-independentmanner(Chendrimada et al.,
2005; Gregory et al., 2005;Maniataki andMourelatos, 2005).
Recognition andPrediction of TargetmRNAs
miRNAs regulate the expression of protein encoding genes at the posttranscriptional level. In this
context, one miRNA was shown to possess multiple target sites, while an mRNA may contain
several target sites for the samemiRNAanddifferent types ofmiRNAs, respectively (Brennecke et al.,
2005; Doench and Sharp, 2004; Sun et al., 2010). Therefore, a cooperative effect ofmultiplemiRNAs
inmRNA repressionwasmentioned in literature (Sun et al., 2010).
The interaction betweenmiRNAandmRNA commonly occurs at the 3'UTR of themRNAwhere a
completely complementary ∼ 7 nt miRNA segment (nucleotides 2 - 8), defined as seed-region,
enables the formation of an RNA duplex which is however commonly not solely sufficient to initi-
ate repression of mRNA (Lewis et al., 2003; Sun et al., 2010). In fact, miRNA-mRNA-interaction and
consequently mRNA repression are promoted by additional features, e. g. accumulation of adenine-
uracil-nucleotides close to themiRNAtarget site, pairingofmiRNAnucleotides 13 - 16withmRNAand
proximity to othermiRNA target sites (Grimson et al., 2007). In general, precise nucleotide pairing is
required at the seed-region and at nucleotides 13 - 16, whereas wobbles, bulges or other nucleotide
mismatches are tolerated at other segments of the miRNA-mRNA duplex (Brennecke et al., 2005;
Grimson et al., 2007; Sun et al., 2010). This property of miRNA-mRNA interaction gives rise to the
fact that target sites are suitable formultiplemiRNAs (Oulas et al., 2012; Sun et al., 2010).
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Table 2.1: Criteria of algorithms and tools for miRNA target prediction. * = sequence preference of tar-
get sites (TargetScan,DIANA-microT), combinatorialmiRNA-mRNA interaction (PicTar), statistical significance
of miRNA-mRNA interaction (RNAhybrid, mirWIP), target site accessibility (PITA, mirWIP), verified miRNA-
mRNA interaction and trainedmodel (TargetProfiler),machine learning frameworkwith integrated features of
miRNA-mRNA interaction (MirTarget2). With changes to Sun et al. (2010). (Hamzeiy et al., 2014; Oulas et al.,
2012, 2015).
seed sequence binding energy of
tool match complementarity miRNA-mRNAduplex others*
PicTar x x x x
TargetScan/TargetScanS x x x x
miRanda x x x
PITA x x x x
DIANA-microT x x x x
TargetProfiler x x x x
RNAhybrid x x x
miRWIP x x x x
miRDB (MirTarget2) x
The specific features ofmiRNA-mRNA interactionwere utilized for thedevelopment of bioinformatic
miRNAtargetpredictiontools. Oulasetal. (2015),Hamzeiyetal. (2014)andSunetal. (2010) reviewed
common miRNA target prediction algorithms (Tab. 2.1) including PicTar, TargetScan/TargetScanS,
miRanda,PITA,DIANA-microT,TargetProfiler,RNAhybrid,mirWIP,miRDB(MirTarget2). Mostof these
tools predict miRNA targets on basis of seed-region match, base complementarity of miRNA and
mRNAaswell ason thebindingenergyofmiRNA-mRNAduplexes (Oulasetal., 2015; Sunetal., 2010).
Although multiple miRNA target prediction tools are available, the low specificity in combination
with a high sensitivity generates a high number of false positives (Sun et al., 2010). Therefore, it is de-
sirable to compare the results of different target prediction tools in order to identify potentialmiRNA
targets. In addition, experimental validation of predicted miRNA targets is required to confirm pre-
dicted miRNA targets. Reporter assays, e. g. luciferase reporter assay or green fluorescent protein
reporter assay, may validate the direct interaction of miRNA and target mRNA, whereas qRT-PCR,
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microarray and Northern blot are applied to investigate changes in mRNA and miRNA expression
levels (Chou et al., 2015).
miRNAandmRNANamingConventions
In order to standardize the naming of conservedmiRNAs fromdifferent organisms, the naming con-
vention of Ambros et al. (2003) introduced the prefix "miR" in combinationwith a unique identifying
number (e. g. miR-1). A similarnamingconvention is applied formiRNAencodinggenes,where italics
and the prefix in lower case are characteristic (e. g.miR-1) (Ambros et al., 2003). According to Ambros
et al. (2003), miRNAs from different organisms but with identical or similar sequences are assigned
the samenumber, whereas numeral/letter suffixes are added to identical and very similarmiRNAs of
an organism, respectively (e. g.mir-1-1,mir-1-2 ormir-10a,mir-10b). Furthermore, an additional suffix
(-3p/-5p) indicates whether thematuremiRNA originated from the 3’ or the 5’ arm of the pre-miRNA
(Griffiths-Jones et al., 2006). Commonly an additional species specific three- or four-letter prefix is
added for clarification of the miRNA origin (Griffiths-Jones et al., 2006). In this context, cgr and hsa
are examples formiRNAs from Cricetulus griseus (Chinese hamster) andHomo sapiens, respectively.
Internationalnomenclaturecommittees, e.g. HGNC(human),MGD(mouse), IUBMB(proteinen-
coding genes) aim at standardizing the naming of genes and gene products across different species
so that each gene/gene product has a single, unique and descriptive name and symbol (Povey et al.,
1997). A gene name briefly describes the function or a specific property of the gene (e. g. lactate
dehydrogenase - LDH) whereas the gene symbol is an abbreviation of the gene name (Shows et al.,
1987). Gene symbols are characterized by a combination of Latin letters and Arabic numbers where
numeral suffixes are used to indicate that different genes encode gene products of similar function
(e. g.HK1,HK2). Historically, letter suffixeswere used in this case so that this naming conventionwas
maintained for the concernedgenesymbols (e. g. LDHA, LDHB) (Showsetal., 1987). Geneswhichwere
annotatedbydatabase searching, thus lacking functional information, are designatedwith the suffix
"L" (like) (Blake et al., 1997).
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Transcriptomic Response of CHOCells toHyperosmotic Culture Conditions
Previous CHO specific transcriptome studies (mRNA and miRNA) focused on correlations between
gene expression changes, µ and qP as well as on time-dependent changes throughout the different
phases of cell growth (Clarke et al., 2011; Hernández Bort et al., 2012; Schaub et al., 2010).
Furthermore, research groups investigated the cellular response upon changing culture conditions
(Baik et al., 2006; Barron et al., 2011b; Bedoya-López et al., 2016; Birzele et al., 2010; Druz et al., 2011;
Gammell et al., 2007; Schaub et al., 2010; Yee et al., 2009). While several of the aforementioned
studies investigated the effects of low culture temperature on mRNA and miRNA expression (Baik
et al., 2006; Barron et al., 2011b; Bedoya-López et al., 2016; Gammell et al., 2007; Yee et al., 2009)
only one research group has described the transcriptomic response of CHO cells upon hyperosmotic
stimulus so far (Shen et al., 2010). In this context, mRNA expression analysis on basis of custom-
madeAffymetrix®CHOmicroarrays andqRT-PCR revealed differential expression (up- anddownreg-
ulation) of genes encoding proteins involved in cell signaling, transport, transcriptional regulation
andmetabolism (Shenet al., 2010). Furthermore, the transcriptomic responseuponchanging culture
conditions was hypothesized to be specific for a defined cell line and condition as minor similarities
were observed in comparison to other stress responses (sodiumbutyrate treatment, low culture tem-
perature) ormammalian cell lines (Shen et al., 2010).
2.8 Improving Cellular Performance of CHOCells by Cell Line
Engineering
Transcriptomic research studies reveal potential targets for the improvement of recombinant CHO
cell lines by cell line engineering. Themutual aims of cell line engineering strategies are an enhance-
ment of cell growth, productivity and yield as well as an improvement of cellular stress resistance
(Fischer et al., 2015a). Modification of gene expression can be realized by transient or stable over-
expressionof target genes, by chromosomal deletionor byRNA interference (Barron et al., 2011b; Fis-
cher et al., 2015a; Wuest et al., 2012). Furthermore, miRNA complementary oligonucleotides, called
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antagomirs, are capable of inhibitingmiRNA function by binding to their target miRNAs (Sun et al.,
2010). Another technique utilizes synthetic RNAs (miRNA sponges) which competitively inhibit the
binding ofmiRNAs to target sites, thus suppressingmiRNA function (Sun et al., 2010).
Multiple research studies described enhancements in recombinant protein production by stable or
transient overexpression of cgr-miR-17, cgr-miR-19b, cgr-miR-20a, cgr-miR-92a, cgr-miR-2861, mmu-
miR-30familymembers,hsa-miR-7,hsa-miR1287,hsa-miR-557 (Barronetal.,2011a;Fischeretal.,2014,
2015b,c; Jadhav et al., 2014; Loh et al., 2014; Strotbek et al., 2013) or inhibition ofmiR-23,miR-34 and
mmu-466-5p (Druz et al., 2011, 2013; Kelly et al., 2015a,b) in CHO cells.
In comparison to the aforementioned miRNAs approximately 100 target genes for CHO cell
engineering were summarized in a review by Fischer et al. (2015a). Related cell line engineering
strategies foran improvementofcellularproductivity focusedonenhancementofapoptosisandstress
resistance (Cost et al., 2010; Doolan et al., 2010; Fischer et al., 2015a; Kim and Lee, 2002; Lee et al.,
2009; Sung et al., 2007; Tan et al., 2015), induction of cell cycle arrest (Bi et al., 2004; Fussenegger
et al., 1998; Mazur et al., 1998) and reduced production of toxic by-products (Chong et al., 2010; Fo-
golin et al., 2004;KimandLee, 2007b; LaoandToth, 1997; Tabuchi andSugiyama, 2013; Tabuchi et al.,
2010; Toussaint et al., 2016;Wlaschin andHu, 2007a; Yang and Butler, 2002).
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Chinese hamster ovary (CHO) cells are the "mammalian workhorses" of biopharmaceutical industry.
Since the approval of the first CHOproduct in 1987 process development has contributed to a remark-
able progress in cellular performance, e. g. cell growth andproduct formation. The switch frombatch
to fed batch mode and the improvement of cell lines, cultivation media and operating parameters
resulted in ∼ 6-fold higher viable cell densities, 4- to 10-fold enhanced qP and ∼ 100-fold higher
cP (Jayapal et al., 2007; Schaub et al., 2012; Seth et al., 2006; Tabuchi and Sugiyama, 2013; Wurm,
2004). Nevertheless, optimization strategies intensified culture conditions and thereforemay cause
stress conditions.Whilemixingof lab scaleSTRs (1 - 100L) isusually efficient, inhomogeneous culture
conditionsarecharacteristic for largescaleSTRs (¤20,000L), thus facilitating theoccurrenceof stress
conditions. In order to prevent cell disruption and inhibition of cell growth and product formation,
volumetric power inputs usually have to be low in large scale STRs, thus contributing to inefficient
mixing and inhomogeneous culture conditions (Gelves et al., 2014; Lara et al., 2006; Nienow, 2006).
Fig. 3.1 exemplarily illustrates the formation ofmicroenvironments in a 300 L STRwith 180 Lworking
volume on basis of a computational fluid dynamics (CFD)model.
Cells cultivated in large scale STRs are consequently exposed to gradients of different culture
conditions (e. g. pH, T, DO, cS, pCO2). Considering that mixing times are in the order of minutes,
changing culture conditions might therefore induce a specific cellular response (Lara et al., 2006).
As described in literature, conditions that differ from standard culture conditions, e. g. hypothermia
(30 - 33°C), hyperosmolality (¥ 350mOsmol kg-1), commonly inhibit cell growth or even induce apop-
tosis (Bollati-Fogolín et al., 2008; Fox et al., 2004; Han et al., 2010; Kaufmann et al., 1999; Lee et al.,
2003a; Ryu et al., 2000, 2001; Shen et al., 2010; Trummer et al., 2006; Yoon et al., 2004, 2005).
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Figure 3.1: Calculated local kLa distribution for a STR with 180 L
working volume. kLa distribution was calculated on basis of a
computational fluid dynamics (CFD) model. The bioreactor had a
definedworkingvolumeof 180Landwasequippedwitharingsparger
and three Rushton turbines. Regions with high kLa values (0.54 h-1)
are colored in red, while green colored areas indicatedmid-range kLa
values of about 0.27 h-1. Regions with extremely low kLa values
(∼ 0.0 h-1) are illustrated in dark blue. With modifications to Gelves
et al. (2014).
Surprisingly, stress conditions like for example hyperosmolality, which may occur in fed batch
cultures, were shown to cause decrease in cell growthwhereas qP was enhanced (Fox et al., 2004; Fu-
rukawa and Ohsuye, 1998; Han et al., 2009; Kaufmann et al., 1999; Lee et al., 2003a; Ryu et al., 2000;
Shen et al., 2010). However, this phenomenon has not been fully deciphered yet, although elucidat-
ing the connectionbetweenhyperosmolality andenhancedqPmay contribute to the identificationof
new strategies to further enhance the cellular performance.
Therefore this research project focuses on the effects of hyperosmotic culture conditions on
antibody producing CHO cell lines in order to reveal toeholds for the improvement of therapeutic
protein production.
High producing mammalian cell lines (qP = 40 - 100 pg cell-1 d-1) synthesize recombinant
proteins in the order of∼ 20% of the total cellular protein (Seth et al., 2006; Tabuchi and Sugiyama,
2013; Wurm, 2004). This substantial recombinant protein production is an energy consuming
process. The formation of each peptide bond requires at least three ATP molecules which adds up
to∼ 4,000 ATP molecules per IgG1 antibody consisting of 12 domains with∼ 110 amino acids each
(Jefferis, 2009; Seth et al., 2006). Disregarding other energy dependent processes during antibody
production (e. g. correct folding and disulfide bond formation in the ER) (Braakman et al., 1992; Mi-
razimi and Svensson, 2000), high producing cell lines utilize about 1.1 - 2.7 pmolATP cell-1 d-1 for the
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synthesis of recombinant antibodies. This daily cellular ATP consumption is an equivalent of ∼ 1 -
13.5% of the specific ATP formation rates (qATP, 20 - 108 pmolATP cell-1 d-1) which have been described
in literature for different mammalian cell lines (Lin et al., 1999; Miller et al., 1987; Mulukutla et al.,
2010; Sidorenko et al., 2008;Wahl et al., 2008).
ATP formation is commonly based on substrate-level phosphorylation and on oxidative
phosphorylation (2.4), the latter being located in mitochondria, the cellular "powerhouses" (2.3). A
preliminarydiplomathesis (Pfizenmaier, 2011) focusedonthedevelopmentofanantibody-mediated
intracellular fluorescence labeling method for flow cytometric qualitative/quantitative analysis of
mitochondrialnumber inCHOcells. Themethodwasappliedto investigate theeffectsofhyperosmotic
culture conditions on the mitochondrial compartment of an anti-interleukin-8 (anti-IL-8)
producing CHO DP-12 cell line (ATCC CRL-12445). Surprisingly research results revealed a decrease
in mitochondrial fluorescence in response to a osmotic shift from∼ 290 to∼ 390 mOsmol kg-1 on
day three of a batch cultivation, thus hypothesizing that the number of mitochondria might have
decreased (Fig. 3.2). As a consequence the suggested hypothesis was the starting point of the
present research project.
Figure 3.2: Effect of hyperosmolality on mitochondrial
fluorescence. The cell line CHO DP-12 was cultivated in four
bioreactors in batch mode. On day three of cultivation, osmolality
was increased in two bioreactor from∼ 290 to∼ 390 mOsmol kg-1
(N,4). The other two cultures served as references (, ). An
antibody-based fluorescence labeling of intracellular mitochondria
(4.2.5) was performed directly before as well as on the following
four days after osmotic shift. The fluorescence intensities of isotype
controls were used to correct the medians of mitochondrial
fluorescence intensities (575 nm). With changes to Pfizenmaier
(2011).
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Effects ofHyperosmotic Culture Conditions on theMitochondrial Compartment
and thePhenotype of CHODP-12 Cells
Themitochondrial compartment is a highly dynamic cellular component (2.3) whosemorphology is
shaped by fusion and fission of mitochondrial membranes as a function of the cellular state and
requirements (CampelloandScorrano,2010;HockandKralli, 2009;PernasandScorrano,2016;Schef-
fler, 2001). A decrease in mitochondrial mass of hyperosmotically stressed CHO DP-12 cells was
indicatedbyfluorescence labelingof themitochondrial targetproteinTOM22(translocaseof theouter
mitochondrial membrane) (Pfizenmaier, 2011). However, this result was based on two biological
replicates (Pfizenmaier, 2011) and was contradictory to results of previous independent studies in-
vestigating the effects of hyperosmolality, oxidative stress and sodiumbutyrate treatment (Lee et al.,
2002a, 2003a; Lin et al., 1999;McMurray-Beaulieu et al., 2009).
Therefore one of the main objectives of this thesis was to characterize the hyperosmotic
phenotype of CHODP-12 cells and to investigate whether mitochondrial fluorescence intensity truly
correlated with mitochondrial mass. With mitochondria being the cellular "powerhouses" for ATP
formation and recombinant protein production being an energy intensive process, analyses of intra-
cellular adenine nucleotide pools and determination of qATP weremajor aspectswhile characterizing
the phenotype of hyperosmotically stressed cells.
The Transcriptomic Response (mRNA/miRNA) of AntibodyProducing CHODP-12
Cells toHyperosmotic Stimulus
In order to reveal the connection between hyperosmotic culture conditions and enhanced product
formation, a complete picture of the cellular response is required. However, while hyperosmotic
effects on cellular metabolism of CHO cells have extensively been investigated (Han et al., 2010; Lee
et al., 2003a; Ryu et al., 2000, 2001; Shen et al., 2010), only Shen et al. (2010) have studied the CHO-
specific hyperosmotic response at the level of mRNA expression so far. Therefore, a further objective
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of the present research project was to characterize the transcriptomic response (mRNA/miRNA) to
hyperosmotic culture conditions on basis of an NGS approach. In this context, NGS analyses were
expected to identify superimposed transcriptional changes that induce characteristic phenotypes of
hyperosmotically stressed cells. Furthermore, the combined analysis of mRNA and miRNA expres-
sionwas supposed to reveal potential targetmRNAsof significantly differentially expressedmiRNAs.
Identification of Strategies for qP Enhancing Cell Line Engineering Strategies
While the characterization of metabolic and transcriptomic response to hyperosmotic culture
conditions most notably aimed at elucidating the reason for the qP enhancing effect, the acquired
knowledge served as well as a basis for the identification of potential strategies to improve cellular
productivity even further. The leadingobjectivewas to identify energy providing cell line engineering
strategies contributing to enhanced recombinant protein production.
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4 Materials andMethods
4.1 Materials
4.1.1 Chemicals
Table 4.1: Chemicals
chemical company
acetonitrile¥ 99.9% VWR, DE
cis-aconitate (cis-aco)¥ 98% Sigma-Aldrich, US
adenosine diphosphate disodium salt (ADP) Gerbu, DE
adenosinemonophosphate disodium salt (AMP) Fluka, US
adenosine triphosphate disodium salt (ATP) Gerbu, DE
algal lyophilized cells U-13C > 99 atom% (lot no. 487945) Sigma-Aldrich, US
amino acid standard (AAS18) Sigma-Aldrich, US
ammonium cuvette test LCK303 Hach, DE
boric acid Merck, DE
bovine serum albumin (BSA) VWR, DE
calibration standard 300mOsmol kg-1 gonotec, DE
chloroform¥ 98% Sigma-Aldrich, US
digitonin 5% Invitrogen, US
digitonin Applichem, DE
dimethyl sulfoxide (DMSO) Sigma-Aldrich, US
D-mannitol Merck, DE
ethanol¥ 96% Carl Roth, DE
ethylenediaminetetraacetic acid (EDTA) Carl Roth, DE
Flow-CheckTM fluorospheres Beckman Coulter, US
Flow-SetTM fluorospheres Beckman Coulter, US
9-fluorenylmethyl chloroformate (FMOC) Sigma-Aldrich, US
fructose-6-phosphate (F6P)¥ 98% Sigma-Aldrich, US
geneticin (G418) Santa Cruz Biotechnology, US
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Table 4.1: Chemicals (continued)
chemical company
glucose-6-phosphate (G6P)¥ 98% Sigma-Aldrich, US
glucose/lactate standard TRACEAnalytics, DE
hydrochloric acid 32% Carl Roth, DE
hydrochloric acid 32% Sigma-Aldrich, US
IsoFlowTM sheath fluid Beckman Coulter, US
L-asparagine (Asn)¥ 99% Sigma-Aldrich, US
L-glutamine (Gln) CELLPURE®¥ 99% Carl Roth, DE
L-norvaline¥ 99% Fluka, US
L-tryptophane¥ 99% Fluka, US
3-mercaptopropionic acid Sigma-Aldrich, US
methanol¥ 99.8% VWR, DE
methotrexate (MTX) Applichem, DE
methoxyamine hydrochloride¥ 98% Sigma-Aldrich, US
2-(N-morpholino)ethanesulfonic acid Sigma-Aldrich, US
pH-buffer solution pH 7.00 0.02 Carl Roth, DE
pH-buffer solution pH 4.00 0.02 Carl Roth, DE
pH-buffer solution pH 9.00 0.02 Carl Roth, DE
phosphoric acid 85% Fluka, US
ortho-phthaldialdehyde (OPA) Fluka, US
R-phycoerythrin Santa Cruz Biotechnology, US
potassiumhydroxide 45% (KOH) Sigma-Aldrich, US
potassiumphosphate dibasic (K2HPO4) Sigma-Aldrich, US
potassiumphosphatemonobasic (KH2PO4) Sigma-Aldrich, US
propidium iodide (PI) Sigma-Aldrich, US
pyridine¥ 99% Sigma-Aldrich, US
pyruvate¥ 99% Sigma-Aldrich, US
13C-pyruvate¥ 99% euriso-top, DE
RNaseA, Pure LinkTM Invitrogen, US
RNAprotect cell reagent Qiagen, DE
sample solution for LaboTRACE TRACEAnalytics, DE
SeramunBlau® SeramunDiagnostica, DE
sodium azide Sigma-Aldrich, US
sodium carbonate (Na2CO3) Carl Roth, DE
sodium chloride CELLPURE®¥ 99.8% Carl Roth, DE
sodiumhydrogen carbonate (NaHCO3) Carl Roth, DE
sodiumhydroxide (NaOH) Carl Roth, DE
sodiumphosphate dibasic (Na2HPO4) Carl Roth, DE
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Table 4.1: Chemicals (continued)
chemical company
sodium tetraborate decahydrate Sigma-Aldrich, US
sulfuric acid¥ 98% Carl Roth, DE
TC-42-Dmedium Xell, DE
N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) Sigma-Aldrich, US
tetrabutylammoniumbisulfate (TBAS) Fluka, US
tris(hydroxymethyl)aminomethane (Tris) base Carl Roth, DE
trypan blue solution 0.4% Sigma-Aldrich, US
Tween 20 Fluka, US
water LC-MS grade VWR, DE
4.1.2 Antibodies
Table 4.2:Antibodies
ELISA
antibody company
anti-human IgG F(c) goat antibody biomol, DE
anti-human kappa chain goat antibody peroxidase conjugated biomol, DE
intracellular staining ofmitochondria
antibody company
anti-TOM22mouse antibody Abnova, Taiwan
mouse IgG2a isotype control Sigma-Aldrich, US
anti-mouse-IgG2a goat antibody phycoerythrin conjugated Santa Cruz Biotechnology, US
4.1.3 Buffers and Solutions
Table 4.3: Buffers and Solutions
buffer or solution recipe
blocking buffer - ELISA 1 L TBS
10 g BSA
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Table 4.3: Buffers and Solutions (continued)
buffer or solution recipe
coating buffer - ELISA 3.7 g NaHCO3
0.64 g Na2CO3
ad 1.0 L NANOpurewater
cryomedium 10 % DMSO (v/v)
90 % culturemedium (v/v)
culturemedium TC-42-Dmedium
CHODP-12 4 mM Gln
200 nM MTX
culturemedium TC-42-Dmedium
BIBH1 preculture 4 mM Gln
200 nM MTX
200 mg L 1 G418
culturemedium TC-42-Dmedium
BIBH1 bioreactor 6 mM Gln
200 nM MTX
200 mg L 1 G418
dilution buffer - ELISA 1 L TBS
10 g BSA
5 mL Tween 20 (10%)
filtration buffer 10 mM KH2PO4
pH 7.1, 290mOsmol kg-1 10 mM K2HPO4
145 mM NaCl
fixation buffer 70 % ethanol
cell cycle analysis 30 % PBS
FMOC reagent 2.5 mg 9-fluorenylmethyl chloroformate
amino acid analysis 1 mL acetonitrile
HPLC elution buffer A 10 mM Na2HPO4
amino acids, pH 8.2 10 mM Na2B4O7
0.5 mM NaN3
HPLC elution buffer B 45 % acetonitrile (v/v)
amino acids 45 % methanol (v/v)
10 % water LC-MS grade (v/v)
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Table 4.3: Buffers and Solutions (continued)
buffer or solution recipe
HPLC elution buffer A 100 mM KH2PO4
nucleotides, pH 6.0 100 mM K2HPO4
4 mM TBAS
HPLC elution buffer B 70 % elution buffer A, nucleotides (v/v)
nucleotides, pH 7.2 30 % methanol (v/v)
LC-MS/MS elution buffer A 10 % ammonium acetate buffer ( 10 mM) (v/v)
pH 9.2 90 % acetonitrile (v/v)
LC-MS/MS elution buffer B 90 % ammonium acetate buffer ( 10 mM) (v/v)
pH 9.2 10 % acetonitrile (v/v)
lysis buffer 0.122% digitonin (m/v)
in filtration buffer
MES-buffer 19.8 mM 2-(N-morpholino)ethanesulfonic acid
pH 7.4 250 mM D-mannitol
OPA reagent 10 mg ortho-phthaldialdehyde
amino acid analysis 1 mL potassiumborate buffer (0.4M, pH 10.2)
8.2 µL 3-mercaptopropionic acid
PBS (phosphate buffered saline) 1.0 mM KH2PO4
pH 7.4 5.6 mM Na2HPO4
154.0 mM NaCl
PEB-buffer 0.5 % BSA (m/v)
2 mM EDTA
in PBS pH 7.4
TBS (Tris buffered saline) - ELISA 6.06 g Tris Base
pH 7.2 - 7.8 8.2 g NaCl
6.0 mL HCl ( 6 M)
ad 1.0 L NANOpurewater
washing solution - ELISA 1 L TBS
5 mL Tween 20 (10%)
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4.1.4 Consumables
Table 4.4: Consumables
consumable company
capillary columnGC (26m x 0.25mm, 0.25 µm) Phenomenex, US
Cedex smart slides Roche, DE
cryo vials Greiner, DE
glass fiber filter type A/D Pall, US
measuring vessels for osmomat gonotec, DE
metrigardTM filters Pall, US
microtiter plates (ELISAMICROLON®200) Greiner, DE
Microplate, 96well, PS, F-bottom, µCLEAR®, black Greiner, DE
Omnifix® luer lock connection (3mL, 5mL, 10mL and 50mL) BraunMelsungen, DE
pipet tips (10µL, 200µL and 5000µL) Sarstedt, DE
pipet tips (1000µL) Greiner, DE
QIAshredder Qiagen, DE
reaction tubes, safe-lock (1.5mL) Eppendorf, DE
reaction tubes black (1.5mL) Carl Roth, DE
reaction tubes flow cytometer (15mL) Beckman Coulter, US
reaction tubes (1.5mL, 2mL, 15mL and 50mL) Sarstedt, DE
RNeasyMini Kit Qiagen, DE
SeQuant ZIC-pHILIC, 5 µm, PEEK 150 x 2.1mm,metal-free di2chrom, DE
serologic pipets (1mL, 5mL, 10mL, 25mL and 50mL) Carl Roth, DE and Sarstedt, DE
shake flasks (125mL, 250mL and 500mL) BD, US and Corning, US
sterilizing grade filter, PES, 0.22 µm Carl Roth, DE
sterilizing grade filter, Sartolab-P20, 0.2 µm Sartorius, DE
Supelcosil LC18, 3 µm, 15 cm x 4.6mm Sigma, US
ZelluTrans/RothMini DialyzerMD 300 (5mL) Carl Roth, DE
Zorbax Eclipse Plus C18/250 x 4.6mm Agilent Technologies, US
4.1.5 Software
Table 4.5: Software
analytics
ChemStation Agilent Technologies, US
MassHunter B.04.00 Agilent Technologies, US
TurboMass 4.1 Perkin Elmer, US
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Table 4.5: Software (continued)
flow cytometry
Cell Cycle Analysis of DNAhistograms Cylchred
CXPAnalysis Beckman Coulter, US
gene expression analysis
DESeq2 1.8.1 Bioconductor
edgeR 3.10.2 Bioconductor (Robinson et al., 2010)
GOrilla (Eden et al., 2009)
GOseq 1.20.0 Bioconductor (Young et al., 2010)
maSigPro 1.40.0 Bioconductor (Conesa et al., 2006; Nueda et al., 2014)
MGI GeneOntology Term Finder http://www.informatics.jax.org
VennDiagram 1.6.16 CRAN
general use
DASGIP Control 4.0 DASGIP, DE
Excel 2010 Microsoft, US
Hmisc 3.17-0 CRAN
R 3.2.1 The R Foundation for Statistical Computing
RStudio 0.98.1103 RStudio
4.1.6 Equipment
Table 4.6: Equipment
instrument company
AutoSystemXL gas chromatograph Perkin Elmer, US
bioblock DASGIP, DE
bioreactor (DS1500ODSS) DASGIP, DE
CEDEX cell counter Roche, DE
centrifuge (Megafuge 1.0R) Heraeus, DE
cryostat F3 Haake, DE
diode array detector (DAD) Agilent Technologies, US
DR 2800 VIS spectrophotometer Hach, DE
flow cytometer FC500 Beckman Coulter, US
fluorescence detector (FLD) Agilent Technologies, US
gasmixingmodule (MX4/4) DASGIP, DE
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Table 4.6: Equipment (continued)
instrument company
HPLC system (1200 series) Agilent, Technologies, US
LaboTRACE TRACEAnalytics, DE
membrane vacuumpump Vaccubrand, DE
microcentrifuge 5417R, FA-45-30-11 rotor Eppendorf, DE
Minitron shaker incubator Infors, CH
module for pH/DOmonitoring (PH4PO4) DASGIP, DE
multi pumpmodule (MP8) DASGIP, DE
Nalgene® Cryo 1°C freezing container Thermo Scientific, US
NanoDrop spectrophotometer Thermo Scientific, US
NANOpure II Barnstead, US
osmomat 030 Gonotec, DE
oxygen sensor Mettler Toledo, US
pH probe Mettler Toledo, US
Pipetboy acu Integra Biosciences, CH
Research pipet 10, 20, 100, 200, 1000, 5000, 10000 Eppendorf, DE
rotary vacuum incubator (RVC 2-33) Martin Christ, DE
SynergyTM microplate reader BioTek, US
temperature/agitationmodule TC4SC4 DASGIP, DE
thermomixer comfort Eppendorf, DE
Triple Quadmass spectrometer 6410Bwith ESI ion source Agilent Technologies, DE
TurboMassmass spectrometer Perkin Elmer, US
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4.2 Methods
Partsof this thesishavealreadybeenpublished. Someof theappliedmethodsweredescribed in these
manuscripts which can be found in supporting information B.Where applicable, cross references are
given.
4.2.1 Cell Lines andAdaptation
Theanti-IL-8producingcell lineCHODP-12clone#1934aIL8.92NB28605/14 (ATCC®CRL-12445TM) and
the cell line BIBH1 producing a humanized IgG1 antibody (kindly provided by Boehringer-Ingelheim
Pharma GmbH& Co. KG, Germany) were adapted to grow in TC-42-Dmediumwith designated sup-
plementationofL-glutamine(Gln)andselectiveadditives (methotrexate (MTX),G418) (Tab.4.3). Cells
were subcultured every two to three days in shake flasks with cell densities of 4 x 105 cells mL-1 upon
inoculation. Cells were incubated at 37°C, 5% CO2, with orbital shaking at 150 rpm and 50 mm
displacement in a humidified shaker incubator (Infors, CH). After 34 (CHO DP-12) or 37 (BIBH1)
passages, master cell banks with 1 x 107 cells mL-1 of cryo medium (Tab. 4.3) were generated. Cells
were stored in liquid nitrogen and used to build upworking cell banks.
4.2.2 Batch CultivationwithOsmotic Shift
Preparation of Inoculum
A cryo culture was thawed and washed once with appropriate culture medium for precultures (Tab.
4.3) (300g, 25°C, 5 min). The cells were seeded at a cell density of 4 x 105 cells mL-1 in 125 mL shake
flasks. Shake flasks were incubated at 37°C, 5% CO2, with orbital shaking at 150 rpm and 50mmdis-
placement inahumidifiedshaker incubator (Infors,CH)andcultureswerescaledupevery twotothree
days for four passages.
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Batch Cultivation inBioreactor
Exponentially growing cells were used to inoculate bioreactors (4 x 105 cells mL-1) of a fourfold
parallel DS15000ODSS bioreactor system (DASGIP, DE) equipped with two pitched-blade impellers
(blade angle: 30°, φimpeller = 50 mm), L-sparger, temperature sensor, dissolved oxygen (DO) sensor
andpHprobe (Mettler Toledo). Tab. 4.7 shows the setpoints ofparameters forbioreactor cultivations.
TC-42-D medium (Xell) supplemented with appropriate cGln and selective additives (MTX, G418) for
CHODP-12 or BIBH1was used as culturemedium (Tab. 4.3). Theworking volume (VR) varied between
1.2 and 1.4 L. The percentage of DO at atmospheric pressure (Tab. 4.7) was controlled by MX4/4 gas
mixing module (DASGIP). While the percentage of oxygen (xO2) in the inlet air was continuously in-
creased, the aeration ratewas controlledby a cascade (Fig. 4.1). pHwas adjusted topH7.1 by sparging
of CO2 or titrationwith 1MNa2CO3.
Table 4.7: Set points of parameters for bioreactor cultivations. N = agitation, DO = dissolved oxygen at
atmospheric pressure, T = temperature.
parameter CHODP-12 BIBH1
N [rpm] 150 150
CO2 overlay [%] 5 5
DO [%] 40 30
pH 7.1 7.1
T [°C] 37 37
Figure 4.1: Cascade control for aeration rate during bioreactor cultivation. Faeration = aeration rate,
xO2 = percentage of oxygen in inlet air.
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Osmotic Shift
Hyperosmotic conditions were induced by the addition of NaCl-enriched cultivation medium. The
time point of osmotic shift during bioreactor cultivation as well as the intensity of the shift were
dependent on the experiment (Tab. 4.8). In order to compensate dilution effects caused by osmotic
shift, equal volumes of culturemediumwere added to the reference cultures.
Table 4.8: Time point and intensity of the osmotic shift during bioreactor cultivation. t = time between
inoculation and osmotic shift.
reference CHODP-12 BIBH1
parameter condition 1 condition 2 condition 3
∆t [h] - 72 35 35 35
osmolality [mOsmol kg-1] 280 380 380 430 445
4.2.3 Fast FiltrationApproach
Fast filtration approaches (Matuszczyk et al., 2015; Pfizenmaier et al., 2015) were applied to prepare
samples for quantification of intracellular andmitochondrialmetabolic pool sizes. The fast filtration
method enables a rapid separation of cells from cultivation medium and quenching of cell
metabolism. Filtration parameters varied according to the type of sample and the number of cells
(Tab. 4.9).
Cell suspension with a defined number of cells was applied on the moistened filter(s) of a filtration
unit whichwas connected to a vacuumpump. A vacuumof 30 or 90mbar (Tab. 4.9) was used to sepa-
rate cells frommedium. Formitochondrial samples, cells were permeabilized by the addition of lysis
buffer (Tab. 4.3) in order to deplete cytosol during the final quenching andwashing stepwith ice-cold
filtration buffer (Tab. 4.9). Filters representing whole cell ormitochondrial samples were transferred
to suitable containers for extraction (Carl Roth) and were frozen in liquid nitrogen. Samples were
stored at -70°C.
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The lysis buffer contained the detergent digitonin which was shown to permeabilize membranes by
interacting with the cholesterol molecules inside the membrane (Kuznetsov et al., 2008). The
molar ratio of cholesterol and phospholipids of the plasma membrane was stated to be 7 - 50-fold
higher compared to the outer or inner mitochondrial membrane (Kuznetsov et al., 2008). Therefore
the optimized fast filtration protocol by Matuszczyk et al. (2015) enabled depletion of cytosol while
retaining themitochondrial compartment. The efficiency of this approachwas validated by quantifi-
cation of cytosolic (glucose-6-phosphate (G6P), fructose-6-phosphate (F6P)) and mitochondrial (cis-
aconitate (cis-aco))markermetabolites in whole cell andmitochondrial samples.
Table 4.9: Parameters for fast filtration approaches. A/D = 47mmborosilicate glass fiber filter type A/Dwith
a pore size of 3 µm (Pall), M = 47mmmetrigardTM filter with 0.5 µmpore size (Pall). Filtration buffer (Tab. 4.3)
was used tomoisten the filters. Lysis buffer (Tab. 4.3) contained 0.122%digitonin.
whole cell sample mitochondrial samples
parameter 107 cells 2 x 107 cells 2 x 107 cells
filter(s) A/D A/D A/D +M
vacuum [mbar] 30 30 90
moistening of filter(s) [mL] 10 10 10
lysis buffer [mL] - - 12.5
filtration buffer [mL] 30 35 43.65
4.2.4 Extraction of IntracellularMetabolites
Metabolites of whole cell or mitochondrial samples which had been prepared by fast filtration were
extractedbyacombinationofmethanol (70%, -20°C,90min)andchloroformtreatment. Thismethod
was described in Pfizenmaier et al. (2015) (manuscript 1,supporting information B.1). The extraction
process included an evaporation step (Tab. 4.10) in order to concentrate the samples and to remove
methanol. The protocol was optimized to keep the temperature of the samples∼4°C (Illner, 2012).
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Table 4.10: Evaporation protocol for cell extracts.
phase pressure [mbar] time [min]
1 20 1
2 20 9
3 15 1
4 15 4
5 10 1
6 10 9
7 8 1
8 8 4
9 6 1
10 6 4
11 4 1
12 4 74
4.2.5 AnalyticalMethods
The following paragraphs describe the analytical methods which were applied to characterize cell
culture processes.
Viable Cell Density andViability
The determination of viable cell density and viability was based on trypan blue staining and analysis
with Cedex XS cell counter (Roche).
Osmolality
A freezing point osmometer (gonotec) was used to analyze osmolality of buffers, solutions and sam-
ples. The osmometerwas calibratedwithNANOpurewater and a 300mOsmol kg-1 standard solution
(gonotec).
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Glucose, Lactate andAmmonium
Abiosensorwith immobilizedglucoseand lactateoxidasewasapplied todetermineglucose (Glc) and
lactate (Lac) concentrations with the Glc/Lac-analyzer LaboTRACE (TRACEAnalytics). LCK303 cuvette
test (Hach)wasapplied toanalyzeammoniumconcentrationsbasedonthe indophenolbluemethod.
AminoAcids
Aminoacidconcentrations insupernatantsofbioreactorcultivationswereanalyzedbyreversed-phase
high performance liquid chromatography (HPLC) with precolumn ortho-phthaldialdehyde/
9-fluorenylmethyl chloroformate derivatization as described in detail by Henderson Jr and Brooks
(2010). Analysis was performed with an Agilent 1200 series apparatus equipped with a fluorescence
detector (λexcitation = 230 nm,λemission = 450 nm), a Zorbax Eclipse Plus C18 guard column (Agilent, 12.5
x 4.6 mm, 5 µm) and a Zorbax Eclipse Plus C18 column (Agilent,250 x 4.6 mm, 5 µm). Measurements
were acquired at a column temperature of 40°C and a flow rate of 1.5 mLmin-1 for the mobile phase.
The percentage of elution buffer A (10 mM Na2HPO4, 10 mM Na2B4O7, 0.5 mM NaN3, pH 8.2) and
elution buffer B (45%methanol, 45% acetonitrile, 10%water) in the mobile phase was changed ac-
cording to a gradient (Henderson Jr and Brooks, 2010). The internal standard L-norvaline was added
to the seven standard calibration levels (AAS18 (Sigma-Aldrich) + L-asparagine, L-glutamine and L-
tryptophane) and diluted samples. Collected datawere analyzedwith ChemStation (Agilent).
Antibody
Enzyme linked immunosorbent assay (ELISA)wasused toquantify antibody concentrations in the su-
pernatantsofbioreactor cultivations. ELISAMICROLON®200plates (Greiner)werecoatedwitha1:500
dilution of anti-human IgG F(c) goat antibody (biomol) in coating buffer (Tab. 4.3) for 1 h. Plateswere
washed three timeswithwashing solution (Tab. 4.3) andnon-specific binding siteswereblockedwith
bovine serumalbumin (BSA) containingblockingbuffer for 30min. Meanwhile the supernatants and
the cell line specific standard were diluted (Tab. 4.3). After another three washing steps, the plates
were incubatedwith diluted standards and samples for 1 h. Thewashing steps were followed by a 1 h
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treatment with a diluted peroxidase conjugated anti-human kappa chain goat antibody (1:90 000,
biomol). After five washing steps the substrate SeramunBlau® containing hydrogen peroxide and
3,3’,5,5’-tetramethylbenzidine (TMB)was added to the plates. By catalyzing the decomposition of hy-
drogen peroxide, the antibody conjugated peroxidase withdraws electrons from TMB thereby form-
ing dimerizing TMB radical cations (Gallati and Pracht, 1985). The enzymatic reaction was stopped
after 30 min by the addition of 0.25 M sulfuric acid and dimerization of TMB was reversed. The ab-
sorbance of the resulting yellow TMB2+ cations was analyzed with a SystecTM microplate reader
(BioTek) at 450 nm (reference 620 nm). The correlation between antibody concentration and
absorbance was determined based on the results for different dilutions of the standard antibody
solution. All steps were performed at room temperature.
Table 4.11: Elution buffer gradient during adenine nucleotide analysis by HPLC. Elution buffer A: 100 mM
K2HPO4/ KH2PO4, 4mMTBAS, pH 6.0. Elution buffer B: 70% elution buffer A, 30%methanol, pH 7.2.
time [min] elution buffer A [%] elution buffer B [%]
0 100 0
3.5 100 0
20 60 40
22 55 45
40 45 55
48 0 100
55 0 100
60 100 0
67 100 0
AdenineNucleotides
Concentrationsof adeninenucleotides in cell extractswereacquiredby ion-pair reversed-phaseHPLC
with changes to a method described by Cserjan-Puschmann et al. (1999) (Pfizenmaier et al., 2015).
Agilent 1200 Series apparatus was equipped with a diode array detector (λdetection = 260 nm) and a
Supelcosil LC 18-T column (15 cm x 4.6mm, 3 µm) protected byHypersilTM BDS C18 guard-column. As
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described in section 4.3, elution buffer A consisted of 100mMK2HPO4/ KH2PO4 and 4mMTBASwith
apHof 6.0. Elutionbuffer B (pH7.2)was preparedof 70%elutionbuffer A and 30%methanol. Amix-
ture of elution buffer A and B served asmobile phase for HPLC analysis (Tab. 4.11). The flow rate was
1mLmin-1 and the columnwas temperedat 30°C. The standard calibration levels (7-points) contained
definedamountsofATP,ADPandAMP.Selected sampleswere spikedwithATP,ADPandAMP inorder
to evaluate the influence of the samplematrix on the quantification of analytes. Collected data were
analyzedwith ChemStation (Agilent).
Glucose-6-Phosphate, Fructose-6-Phosphate and cis-Aconitate
The concentrations of G6P, F6P and cis-aco in extracts of whole cell andmitochondrial samples were
determinedbasedonhydrophilic interaction liquidchromatography-electrospray ionization-tandem
mass spectrometry (HILIC-ESI-MS/MS) applying high selectivity in multiple reaction monitoring
(MRM) mode as described by Teleki et al. (2015), Matuszczyk et al. (2015) and in manuscript 2
(supporting information B.2). Agilent 6410B Triple Quad mass spectrometer (Agilent Technologies,
US) with ESI ion source was equipped with Sequant ZIC–pHILIC column (150 x 2.1 mm, 5 µm) pro-
tected by Sequant ZIC–pHILIC guard column (20 x 2.1 mm, 5 µm). Measurements were acquired in
negative ionizationmodewith high selectivity.
The samples for HILIC-ESI-MS/MS analysis were prepared as described in Tab. 4.12.
Table 4.12: Composition of the samples for analysis byHILIC-ESI-MS/MS.
component amount [%]
13C-algal extract 10
cell extract/standard analytes 29
ammonium acetate (1M, pH 9.2) 1
acetonitrile 60
Isotope dilution mass spectrometry (IDMS) method which had previously been described by Teleki
et al. (2015) was used to analyze the data sets. The determination ofmetabolite concentrations with
74
4 Materials andMethods
this method is based on 12C/13C-ratios. Therefore external calibration standards (8-point calibration)
and samples had been supplemented with a defined amount of 13C-labeled internal standard prior
to LC-MS/MS measurement. Lyophilized U-13C-labeled algal cells (> 99 atom% 13C, Sigma-Aldrich)
containing all analyzed metabolites served as substrate for the extraction of 13C-labeled internal
standard as described by Vielhauer et al. (2011). External calibration curves were prepared by linear
regression thereby plotting 12C/13C-ratios of analyte peak areas against the corresponding
12C-concentration of the analyzedmetabolite.
Pyruvate
Pyruvate concentrations in supernatants of bioreactor cultivations were analyzed by gas chromato-
graphy-mass spectrometry (GS-MS). An AutoSystem XL gas chromatograph (Perkin Elmer) with
TurboMassmass spectrometer (PerkinElmer)wasequippedwitha capillary column (26mx0.25mm,
0.25 µm, Phenomenex). Heliumwas used asmobile phase with a flow rate of 1 mLmin-1. During the
time ofmeasurement the temperature of the column ovenwas controlled at 320°C.
The supernatants were thawed and diluted 1:50 with water (LC-MS grade). The internal standard
(100µM 13C-pyruvate)wasmixed1:1 (V=100µL)withsampleor 12C-pyruvatestandardcalibration level
andevaporateduntil completedryness therebykeeping sample temperaturebelow10°C.Methoxam-
ine hydrochlorid was dissolved in pyridine (20 mg mL-1) and 60 µL each were used to
dissolve the dried samples. The samples were incubated at 60°C and 12 000 rpm for 30 min
(Thermomixer comfort, Eppendorf). Reaction tubes were centrifuged at 10 000g for 3 min and 30 µL
of the received supernatant were transferred to GC-MS vials containing 60 µL N-tert-butyldimethyl-
silyl-N-methyltrifluoroacetamide (MTBSTFA, Sigma-Aldrich). The vials were incubated at 60°C and
600 rpm for 60min. A volume of 1 µL was injected for analysis by GC-MS.
The collected datawere analyzedwith TurboMass 4.1 (Perkin Elmer).
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AntibodyDependent Fluorescence Labeling of IntracellularMitochondria
Pfizenmaier (2011) developed a flow cytometricmethod for analyzation of changes of themitochon-
drial compartment. Fluorescence labelingofmitochondriawasbasedonthepermeabilizationof cells
followed by antibody dependent fluorescence labeling of a mitochondrial target protein.
Digitoninwas used for the selective permeabilization of the plasmamembrane. 1 x 107 cellswere har-
vested (300g, 5 min, 4°C) and washed with 1 mL MES-buffer (Tab. 4.3). The cells were resuspended
in 1 mL of MES-buffer containing 0.02% (v/v) digitonin and were incubated on ice for 10 min. The
permeabilized cells were separated from the digitonin containing buffer by centrifugation (600g,
5min, 4°C) andwere resuspended in 1mLPEB-buffer (Tab. 4.3). In order to block non-specific binding
sites, the cells were incubated at 4°C for 15 min. Cells were pelleted (1 000g, 3 min, 4°C) and resus-
pended in 100 µL PBS (pH 7.4) containing 1 µg of IgG2a (mouse) antibody detecting translocase of
the outer mitochondrial membrane 22 (TOM22, Abnova). The samples were incubated for 30 min
at 4 °C followed by two washing steps with 1 mL of PEB-buffer. Thereafter, cells were incubated with
an isotype specific anti-mouse-IgG2a (goat) phycoerythrin (PE) conjugated antibody (1 µg/107 cells,
Santa Cruz Biotechnology) for 30min at 4°C in the dark. The cells were washed three times with 1mL
PEB-buffer andwere finally resuspended in 0.5mLPEB-buffer. Isotype controls functioned as control
for non-specific antibody binding. For this purpose, the primary antibody was replaced by a mouse
IgG2a isotype control antibody (Sigma-Aldrich). Three technical replicates of the staining procedure
were performed for each sample type and timepoint. Samples and isotype controlswere analyzed by
flow cytometry at low flow rate (FC500, Beckman Coulter).
Tab. 4.13 summarizes the flow cytometer settings which were used to detect 40 000 events for each
analyzed sample. Fluorescence intensity of FlowSet calibration beads (Beckman Coulter) was deter-
mined with FC500 on each day of flow cytometric measurement in order to analyze variances of the
flow cytometer. All fluorescence intensitieswere normalized on the fluorescence intensity of FlowSet
beads.
76
4 Materials andMethods
Table 4.13: Flow cytometer settings for analyzingmitochondrial fluorescence intensity. λexcitation = 488 nm,
FS= forward scatter, SS= sidewards scatter, FL2= fluorescence channel 2 (575nm), Lin= linear, Log= logarithmic
channel voltage [V] type of amplification amplification factor
FS 750 Lin 2.0
SS 850 Lin 5.0
FL2 430 Log 1.0
Mitochondrial fluorescence intensity (Ψmit) was calculated according to Eq. 4.1
Ψmit 
Ψsamplet Ψisot
Ψsamplet0 Ψisot0
(4.1)
with Ψsample as the arithmetic mean (n = 3) of the normalizedmedian fluorescence intensities of the
sample and Ψiso as the arithmetic mean (n = 3) of the normalizedmedian fluorescence intensities of
the isotype control. The index t represents the time between osmotic shift and analysis.
Influence ofOsmolality on the Fluorescence Intensity of Phycoerythrin
R-phycoerythrin (Santa Cruz Biotechnology) was dissolved in 500 µL of 10mMpotassium phosphate
buffer (pH7.1)withanosmolalityofeither290or380mOsmolkg-1 resulting ina final concentrationof
approximately 380µgmL-1. The suspensionsweredialyzed (MiniDialyzerMD300)against phosphate
buffer with the corresponding osmolality for 8 h at 4°C in the dark, whereby buffers were replaced
twice. Osmolalities of the phycoerythrin suspensions were subsequently confirmed with a freezing
point osmometer (gonotec) followed by serial dilution of phycoerythrin suspensions in correspond-
ing phosphate buffer on a 96 well microplate (Greiner). Fluorescence intensities were analyzed with
SynergyTM microplate reader (BioTek) withλexcitation = 485 nmandλemission = 590 nm.
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Apoptosis Assay
The Annexin V-FITC kit (Beckman Coulter) was used to perform testing for apoptosis according to the
specifications of themanufacturer. In order to distinguish apoptotic or necrotic cells fromviable cells,
different kinds of controls were used to adjust flow cytometer settings. Apoptotic cells (positive con-
trol) were received by incubation of cells with 1 µMstaurosporine for 6 h at 37°C, 5%CO2 in a humidi-
fied shaker incubator (150 rpm, 50mmdisplacement). Viable cells servedasnegative control. Control
samples were either treated with both, Annexin V-FITC and propidium iodide or with just one of the
components. Directlybefore (0h)and24hafter the inductionofhyperosmotic conditions, 5x 105 cells
mL-1) were incubated with Annexin V-FITC and propidium iodide for 15 min on ice followed by flow
cytometric analysis of 50,000events. ApositiveAnnexinV-FITCsignal indicatesapoptosis and in com-
binationwith a positive propidium iodide signal necrosis.
Table 4.14: Flow cytometer settings for apoptosis assay. λexcitation = 488 nm, FS = forward scatter, SS = side-
wards scatter, FL1 = fluorescence channel 2 (525 nm), FL3 = fluorescence channel 3 (620 nm) Lin = linear,
Log = logarithmic
channel voltage [V] type of amplification amplification factor
FS 690 Lin 2.0
SS 1000 Lin 5.0
FL1 370 Log 1.0
FL3 402 Log 1.0
Cell Cycle Analysis
Cells were harvested by centrifugation (300g, 5 min, 4°C) and were washed once with PBS. Fixation
of cells was performedwith -20°C-cold ethanol containing fixation buffer (Tab. 4.3) and cell samples
(1 x 107 cells mL-1) were stored at -20°C. Fixed cells were washed and resuspended with PBS, treated
with RNase A and finally stainedwith propidium iodide (10 µg/107 cells). The stained cells were ana-
lyzed by flow cytometry detecting 35 000 events (Tab. 4.15).
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Propidium iodide intercalates into the DNA and therefore the fluorescence intensity of a cell corre-
lates with its DNA-content (Crissman and Steinkamp, 1973). Resulting histograms for fluorescence
channel 3 (620nm)were analyzedwith the software Cylchred (4.5) in order to determine the percent-
age of cells in G1-, G2- and S-phase of cell cycle.
Table 4.15: Flow cytometer settings for cell cycle analysis. λexcitation = 488 nm, FS = forward scatter, SS = side-
wards scatter, FL3 = fluorescence channel 3 (620 nm), Lin = linear, Log = logarithmic
channel voltage [V] type of amplification amplification factor
FS 896 Lin 2.0
SS 1000 Lin 2.0
FL3 409 Log 1.0
4.2.6 Determination of SpecificMetabolic Rates
Specificmetabolic rates were determined for defined time intervals of bioreactor cultivations.
Time variant process parameters, e. g. biomass, can be described bymass balances (Eq. 4.2)
mX
dt

dpcX  Vq
dt
(4.2)
withmX as the amount of biomass (in g), t as the time of cultivation (in d), cX as the concentration of
biomass (in g L-1) and V as theworking volume of the bioreactor (in L).
Eq. 4.2 can be simplified by product rule and
dV
dt
 0 which applies for batch cultivations. The
resulting equation defines the specific growth rate (µ in d-1) as follows
µ 
1
cX

dcX
dt
(4.3)
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µwasanalyzed in theexponential growthphasewhereµ=constantapplies. Therefore the integration
of Eq. 4.3 leads to
ln
cX
cX0
 µ t (4.4)
For mammalian cell culture it was assumed that the number of cells (Ncells) approximates mX.
In accordance, the viable cell density (VCD in cells L-1) approximates cX.
Based on Eq. 4.4 plotting of ln
VCD
VCD0
versus (vs.) t followed by linear regression reveals µ as the slope
of the regression line.
The specific substrate formation rate (qS inmol cell-1 d-1) is defined as follows:
qS 
1
cX

dcS
dt
(4.5)
with cS as the concentration of substrate (inmol L-1).
The integration of Eq. 4.5 for a time interval i to i+1 leads to
qS 
1
cXptq

cS, i 1  cS, i
ti 1  ti
(4.6)
qS was determined by plotting cS vs. the integral of viable cell density (IVCD) thereby analyzing qS as
the slope of the regression line.
In addition cS was plotted vs. t and the resulting slope of the regression line was divided by the
arithmeticmean of VCD in order to obtain qS.
The specific product formation rate (qP inmol cell-1 d-1) was determined in accordance to qS.
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4.2.7 Carbon/OxygenBalancing andCalculation of ATP FormationRates
Specific ATP formation rates (qATP) were estimated on basis of carbon and oxygen balancing. There-
fore changes in the amount of substrates and by-products during time intervals of bioreactor cultiva-
tions were calculated in C-mol (∆nmetabolitepxq, Cmol) as described by Eq. 4.7
∆nmetabolitepxq, Cmol  NC, metabolitepxq  pcmetabolitepxq, ti 1  Vti 1  cmetabolitepxq, ti  Vtiq
(4.7)
withNC, metabolitepxq as thenumberof carbonatomsofmetabolite(x), cmetabolitepxq, ti as concentration
of metabolite(x) (in mol L-1) at time point i and Vti as the working volume in the bioreactor (in L) at
time point i. Meinhold (2012) analyzed themolar composition of exponentially growing CHODP-12
cells. Cells contained 1.51 x 10-11mol carbonper cell. ∆nbiomass, Cmol was calculatedonbasis of Eq. 4.8
with VCDt=i as the viable cell density (in cells L-1) at time point i of cultivation.
∆nbiomass, Cmol  1.51 10
11

Cmol
cell

pVCDti 1  Vti 1  VCDti  Vtiq (4.8)
Changes in theamountofmetabolite(x) inO-mol (∆nmetabolitepxq inO-mol)werecalculatedas follows:
∆nmetabolitepxq, Omol  XO{C, metabolitepxq ∆nmetabolitepxq, Cmol (4.9)
XO{C, metabolitepxq represented the ratio of oxygen and carbon in metabolite(x), e. g. 1 for C6H12O6 or
0.487 for biomass (Meinhold, 2012).
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The sum of all negative ∆nmetabolitepxq, Cmol or ∆nmetabolitepxq, Omol values formed the carbon or
oxygen influx (Eq. 4.10) while carbon and oxygen efflux were represented by the sum of all positive
values of∆nmetabolitepxq, Cmol or∆nmetabolitepxq, Omol respectively (Eq. 4.11).
carboninflux 
¸
∆nmetabolitepxq, Cmol oxygeninflux 
¸
∆nmetabolitepxq, Omol (4.10)
with ∆nmetabolitepxq, Cmol   0 with ∆nmetabolitepxq, Omol   0
carboneﬄux 
¸
∆nmetabolitepxq, Cmol oxygeneﬄux 
¸
∆nmetabolitepxq, Omol (4.11)
with ∆nmetabolitepxq, Cmol ¡ 0 with ∆nmetabolitepxq, Omol ¡ 0
As the composition of the exhaust gas could not be analyzed for bioreactor cultivations it was as-
sumed that the amount of produced CO2 in a time interval (∆nCO2 in C-mol) was represented by the
difference between carboninflux and carbonefflux (Eq. 4.12). The samewas assumed for∆nO2 (4.13).
∆nCO2  p1q  carboninflux  carboneﬄux (4.12)
∆nO2  p1q  oxygeninflux  oxygeneﬄux (4.13)
Specific CO2 and O2 formation rates (qCO2 , qO2) were calculated for different time intervals (∆t)
according to Eq. 4.14 with VCD describing the geometric mean of viable cell density in the analyzed
time interval.
qCO2 
1
∆t

∆nCO2
VCD
qO2 
1
∆t

∆nO2
VCD
(4.14)
82
4 Materials andMethods
qO2 is connected to qATP as described by Eq. 4.15:
qATP  p1q  P{O qO2 (4.15)
where P/O represents the number of ATPmolecules which is produced per reduced oxygen atom by
the respiratory chain (Hinkle, 2005). Balcarcel and Clark (2003), Hinkle (2005) andWahl et al. (2008)
described a NADH-linked P/O-ratio of 2.5 and a FADH2-linked P/O-ratio of 1.5. In general a P/O-ratio
of 2.5 was considered in this study. Nevertheless P/O-ratios of 1.5 were also taken into consideration
for a representative interpretation of data.
4.2.8 Calculation of AdenineNucleotide Pool Sizes
Adenine nucleotide pools were determined for whole cell and mitochondrial samples which were
acquired by fast filtration approaches and methanol/chloroform extraction (4.2.3, 4.2.4). The com-
plete extraction process of intracellular metabolites was gravimetrically documented to determine
thevolumeofextractionsolute (Vextract. solute inL)andthefactorofconcentrationbyevaporation(Cevap.).
The intracellular amount of a metabolite (nmetabolite in mol cell-1), e. g. nATP or nG6P, was calculated
based on Eq. 4.16
nmetabolite  cmetabolite  Cevap.  Vextract. solute 
1
Ncells
(4.16)
with cmetabolite (inmol L-1) as the concentrationof themetabolite in the cell extractwhichwasanalyzed
by HPLC or LC-MS/MS (4.2.5) and Ncells as the number of cells which were used for the extraction of
intracellularmetabolites.
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MitochondrialATPpools (nATPmit inmol cell-1)weredeterminedbyEq. 4.17 therebyconsidering the loss
ofmitochondrial compartmentand the remaining cytosol onbasisof specificmarkermetabolites. cis-
aco was used asmitochondrial marker and G6P and F6P functioned as cytosolic markermetabolites.
Index (C) defines whole cell samples and (M) mitochondrial samples. (M)/(C)-ratios represent the
remaining fraction of mitochondrial or cytosolic marker metabolites in cytosol depleted/
mitochondrial samples.
nATPmit 
ncisacopCq
ncisacopMq
 nATP pMq 

1 0.5
nG6P pMq
nG6P pCq
 0.5
nF6P pMq
nF6P pCq

(4.17)
Eq. 4.18 was used to calculate cytosolic ATP-contents (nATPcyt inmol cell-1).
nATPcyt  nATPpCq  nATPmit (4.18)
Mitochondrial and cytosolic ADP (nADPmit , nADPcyt) and AMP (nAMPmit , nAMPcyt) contents were calculated
in accordance to the equations used for ATP (Eq. 4.17 and 4.18). Intracellular adenine nucleotide con-
centrations were calculated on basis of intracellular adenine nucleotide contents and corresponding
cell diameters (CEDEX), thereby assuming a spherical cellularmorphology.
Adenylate energy charges for whole cell samples and the cytosolic andmitochondrial compartment
were calculated according to Atkinson andWalton (1967), Eq. 4.19.
AEC 
nATP   0.5 nADP
nATP   nADP   nAMP
(4.19)
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4.2.9 Calculation of Errors and Statistics
Analyzedmetabolic parameterswere based on three technical and at least three biological replicates
if not stated otherwise.
As the calculation of the standard deviation for a metabolic parameter x (σx) was based on the
assumptionof normally distributeddata, Shapiro-Wilk normality testwas applied to validate normal
distribution of data (P¥ 0.05).
σx was calculated as follows:
σx 
d°n
i1pxi  x¯q
2
n 1
(4.20)
with xi as an individual data point, x¯ as the arithmeticmean of all data points and n as the number of
data points.
The calculation of somemetabolic quantities, e. g. nATPmit or AEC, (Eq. 4.21) was based on error-prone
parameters like for example nG6P or nADP . Standard deviations for aforementionedmetabolic quan-
tities (σ¯f ) were calculated based on Gaussian error propagation as described in Eq. 4.22
f  fpx¯, ..., n¯q (4.21)
σ¯f 
gffeBf
Bx¯
 σx
2
  ... 

Bf
Bn¯
 σn
2
(4.22)
with x as error-prone metabolic parameter,
δf
δx¯
as partial derivative of f with respect to x¯ and σx as
standard deviation of x¯.
A two-sidedunequal variance t-testwasapplied todeterminesignificantdifferences inmetabolismof
hyperosmotically treated cells compared to cells grownat reference conditions. According to the con-
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vention described by Cumming et al. (2007), P-values (P)¤ 0.05 indicated a statistically significant
differencewhile P¤0.01 represented a highly significant difference between the results for hyperos-
motic and reference conditions.
4.2.10 miRNAandmRNAExpressionAnalysis
Next generation sequencing (NGS) was applied to investigate the effects of an osmotic upshift on
mRNA andmiRNA expression of CHODP-12 cells.
Cells (2 x 106) were harvested by centrifugation (400g, 4°C, 5min), resuspended in 300µLRNAprotect
Cell Reagent (Qiagen) and frozen in liquid nitrogen. Cell samples were stored at -70°C until isolation
of RNA.
MFT-Services (http://www.mft-services.de) in Tübingen performed the steps from RNA-isolation to
the lists of raw counts formiRNAs andmRNAs as described inmanuscript 2, supporting information
B.2.
Identification of SignificantlyDifferentially ExpressedmiRNAs andmRNAs
miRNA and mRNA counts were further analyzed with edgeR (version 3.10.2) (Robinson et al., 2010)
in RStudio (version 0.98.1103, R version 3.2.1). The detailed R scripts for miRNA and mRNA analysis
can be found in supporting information A.2.2 and A.2.3.
In summary, 10 counts were added to each mRNA andmiRNA raw count. Only those mRNAs which
showed more than 10 counts in at least 12 of 25 samples were considered for further analysis. In
accordance to the mRNA protocol, a minimal read count of 11 in each of the samples was the crite-
rion to select amiRNA for further analysis.
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In another step, only those genes and miRNAs which revealed at least one count per million (CPM)
in 3 ormore samples remained in the datasets for subsequent differential expression analyses. CPM
were calculated as described in Eq. 4.23
CPM 
Γi°n
i1 Γi
 106 (4.23)
with Γi as the number of counts for gene i and
°n
i1 Γi as the sumof counts for gene i=1 to n.
Differential expression analysis was performedwith the negative binomial generalized linearmodel
(GLM)method developed byMcCarthy et al. (2012). Gene-specific variations were estimatedwith an
empirical Bayes approach (McCarthy et al., 2012). Cox-Reid adjustedprofile likelihood statistics, Pear-
son's chi-square test and Benjamini-Hochberg method (Benjamini and Hochberg, 1995) were used
for identification of significantly differentially expressed genes (DEG). miRNAs andmRNAs showing
log2-fold changes (log2(FC))¥ |1.0|, P¤0.02 and false discovery rates (FDR)¤0.02were defined as
DEGs. Principal Component Analyses were performed for mRNA and miRNA datasets with DESeq2
(4.5).
GeneExpressionDynamics
The number of significantly up- and downregulated mRNAs at defined time points was visualized
by VennDiagram (version 1.6.9). MaSigPro (version 1.40.0) with hierarchical clustering was applied
to investigate expression dynamics of up- and downregulated mRNAs (Conesa et al., 2006; Nueda
et al., 2014). Gene count datasets were filtered as described in the previous abstract and were CPM-
normalized with edgeR before they were further analyzed with maSigPro. A detailed example of a
maSigPro R script is shown in supporting information A.2.4. In 2014, Nueda et al. expanded the
maSigPro supportedmodelsbyGLMs therebyenabling theanalysis ofRNAcountdata sets. maSigPro
analysis was based on a combination of two polynomial regression steps (Conesa et al., 2006; Nueda
et al., 2014). In the first step a regressionmodelwas fit to each genewith least-square parameter esti-
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mation and significant genes (P-value and FDR¤ 0.02) were identified by F-statistic and Benjamini-
Hochbergmethod (Nuedaet al., 2014). The first stepwas followedbya stepwise regression inorder to
identify the best regression coefficients for each of the selected genes in step one. Genes were
defined as statistically significant if the R-square value (R2) for the regressionmodelwas greater than
0.7 and P-value and FDR were lower than 0.02. Finally genes were clustered with hierarchical
clustering algorithm.
GeneOntology EnrichmentAnalysis
Gene Ontology (GO) Enrichment Analysis was performed with GOseq (version 1.20.0,
Young et al. (2010)), MGI Gene Ontology Term Finder (http://www.informatics.jax.org) and GOrilla
(Eden et al., 2009). As C. griseuswas not supported by the three tools, analyses were based on the GO
data sets forHomo sapiens,Musmusculus and Rattus norvegicus.
miRNATarget Prediction
ValidatedmRNA targets of differentially expressed (DE)miRNAswere identified on basis of themiR-
TarBase database (http://mirtarbase.mbc.nctu.edu.tw/, Chou et al. (2015)). mRNAswere assumed to
be targets of a specificmiRNA if their identificationwas based on luciferase or green fluorescent pro-
tein (GFP) reporter assay,Western blot and/or quantitative polymerase chain reaction (qPCR).
In addition, miRDB (http://mirdb.org/miRDB/, Wong and Wang (2015)), DIANA-microT web server
version 5.0 (http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=microT_CDS/index,
Paraskevopoulou et al. (2013); Reczko et al. (2012)) and TargetScanHuman release 6.2 (http://www.
targetscan.org/vert_61/) were applied to predict targets of DE miRNAs. Target prediction was per-
formed for human ormurinemiRNAhomologs.
MGI Gene Ontology Term Finder (http://www.informatics.jax.org), GOrilla (Eden et al., 2009) and
AmiGOTermEnrichmentServices (http://amigo.geneontology.org/rte) connectedtoProteinANalysis
THrough Evolutionary Relationships (PANTHER) Classification System were applied for GO enrich-
ment analysis of DE predicted targets.
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The production of heterologous proteins by mammalian host cell lines is an energy consuming
process. Thehighestamountofcellularenergy in formofATPisproducedbymetabolicpathways (TCA
cycle, electron transport chain, oxidative phosphorylation) located in the mitochondrial
compartment: the cellular "powerhouse". Therefore, the key interest of a preliminary diploma
thesis (Pfizenmaier, 2011) was the development of a flow cytometric method to investigate resizing
of themitochondrial compartment in relation to qp enhancing hyperosmotic culture conditions. The
translocase of the outer mitochondrial membrane 22 (TOM22) represented the target molecule for
the developed antibody-based fluorescence labeling of intracellular mitochondria (4.2.5). This
method was utilized by Pfizenmaier (2011) in order to investigate the mitochondrial response upon
osmotic upshift from290 to 390mOsmol kg-1 during batch cultivation of an anti-IL-8-IgG1 producing
CHODP-12cell line (4.2.2). Thus, adecline inmitochondrial fluorescence (Fig. 3.2)uponhyperosmotic
stimulus was revealed and a reduced size of themitochondrial compartment was assumed.
This hypothesis in relation to the qP enhancing effect of hyperosmotic culture conditions
represented the starting point to conduct further research concerning this complex of themes in the
current study.
In the first part of this research study, experiments were performed to validate and to further charac-
terize the phenotype of hyperosmotically stressed CHODP-12 cells.
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5.1 Phenotype of CHODP-12 Cells Exposed toHyperosmotic
Stimulus (+ 100mOsmol kg-1)
Results of this section have partially been published in Pfizenmaier et al. (2015) (manuscript 1
supporting information B.1).
5.1.1 G1-phaseArrest and Inhibition of Cell Growthdue toHyperosmolality
Bioreactorcultivations (4.2.2)wereperformedinbatchmodeto investigate thephenotypeofhyperos-
motically stressedCHODP-12cells. Hyperosmotic culture conditions (390mOsmolkg-1)were induced
by addingNaCl-enriched cultivationmedium to four of eight cell cultures (VR = 1.2 L) 72 h after inocu-
lation, thus resulting in a highly significant difference (P < 0.001) in osmolality of∼ 100mOsmol kg-1
compared to reference cultures (Fig. 5.1). Osmolality slightly increased with the time of cultivation
whereby the ∼100 mOsmol kg-1 difference between reference and hyperosmotic batch cultures
remained rather constant until the end of cultivation (Fig. 5.1).
Starting with approximately identical profiles of viable cell densities (VCD) in all batch cultures,
hyperosmotic culture conditions lowered the VCD compared to reference cultures. However, post-
shift profiles of VCD showed high inter-culture variances, thus alleviating the effect on VCD. While
VCD reached a maximal level (VCDmax) of 9.0 1.4 x 106 cells mL-1 on day 6 at reference conditions,
hyperosmolality reduced VCDmax to 6.4 1.1 x 106 cells mL-1. Analysis of cellular growth rates (µ) for
the time interval day 4 to 6 revealed a significantly lower µ for hyperosmotically stressed cells com-
pared to reference cells (µ =0.28 0.04 d-1 vs. µ =0.48 0.11 d-1, P = 0.02, n = 4).
In contrast to VCD, the osmotic upshift from290 to 390mOsmol kg-1 did not affect the viability of
CHODP-12 cells. Viability of both, reference and hyperosmotically stressed CHODP-12 cells, showed
levels > 97%until culture day 6where viability started to decline, consequently reaching levels below
90%on culture day 8 (Fig. 5.1).
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Figure 5.1: Profiles of osmolality, viable cell density and viability of CHODP-12 cells cultivated inbioreactor.
NaCl-enriched cultivation medium (Tab. 4.3) was added 72 h after inoculation (arrow) to defined cultures in
order to induce hyperosmotic conditions (n = 4,N4). An equal volume of standard CHO DP-12 cultivation
mediumwasadded to reference cultures (n=4,). Errorbars represent standarddeviationsof fourbiological
replicates thereby considering as well the technical error ofmeasurement (n = 3). Highly significant difference
in osmolality between day 3 and 7 (P < 0.001). With changes to Fig. 1AB of Pfizenmaier et al. (2015) (supporting
information B.1).
A cell cycle arrest related inhibition of cell growth was described for CHO cells exposed to hyperos-
motic culture conditions by Ryu et al. (2001). Therefore, the cell cycle distribution of reference and
hyperosmotic cultures was analyzed in this study.
Directly before the osmotic stimulus, all CHO DP-12 batch cultures showed a similar population
composition with respect to cell cycle distribution (Fig. 5.2). Thereafter, the percentage of hyper-
osmotically stressed cells in G1-phase increased from∼ 40% on day 3 to 79% on day 7 (Fig. 5.2 A). In
addition, the cell population in S-phase decreased significantly from 46% to 16% in the same time
interval while a slight decrease from 14% to 5%was detected for G2-phase (Fig. 5.2 BC). An increase
in the percentage of cells in G1-phase together with a decrease of cells in S- and G2-phase was also
characteristic for reference cultures. However, a comparison of hyperosmotic and reference cultures
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revealed significantly higher G1-phase populations and significantly lower S-phase populations
(P < 0.005, n = 4) for hyperosmotically stressed cells on day 4 to 6 ( (Fig. 5.2 AB). Consequently, the
results suggest an induction of G1-phase arrest by osmotic upshift.
Figure 5.2: Effect of hyperosmolality (+ 100 mOsmol kg-1) on the cell cycle distribution of CHO DP-12 cul-
tures. NaCl-enriched cultivation medium (Tab. 4.3) was added 72 h after inoculation (arrow) resulting in
an osmolality of ∼ 390 mOsmol kg-1 (N) for hyperosmotic cultures. Osmolality of reference cultures was
∼ 290mOsmol kg-1(). Determination of the distribution of cells inG1- (A), S- (B) andG2-phase (C) of cell cycle
was based on propidium iodide staining and flow cytometric analysis (4.2.5). Error bars represent standard de-
viations of four biological replicateswith three technical replicates each. Figure A is amodified version of Fig. 2
of Pfizenmaier et al. (2015) (supporting information B.1). Highly significant difference due to hyperosmolality
for G1- and S-phase on days 4 to 6 (P < 0.005).
5.1.2 Metabolic Rates IncreaseUponOsmotic Shift
Toobtainabetter ideaof themetabolicactivityandtheproductivityofhyperosmotically stressedCHO
DP-12 cells (+ 100mOsmol kg-1), specific metabolic formation rates were determined for Glc, Lac and
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the produced mAb (Tab. 5.1). Highly significantly reduced qGlc and increased qLac were observed for
cells exposed to hyperosmotic culture conditions in the post-shift period day 4 to 6. To be precise, qGlc
and qLac changed by 35 and 40%, respectively, thusmaintaining themolar yield in Lac per consumed
mol of Glc (YLac/Glc, 1.10 0.14 vs. 1.06 0.25 molLac molGlc-1 for reference cells). Limiting conditions
with respect to the nutrient Glc (∼ 5mM, Ozturk andHu (2005)) occurred on culture day 6 (support-
ing information Fig. A.1). Noteworthy, the concentration of the accumulated Lac in the culture broth
started to decline at the same time point (supporting information Fig. A.1). In addition to the afore-
mentioned changes, qP improved from3.69 to 5.55 pgmAb cell-1 d-1 in response to hyperosmotic stimu-
lus resulting inamaximal cP of∼90mgL-1 compared to∼60mgL-1 for reference cultures (supporting
information Fig. A.2).
Table 5.1: Effect of hyperosmolality (390 mOsmol kg-1) on qGlc, qLac and qP in the time interval day 4 - 6.
Negative values indicate consumption whereas positive values stand for production. ** highly significant
difference between reference and hyperosmotic conditions (P¤ 0.002, n = 4)
qGlc ** qLac ** qP
[pmol cell-1 d-1] [pgmAb cell-1 d-1]
reference - 1.55 0.18 1.64 0.19 3.69
hyperosmolal - 2.09 0.13 2.29 0.12 5.55
5.1.3 Osmotic Upshift Reduces TOM22-MediatedMitochondrial Fluorescence
Stress conditions affect the cellular response (2.6 and2.7) andmay therefore cause changes in energy
demand and variations in the size of themitochondrial compartment. An antibody-based technique
for intracellular fluorescence labeling of mitochondria (4.2.5) was applied to investigate changes of
the mitochondrial compartment as response to hyperosmotic stimulus. Directly before osmotic
upshift, flow cytometric analyses revealed congruent histograms and equal median fluorescence
intensities for cells of all batch cultures (Fig. 5.3 B, supporting information Fig. A.5). About 24 h after
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hyperosmotic stimulus (+ 100mOsmol kg-1), osmotically stressed cells showed amore than 50% de-
crease inmitochondrial fluorescence intensity compared to reference cells which showed only slight
changes (Fig. 5.3 B). More precisely, hyperosmotic culture conditions shifted the histogram to lower
fluorescence intensities whereas similar histograms were observed for isotype controls of reference
andhyperosmotic cultures (Fig. 5.3A).Mitochondrial fluorescence intensitiesdecreasedwith thetime
of cultivation, thereby showing significantly lower fluorescence levels for hyperosmotically stressed
cells onday4and5 (P<0.01). In contrast, comparable values for both reference andhyperosmotically
stressed cells were detected on day 6 and 7 (Fig. 5.3).
In summary, experiments validated the previously described decrease inmitochondrial fluorescence
intensity at hyperosmotic culture conditions (Pfizenmaier, 2011).
Figure 5.3: A: Histogram of flow cytomerically analyzed CHO DP-12 cells 24 h after osmotic shift. B: Time
courses ofmitochondrial fluorescence. Intracellular mitochondria were labeled by a combination of an anti-
translocase of the outer mitochondrial membrane 22 (TOM22) and a phycoerythrin (PE)-conjugated isotype-
specific anti-IgG2a antibody. The fluorescence intensity of the cells was analyzed by flow cytometry, thereby
detecting 40,000 events (4.2.5). Mitochondria of CHO DP-12 cells were stained directly before osmotic shift
(arrow) and on each of the following days of cultivation (4.2.2). Osmotic shift resulted in an osmolality of
∼ 390mOsmol kg-1 (grey,N, n=4) compared to∼ 290mOsmol kg-1 for the reference cultures (black,, n = 4).
Mitochondrial fluorescence (Fig. B) was normalized and corrected for non-specific binding as described in
Eq. 4.1. Error bars were smaller than the symbols of the plotted data points. Highly significant difference in
mitochondrial fluorescence on days 4 and 5 (P < 0.01).
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5.1.4 Hyperosmotically Stressed Cells ShowEnhancedAvailability of ATP
Initial results for the hyperosmotic stimulus study revealed increased consumption of Glc and
production of Lac in combinationwith a decrease in themitochondrial fluorescence signal of osmoti-
cally stressed CHODP-12 cells. As these resultsmay indicate contradictory effects of hyperosmolality
on the cellular energy level, cell specific O2, CO2 and ATP formation rates (qO2 , qCO2 , qATP) as well as
intracellular adenine nucleotide pools were subsequently analyzed.
Carbon and oxygen balancing (4.2.7, supporting information Tab. A.2) were applied in order to
calculate qO2 and qCO2 for both hyperosmotic and reference cultures. In the post-shift period day 3 to
4, qO2 wasapproximately -0.32pmol cell-1 h-1 for referenceandosmotically stressedcellswhereasqCO2
was as high as 0.25 pmol cell-1 h-1 (Fig. 5.4). Thereafter hyperosmolality resulted in even lower values
for qO2 and higher values for qCO2 , thus depicting increased consumption of O2 and
production of CO2, respectively (Fig. 5.4).
Figure 5.4: Effect of osmotic shift (+ 100 mOsmol kg-1) on specific carbon dioxide (qCO2 ) and oxygen for-
mation rates (qO2 ) of CHO DP-12 cells. Hyperosmotic conditions (∼ 390 mOsmol kg-1,N) were induced by
the addition of NaCl-enriched cultivation medium (Tab. 4.3) 72 h after inoculation of bioreactors (4.2.2). Os-
molality of reference cultures was ∼ 290 mOsmol kg-1(). The determination of qCO2 and qO2 was based
on carbon and oxygen balancing (4.2.7) for defined time intervals. Data points are arithmetic means of two
biological replicates.
To be precise, qO2 reached -0.39 or -0.36 pmol cell-1 h-1 in the time interval day 4 to 5 and day 5
to 6 while values of 0.43 and 0.40 pmol cell-1 h-1 were calculated for qCO2 (Fig. 5.4). In the same time
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intervals, reference cells showed comparatively minor changes in qO2 and qCO2 (Fig. 5.4). Respiratory
quotient (RQ 1) functioned as a quality standard for the calculated rates and therefore average RQs
were analyzed for the time interval day 4 to 7. Noteworthy, the average RQ for reference cultures
(1.07 0.14) resembled the RQ at hyperosmotic conditions (1.08 0.04).
To obtain qATP in relation to the determined qO2 (Eq. 4.15, 4.2.7) a P/O-ratio of 2.5 was assumed on
basis of values from literature (Balcarcel and Clark, 2003; Hinkle, 2005; Nath and Villadsen, 2015;
Wahl et al., 2008). Starting from comparable qATP of approximately 19 pmol cell-1 d-1 in the post-
shift interval day 3 to day 4, qATP of CHODP-12 cells exposed to hyperosmolality increased by∼ 20%
whereas almost no change was observed for reference cells (Fig. 5.5). Although qATP declined from
day 4 to 7, approximately 30 to 39%higher values were observed for hyperosmotically stressed cells.
Figure 5.5: Influence of hyperosmolality (+ 100mOsmol kg-1) on intracellular ATP-content and specific ATP
formation rate (qATP) of CHO DP-12. NaCl-enriched cultivation medium (Tab. 4.3) was added 72 h after
inoculation (arrow) resulting in an osmolality of ∼ 390 mOsmol kg-1 (N4) for hyperosmotic cultures. Os-
molality of reference cultures was∼ 290mOsmol kg-1(). Intracellular ATP-contents were determined by a
combination of a fast filtration approach for 107 cells (4.2.3),methanol/chloroformextraction (4.2.4) andHPLC
analysis (4.2.5). Two biological replicates with three technical replicates each were analyzed at all time points
and were used to calculate the standard deviations represented by error bars. qATP was determined by carbon
andoxygenbalancing (4.2.7) andaP/Oratioof2.5 (Balcarcel andClark, 2003;Hinkle, 2005;NathandVilladsen,
2015;Wahl et al., 2008). With changes to Fig. 3 of Pfizenmaier et al. (2015)(supporting information B.1.)
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In concurrence with the enhanced qATP, CHO DP-12 cells exposed to hyperosmolality possessed
higher intracellular ATP-contents (nATP) on day 5, 6 and 7 (Fig. 5.5). Precisely, all cell cultures showed
similar nATP of ∼ 3 fmol cell-1 directly before and 24 h after osmotic upshift. In the following time
of cultivation, nATP of osmotically stressed cells increased up to 3.30 fmol cell-1 on day 6 and subse-
quently lowered to 1.60 fmol cell-1. During the same time interval, nATP of reference cells decreased
almost gradually from2.86 to 0.95 fmol cell-1, thus revealing a distinct enhancement of nATP at hyper-
osmotic culture conditions. In addition, analysis of intracellular adenine nucleotides revealed ADP-
contents (nADP) between 0.15 and 0.29 fmol cell-1 whereby nADP tended to be higher for hyperosmot-
ically stressed cells (supporting information Fig. A.4). Intracellular AMP levels were even lower than
nADP and consequently themeasured AMP values were below the reliable detection limit.
Theadenylateenergycharge(AEC)accordingtoAtkinsonandWalton(1967) isan importantandhighly
stable metabolic control parameter that is defined as the sum of nATP and 1{2 nADP divided by the
sum of nATP, nADP and nAMP (Eq. 4.19 section 4.2.8). Therefore, AECs were determined directly
before osmotic upshift (day 3) and in the post-shift period day 4 to 7, thereby disregarding AMP
levels (Tab. 5.2). Reference andosmotically stressedCHODP-12 cells showedequal and stableAECsof
0.97 0.01 on day 3 to 5 (Tab. 5.2). Thereafter, AECs declined but still remained at levels above 0.90.
Table 5.2: Effect of osmotic upshift (+ 100mOsmol kg-1) on adenylate energy charges. Day 3 represents the
timepoint directly before osmolalitywas increased from∼290mOsmol kg-1 (reference) to∼ 390mOsmol kg-1
(hyperosmolal) during batch cultivation of CHODP-12.
day 3 day 4 day 5 day 6 day 7
reference 0.97 0.01 0.97 0.01 0.97 0.01 0.96 0.01 0.93 0.02
hyperosmolal 0.97 0.01 0.97 0.01 0.97 0.01 0.92 0.06 0.91 0.02
According to independent studies (Alfieri and Petronini, 2007; Burg et al., 2007; Kiehl et al., 2011;
Lang et al., 1998) hyperosmotic culture conditions can induce RVI (2.6), thus being able to affect in-
tracellular metabolite concentrations and pool sizes, respectively. To review whether enhanced qATP
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andnATP at hyperosmotic culture conditionswere related to RVI, cell diameters and intracellular ATP-
concentrations (cATP)were investigated (4.2.8). Reference andosmotically stressed cells showed com-
parablecelldiametersof∼ 11.6µminthepre-shiftperiodanddirectlyafterosmoticupshift (Fig. 5.6B).
Subsequently, hyperosmolality induced a steady increase in cell diameter, reaching 13.5 µmon day 7.
In contrast, cell diameters of reference cells remained rather constant until day 6, followed by a dis-
tinct increase to 12.9µmonday 7. After cultureday 7, cell diameters of both reference andosmotically
stressed cells declinedwhereby cell diameters of cells exposed tohyperosmotic stimulus tended tobe
higher (Fig. 5.6 B).
Figure 5.6: Changes in intracellular ATP-concentration (A) and cell diameter (B) of CHO DP-12 due to
hyperosmolality (+ 100mOsmolkg-1).Osmolalitywas increased 72hafter inoculationby the additionofNaCl-
enriched cultivation medium (arrow). This resulted in an osmolality of∼ 390 mOsmol kg-1 (N) compared to
∼ 290 mOsmol kg-1 for reference cultures (). Cell diameters were determined by Cedex XS cell counter. In-
tracellular ATP-concentrationswere analyzed by a combination of a fast filtration approach for 107 cells (4.2.3),
methanol/chloroform extraction (4.2.4), HPLC analysis (4.2.5) and the assumption of spherical cells. Error bars
of Fig. A represent standard deviations based on two biological replicates and three technical replicates each
while error bars of Fig. B represent standard deviations of four biological replicates.
Inaccordance to thehyperosmotically induced2-fold increase innATP oncultureday6 (Fig. 5.5), os-
motically stressedCHODP-12 cells showed∼ 1.7-fold elevated cATP at the same timepoint (Fig. 5.6 A).
On day 5 and 7, however, the difference in cATP compared to reference cells was slightly less distinct
as for nATP (Fig. 5.6 A). As the time course of cell diameters for osmotically stressed CHO DP-12 cells
indicated RVI, the required qATP to compensate RVI (qATP,+) was estimated. Regarding the time in-
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terval day 3 to 5, osmotically stressed cells showed a daily increase in cell volume of approximately
0.75pL cell-1. Considering theaverage cATP of 3.4mMfor this time interval, a qATP,+ of0.26 fmol cell-1 d-1
would have been required to maintain cATP. Noteworthy, the enhancement of qATP was as high as
4910 fmol cell-1 d-1 for the time interval day 3 to 4, thus being severalmagnitudes higher than qATP,+.
Concluding, hyperosmotically stressed CHO DP-12 cells showed enhanced qATP in combination with
increased nATP and cATP.
5.1.5 Reliability of theMitochondrial StainingProcedure
Theobserved improved energetic capacity of hyperosmotically stressedCHODP-12 cellswas contrary
to thehypothesized reducedsizeof themitochondrial compartmentas response tohyperosmotic cul-
tureconditions. Inorder to investigatewhether theantibody-basedmitochondrial stainingprocedure
produced reliable results, additional flow cytometric parameters were analyzed and further control
experiments were performed.
As part of the flow cytometric analysis of mitochondrial fluorescence intensities, signals of forward
and sidewards scatter were investigated in order to reveal potential changes in cell size or cellular
structure which may influence the binding of the anti-TOM22 antibody to its mitochondrial target.
Both, reference and batch cultures undergoing hyperosmotic treatment, showed comparable
histograms for forward and sidewards scatter prior to osmotic upshift onday 3 of cultivation (Fig. 5.7).
Broader but similar forward scatter histogramswere received for reference andhyperosmotic cul-
tures onday 7, thereby showing a tendency to elevated values for forward scatterwhichmay correlate
with enlarged cell size (Fig. 5.7). An increase in intra-culture variancewas also observed for sidewards
scatter fromday3 to7. However, this effectwasmorepronouncedathyperosmotic culture conditions.
Furthermore, the sidewards scatter histogram of osmotically stressed cells was shifted to higher val-
ues resulting in a distinct difference with respect to reference conditions (Fig. 5.7). Concluding, this
difference in sidewards scatter which developed during the four day post-shift period may indicate
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hyperosmotically induced changes in cellular structure.
Figure 5.7: Effect of hyperosmotic stimulus on forward and sidewards scatter of CHODP-12 cells. Informa-
tion of forward and sidewards scatter was acquired as part of the flow cytometric analysis of mitochondrial
fluorescence intensities (4.2.5). Measurements were performed directly before (day 3) as well as on the follow-
ing four days after hyperosmotic stimulus (+ 100mOsmol kg-1). Addition ofNaCl-enriched cultivationmedium
to four CHO DP-12 batch cultures resulted in an average culture osmolality of∼ 390mOsmol kg-1 (grey) com-
pared to∼ 290mOsmol kg-1 for reference cultures (n = 4). Histograms for day 3 and 7 are based on at total of
40,000 events.
Additional experiments were performed in order to elucidate whether hyperosmotic culture
conditions may affect the reliability of the staining procedure. Although all washing steps during
the mitochondrial staining procedure should have resulted in comparable sample osmolalities, the
influence of osmolality on the intensity of the fluorescent label phycoerythrin was investigated. The
resulting data revealed that hyperosmolality had no effect on the fluorescence intensity of phyco-
erythrin (supporting information Fig. A.7). Furthermore, a potential interaction between the
mitochondrial staining target TOM22 and the pro-apoptotic protein BAX (2.3) which might reduce
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mitochondrial fluorescence, was rejected on basis of comparable amounts of apoptotic cells in both
reference and hyperosmotic cultures (supporting information Fig. A.6).
Additional experimentseliminatedapossible influenceof sampleosmolalityor interactionofTOM22
and BAX on the antibody-mediated fluorescence staining of intracellular mitochondria. However,
hyperosmolality caused changes in the flow cytometric sidewards scatter signal, thus indicating
structural changes of CHO DP-12 cells which may in fact influence the binding of the anti-TOM22
antibody to itsmitochondrial target.
5.2 Optimization of Experimental Setup for Further Analyses
This section describes how the experimental setupwas adjusted in order to receive optimized condi-
tions for further investigations of the effects of hyperosmolality on antibody producing CHO cells.
5.2.1 Determination of the Time Interval for Analyses
First experiments with hyperosmotic stimulus revealed a rather short post-shift time interval of
∼ 3 days before limiting cGlc occurred. With respect to the detected differences in qATP and nATP in
the time interval day 4 to 7 limiting cGlc may influence the validity of these results. Therefore, the pre-
cise time interval of exponential growthwas determined in order to identify an earlier time point for
osmotic upshift. Likewise, the preparation of inoculum as well as the inoculation process itself were
standardized to a greater extent to reduce inter-culture variance and to improve the comparability of
results fromdifferent batch processes.
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Figure 5.8: A: Time course of viable cell density and viability of a reference CHODP-12 process. CHO DP-12
cells were cultivated in batch mode in bioreactors (4.2.2). Error bars represent standard deviations for three
biological replicates considering as well the technical error of measurements. B: Determination of "exponen-
tial growth phase" and specific growth rate (µ) by linear regression. A µ of 0.72 d-1 was determined for "expo-
nential growth phase" () and µ= 0.38 d-1 for "decelerating phase" (). Regression lines showed R2 > 0.99.
CHO DP-12 cells were inoculated in three STRs (VR = 1.2 L) and were cultivated in batch mode to
monitor VCD and viability (4.2.2). Starting from a VCD of approximately 0.4 x 106 cells mL-1 upon
inoculation, VCD reached a VCDmax of ∼ 10 x 106 cells mL-1 during the first five days of cultivation
(Fig. 5.8 A). This phase of cell growth was characterized by a constant and maximal µ of 0.72 d-1 for
the time interval day 1 to 4, followed by a reduced µ of 0.38 d-1 between day 4 and 5 (Fig. 5.8 B). These
two time intervals represent the "exponential growthphase" and the subsequent "deceleratingphase"
(Fig. 2.9). Instead of a significant "stationary phase" with rather constant VCD, decreasing VCD and
viability indicated entry into "declining phase" nearly subsequent to "decelerating phase".
Concluding, induction of hyperosmotic stimulus during "exponential growth phase" could be real-
ized as early as culture day 1 thereby extending the time for culture related analyses. However, the
required amount of cells for intracellular metabolite analysis was with 1 - 2 x 107 cells per sample
reasonably high (Tab. 4.9). Thus, low VCDs increase sample volumes and may prolong the filtration
step which was utilized for a fast separation of cells and culture broth (4.2.3). In order to minimize
this effect, VCD should at least reach 1 x 106mL-1 before hyperosmotic culture conditions are induced.
Consequently, themost adequate time for hyperosmotic stimulus according to experimental results
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was stated to be 35 h after inoculation.
5.2.2 Preliminary TranscriptomeAnalysis
First research studies revealed a defined phenotype for CHO DP-12 cells exposed to hyperosmotic
culture conditions (5.1). However, a holistic view seemed to be required to elucidate the reasons for
enhanced energetic capacity and qP of osmotically stressed cells. Therefore, a combined analysis of
mRNA andmiRNA expression of hyperosmotically stressed cultures was expected to contribute to a
better understanding of superimposed transcriptional effects.
RNA-Content of CHODP-12 Cells
An important aspect in this context was the determination of the RNA-content of CHO DP-12 cells
during a batch process in order to provide sufficient amounts of RNA forNGS (∼ 2µgRNA). Therefor,
volumescorresponding to 1x 106, 2 x 106 and4x 106 cellswere centrifuged to receive cell pellets,which
were subsequently resuspended in RNAprotect (Qiagen, US), frozen in liquid nitrogen and stored at
-70°C. Isolation of RNA by a combination of QIAshredder andmiRNeasyMini Kit according to the in-
structions of themanufacturer (Qiagen, US) revealed RNA concentrations of approximately 230, 490
and 650 ng µL-1 in a total of 30 µL for the corresponding cell numbers 1 x 106, 2 x 106 and 4 x 106. In
addition, RNA-contents remained rather constant from culture day 1 to 3. With respect to these re-
sults, even 1 x 106 cells provided a more than sufficient amount of RNA. However, considering the
requirement for a rerun of sequencing or significantly reduced RNA-contents due to hyperosmotic
culture conditions, a number of 2 x 106 cells per sample was selected for a preliminary transcriptome
analysis.
Cell Growth andMetabolism
The preliminary transcriptome analysis was performed to validate sample preparation in terms of
RNA-content and -quality aswell as todetermine the time interval and setup for the finalNGSexperi-
ment. For this purpose, two batch processes (VR =1.2 L) with CHODP-12 cells were performed in STR,
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thereby increasingosmolalityby∼ 100mOsmolkg-1 inoneof the twobatchcultures (Fig. 5.9). Accord-
ing to the results for the identificationofanearlier timepoint forosmoticupshift (5.2.1), hyperosmotic
culture conditionswere induced35hafter inoculation. The resultingosmolalityof∼380mOsmolkg-1
increased over the time of cultivation, finally reaching∼ 430mOsmol kg-1 (Fig. 5.9). Likewise, osmo-
lality of the reference culture changed from approximately 280 mOsmol kg-1 to∼ 330 mOsmol kg-1
(Fig. 5.9).
Figure 5.9: Time course of osmolality, viable cell density and viability during cultivation for preliminary
transcriptomeanalysis. Twobioreactorswere inoculatedwith the cell lineCHODP-12. 35h thereafter, osmolal-
itywas increased in one bioreactor by the addition ofNaCl-enrichedmedium (N4) (Tab. 4.3, 4.2.2). A compa-
rable volumeof standard cultivationmediumwas added to the reference bioreactor (). Error bars represent
the technical error of themeasurement (n = 3).
In accordance with previous results (Fig. 5.1), hyperosmotic stimulus caused an inhibition of cell
growth and consequently lowered VCDmax from 7.3 0.4 x 106 cells mL-1 to 4.3 0.2 x 106 cells mL-1
(Fig. 5.9). First effects of this well-known phenomenon of hyperosmolality were observed on culture
day 3.5 where VCD of reference culture tended to be higher compared to VCD of hyperosmotic cul-
ture. Noteworthy, two days lay between the hyperosmotic stimulus on day 1.5 and the occurrence of
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reduced VCDs (Fig. 5.9). This was in accordance with the period of time observed for an osmotic shift
on culture day 3 (Fig. 5.1). Viability of both reference and hyperosmotic culture remained at levels
> 98% until day 5. Thereafter, reference cells showed a more distinct decline in viability than hyper-
osmotically stressed cells whose viability stayed above 90% (Fig. 5.9).
The decline in viability of reference culture was associated with significantly decreasing VCD,
limitingcGlc andslightlydecreasingcLac (Fig. 5.10A).AlthoughtheoccurrenceofGlc limitationseemed
not to be influence by culture osmolality, VCD of hyperosmotically stressed cells decreased only
slightly from day 6 to 7. Analysis of glutamine concentration (cGln) for reference and hyperosmotic
culture revealed almost congruent time courses until day 3.5 of cultivation. Thereafter, cGln began to
accumulate inhyperosmotic cultureuntil day5.5 (Fig. 5.10B)whereas cGln of reference culture reached
growth limiting levels (0.1 - 0.5 mM, Ozturk and Hu (2005)). This phenomenon was less characteris-
tic for the previous experiment with osmotic upshift on day 3 of cultivation but seemed to be associ-
atedwith growth inhibiting cNH4+ of approximately 8mMwhichwere observed in both reference and
hyperosmotic cultures on day 4 of cultivation (supporting information Fig. A.1 and A.3).
Figure 5.10: Effects of osmotic shift (+ 100 mOsmol kg-1, 35 h) on the metabolites glucose, lactate (A) and
glutamine.NaCl-enriched cultivationmedium (Tab. 4.3) was added to the CHODP-12 culture 35 h after inocu-
lation (arrow). Osmolality was increased from∼ 280mOsmol kg-1 () to∼ 380mOsmol kg-1 (N4). cglucose
andclactateweredeterminedenzymaticallywithLaboTRACE.Errorbars represent the technical errorof themea-
surement (n = 3). cglutamine was analyzed byHPLC (4.2.5)
To examine whether the earlier osmotic upshift caused a similar increase in nATP and nADP as
hyperosmotic stimulusoncultureday3, intracellular adeninenucleotidepoolswereanalyzeddirectly
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before and for the "exponential growth phase" after osmotic shift (Fig. 5.11). Similar nATP of
∼ 3 fmol cell-1 were observed for both cultures prior to the induction of hyperosmolality. About 12 h
after osmotic upshift, CHODP-12 cells exposed to hyperosmotic conditions showed a slight decrease
to 2.61 0.04 fmolATP cell-1 followed by a subsequent increase to 3.24 0.15 fmolATP cell-1 on culture
day 4 (Fig. 5.11). Considering the technical error of analysis, nATP of reference cells remained
relatively constant until day 3. Subsequently, a decline innATP from3.070.09 fmolATP cell-1 to 2.65
0.06 fmolATP cell-1 on day 4 was observed. Hyperosmotic stimulus resulted in 1.2-fold elevated nATP
and 1.3-fold increased nADP on day 4 (Fig. 5.11).
In contrast to nATP, pre-shift intracellular ADP-pools differed between the two batch cultures
showing nADP =0.270.03 fmol cell-1 for the later reference culture andnADP =0.220.01 fmol cell-1
for the culture undergoing osmotic upshift (Fig. 5.11). However, similar nADP were observed on day 2
and 3. While nADP of reference cells remained at∼ 0.20, nADP of hyperosmotically stressed cells in-
creased from0.22 0.01 to 0.27 0.02 fmol cell-1 on day 3 to 4 (Fig. 5.11).
Figure 5.11: Influence of osmotic upshift (+ 100mOsmol kg-1, 35 h) on intracellular ATP- and ADP-contents
of CHODP-12 cells.Osmolalitywas increased from∼ 280mOsmol kg-1 () to∼ 380mOsmol kg-1 (N) by addi-
tion of NaCl-enriched cultivationmedium (Tab. 4.3) to CHODP-12 batch culture 35 h after inoculation (arrow).
Intracellular ATP- and ADP-contents were analyzed by a combination of a fast filtration approach for 107 cells
(4.2.3),methanol/chloroformextraction (4.2.4) andHPLC (4.2.5). Error bars represent the technical error of the
measurement (n = 3).
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Quality of IsolatedRNAandNGSData
AnalysisofmRNAandmiRNAexpressionwasperformeddirectlybefore (day1.4)aswellas 12and42h
after osmotic upshift for reference and hyperosmotic culture. MFT-Services Tübingen was
provided with cell samples (2 x 106 cells per sample) in order to performNGS for mRNA andmiRNA
expression analysis.
In a first step, the quality of the isolate RNA was analyzed with Bioanalyzer 2100 (Agilent
Technologies, US), revealing high values for the quality criterion RNA integrity number (RIN) and
cRNA levels between 441 and 799 ng µL-1 whereby three of six samples contained ∼ 530 ngRNA µL-1
(Tab. 5.3). With RINs¥ 9.0 compared to an optimal RIN of 10.0 and cRNA in the range of the preas-
signed level, the quality of samples was adequate for subsequent NGS. Furthermore, hyperosmotic
culture condition did not tend to influence cRNA.
Table 5.3: Quality of isolated RNA.Osmolality was increased 35 h (t = 0) after inoculation of CHODP-12 cells.
At given time points after the osmotic shift, RNAwas isolated from2 x 106 cells withmiRNeasy kit. The quality
of the isolated RNA was determined with Bioanalyzer 2100. cRNA = RNA concentration, RIN = RNA integrity
number.
osmolality time cRNA RIN
[mOsmol kg-1] [h] [ngµL-1]
280 0 441 9.4
380 0 570 9.0
280 12 534 9.1
380 12 536 9.5
280 42 535 9.3
380 42 799 9.0
Isolated RNA was utilized for NGS, resulting in NGS data sizes of∼ 10 million reads for mRNA
samples and∼ 1 -2 million reads for miRNA samples, respectively. With FastQC quality scores¥ 20
foreachbaseand read,miRNAandmRNANGSdatasets revealedgoodsequencingqualities. Approx-
imately 90% of mRNA reads were mapped to the CHO K1 reference genome whereby 60% of reads
were mapped to annotated genes. In contrast, the percentage of mapped miRNA reads was signifi-
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cantly lower (0.8 - 21%) and associatedwith the small number of total reads. Consequently, with less
than 1%of readsmapped tomiRNAs (e. g. cgr-miR-147, cgr-miR-184and cgr-miR-1973), thesedatasets
could not be utilized for reliable miRNA expression analyses. MFT-Services used the gained know-
ledge about NGS for miRNA expression analysis of CHODP-12 cell samples to improve the sequenc-
ing protocol for future experiments. Comparison ofNGSmiRNAdata for reference andhyperosmotic
samples with respect to raw read counts of cgr-miR-147, cgr-miR-184 and cgr-miR-1973 revealed com-
parable read counts directly before hyperosmotic stimulus. In addition, miRNA read count levels of
the aforementionedmiRNAs increased over time in reference samples whereas reduced levels were
detected in hyperosmotic samples. The most distinct differences were observed 42 h after osmotic
upshift.
Processing andAnalysis ofNGSData
In order to identify significantly differentially expressed genes (DEGs) with log2(FC)¥ |1.0|, P¤ 0.02
and FDR ¤ 0.02, mRNA read count datasets were processed and analyzed with the Bioconductor
package edgeR (4.2.10).
In a first step, low-abundance genes were removed from the dataset. More precisely, only those
mRNAs with read counts greater than ten in more than three samples and mRNAs with more than
1 CPM in all samples were used for further analysis. The comparison of total read counts per sample
(library size) before and after filtering revealed slightly lower values after filtering (Fig. 5.12 A).
However, the effect of filtering was less pronounced than the sample-specific differences in li-
brary size. Noteworthy, significantly reduced library sizes were observed for the sample which was
drawndirectly before osmotic upshift from reference culture and for the sample representing the hy-
perosmolal state 42 h after induction. TMMand CPMnormalizationwere applied to compensate for
sample-specific effects, e. g. differences in library size, sequencing depth or RNA-composition. Visu-
alization of CPM normalized read counts for each sample in a boxplot revealed similar interquartile
ranges for reference andhyperosmolal samples at different timepoints (Fig. 5.12 B). Thus, normaliza-
tion effectively adjusted the aforementioned sample-specific differences.
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Figure 5.12: Processing of NGS data from preliminary experiments. A: Effect of filtering on number of
counts. B:Boxplot forCPMnormalized filtereddatasets. Transcriptomeanalysiswasperformedduringbatch
cultivation of CHODP-12 cells directly before (0 h) as well as 12 and 42 h after osmotic upshift on day 1.45 (280
Ñ 380mOsmol kg-1). The receivedNGSdatawere processed: mRNAswith read counts greater than 10 inmore
than three samples andmRNAswithmore than 1 CPM in all sampleswere used for further analysis. Fig. A com-
pares the total number of read counts for each sample before (raw) and after (filtered) the filtering step. Fig. B
compares samples after counts permillionmapped reads (CPM, Eq. 4.23 normalization, 4.2.10)
Figure 5.13: MA plot for gene expression changes 12 h (A) and 42 h (B) after hyperosmotic stimulus
(+ 100 mOsmol kg-1). Transcriptome analysis was performed during batch cultivation of CHO DP-12 cells di-
rectly before as well as 12 h (A) and 42 h (B) after osmotic upshift on day 1.45 (280Ñ 380mOsmol kg-1). EdgeR
analysis of NGS data revealed changes in gene expression. Each symbol (N) stands for a genewithN repre-
senting significantly differentially expressed genes (log2(FC)¥ |1.0|, P¤ 0.02, FDR¤ 0.02).
Further steps of edgeR analysis considering a biological coefficient of variation (BCV) of 0.05 (4.2.10)
served to identify DEGs due to hyperosmotic stimulus. Therefor, mRNA levels of hyperosmotically
stressed cells were compared to those of reference cells at each time point of analysis
(0 h, 12 h, 42 h). At the reference point directly before osmotic upshift, no DEGs were observed, thus
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revealing comparable gene expression patterns for both reference and the subsequent hyperosmolal
cell culture. Twelve hours after osmotic upshift, edgeRanalysis identified 4DEGswhereby all of these
geneswere upregulated (Fig. 5.13 A). An additional 30 h later, the number ofDEGs increased to 9with
8 genes being upregulated and 1 being downregulated (Fig. 5.13 B). Average logCPM values ranged
between 1 and 12 for all genes which passed the previous data filtering step (Fig. 5.13). Genes defined
as DEGs 12 h after osmotic upshift revealed average logCPM values of approximately 4 to 6. Similar
average logCPM levelswere observed for about half of theDEGs at timepoint 42hpast hyperosmotic
stimulus whereas the other half of DEGswere less abundant in the RNA samples (Fig. 5.13).
Table 5.4: Preliminary experiment reveals significantly up-/ downregulated genes 12 and 42 h after os-
motic upshift (+ 100 mOsmol kg-1). Osmolality was increased 35 h after inoculation of CHO DP-12 from 280
to 380 mOsmol kg-1. NGS and subsequent data analysis with edgeR revealed significantly upregulated genes
compared to reference culture (280mOsmol kg-1). Data arebasedon singlebiological replicateswherebyabio-
logical coefficient of variationof0.05wasassumed fordataanalysis. Values inboldmet the significance criteria
for differentially expressed genes (log2(FC)¥ |1.0|, P¤ 0.02 and FDR¤ 0.02) whereas values in brackets did
not.
log2(FC) log2(FC)
gene 12 h 42h gene 12 h 42h
CHN1 (1.7) 2.4 IL1R2 (2.4) 4.1
CITED1 (1.5) 2.1 MATN4 (-1.4) -2.1
DDIT4 2.4 2.4 OLFM1 2.2 (1.6)
FIGF (0.8) 2.3 SEMA4D 3.2 2.9
FMO4 2.3 2.1 SUCNR1 (1.1) 2.5
CHN1: chimerin 1, CITED1: CREB binding protein/p300-interacting transactivator, DDIT4: DNA damage inducible tran-
script4, FIGF: c-fos inducedgrowth factor,FMO4: flavin containingmonooxygenase4, IL1R2: interleukin 1 receptor type II,
MATN4: matrilin 4, OLFM1: olfactomedin 1, RANBP3L: RAN binding protein 3-like, SEMA4D: semaphorin 4D, SUCNR1:
succinate receptor 1
Three genes which were defined as DEG were significantly upregulated at both analyzed time
points (Tab. 5.4): DNA damage inducible transcript 4 (DDIT4), flavin containing monooxygenase 4
(FMO4) and semaphorin 4D (SEMA4D) showed log2(FC) between 2.1 and 3.2 due to osmotic upshift.
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In general, log2(FC) of DEGs ranged between 2.1 and 4.1 for upregulated geneswhile a log2(FC) of -2.1
was observed for the only downregulated genematrilin 4 (MATN4).
To identify a commonbiological function of significantly upregulated genes at hyperosmotic cul-
ture conditions, GO enrichment analysis was performed. Thus, 7 of 9 genes were assigned to "signal
transduction" (GO:0007165), among these chimerin 1 (CHN1), CREBbindingprotein/p300-interacting
transactivator (CITED1), c-fos inducing growth factor (FIGF),olfactomedin 1 (OLFM1) and succinate re-
ceptor 1 (SUCNR1) as well asDDIT4 and SEMA4D.
5.2.3 Intensification ofHyperosmotic Stress
The earlier osmotic upshift did not benefit the elucidation of the reasons for enhanced energy
supply and qP of hyperosmotically stressed cells. More precisely, although increased nATP occurred
at an earlier time point, proximity to Glc limitation could still not be neglected (Fig. 5.11, Fig. 5.10).
Furthermore, results from the preliminary transcriptomeanalysis did not reveal an informative num-
ber of DEGs to describe the dynamic changes in gene expression due to hyperosmotic stimulus. Con-
sequently, the decision tomake was to intensify hyperosmotic stress in order to receivemore signifi-
cant results.
Therefore, osmolalities of CHO DP-12 batch cultures (VR =1.2 L) were increased by 130 or
150mOsmol kg-1 35 h after inoculation in order to analyze the effect on cell growth, metabolism and
cell cycle distribution.
Prior to osmotic upshift (day 1.4) the average osmolality of all three batch cultures was 278 
2 mOsmol kg-1 (Fig. 5.14). The subsequent hyperosmotic stimulus (day 1.45) resulted in culture
osmolalities of 408  3 mOsmol kg-1 or 425  2 mOsmol kg-1 compared to an osmolality of 280 
2 mOsmol kg-1 for reference culture (Fig. 5.14). Osmolalities changed slightly with the time of culti-
vation reaching maximal values of approximately 290, 418 and 435 mOsmol kg-1, respectively. Thus,
referenceandhyperosmotic culturesshowedacomparable increase inosmolalityof+10mOsmolkg-1.
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The pre-shift period was characterized by similar VCDs and viabilities for all CHO DP-12 cell
cultures, so that hyperosmotic stimulus occurred at an average VCD of 1.02  0.05 x 106 cells mL-1
and at an average viability of 98.9 0.6% (Fig. 5.14). Hyperosmotic stimulus reduced µ in both cul-
tures from0.81d-1 (reference) toapproximately0.55d-1 in thepost-shift intervalday 1.5 to2.5andfrom
0.83 d-1 (reference) to∼ 0.40 d-1 in the time interval day 2.5 to 3.2. Thus, significantly lower VCDmax
were observed for cell cultures undergoing hyperosmotic stress. More precisely, the culture with the
highest osmolality achieved the lowest VCDmax while the highest VCDmax was observed at reference
conditions (3.2 x 106 cells mL-1 < 3.8 x 106 cells mL-1 < 14.0 x 106 cells mL-1, Fig. 5.14). After reaching
VCDmax on culture day 5.5, reference culture showed a direct decline in VCD. In contrast, rather sta-
tionary VCDswere observed for hyperosmotic cultures in the same time interval (Fig. 5.14).
Figure5.14: Increasedhyperosmotic stress (+ 130/+ 150mOsmolkg-1) and its effect onviable cell densityand
viability of CHODP-12. Osmolality was increased during bioreactor cultivations of CHO DP-12 (arrow) by the
addition of NaCl-enriched TC-42-D cultivation medium 35 h after inoculation (Tab. 4.3). Compared to the ref-
erence culture  ) osmolality was increased by ∼ 130 mOsmol kg-1 ( ) and ∼ 150 mOsmol kg-1 (N4),
respectively. Datawere determined as described in section 4.2.5. Error bars represent the technical error of the
measurements (n = 3).
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Viabilities¥ 98%were observed for hyperosmotic cultures during the whole time of cultivation.
The reference culture showed equally high viability until day 6 followed by amoderate declinewhich
resulted in a viability below 90%on day 8 (Fig. 5.14).
Besides theeffectsof intensifiedhyperosmotic stressoncellgrowthandviability, the influenceonnATP
andcGlcwas investigated. Starting fromanaveragepre-shift nATP of2.510.40 fmol cell-1 (day 1.4) in-
tracellular ATP-content was not affected by hyperosmotic stimulus until culture day 4 where
approximately 1.8-fold increasednATPwere observed for hyperosmotically stressed cells independent
of the exact osmolality (Fig. 5.15 A). CHODP-12 cells exposed to osmotic upshift showed a further in-
crease in nATP from day 4 to 5 while nATP of reference cells remained rather constant. Therefore the
aforementioned 1.8-fold difference between nATP of reference and osmotically stressed cells raised to
twofold (Fig. 5.15 A). Noteworthy, hyperosmotic stimulus of 130 or 150 mOsmol kg-1 enhanced nATP
from approximately 2.4 to 4.5 fmol cell-1 on day 5 of cultivation. Thus, resulting nATP-levels were 23%
higher on day 4 of cultivation compared to previously described levels for a batch culture with an os-
molality of 380mOsmol kg-1 (Fig. 5.11).
Figure 5.15: Influence of hyperosmolality (+ 130/+ 150 mOsmol kg-1) on intracellular ATP-content (A) and
glucoseconcentration (B).Osmolalitywas increasedby theadditionofNaCl-enriched cultivationmedium35h
after inoculation of bioreactors with the cell line CHO DP-12 (Tab. 4.3, 4.2.2). While the osmolality of the ref-
erence culture was∼ 280 mOsmol kg-1 (), hyperosmotic cultures showed values of∼ 410 mOsmol kg-1 ()
or∼ 430 mOsmol kg-1 (N). Intracellular ATP-contents were determined by a combination of a fast filtration
approach for 107 cells (4.2.3), methanol/chloroform extraction (4.2.4) and HPLC analysis (4.2.5). cglucose was
measuredenzymaticallywithLaboTRACE(TRACEAnalytics). Errorbars represent thetechnicalerrorof themea-
surements (n = 3).
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Analysis of cGlc revealed significantly different time courses for reference and hyperosmotic
cultures. Starting with similar cGlc profiles in the pre-shift and the 24 h post-shift period, faster de-
creasing cGlc levels were observed for reference culture in the subsequent time interval. As a result a
twodaysdelayed timepoint for complete consumptionofGlcwasdetected for hyperosmotic cultures
which had not been demonstrated in the previous experiments (day 7.5 vs. day 5.5, Fig. 5.15 B). Limit-
ing cGlc occurred in reference culture after day 5 of cultivation with an associated decline in cLac from
39.1 mM on day 5.5 to 33.2mM on day 8 (supporting information Fig. A.8). In contrast, hyperosmotic
cultures showed lower levels of approximately 30mMLac on day 5.5 to 8.
With respect to these results, enhanced nATP of hyperosmotically stressed cells were observed
prior to the Glc limitation of reference cells (Fig. 5.15).
Toobtainan ideahowosmolalitiesashighas410and430mOsmolkg-1, respectively, affected thepop-
ulation composition with respect to cell cycle mapping, percentages of cells in G1-, G2- and S-phase
were analyzeddirectly before andon the following fourdays of cultivation (Fig. 5.16, supporting infor-
mation Fig. A.8 B).
Figure5.16: Effectofosmotic shift (+ 130/+150mOsmolkg-1)ontheamountofCHODP-12cells inG1-phaseof
cell cycle.NaCl-enriched cultivationmediumwas added to batch cultures 35 h after inoculation (4.2.2). Osmo-
lalitywas increased from∼280mOsmolkg-1 (referencecondition,) to∼410 () or430mOsmolkg-1 (N). The
determinationof cell cycle distributionwasbasedonpropidium iodide staining and flowcytometric analysis of
the cells (4.2.5). Error bars represent the technical error of themeasurements (n = 3).
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As previous experiments described an arrest of hyperosmotically stressed cells in G1-phase (5.1),
cell cycle analysis focused on the influence of intensified hyperosmotic culture conditions on the per-
centage of cells inG1-phase. Directly before osmotic upshift in twoof three CHODP-12 batch cultures
an average percentage of cells in G1-phase of 37 2%was determined (Fig. 5.16). This percentage re-
mained rather constant in reference culture until day 3 of cultivation, thus being in concurrencewith
the cell cycle analysis for the first hyperosmotic stress experiment of this thesis (Fig. 5.2 A). From cul-
ture day 3 to 5, cell cycle analysis revealed an increasing number of reference cells in G1-phase, finally
reaching62%(Fig. 5.16). In comparison, thepercentagesof cells inG1-phase increasedapproximately
1.5- to 1.6-foldwithin the first 12 h after osmotic upshift, thereby revealing ahigher percentage for the
430 mOsmol kg-1 culture (Fig. 5.16). During the following two days of cultivation, a further accumu-
lation of hyperosmotically stressed cells in G1-phase was observed. Thus, approximately 76 - 79% of
cells were assigned to G1-phase on day 4 and 5. In contrast to the increasing percentage of cells in G1-
phase, the number of cells in S-phase declined from∼49%on day 1.4 to approximately 14%on day 5
while the percentage of cells in G2-phase decreased only slightly (supporting information Fig. A.8 B).
Concluding, intensified hyperosmotic culture conditions enhanced the previously described ef-
fects on cell growth and nATP. However, hyperosmotically stressed cultures still showed high viability
and sufficient cell growth in order to provide enough cells formetabolic and transcriptome analyses.
The selected 20 mOsmol kg-1 difference in osmotic upshift (+ 130/+ 150 mOsmol kg-1) resulted in in-
significant differences and therefore a hyperosmotic stimulus of + 150 mOsmol kg-1 was chosen for
the subsequentmain experiment (5.3). Another important aspect for this decisionwas that increased
osmotic stress levels contributed to more significant results which had been the initial intention of
this experiment.
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5.3 Metabolic and Transcriptomic Response of CHODP-12 upon
Hyperosmotic Stimulus (+ 150mOsmol kg-1) 35 hAfter
Inoculation
Results of this sectionhave inpartsbeenpublished inPfizenmaier et al. (2016) (manuscript 2 support-
ing information B.2).
The pivotal results of this thesiswere basedon sevenCHODP-12 batch cultures (VR =1.4 L)whichwere
performed in STRs (4.2.2). In order to study the metabolic and transcriptomic response to hyper-
osmotic culture conditions, four of seven batch cultures were supplemented with NaCl-enriched
cultivationmedium to increase osmolality by approximately 150mOsmol kg-1 35 h after inoculation.
The other three batch cultures were supplemented with an equal amount of standard cultivation
medium and served as references.
5.3.1 ReducedCell GrowthHampers an Increase in cP by EnhancedqP
Starting fromanaverageosmolalityof approximately280mOsmolkg-1 in all sevenbatch cultures, hy-
perosmotic stimulus resulted inahighlysignificantlyelevatedcultureosmolalityof∼430mOsmolkg-1
for batch cultures exposed to osmotic stress (P < 0.001, Fig. 5.17). The approximately 150mOsmol kg-1
difference in osmolality of reference and hyperosmotic cultures enhanced over time as osmolality of
hyperosmotic cultures increasedby∼ 10mOsmolkg-1whereasa slightdecrease inosmolalitywasob-
served for reference cultures (Fig. 5.17). In response to hyperosmotic culture conditions, significantly
reduced µ (Tab. 5.5) were revealed in the post-shift time intervals day 1.5 to 2.5 (0.60  0.03 d-1 vs.
0.68 0.03 d-1, P < 0.05) and day 3 to 4 (0.26 0.04 d-1 vs. 0.83 0.08 d-1, P < 0.01), thus resulting
in highly significantly lower VCDs from day 2.5 to 8 (P < 0.001, Fig. 5.17). Based on an average VCD of
1.2 0.1 x 106 mL-1, the growth inhibiting effect of hyperosmotic culture conditions reduced VCDmax
by∼ 67% from 12.0 x 106 cells mL-1 to 4.0 x 106 cells mL-1 (Fig. 5.17). After reaching a maximal level
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on day 5, reference cultures showed a distinct decline in VCD on the subsequent days of cultivation
whereas hyperosmotic culturesmaintained VCDs similar to VCDmax (Fig. 5.17).
Figure5.17:Profilesofosmolality,viablecelldensityandviabilityduringbatchcultivationofCHODP-12with
osmoticshift (arrow,+150mOsmolkg-1). Cellswerecultivated inSTRs (4.2.2)andosmolalitywas increased35h
after inoculation by the addition of NaCl-enriched cultivationmedium (n = 4,N4). An equal volume of culti-
vationmedium (Tab. 4.3) was added to reference cultures (n = 3,). Error bars represent standard deviations
for biological replicates considering as well the technical error of measurements (n = 3). Highly significant dif-
ferences in osmolality (P<0.001, day 1.5 - 8), viable cell density (P<0.001, day 2.5 - 8) and viability (P < 0.001,
day 5 - 6.5). With changes to Fig. 1 ofmanuscript 2 (supporting information B.2).
Analysisof thecellularviability revealedanaveragepercentageof99.30.5%viablecells inbatch
cultures directly before osmotic upshift (Fig. 5.17). Thereafter similarly high levels (> 98%)weremain-
tained in hyperosmotic cultures until day 6 of cultivation followed by a slight decline in viability to
∼ 95% on day 8. In contrast, an earlier onset (day 5) of decreasing viabilities was observed for refer-
ence cultures, thus being in concurrence with the aforementioned starting point for declining VCD
(Fig. 5.17). Although the average percentage of viable cells tended to be lower in reference cultures,
inter-culture variances hampered the validation of a significant difference compared to viabilities of
hyperosmotic cultures (Fig. 5.17).
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Table 5.5: Effect of hyperosmolality on specific product formation rate and growth rate of CHODP-12 cells.
** = highly significant difference (P < 0.01), * = significant difference (P < 0.05).
qP [pgmAb cell-1 d-1] µ [d-1]
day 1.5 - 2.5 * reference 13.77 1.02 0.68 0.03hyperosmolal 11.46 0.76 0.60 0.03
day 3.0 - 4.0 ** reference 8.05 0.85 0.83 0.08hyperosmolal 12.98 0.18 0.26 0.04
Figure 5.18: Time course of the antibody concentration during batch cultivation of CHODP-12with osmotic
shift (+ 150 mOsmol kg-1). Hyperosmotic culture conditions were induced 35 h after inoculation (arrow) by
the addition of NaCl-enriched cultivation medium (Tab. 4.3, 4.2.2). Osmolality of hyperosmotic cultures was
∼ 430mOsmol kg-1 (N) compared to∼ 280mOsmol kg-1 for reference cultures (). The concentration of the
produced anti-IL-8-IgG1 antibodywas determined by ELISA as described in 4.2.5. Error bars represent the stan-
dard deviation for four biological replicates thereby considering as well the technical error of measurements
(n = 3). Highly significantly lower cP were observed on day 3.5 to 5 (P¤ 0.01)
As the cultivated CHO DP-12 cell line produced an anti-IL-8-IgG1 antibody, qP was determined
for the post-shift time intervals day 1.5 to 2.5 and day 3 to 4 (Tab. 5.5). While hyperosmotic stimulus
induced significantly reduced qP on day 1.5 to 2.5 (11.46  0.76 pgmAb cell-1 d-1 vs. 13.77 
1.02pgmAb cell-1 d-1, P <0.05), a highly significantly enhancedqPwasobserved in the subsequent time
interval (12.98 0.18 pgmAb cell-1 d-1 vs. 8.05 0.85 pgmAb cell-1 d-1, P < 0.01). However, the combi-
nation of enhanced qP and reduced µ did not improve cP. Noteworthy, highly significantly reduced
cP were observed at hyperosmotic culture conditions in the post-shift period day 3.5 to 5.0 whereby
this difference between reference and hyperosmotic cultures declined with the time of cultivation
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(Tab.5.18). Thus, final cPdidnotsignificantlydiffer inhyperosmoticandreferencecell cultures (163.3
17.1mgmAb L-1 vs. 175.7 21.4mgmAb L-1 on day 8).
5.3.2 Changes inMetabolic Rates
Concentrations of amino acids, Glc, Lac and NH4+ were analyzed throughout the time of cultivation,
in order to identify characteristic changes in the occurrence of growth-inhibiting levels and in specific
metabolite formation rates (q) of substrates (Glc, Gln, Asn) and by products (Lac, NH4+) due to hyper-
osmotic stimulus (Tab. 5.6, Fig. 5.19, Fig. 5.20). Furthermore, theseanalyses contributed toelucidating
the relation between hyperosmotic stress and the previously identified enhanced energetic capacity
of CHO DP-12 cells (5.1.4, 5.2.3) which as part of the pivotal experiments was studied in more detail
(5.3.3).
Hyperosmotic stimulus did not affect metabolic rates in the post-shift time interval day 1.5 to 2.5
(Tab. 5.6). In contrast, significantly increased qGln (60%, P < 0.01) and qNH4+ (240%, P < 0.001) were
observed forCHODP-12 cells exposed tohyperosmolality in the subsequentperiodday 3 to4whereas
qGlcwassignificantly reduced (56%,P=0.05). Thus, hyperosmotic stimulus significantly increased the
molar yield in NH4+ per consumedmol of Gln (YNH4+/Gln). Although CHODP-12 cellsmetabolized Asn
in a non-neglectable manner, Asn formation rates (qAsn) were not affected by culture osmolality. To-
getherwith the increasedconsumptionofGlc, hyperosmotically stressedcells showedanelevatedqLac
(139%, P = 0.07). With respect to the hyperosmotically induced changes in qGlc and qLac, the decrease
in YLac/Glc from one analyzed time interval to the other was less pronounced at hyperosmotic culture
conditions. More precisely, YLac/Glc levels of approximately 1.32 molLac molGlc-1 were revealed for both
culture conditions in the post-shift period day 1.5 to 2.5 while YLac/Glc of reference and hyperosmoti-
cally stressed cells subsequently reduced to 0.730.08molLac molGlc-1 and 1.110.21molLac molGlc-1,
respectively.
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Table 5.6: Effect of a 150 mOsmol kg-1 hyperosmotic stimulus on metabolic rates of CHO DP-12. Hyperos-
motic culture conditionswere induced in4of 7 batch cultures 35hafter inoculation. Reference cultures showed
an osmolality of∼ 280mOsmol kg-1 compared to∼ 430mOsmol kg-1 for hyperosmolal cultures. Metabolites
were analyzed as described in section 4.2.5 and subsequently specific metabolite formation rates (q) were de-
termined for define time intervals. Values in bold represent significant differences in response to hyperosmotic
stimulus (P < 0.05).
q [pmol cell-1 d-1]
day 1.5 - 2.5 day 3.0 - 4.0
metabolite reference hyperosmolal reference hyperosmolal
glutamine -0.96  0.08 -0.86  0.06 -0.40  0.05 -0.16  0.03
asparagine -0.51  0.06 -0.46  0.03 -0.30  0.03 -0.35  0.04
glutamate 0.46  0.05 0.34  0.01 0.12  0.04 0.15  0.04
ammonium 0.86  0.08 0.91  0.07 -0.10  0.02 0.14  0.02
glucose -3.01  0.19 -3.02  0.15 -1.61  0.10 -2.52  0.35
lactate 3.92  0.33 3.98  0.33 1.18  0.19 2.80  0.77
The aforementioned hyperosmotically induced differences in metabolic rates affected the
profiles of metabolite concentrations. Despite significantly lower VCDs at hyperosmotic culture
conditions (Fig. 5.17), elevated qLac resulted in similar cLac in hyperosmotic and reference cultures in
the post-shift period day 1.5 to 5.5 (Fig. 5.19 A). Subsequently, a further increase in cLac was observed
for hyperosmotic cell cultures, thus achieving a maximal cLac of 40.7 5.0 mM compared to 34.5
6.8mMat reference conditions (Fig. 5.19A).However, high inter-culture variances hampered the vali-
dation of significantly elevated cLac for the time interval day 6 to 8. Starting from rather congruent
cGlc profiles, significantly increased cGlc were observed in hyperosmotic cultures in the time interval
day 4.5 to 5.0 (P < 0.05). Consequently, hyperosmotic stimulus delayed the occurrence of limiting cGlc
by approximately 12 h (day 5.5 vs. day 5.0, Fig. 5.19 A).
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Figure 5.19: Profiles ofmetabolite concentrations during batch cultivation of CHODP-12with osmotic shift
(arrow, + 150mOsmol kg-1). NaCl-enriched cultivationmedium (Tab. 4.3) was used to increase osmolality 35 h
after inoculation (4.2.2). This resulted in an osmolality of∼ 430mOsmol kg-1 for hyperosmotic cultures (n = 4,
N4 ) compared to∼ 280 mOsmol kg-1 for reference cultures (n = 3,  ). cglucose and clactate were analyzed
enzymaticallywhile cglutamine andcglutamateweredeterminedbyHPLCasdescribed in4.2.5. Errorbars represent
standard deviations for biological replicates considering as well the technical error ofmeasurements (n = 3).
Starting from an average cGln of 2.9 0.3 mM directly before osmotic upshift, reference cultures
showed a more distinct decrease in cGln than hyperosmotic cultures, thus reaching limiting
concentrations on culture day 3 (Fig. 5.19 B). Noteworthy, cGln of hyperosmotic cultures stopped to
decline at approximately the same time point although cGln levels were in the range of ∼ 0.7 mM
(Fig. 5.19 B). Consequently, no further accumulation of Glu was observed in reference and hyper-
osmotic cultures. In addition to the aforementioned phenomenon, hyperosmotic culture conditions
induced a characteristic accumulation of Gln after reaching the minimal cGln of 0.7 mM (Fig. 5.19 B).
Due to the link betweenmetabolization of Gln and the formation of NH4+ which had been shown to
be increased due to hyperosmolality in the time interval day 3 to 4, culture specific NH4+ levels were
determined (Fig. 5.20).
Prior to osmotic upshift and in the post-shift period day 1.5 to 3.5, similar profiles for cNH4+ were ob-
served in all batch cultureswhereby cNH4+ tended to be slightly higher at hyperosmotic culture condi-
tions (Fig. 5.20). On day 3.5, reference cultures showed amaximal cNH4+ of 7.70.3mMcompared to
8.3 0.2mM for hyperosmotic cultures. Thereafter, reference cNH4+ declined to approximately 6mM
on day 5.5 whereas hyperosmotic cNH4+ remained at levels of∼ 8mM.With respect to the cGln profile
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for hyperosmotic culture conditions a timely concurrence with high cNH4+ was observed (Fig. 5.19 B,
Fig. 5.20).
Figure 5.20: Effect of hyperosmolality on the accumulation of ammonium in CHO DP-12 culture.
Osmolality was increased (arrow) by NaCl-enriched cultivationmedium (Tab. 4.3) 35 h after the inoculation of
bioreactors (4.2.2). Hyperosmotic cultures (n = 4) showedosmolalities of∼ 430mOsmol kg-1 (N4) compared
to∼280mOsmolkg-1 for referencecultures (n=3,). AmmoniumconcentrationswereanalyzedwithLCK303
cuvette test (Hach) (4.2.5). Error bars represent standard deviations for biological replicates.
5.3.3 EnhancedqATP and IncreasedATP-Pools Reveal a Surplus of Energy
Preliminary experiments indicated a relationship between hyperosmotic culture conditions and
elevated intracellular adeninenucleotide pools aswell as enhancedqATP (5.1.4, 5.2.3). Noteworthy, an
increase in osmolality from∼ 290 to∼ 390mOsmol kg-1 on day 3 of cultivation resulted in 20 to 39%
enhanced qATP and 1.2- to 2.2-fold elevated nATP (5.1.4). Furthermore, 1.7- to 2.1-fold increased nATP
were observed for a + 150 mOsmol kg-1 osmotic stimulus 35 h after inoculation (5.2.3). The
phenomenon of enhanced energetic capacity in response to hyperosmotic culture conditionswas ex-
amined inmoredetail onbasisof three referenceculturesandthreeculturesexposedtohyperosmotic
stimulus (+ 150 mOsmol kg-1) 35 h after inoculation. In this context, datasets were analyzed with re-
spect to statistical significance.
Carbon and oxygen balancing (supporting information Tab. A.2) were applied to determine qCO2 and
qO2 , thus revealing 1.4- to 3-fold increased qCO2 at hyperosmotic culture conditions while qO2 were
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similarly reduced (supporting information Fig. A.9). Consequently, similar RQs close to the quality
criterion RQ 1 (0.9 - 1.1) were determined for cells grown at reference or hyperosmotic culture con-
ditions. qATP were subsequently calculated on basis of qO2 and the assumption of a P/O ratio of 2.5
(Eq. 4.15, 4.2.7). Thereby, significantly enhanced qATP (+ 140 - 176%) were observed for hyperosmoti-
cally stressed cells in the post-shift time interval day 3 to 6 (Fig. 5.21). Noteworthy, qATP of osmotically
stressed CHODP-12 cells were in the range of approximately 32 to 44 pmol cell-1 d-1 compared to∼ 12
to 25 pmol cell-1 d-1 for reference cells (Fig. 5.21). Considering the possibility of a reduced P/O ratio of
1.5 (2.4) for hyperosmotically stressed cells, qATP would nevertheless be significantly enhanced in the
time intervals day 4 to 5 and day 5 to 6 (P < 0.03).
To obtain information on the subcellular distribution of adenine nucleotides, a
compartment-specific fast filtration approach (4.2.3) was utilized to determine pool sizes for the two
most important compartments in this context - cytosol andmitochondria. Themitochondrialmarker
cis-aco and the cytosolic markers G6P and F6P were utilized to evaluate the efficiency and quality
of the cytosol depleted/mitochondrial samples. While intracellular amounts of G6P and F6P were
depleted by approximately 75 - 87%, 81 - 96% of the whole cell cis-aco contents were retained in
mitochondrial samples (supporting information Tab. A.3).
Starting from similar cytosolic ATP-contents (nATPcyt) of approximately 2.7 fmol cell-1 on the
pre-shift culture day 1.4, nATPcyt of hyperosmotically stressed cells steadily increased to 3.66 
0.24 fmol cell-1 on day 5 while reference cells showed a decline to 2.04 0.28 fmol cell-1 (Fig. 5.21).
Thus, hyperosmotic stimulus resulted inhighly significantlyelevatednATPcyt onday4and5 (+ 1.6-/+ 1.8-
fold, P < 0.01). In comparison,mitochondrial ATP-contents (nATPmit) were∼ 13.5-fold lower than nATPcyt
on day 1.4 (Fig. 5.21, Tab. 5.7). This distinct difference increased even further in the subsequent post-
shift period as nATPmit decreased in both reference and hyperosmotically stressed cells from day 1.4 to
3 followed by rather constant levels of approximately 0.12 0.02 fmol cell-1 for reference cells and
∼ 0.19 0.03 fmol cell-1 for hyperosmotically stressed cells (Fig. 5.21, Tab. 5.7). In concurrence with
significantly elevated nATPcyt , hyperosmotic stimulus resulted also in significantly increased nATPmit on
day 4 and 5 of cultivation (+ 1.5-/+ 1.6-fold, P < 0.05).
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Figure 5.21: Changes in cytosolic andmitochondrial ATP-content and ATP formation rates (qATP) at hyper-
osmotic conditions. Directly before osmotic shift (arrow)and on each of the following days of cultivation a
compartment-specific fast filtration approach for 2 x 107 cells (4.2.3) was applied to generate whole cell and
mitochondrial samples ofCHODP-12. Extractionofmetaboliteswasperformedbymethanol/chloroformtreat-
ment of cell samples (4.2.4) andATP-concentrations of cell extractswere determinedbyHPLC (4.2.5). Cytosolic
andmitochondrial ATP-contents were calculated according to Eq. 4.17 and Eq. 4.18 (4.2.8). Hyperosmotic cul-
tures (N4) showed osmolalities∼ 430mOsmol kg-1 compared to reference cultureswith∼ 280mOsmol kg-1
(). Errorbars represent standarddeviations forbiological replicates (n=3). DeterminationofqATPwasbased
on C- andO-balancing (4.2.7) and the assumption of a P/O ratio of 2.5 (Balcarcel and Clark, 2003; Hinkle, 2005;
Nath andVilladsen, 2015;Wahl et al., 2008). * statistically significant (P < 0.05), ** highly significant difference
(P < 0.01) between hyperosmotic and reference conditions. With changes to Fig. 2 ofmanuscript 2 (supporting
information B.2)
Table 5.7: Cellular distribution of ATP for reference and hyperosmotically stressed cells. nATPcyt = cytosolic
ATP-content [fmol cell-1], nATPmit =mitochondrial ATP-content [fmol cell
-1].
nATPcyt/nATPmit
t [d] reference hyperosmolal
1.4 13.9 1.0 13.1 1.2
3.0 21.6 2.1 16.9 1.3
4.0 16.6 1.9 17.7 1.3
5.0 17.0 2.3 19.5 1.3
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Hyperosmotic culture conditions may induce changes in cell size, thus influencing intracellular
metabolite pool sizes and concentrations. Hyperosmotically stressed CHO DP-12 cells revealed en-
larged cell diameters in the post-shift time interval day 2.5 to 3.5. In the subsequent period (day 4)
rather similar cell diameterswereobserved for referenceandhyperosmotically stressedcells followed
by significantly elevated cell diameters for reference cells fromday 4.5 to 5.5 (supporting information
Fig.A.10B). Inconcurrencewith thesechanges incell sizeandpreviously identifiedelevatednATPcyt and
nATPmit , hyperosmotically stressed cells showed increased cATP on day 4 and 5 (day 4: 1.4-fold, P = 0.07,
day 5: 2.3-fold, P = 0.001, supporting information Fig. A.10 A).
Regarding the effects of hyperosmotic stimulus onnATPcyt andnATPmit , similar effectswere observed for
cytosolic and mitochondrial ADP-contents ( nADPcyt , nADPmit , supporting information Fig. A.11), while
AMP levels were commonly below the reliable detection limit of HPLC analysis. Noteworthy, with
levels of 0.05  0.01 fmolADP cell-1 and 0.06  0.01 fmolADP cell-1, hyperosmotically stressed cells
showed 1.8- and2.0-foldhighernADPmit on cultureday4and5 (P<0.05, Fig. A.11). nADPcyt were similarly
elevated by osmotic upshift as nADPmit whereby a statistically significant difference could be validated
for day 5 (0.31 0.10 vs. 0.13 0.02 fmolADP cell-1).
Figure5.22:CytosolicandmitochondrialadenylateenergychargesofCHODP-12cellsunder isotonicandhy-
perosmotic conditions. Cytosolic andmitochondrial adenine nucleotide contents were analyzed (4.2.3, 4.2.4,
4.2.5, 4.2.8) directly before osmotic shift and on the following days of cultivation. Addition of NaCl-enriched
medium 35 h after inoculation resulted in∼ 430 mOsmol kg-1 compared to∼ 280 mOsmol kg-1 for reference
cultures. Energychargeswerecalculatedaccording toEq. 4.19 (AtkinsonandWalton, 1967). Errorbars represent
standard deviations for biological replicates (n = 3). Statistically significant difference betweenmitochondrial
and cytosolic energy charges (P < 0.05).
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To obtain a better idea of the cellular state at hyperosmotic culture conditions, cytosolic andmi-
tochondrialAEC (AECcyt, AECmit)weredetermineddirectly before (day 1.4) and in thepost-shift period
day 3 to 5 (Fig. 5.22). As reliable nAMP weremissing for multiple time points, the influence of nAMP on
AEC was analyzed on basis of available and reliable AMP data. Consideration of the rather low nAMP
levels reduced AEC by 0.01 - 0.02. Due to the minor differences in AECs calculated with or without
consideration of nAMP, the following AECcyt and AECmit were solely based on nATPcyt and nADPcyt or on
nATPmit and nADPmit (Fig. 5.22).
CHODP-12 cells of reference and hyperosmotic cultures showed similar physiological AECcyt and
AECmit (¥ 0.9) directly before osmotic upshift and at all analyzed time points of the post-shift period
(Fig. 5.22). More precisely, AECcyt of both reference and hyperosmotically stressed cells were in the
range of 0.97 0.01 compared to significantly lower AECmit of 0.90 0.02 (P < 0.05, Fig. 5.22).
Figure 5.23: Cytosolic and mitochondrial ATP/ADP ratios of CHO DP-12. Results for hyperosmotic
(∼ 430mOsmol kg-1,N4) and isotonic conditions (∼ 280mOsmol kg-1,) were compared. NaCl-enriched
cultivation medium (Tab. 4.3) was used to increase osmolality 35 h after inoculation (arrow) of batch cultures
(4.2.2). Adenine nucleotide contents were determined by a combination of a compartment-specific fast filtra-
tion approach (4.2.3), methanol/chloroform extraction (4.2.4) as well as HPLC and LC-MS/MS analysis (4.2.5).
Eq. 4.17 and Eq. 4.18 were applied to calculated cytosolic and mitochondrial adenine nucleotide pools. Error
bars represent standard deviations for biological replicates (n = 3).
Asimilar resultwasobtainedbycomparisonof cytosolicnATP/nADP ratios (ATP/ADPcyt) of reference
and hyperosmotically stressed cells as well as for the corresponding mitochondrial counter-
part ATP/ADPmit (Fig. 5.23). Although ATP/ADPcyt of cells exposed to hyperosmotic culture condi-
tions tended to be lower than for reference cells, no statistically significant difference was observed.
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ATP/ADPmit were approximately 3- to 4.5-fold lower than ATP/ADPcyt, whereby ATP/ADPmit of
hyperosmotically stressed cell tended to be slightly reduced on day 4 and 5 compared to ATP/ADPmit
of reference cells (day 4: 3.5 0.7 vs. 4.3 0.8, day 5: 3.4 0.8 vs. 4.2 1.0).
5.3.4 Quality of RNAandNGSRawCounts
Cell samples for transcriptome analysis were prepared directly before (0 h) as well as 2, 4, 6 and 8 h
after osmotic upshift (+ 150 mOsmol kg-1, 35 h) for three hyperosmotic and two reference batch cul-
tures of antibody producing CHO DP-12 cells (4.2.10). The subsequent isolation, quantification and
quality control of RNA by MFT-Services Tübingen revealed cRNA levels between 286 and 1215 ng µL-1
with RINs of 9.8 - 10 (supporting information Tab. A.4). These results indicated a very good RNA
quality incombinationwithsufficientamountsofRNAwherebynocorrelationbetweencultureosmo-
lality and cRNA or RINwas observed (supporting information Tab. A.4).
While sequencing of mRNAs was performed at all aforementioned time points, sequencing of
miRNAs was limited to the time point directly before osmotic upshift as well as to the time points
4 h and 8 h after hyperosmotic stimulus. This decision was a consequence of the relatively poor NGS
quality formiRNAs in thepreliminary transcriptomeanalysis in combinationwitha tendency tomore
distinctdifferencesbetween referenceandhyperosmotic cultures at theposterior of the twoanalyzed
time points (5.2.2).
The quality scores across all bases of a read were in the range of 30 to 40 for all samples, thus
showingverygoodbasequalities. Despite theaforementionedproblemsduring thepreliminary tran-
scriptome analysis, improvement inNGS formiRNA expression analysis resulted in library sizes of 6 -
13 million reads whereby∼ 42%were mapped to annotated CHOmiRNAs. In comparison, NGS for
mRNA expression analysis produced libraries of 9 - 11million readswith approximately 60%of reads
being mapped to annotated CHO genes. The resulting mRNA and miRNA raw count datasets were
processed according to defined protocols whereby especially low-abundance mRNAs and
miRNAswereremovedfromdatasets (supporting informationA.2.2,A.2.3). In this context, only those
mRNAsshowing readcountsgreater than ten inmore than50%of samplesandgeneswithmore than
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1CPMinat least twosampleswerekept for subsequentanalysis ofDEGs. Similar filtering criteriawere
applied onmiRNA raw count datasets (A.2.3).
Filtering of low-abundancemRNAs andmiRNAs slightly reduced the total number of reads (sup-
porting information Fig. A.15, Fig. A.17 A) However, this effect was less pronounced than the overall
differences in library size. TMM and CPM normalization were applied to compensate for sample-
specific effects like e. g. differences in library size. Visualization of CPM normalization of filtered
mRNA datasets in a boxplot revealed rather similar medians for CPM of different samples (support-
ing information Fig. A.16, Fig. A.17 B). The same procedure was applied for filtered miRNA datasets,
thus showing more distinct differences in median and interquartile regions compared to the results
for mRNA. The final application of TMMnormalization, negative binomial generalized linear model
(GLM)method in combinationwith tagwise dispersion estimation resulted in amedian tagwise BCV
of 0.03 for mRNA (BCVmin = 0, BCVmax = 0.17) and median BCV = 0.11 for miRNA (BCVmin = 0.01,
BCVmax =0.46). Incomparison,aBCVof0.05wasappliedforpreliminary transcriptomeanalysis (5.2.2)
due to the lack in biological replicates.
5.3.5 Principal Component andDifferential Gene ExpressionAnalysis
Prior to the detailed investigation of changes in mRNA (gene) expression, principal component
analysis (PCA) of the rlog-transformedmRNAdataset enabled amore global view at the influence of
hyperosmotic stimulus on gene expression of CHO DP-12 cells (Fig. 5.24). About 88% of data vari-
ability were preserved in the first and the second principal component (PC1, PC2) whereby projec-
tion of all samples onto these components revealed a distinct separation of samples. Noteworthy, all
samplesderived frombatchcultureswithosmolalitiesofapproximately280mOsmolkg-1 clusteredat
a distinct position in the PC1-PC2-plot, thus indicating low variability inmRNA levels among these 13
samples. On the contrary, the significantly different projection of hyperosmotic and reference
samples onto PC1 elucidated a high variability in gene expression due to hyperosmotic stimulus.
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Furthermore, projection of samples onto PC2 illustrated a potential time-dependent variability in
mRNA levels among hyperosmotic samples (Fig. 5.24).
Figure 5.24: Principal component analysis for time series data of mRNA expression. The first principal
component (PC1) contained 64% and PC2 24% of the variability in the dataset. mRNA expression data were
analyzed directly before (0 h) as well as 2, 4, 6 and 8 h after osmotic upshift for reference ( black symbols, ref,
280mOsmol kg-1) and hyperosmotic cultures (red symbols, osmo, 430mOsmol kg-1).
The subsequent detailed gene expression analysis confirmed the picture of the PCA. Reference cells
showedno significant changes ingeneexpression fromoneanalyzed timepoint to theother. Further-
more, similar gene expression patterns were observed for all cell cultures directly before osmotic up-
shift. Thereafter, hyperosmotic stimulus resulted in 4,200 to 4,900DEGs (P¤ 0.02 and FDR¤ 0.02),
whereby only 5 to 13%of DEGs showed a significant log2(FC)¥ |1.0| (Tab. 5.8).
Table 5.8: Effect of hyperosmotic stimulus on the number of differentially expressed genes. DEG = differ-
entially expressed gene with P ¤ 0.02 and FDR ¤ 0.02, UP = DEG with log2(FC) ¥ 1.0, DOWN = DEG with
log2(FC)¤ - 1.0, NA = not applicable.
DEG DEG DEG DEG DEG
0h 2h 4h 6h 8h
0 4,228 4,256 4,876 4,606
UP DOWN UP DOWN UP DOWN UP DOWN UP DOWN
NA NA 369 163 232 58 186 60 156 58
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Two hours after induction of hyperosmotic culture conditions, 369 genes were significantly upregu-
lated and 163 significantly downregulated with respect tomRNA levels of reference cells at the same
time point. Thereafter the number of upregulated genes decreased during each 2 h interval (2 h: 369,
4 h: 232, 6 h: 186, 8 h: 156)whereas the number of downregulated genes decreased from 163 to 58 and
remained rather constant afterwards (2 h: 163, 4 h: 58, 6 h: 60, 8 h: 58).
5.3.6 Gene ExpressionDynamics andRelation toBiological Function
Hyperosmotic stimulus during batch cultivations of CHODP-12 cells induced characteristic dynamic
changes in gene expression which were illustrated by Venn diagrams (Fig. 5.25, supporting informa-
tion A.2.7, A.2.8).
Figure 5.25: Venn diagrams for significantly up or downregulated mRNAs at hyperosmotic culture
conditions. Osmolality was increased 35 h after inoculation of CHO DP-12 by the addition of NaCl-enriched
cultivation medium (280Ñ 430 mOsmol kg-1, Tab. 4.3, 4.2.2). Cell samples of reference and hyperosmotic
cultures were prepared directly before and 2, 4, 6 and 8 h after osmotic shift. Gene expression anal-
ysis was based on NGS. Data were analyzed with edgeR and visualized with VennDiagram (4.2.10).
mRNAs with log2(FC) ¥ |1.0|, P ¤ 0.02 and FDR ¤ 0.02 were defined as significantly differentially
expressed (supporting information A.2.7, A.2.8). With changes to Fig. 3A of manuscript 2 (supporting infor-
mation B.2)
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While approximately 40% of upregulated (218 of 558) and∼ 54% of downregulated genes (152
of 282) were exclusively significantly differentially expressed 2 h after hyperosmotic stimulus, the re-
maining genes showed different expression dynamics. In general, about 44% of upregulated genes
showed significantly elevatedmRNA levels atmore thanoneof the four analyzed timepoints. In con-
trast, significantly reducedmRNA levels atmore than a single time point were observed for only 16%
of downregulated genes. In this context, EGR1 (early growth response 1) was the only gene with sig-
nificantly downregulated gene expression levels during the whole time of analysis compared to 32
genes (Tab. A.8) with significantly upregulated expression levels at all time points after osmotic up-
shift (Fig. 5.25).
To investigate dynamic changes in gene expression instead of the number of significantly up-/
downregulated DEGs, maSigPro analysis with subsequent hierarchical clustering was applied on the
558 significantlyupregulatedand the282significantlydownregulatedgenes (Fig. 5.26, supporting in-
formationFig.A.18). Furthermore,GeneOntology (GO)enrichmentanalyses (4.2.10)wereperformed
for Venn diagram groups andmaSigPro clusters in order to elucidate potential correlations between
gene expression dynamics and biological functions (Tab. 5.9).
About 50% of the 558 upregulated genes were assigned to one of the nine clusters illustrating
distinct gene expressiondynamics at hyperosmotic culture conditions (Fig. 5.26, supporting informa-
tion Fig. A.18). Accordingly,∼ 40%of the 282 downregulated geneswere part of one of the 6 clusters
for downregulated genes (supporting informationA.2.6). Noteworthy, maSigPro analysis revealed
no significant time-dependent changes in gene expression for the majority of corresponding genes
at reference conditions (Fig. 5.26, supporting information Fig. A.18). Only cluster 4 and 5 for down-
regulated genes showed a slight increase in themedian gene expression from time point 6 h to 8 h.
Somegene groups of the Venndiagram for significantly downregulated geneswere assigned to a
distinct cluster, e. g. geneswith significantly lowered expression levels at timepoints 6 h and 8hwere
part of cluster 5. However, neither gene groups of the Venn diagram nor maSigPro clusters encom-
passed downregulated genes enriched in specific biological processes.
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Figure 5.26: Clusters of gene expression dynamics of significantly upregulated mRNAs. Osmolal-
ity was increased during batch cultivation of CHO DP-12 by the addition of NaCl-enriched cultivation
medium (Tab. 4.3, 4.2.2). This resulted in an osmolality of ∼ 430 mOsmol kg-1 for hyperosmotic cul-
tures (n = 3, N) compared to ∼ 280 mOsmol kg-1 for reference cultures (n = 2, ). Gene expression
analysis was based on NGS and data were analyzed with edgeR and maSigPro (4.2.10). Diagrams show
medians of the gene expression of clustered genes. With changes to Fig. 3B of manuscript 2 (supporting in-
formation B.2)
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Ingeneral, results revealed little relationbetweengeneexpressiondynamicsandannotationofgenes
to defined biological processes. Only four groups of the Venn diagram for significantly upregulated
genesaswellasmaSigProcluster3 revealedanenrichmentofgenes inspecificGO-categories (Tab.5.9).
Genes with significantly upregulated expression at all analyzed time points after hyperosmotic
stimulus, were partially involved in "small anatomical structure development" and
"negative regulation of cellular metabolic process". One of the genes of the latter GO-category was
CDK1A which encodes the G1-phase arrest mediating cyclin dependent kinase inhibitor protein 1A
(p21, Bedoya-López et al. (2016); Roobol et al. (2011)). Furthermore, DDIT4 which had already been
observed in thepreliminary transcriptomeanalysiswasannotated tobothof theaforementionedGO-
categories (Tab. 5.9). maSigPro analysis assigned 14 of the 32 genes to cluster 2, thus showing short
time of response (¤ 2 h) in combinationwith rather constantly high gene expression levels (Fig. 5.26,
supporting informationTab.A.8). The remaining 18genes of this genegroupwere equally distributed
among clusters 3, 4, 5 and 6. Significantly upregulated genes at the post-shift time points 4, 6 and 8 h
after osmotic upshift were also members of cluster 3 and 5, whereby some of these genes were in-
volved in "cell adhesion" (GO:0007155). A delayed and gradually enhancing gene expression response
(cluster 5 or 8) was characteristic for genes encoding Na+-transporting proteins (ATP1B1, SLC28A1,
SLC5A3 and SLC6A13) whichwere part of the GO-category "cation transport" (Fig. 5.26, Tab. 5.9). These
geneswere enriched in theVenndiagramgroupof geneswith significantly elevated expression 6 and
8 h after hyperosmotic stimulus (Fig. 5.25). In contrast, genes involved in "cell surface receptor sig-
naling" showed an immediate and short-term response (¤ 2 h) upon osmotic upshift (Tab. 5.9). The
maSigPro cluster 3 was the only one which encompassed genes enriched in a specific biological pro-
cess, namely "regulation of programmed cell death" (Fig. 5.26, Tab. 5.9).
Besides the aforementioned relations between gene expression dynamics and biological func-
tion, gene expression analysis revealed genes encoding proteins with strictly tissue related function.
These genes, e. g. mucin 2 (MUC2), oviductal glycoprotein 1 (OVGP1), interleukin 15 (IL15), nebulin
(NEB) and titin (TTN), showed a short time of response (¤ 2 h) in combination with significantly el-
evated mRNA levels for at least 6 h after hyperosmotic stimulus (supporting information Tab.A.8,
Tab. A.10).
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Table 5.9:GOenrichment analysis for upregulated genes at indicated timepoints or for gene cluster.
218 genes (2 h Ò) 32 genes ( 2 h, 4 h, 6 h, 8 h Ò)
GO:0007166 GO:0048856 GO:0031324
cell surface small anatomical structure negative regulation of
receptor signaling development cellularmetabolic process
ADORA2A BCL6 BCL6
AMHR2 CRYAB CDK1A
BAG3 DDIT4 CRYAB
BCL9L DYRK3 DDIT4
CDK5R1 ETS2 DUSP1
CELSR3 HEXIM1 ETS2
CHRM4 HOXC6 GPD1L
CNTF IL15 HEXIM1
DTX2 NEB IER3
DUOX1 NUPR1 SMYD1
FGFR2 PHEX SPOCD1
FZD9 SEMA6C ZBTB38
GPR97 SMYD1
GRIN2C TTN
HIC1
HOXD3
ID1 30 genes (6 h, 8 h Ò) 51 genes (4 h, 6 h, 8 h Ò)
IQUB GO:0006812 GO:0007155
ITGA10 cation transport cell adhesion
ITGAE AQP1 COL7A1
JMJD6 ATP1B1 CTGF
KIF27 ITPR2 GPR98
KREMEN2 SERINC2 IL7R
L1CAM SLC28A1 KIFC3
MYO1G SLC5A3 LMO7
RLTPR SLC6A13 MERTK
SPEN SEMA4D
SPRY2 cluster 3
TGIF1 GO:0043067
TGIF2 regulation of
TLE4 programmed cell death
TNFRSF4 AHI1 DUSP1
WNT5B BTG2 MKL1
CLN8 NUPR1
CTGF SERPINE1
ADORA2A: adenosine A2a receptor, AHI1: Abelson helper integration site 1, AMHR2: anti-Mullerian hormone type 2 receptor, AQP1: aquaporin 1, ATP1B1: ATPase Na+/K+ transporting subunit beta 1,
BAG3: BCL-2 associated athanogene 3, BCL6: B-cell lymphoma 6, BCL9L: B-cell lymphoma 9-like, BTG2: BTG family member 2, CDK1A: cyclin dependent kinase inhibitor 1A, CDK5R1: cyclin dependent
kinase 5 regulatory subunit 1, CELSR3: cadherin EGF LAG seven-passG-type receptor 3, CHRM4: cholinergic receptormuscarinic 4,CLN8: ceroid-lipofuscinosis, neuronal 8,CNTF: ciliary neurotrophic fac-
tor, COL7A1: collagen type VII alpha 1 chain, CRYAB: crystallin alpha B, CTGF: connective tissue growth factor,DDIT4:DNAdamage inducible transcript 4,DTX2: deltex E3 ubiquitin ligase 2,DUOX1: dual
oxidase 1, DUSP1: dual specificity phosphatase 1, DYRK3: dual specificity tyrosine phosphorylation regulated kinase 3, ETS2: ETS proto-oncogene 2, transcription factor, FGFR2: fibroblast growth fac-
tor receptor 2, FZD9: frizzled class receptor 9, GPD1L: glycerol-3-phosphate dehydrogenase 1-like, GPR97: adhesion G protein-coupled receptor G3, GPR98: adhesion G protein-coupled receptor V1,
GRIN2C: glutamate ionotropic receptor NMDA type subunit 2C, HEXIM1: hexamethylene bisacetamide inducible 1, HIC1: hypermethylated in cancer 1, HOXC6: homeobox C6, HOXD3: homeobox D3,
ID1: inhibitor of DNA binding 1, HLH protein, IER3: immediate early response 3, IL15: interleukin 15, IL7R: interleukin 7 receptor, IQUB: IQ motif and ubiquitin domain containing, ITGA10: integrin sub-
unit alpha 10, ITGAE: integrin subunit alpha E, ITPR2: inositol 1,4,5-trisphosphate receptor type 2, JMJD6: arginine demethylase and lysine hydroxylase, KIF27: kinesin familymember 27, KIFC3: kinesin
family member C3, KREMEN2: kringle containing transmembrane protein 2, L1CAM: L1 cell adhesion molecule, LMO7: LIM domain 7,MERTK:MER proto-oncogene, tyrosine kinase,MKL1: megakary-
oblastic leukemia 1,MYO1G:myosin IG,NEB: nebulin,NUPR1: nuclear protein 1 transcriptional regulator, PHEX: phosphate regulating endopeptidase homolog X-linked, RLTPR: RGDmotif leucine rich
repeats tropomodulin domain, andproline-rich containing, SEMA4D: semaphorin 4D,SEMA6C: semaphorin 6C,SERINC2: serine incorporator 2, SERPINE1: serpin peptidase inhibitor, clade Emember 1,
SLC28A1: solutecarrier family28member1,SLC5A3: solutecarrier family5member3,SLC6A13: solutecarrier family6member13,SMYD1:SETandMYNDdomaincontaining1,SPEN: spenfamily transcrip-
tional repressor, SPOCD1: SPOC domain containing 1, SPRY2: sprouty RTK signaling antagonist 2, TGIF1: TGFB induced factor homeobox 1, TGIF2: TGFB induced factor homeobox 2, TLE4: transducin-like
enhancer protein 4, TNFRSF4: TNF receptor superfamilymember 4, TTN: titin,WNT5B:Wnt familymember 5B, ZBTB38: zinc finger and BTB domain containing 38.
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5.3.7 Osmotic Upshift InducesUpregulation of SevenmiRNAs
To obtain information on sample-specific differences inmiRNA expression levels, a PCA in combina-
tionwith subsequent projection of samples onto PC1 and PC2was performed for themiRNAdataset.
The resulting PC1-PC2-plot which preserved 71% of variability in these two PCs did not show distinct
clustering of biological replicates, thus revealing considerable variability inmiRNA expression levels
of biological replicates (Fig. 5.27). The only exception in this context, were the 8 hhyperosmotic treat-
ment samples which were located in close proximity to each other. However, the variability in PC1
seemed to be associated with culture osmolality due to a distinct separation of reference and hyper-
osmotic samples (Fig. 5.27).
Figure 5.27: Principal component analysis for time series data of miRNA expression. The first principal
component (PC1) contained 48% and PC2 23% of the variability in the dataset. miRNA expression data were
analyzed directly before (0 h,,) as well as 4 h (N,N) and 8 h (,) after osmotic upshift for reference (ref,
280mOsmol kg-1, black symbols) and hyperosmotic cultures (osmo, 430mOsmol kg-1, red symbols).
Detailed analysis of miRNA expression of hyperosmotically stressed CHO DP-12 cells at time points
4 h and 8 h after osmotic upshift revealed sevenmiRNAs (miR-132-3p, miR-132-5p, miR-182, miR-183,
miR-194,miR-215-3p,miR-215-5p)with significantly elevatedexpression levels (P¤0.02, FDR¤0.02,
log2(FC)¥ 1.0, Tab. 5.10). Noteworthy, hyperosmotic stimulus resulted in a 2.5- to 5.3-fold upregu-
lation of the aforementioned sevenmiRNAs within the 4 h post-shift period (Tab.5.10). Another four
hours lateradecrease indifferentialexpression levelswasobservedformiR-182 (-7%),miR-183 (-13%),
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miR-215-5p (-13%),miR-194 (-19%)andmiR-215-3p (-43%)whereas thedifferential expression level of
miR-132-5p increased by 23%. In contrast,miR-132-3p showed a constant 4-fold upregulation at both
analyzed time points after hyperosmotic stimulus (Tab. 5.10).
Table 5.10: Significantly differentially expressed miRNAs due to hyperosmotic shift. Osmolality was in-
creased 35 h after inoculation of CHO DP-12 (280Ñ 430 mOsmol kg-1). Next generation sequencing (4 and
8h after osmotic shift) and subsequent data analysiswith edgeR revealed significantly upregulatedmiRNAs in
comparison to reference cultures (280 mOsmol kg-1). miRNAs with log2(FC)¥ 1.0, P¤ 0.02 and FDR¤ 0.02
were defined as significantly differentially expressed.
log2(FC)
miRNA 4h 8h
cgr-miR-132-3p 2.0 2.0
cgr-miR-132-5p 1.3 1.6
cgr-miR-182 2.4 2.3
cgr-miR-183 1.3 1.1
cgr-miR-194 2.3 2.0
cgr-miR-215-3p 2.3 1.5
cgr-miR-215-5p 2.5 2.3
5.3.8 Prediction of PotentialmiRNATargets
miRNAs commonly repress translation of targetmRNAs or inducemRNAdegradation. To reveal cor-
relations between the observed changes in mRNA and miRNA expression levels, target prediction
toolswere utilized to identify potentialmiRNA targets among the significantly up- or downregulated
DEGs. Application of miRDB, TargetScan and DIANA-microT resulted in the prediction of 14 to 1609
miRNA targets for a single miRNA, whereby the highest numbers were commonly received from
DIANA-microT (Tab. 5.11). However, the numbers of consistently predicted miRNA targets (core tar-
gets)onbasisof the resultsofall three targetprediction tools rangedbetween0(miR-132-5p,miR-215-
3p) and298. The subsequent comparisonof core targetswith the lists of significantly up- or downreg-
ulatedmRNAs revealed a total of 26 potential miRNA targets (up: 17, down: 9). Concluding, miRNA
target prediction revealed a total of 26 potential targets for miR-132-3p (5), miR-182 (13), miR-183 (6)
136
5 Results
andmiR-215-5p (2)whereasnomiRNAtargetswereobserved formiR-132-5p,miR-194andmiR-215-3p
(Tab. 5.11).
Table 5.11: Summary ofmiRNA target prediction. ThemiRNA target prediction toolsmiRDB, TargetScan and
DIANA-microT were applied to identify targets (mRNAs) for miRNAs showing significant upregulation in re-
sponse to hyperosmotic stimulus (4.2.10). Ntargetsvalid. = number of validated targets according to independent
studies, NmiRDB = number of predicted miRNA targets by miRDB, NTargetScan = number of predicted miRNA
targets by TargetScan, NmicroT = number of predicted miRNA targets by DIANA-microT, Ncore targets = number
of consistently predicted miRNA targets by all three tools, NDE core targets = number of consistently predicted
miRNA targets and significantly up- or downregulated in the current study, NDE targetsvalid. = number of tar-
gets which were differentially expressed in the current study and validated as miRNA targets in independent
studies.
Ntargetspredicted NDE core targets
miRNA Ntargetsvalid. NmiRDB NTargetScan NmicroT Ncore targets up down NDE targetsvalid.
miR-132-3p 10 364 407 1108 114 3 2 0
miR-132-5p 0 40 407 57 0 NA NA NA
miR-182 22 634 1121 1609 298 8 5 2
miR-183 12 376 387 748 147 5 1 1
miR-194 18 291 14 810 9 0 0 0
miR-215-3p 0 212 110 545 0 NA NA NA
miR-215-5p 3 132 156 258 24 1 1 0
As all significantly differentially expressed miRNAs were upregulated in response to hyperosmotic
culture conditions, gene expression data for predictedmiRNA targets (mRNAs) were examinedwith
respect to negative or declining log2(FC). As a result 17 of the 26 potential miRNA targets showed
either significantly reduced gene expression levels or a time-dependent decline in differential gene
expression (Fig. 5.28). A subsequent GO-enrichment analysis revealed that the majority of the pre-
dictedmiRNA targets was involved in "regulation of cell proliferation and cell signaling". Altogether,
potentialmiRNA targetswere observed for four of the seven significantly upregulatedmiRNAs (miR-
132-3p (3),miR-182 (9),miR-183 (3) andmiR-215-5p (2)). Among thesemiRNAtargetswere themRNAs
of early growth response 1 (EGR1), snail family transcriptional repressor 2 (SNAI2) andmetastasis sup-
pressor 1 (MTSS1) which had been validated as targets of miR-183 or miR-182 in independent studies
(Liu et al., 2012; Qu et al., 2013; Sarver et al., 2010;Wang et al., 2012).
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Figure 5.28: Heatmap of predicted and differentially expressed miRNA targets. miRNA targets
(mRNAs) were predicted for significantly upregulated miRNAs with miRDB, TargetScan and microT (4.2.10).
The heatmap shows log2-fold-changes (log2(FC)) for consistently identified targets with downregulated or
decreasing gene expression levels. All targets were significantly differentially expressed (log2(FC)¥ |1.0|, P¤
0.02 and FDR¤ 0.02) at at least one point during the time of analysis. Functional clusteringwas based onGO-
enrichment analysis (4.2.10). FOXP2: forkhead box protein 2, SGK3: serum/glucocorticoid regulated kinase 3,
MTSS1: metastasis suppressor 1, ARRDC3: arrestin domain containing 3, FGD4: FYVE, RhoGEF and PH domain
containing 4, L1CAM: L1 cell adhesion molecule, SLC30A1: solute carrier family 30 member 1, SNAI2: snail
family transcriptional repressor 2, EGR1: early growth response 1, RHOBTB1: Rho related BTB domain
containing 1, SPRY2: sprouty RTK signaling antagonist 2, EREG: epiregulin.  = validated in independent
studies.
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5.4 Hyperosmotic Phenotype of a Cell Linewith CHODG44Origin
Industrial CHO production cell lines originate from different parental backgrounds, e. g. CHO DG44
or CHO DXB11, and may therefore show differences in the response to changing culture conditions.
As the CHO DP-12 cell line of the previous experiments originates from CHO DXB11 the following
section investigates the phenotype of a CHO DG44 derived cell line named BIBH1 (kindly provided
by Boehringer-Ingelheim PharmaGmbH&Co. KG) in response to hyperosmotic stimulus.
Suitable culture conditions for this purpose were determined in preliminary experiments as part of
the bachelor thesis of Elena Bollgönn (Bollgönn, 2014).
5.4.1 Hyperosmolality Enhances Product FormationRates at ReducedCell
Growth
Designated hyperosmotic culture conditions (+ 155mOsmol kg-1) were induced in four of eight BIBH1
batch cultures (VR = 1.3 L) by the addition of NaCl-enriched cultivationmedium 35 h after inoculation
of bioreactors (4.2.2). Each of the other four reference cultureswas supplementedwith a comparable
amount of standard cultivationmedium (4.3) to compensate for diluting effects.
Directly before hyperosmotic stimulus (day 1.4) batch cultures showed an average culture osmolality
of 283  5 mOsmol kg-1 (Fig. 5.29). Subsequently, addition of NaCl resulted in a significantly
elevated culture osmolality of 435  6 mOsmol kg-1 (P ¤ 0.02, Fig. Fig.5.29) compared to 281 
3 mOsmol kg-1 for reference cultures. Osmolalities of both, reference and hyperosmotic cultures, in-
creased by approximately 35 mOsmol kg-1 over the time of cultivation, still maintaining the approxi-
mately 155mOsmol kg-1 difference between the two types of cultures (Fig. 5.29).
Starting with VCDs of approximately 0.4 x 106 cells mL-1 upon inoculation, an average VCD of
1.0 0.1 x 106 cells mL-1 was observed for batch cultures directly before osmotic upshift (Fig. 5.29).
Significantly reduced µ (P < 0.005, n = 4, Tab. 5.12) were observed for the post-shift time intervals
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day1.5 to2.5 (-36%)andday3 to4 (-47%), thus resulting in likewise lowerVCDathyperosmolal culture
conditions subsequently today3 (day3 - 5: P<0.05, day5 - 7: P<0.01, n=4). Consequently, anapproxi-
mately 63% lower VCDmax was achieved in hyperosmolal BIBH1 cultures in comparison to reference
cultures (3.10.4 x 106 cellsmL-1 vs. 8.50.8 x 106 cellsmL-1). Rather similar viabilities (¥ 95%)were
determined until day 2 of cultivation followed by a tendency to reduced viabilities at hyperosmotic
culture conditions whereby no statistically significant difference compared to reference conditions
was observed (Fig. 5.29). Viabilities of both reference andhyperosmotic cultures started to decline on
day 4.5 of cultivation. Thus, hyperosmotic cultures reached levels below 90% on day 5 and reference
cultures on day 6 (Fig. 5.29).
Figure 5.29: Influence of hyperosmolality on viable cell density and viability of BIBH1 cells. NaCl-enriched
cultivationmediumwas used to inducedhyperosmotic conditions (arrow,N4) 35 h after inoculation of biore-
actors (4.2.2). An equal volume of standard cultivation medium was added to reference cultures ( ). Error
bars represent standarddeviations forbiological replicates (n=4) consideringaswell the technicalerrorofmea-
surements (n = 3). Highly significant difference in osmolality between reference and hyperosmotic cultures in
the post-shift period (P¤ 0.02). Significant difference in viable cell density on day 3 - 5 (P < 0.05) and highly
significant difference after day 5 (P < 0.01).
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Together with the aforementioned inhibition of cell growth, hyperosmotic culture conditions in-
duced a highly significant enhancement of qP in the post-shift time intervals day 1.5 to 2.5 (+ 46%)
andday 3 to4 (+ 104%, Tab. 5.12). Tobeprecise, qP ofBIBH1 cells exposed to∼ 155mOsmol kg-1 higher
culture osmolality were as high as 34.55 3.41 pgmAb cell-1 d-1 and 23.75 3.30 pgmAb cell-1 d-1 in the
aforementioned time intervals compared to23.67 1.15pgmAb cell-1 d-1 and11.673.06pgmAb cell-1 d-1
for reference BIBH1 cells (Tab. 5.12). However, enhanced qP did not significantly improve the final cP
which reached a level of approximately 337 25 mg L-1 compared to 320 50 mg L-1 for reference
culture (supporting information Fig. A.13).
Table 5.12: Effect of Hyperosmolality on specific product formation rate and growth rate of BIBH1
cells. Osmotic upshift resulted in an approximately 155 mOsmol kg-1 difference in osmolality of reference
(280mOsmol kg-1) and hyperosmolal cultures (435mOsmol kg-1). ** = highly significant difference (P < 0.005,
n = 4), * = significant difference (P < 0.05)
qP ** [pgmAb cell-1 d-1] µ * [d-1]
day 1.5 - 2.5 reference 23.67  1.15 0.77  0.05hyperosmolal 34.55  3.41 0.49  0.03
day 3.0 - 4.0 reference 11.67  3.06 0.64  0.03hyperosmolal 23.75  3.30 0.34  0.03
5.4.2 Osmotic Upshift Increases theNumber of BIBH1 Cells inG1-Phase
In order to analyze whether the DG44-derived BIBH1 cell line showed similar changes in population
compositionwith respect to cell cyclemappingas theDXB11-derivedCHODP-12 cell line, thepercent-
ages of cells in G1-, S- and G2-phase were determined at the pre-shift time point day 1.4 and on the
following days after osmotic upshift (Fig. 5.30).
Cell cycle analysis revealed similar population composition for all BIBH1 batch cultures for the
pre-shift time point, with 40 6%of cells in G1-phase, 43 6% in S-phase and 17 2% in G2-phase
(Fig. 5.30). In the subsequent post-shift period, hyperosmotic culture conditions induced an accumu-
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lationofBIBH1cells inG1-phase. Noteworthy, oncultureday3.5 524%ofhyperosmotically stressed
BIBH1cellswereassignedtoG1-phase followedbya further increase to713%onday4.5 (Fig. 5.30A).
Thus, thepercentageofhyperosmotically stressedcells inG1-phasewas significantlyhigher (P¤0.01,
n = 4) than those of reference cells (33 5% and 57 5%).
In conjunctionwith the accumulationof hyperosmotically stressed cells inG1-phase, thepercent-
ages of cells in S- and G2-phase declined from 43 8% on day 1.4 to 22 5% on day 4.5 and from
17 2% to 7 3%, respectively (Fig. 5.30 BC). Although hyperosmotic cultures tended to have lower
percentages of cells in S- andG2-phase than reference cultures, elevated inter-culture variancesham-
pered the identification of statistically significant differences (Fig. 5.30).
Figure 5.30: Percentage of BIBH1 cells in G1- (A), S- (B) and G2-phase (C) of cell cycle. Hyperosmotic
culture conditions (∼435mOsmol kg-1,N)were induced 35hafter inoculation (arrow) by the additionofNaCl-
enriched cultivation medium (Tab. 4.3, 4.2.2). Reference cultures showed osmolalities of∼ 280 mOsmol kg-1
(). Cell cycle distribution was determined by propidium iodide staining and flow cytometric analysis of cells
(4.2.5). Error bars represent standard deviations for biological replicates (n = 4) considering as well the techni-
cal error ofmeasurements (n = 3). Highly significant difference in the amount of cells in G1-phase (A) on day 3.5
and 4.5 (P¤ 0.01).
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5.4.3 Hyperosmotically StressedBIBH1 Cells ShowEnhancedMetabolic Activity
Concentrations of the main metabolites Glc, Lac and Gln were analyzed throughout the time of cul-
tivation (Fig. 5.31) and specific metabolite formation rates (q) were calculated for defined time inter-
vals (Tab.5.13). Starting from cGlc of approximately 36 mM in all batch cultures, hyperosmotic BIBH1
cultures showed adecelerated decrease in cGlc and consequently an∼ 12 h delayed entry intoGlc lim-
itation (day 4.5 vs. day 4, Fig. 5.31 A). In concurrence with the decelerated decrease in cGlc, a delayed
increase in cLac was observed at hyperosmotic culture conditions, finally reaching a maximal cLac of
47.1 2.2 mM on day 5. In comparison, reference cultures revealed amaximal cLac of 52.1 2.0mM
on day 4. After reaching maximal values, cLac declined to 33.3 2.2 mM in reference cultures and to
38.7 2.2mM in hyperosmotic cultures until the end of cultivation (Fig. 5.31 A).
BIBH1 batch cultures showed congruent profiles for cGln in the pre-shift period day 0 to 1.4,
followed by slightly faster decreasing cGln in hyperosmotic cultures from day 1.45 to 3 (Fig. 5.31 B).
Subsequently, limiting cGln levels (cGln < 0.5 mM) were revealed for both reference and hyperosmotic
cultures on day 3.5 (Fig. 5.31 B). While a further decrease in cGln was observed in reference cultures,
hyperosmotic cultures showed a slight accumulation of Gln.
Figure 5.31: Concentrations of glucose, lactate (A) andglutamine (B) duringbatch cultivation of BIBH1with
osmotic shift. Osmolality was increased 35 h after inoculation of bioreactors (arrow, 4.2.2). Reference cultures
showedosmolalities∼280mOsmol kg-1 () compared tohyperosmotic cultureswith∼435mOsmol kg-1 (N
4). Metabolite concentrationswereanalyzedasdescribed in4.2.5. Errorbars represent standarddeviations for
biological replicates (n = 4) considering as well the technical error ofmeasurements (n = 3).
143
5 Results
Although hyperosmotic culture conditions caused a decelerated decrease in cGlc, hyperosmotically
stressed cells showed significantly enhanced cell specific consumption of Glc in the time interval
day1.5 to2.5 (qGlc =-5.500.20vs. -4.400.44pmolGlc cell-1 d-1, P<0.05,n=4)andonday3 to4 (qGlc =
-4.45  0.10 vs. -3.23  0.45 pmolGlc cell-1 d-1, P < 0.05, n = 4). In concurrence to qGlc,
hyperosmotic stimulus resulted in ahighly significantly reducedqGln in thepost-shift periodday 1.5 to
2.5 (-2.080.01pmolGln cell-1 d-1 vs. -1.400.05pmolGln cell-1 d-1, P <0.01, n=4) and ina significantly
lowerqGln in thetimeintervalday3to4(-0.480.08pmolGln cell-1d-1 vs. -0.200.00pmolGln cell-1d-1,
P < 0.05, n = 4). Furthermore, a highly significantly increased qLac was observed for hyperosmotically
stressed cells (10.30 1.04 pmolLac cell-1 d-1 vs. 6.10 0.89 pmolLac cell-1 d-1) in the post-shift period
day 1.5 to 2.5 (Tab. 5.13).
The approximately 69% increase in qLac in the post-shift period day 1.5 to 2.5 together with the
∼ 25% enhanced consumption of Glc resulted in an ∼ 25% elevated YLac/Glc for hyperosmotically
stressed BIBH1 cells (1.73  0.15 molLac molGlc-1 vs. 1.38  0.07 Lac molGlc-1, P < 0.05, n = 4). In the
subsequent time interval day 3 to 4, YLac/Glc of osmotically stressed cells decreased to 1.12 
0.08molLacmolGlc-1whileYLac/Glc of referencecells remainedratherconstant (1.330.15molLacmolGlc-1).
However, hyperosmotically induced significant differences in YLac/Glc could not be validated for the
time interval day 3 to 4 (P = 0.12, n = 4).
Table 5.13: Effect of Hyperosmolality on metabolic rates of BIBH1 cells. Osmotic upshift resulted in an ap-
proximately 155 mOsmol kg-1 difference in osmolality of reference (280 mOsmol kg-1) and hyperosmolal cul-
tures (435mOsmol kg-1). Negative values represent consumptionwhereas positive values stand for formation.
** = highly significant difference (P < 0.01, n = 4), * = significant difference (P < 0.05, n = 4), ° = no significant
difference
qGlc * qLac **/ ° qGln **/ *
[pmol cell-1 d-1] [pmol cell-1 d-1] [pmol cell-1 d-1]
day 1.5 - 2.5 reference - 4.40  0.44 6.10  0.89 - 1.40  0.10hyperosmolal - 5.50  0.20 10.30  1.04 - 2.08  0.05
day 3.0 - 4.0 reference - 3.23  0.45 4.33  0.91 - 0.20  0.00hyperosmolal - 4.45  0.10 4.98  0.24 - 0.48  0.08
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5.4.4 EnhancedATP FormationRatesDoNotResult in ElevatedATP-Contents
To identifywhetherBIBH1would showacomparable enhancement in energetic capacity uponhyper-
osmotic stimulus as CHODP-12 cells, qATP, nATP and cATP were determined.
While qATP of reference and hyperosmotically stressed BIBH1 cells did not differ in the post-shift
interval day2 to3, significantly enhancedqATP (+ 114%/+ 157%)weredetermined forhyperosmotically
stressed cells in the subsequent period day 3 to 4.5 (Fig. 5.32 A, P < 0.01, n = 4). Noteworthy, qATP in-
creased from27.8 6.7 pmol cell-1 d-1 to 59.7 7.0 pmol cell-1 d-1 and from20.5 1.9 pmol cell-1 d-1 to
52.7 5.6 pmol cell-1 d-1, respectively (Fig. 5.32 A).
Figure 5.32: Effect of hyperosmolality on qATP (A) and nATP (B) of BIBH1 cells. Hyperosmotic culture condi-
tions (∼435mOsmol kg-1,N)were inducedduringbatch cultivationby the additionofNaCl-enrichedmedium
(arrow). Osmolality of reference cultures was∼ 280mOsmol kg-1 (). A: Determination of qATP was based on
C- and O-balancing (4.2.7) and the assumption of a P/O ratio of 2.5 (Balcarcel and Clark, 2003; Hinkle, 2005;
Nath and Villadsen, 2015; Wahl et al., 2008). Error bars represent standard deviations based on four biologi-
cal replicates each. qATP were highly significantly elevated in the post-shift time interval day 3 to 4.5 (P < 0.01).
B: Intracellular ATP-content was determined by a combination of fast filtration approach for 107 cells (4.2.3),
methanol/chloroformextraction (4.2.4) andHPLC analysis (4.2.5). Error bars represent standard deviations for
biological replicates (n = 4) considering as well the technical error ofmeasurements (n = 3).
However, this significant increase in qATP did not result in likewise elevated nATP. Starting from an
average level of 7.97 1.33 fmol cell-1 prior to osmotic upshift, nATP of reference and hyperosmotically
stressed cells declined with the time of cultivation, thereby showing rather congruent profiles until
culture day 4 (Fig. 5.32 B). An additional 12 h later, nATP of reference cells tended to be lower com-
pared to nATP of cells exposed to hyperosmotic culture conditions (3.640.65 fmolATP cell-1 vs. 5.01
145
5 Results
0.82 fmolATP cell-1) but this effect was not statistically significant. Likewise, nADP and nAMP of refer-
ence and hyperosmotically stressed BIBH1 cells did not differ significantly although values tended
to be elevated at hyperosmotic culture conditions (supporting information Fig. A.14). Consequently,
hyperosmotic stimulus did not affect AEC which showed values greater than 0.9 at all analyzed time
points.
Analysis of cell diameters for the subsequent calculation of cATP revealed similar cell sizes in the
pre-shift period while significantly elevated cell diameters were determined for BIBH1 cells exposed
to hyperosmotic culture conditions in the time interval day 2 to 3.5 (P < 0.05, n = 4, Fig. 5.33 B). In
general, cell diameters of hyperosmotically stressed cells (∼ 15 µm) tended to be larger than those of
reference cells (∼ 14.0 - 14.5 µm).
Figure 5.33: Time courses for intracellular ATP-concentration (A) and cell diameter (B) of hyperosmotically
stressedBIBH1 cells.Osmolality was increased 35 h after inoculation by the addition ofNaCl-enriched cultiva-
tionmedium(arrow). This resulted inanosmolalityof∼435mOsmolkg-1 (N) compared to∼280mOsmolkg-1
for reference cultures (). Intracellular ATP-concentrations were analyzed by a combination of a fast filtration
approach for 107 cells (4.2.3),methanol/chloroformextraction (4.2.4),HPLCanalysis (4.2.5)andtheassumption
of spherical cells. Error bars represent standard deviations for biological replicates (n = 4) considering as well
the technical error ofmeasurements (n = 3). Significant difference in cell diameters on day 2 and 2.5 (P < 0.05).
Highly significant difference in cell diameters in the time interval day 3 to 3.5 (P¤ 0.01).
The calculation of cATP on basis of cell diameters and nATP revealed a comparable cATP level of
approximately 4.8 mM for cultures undergoing hyperosmotic treatment and reference cultures on
day 1.4 (Fig 5.33 A). Thereafter, hyperosmotically stressed cells showed a steady decline in cATP finally
reaching a value of 2.8  0.6 mM on day 4.5. In contrast, cATP of reference cells remained at high
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levels of∼ 4.9mMuntil culture day 3 followed by a continuous decrease to 2.2 0.6mM on day 4.5
(Fig 5.33 A). However, differences in cATP were not regarded as statistically significant.
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Inhomogeneous mixing, base titration and feeding of concentrated substrate solutions may induce
hyperosmotic culture conditions (¥ 350 mOsmol kg-1) during large scale fed batch production pro-
cesses of antibody producing CHO cells (Jayapal et al., 2007; Lara et al., 2006; Nienow, 2006;Wurm,
2004). Multiple independent hyperosmolality studies revealed an inhibition of cell growth in com-
bination with a qP enhancing effect (Han et al., 2010; Lee et al., 2003b; Ryu et al., 2000, 2001; Shen
et al., 2010). However, the underlying reason for the enhancement of cellular productivity has not
been elucidated so far.
Therefore this thesis characterized the hyperosmotic phenotype of an antibody-producing CHO
DP-12 cell line. With respect to the energy consuming process of recombinant protein production, re-
search focused on the analysis of hyperosmotic effects on mitochondrial compartment and cellular
energetic capacity. Furthermore, this study combinedmRNAandmiRNAexpression analysis in order
to contribute to a better understanding of superimposed transcriptional changes regarding hyperos-
motic stress responseand to identify suitable targets forqP enhancingcell lineengineering strategies.
6.1 Hyperosmotic Phenotype of CHODP-12 Cells
The characterization of the hyperosmotic phenotype of CHO DP-12 cells was based on different ex-
perimental setups regarding time point (35 h/72 h after inoculation) and intensity of hyperosmotic
stimulus (+ 100/+ 130/+ 150mOsmol kg-1) during batch cultivations.
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6.1.1 Cell Growth andMetabolism
Hyperosmotic stimulus reduced µ of CHO DP-12 cells in a dose-dependent manner whereby more
characteristic differenceswere commonly observed after a 24h latency. While a direct correlationbe-
tween µ andVCDwas observed for cell cultures exposed to an osmotic stimulus of + 150mOsmol kg-1
(5.3.1), high inter-culture variances hampered the validation of a comparable relation between µ and
VCDfora50mOsmolkg-1 lowerosmoticupshift, so thatsignificantly reducedµdidnot result inequally
different VCD (5.1). In summary, the dose-dependent decrease in µ and VCD was in agreement with
previous independent hyperosmolality studies which described decreasing µ and VCD with increas-
ing culture osmolality (Lee et al., 2003a; Ryu et al., 2000, 2001; Shen et al., 2010).
Inhibition of cell growth by hyperosmolality was shown to be associatedwithDNAdamage, thus
inducing p53-mediated cell cycle arrest or even apoptosis at osmolalities of approximately
500 mOsmol kg-1 (Cherlet and Marc, 1999; Han et al., 2010; Kim and Lee, 2002; Ryu et al., 2001). In
this context, first signs for a decline in viability were usually identified at culture osmolalities above
450 mOsmol kg-1 (Kim and Lee, 2002; Shen et al., 2010; Zhang et al., 2010). Hyperosmotic CHO DP-
12 cultures which formed the basis for the majority of research studies of this thesis showed final
culture osmolalities in the range of 380 to 430 mOsmol kg-1, thus being below the critical limit of
450 mOsmol kg-1. Consequently, the observation of similarly high viabilities for both, reference and
hyperosmotic cultures (Fig. 5.1, Fig. 5.9, Fig. 5.14, Fig. 5.17),were inagreementwith findingsofprevious
independent studies (Kim and Lee, 2002; Shen et al., 2010; Zhang et al., 2010).
Furthermore, cell cycle analysis revealed a dose-dependent accumulation of hyperosmotically
stressedCHODP-12 cells inG1-phase (Fig. 5.2, Fig. 5.16)within the first 12 h after hyperosmotic stimu-
lus followed by a further increase to approximately 75 - 80%. Thus, reduced µ and VCD of CHODP-12
cells exposed tohyperosmotic culture conditionswereshowntobea resultofG1-arrestwhichhadalso
beendescribed byRyu et al. (2001) for a hyperosmotically stressed antibody-producing CHO cell line.
Independent research studies linked deceleration of cell growth with enhanced cell specific con-
sumption of themainmetabolites Glc andGln (qGlc, qGln Ó) thereby anticipating a contribution to the
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qP enhancing effect of hyperosmotic culture conditions (Ozturk and Palsson, 1991; Ryu et al., 2000,
2001; Shen et al., 2010). Likewise, specific formation rates for the corresponding by-products Lac and
NH4+ (qLac, qNH4+) were shown to increase upon hyperosmotic stimulus. In this context, YLac/Glc and
YNH4+/Gln either remained at reference levels or showed significantly elevated values (Ozturk andPals-
son, 1991; Shen et al., 2010). In accordance to the aforementioned findings of independent research
studies for CHO and murine hybridoma cell lines, qP of CHO DP-12 cells improved by 50% at
380mOsmol kg-1 (+ 100mOsmol kg-1, ) and by 61% at 430mOsmol kg-1 (+ 150mOsmol kg-1, Tab. 5.6).
However, the reduced µ of osmotically stressed CHODP-12 cells prevented likewise elevated cP, thus
being inagreementwithunchangedor evendecreased cPwhichweredescribed in literature (Kimand
Lee, 2002; Lee et al., 2003a; Ozturk and Palsson, 1991; Ryu et al., 2000, 2001; Shen et al., 2010). The
aforementioned enhancement in qP for CHO DP-12 cells exposed to osmotic upshift of
+ 100 mOsmol kg-1 or + 150 mOsmol kg-1 (5.1.2, Tab. 5.6) was associated with significantly reduced
qGlc in combination with increased qLac. Furthermore, a hyperosmotic stimulus of 150 mOsmol kg-1
significantly elevated qNH4+ (Tab. 5.6). While the effects of hyperosmolality on qP, qGlc, qLac and qNH4+
of CHO DP-12 cells were in agreement with those described in literature (Ozturk and Palsson, 1991;
Ryu et al., 2000, 2001; Shen et al., 2010), the contrary applied for qGln.
Hyperosmotically stressedCHODP-12cells (430mOsmolkg-1) consumedapproximately60%less
Gln than reference cells, whereas Shen et al. (2010) described∼ 40 to 46% enhanced qGln for a Fc-
fusion protein producing CHO B0 cell line grown at comparable culture osmolalities of 410 and
450 mOsmol kg-1, respectively. Strikingly, CHO DP-12 cells exposed to hyperosmotic stimulus 35 h
after inoculation (380/430mOsmol kg-1) stoppedmetabolization of extracellular Gln on day 4 of cul-
tivation and exported Gln instead, thus resulting in an accumulation in the culture broth (Fig. 5.10 B,
Fig. 5.19 B). This phenomenon seemed to be related to high cNH4+ levels (∼ 8 mM) in combination
with the availability of Asn as a second main amino acid substrate. Noteworthy, Asn is metabolized
by deamidation in combinationwith a subsequent transamination of aspartate andα-ketoglutarate
into Glu and oxaloacetate which is then fueled into TCA cycle (Zhang et al., 2016a). Consequently,
the consumption of 1 mol Asn produces less NH4+ than the deamidation and oxidative deamination
based metabolization of 1 mol Gln (1 mol instead of 2 mol NH4+, 2.4). Therefore, the relatively low
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levels of Gln (∼ 0.7mM) compared to cAsn of approximately 2mMon day 4 in combinationwith high
cNH4+ (∼ 8 mM) may have caused a switch from combined consumption of Asn and Gln towards an
exclusive metabolization of Asn. As Glu is an intermediate of Asn metabolization, the observed in-
crease in cGln may originate from the glutamate-ammonia ligasemediated synthesis of Gln fromGlu
and NH4+ (2.4). This assumption is in part confirmed by comparable but opposite changes in cNH4+
(-0.7mM) and cGln (+ 0.6mM) in the post-shift period day 4 to 6 (Fig. 5.19 B, Fig. 5.20). In this context,
metabolic flux analysis (MFA) would be a suitable tool to validate the aforementioned hypotheses.
Summarizing, except for qGln all other characteristic changes (µ Ó, G1-arrest, qP Ò, qGlc Ó, qLac Ò, qNH+ Ò)
of hyperosmotically stressed anti-IL-8-IgG1 producing CHO DP-12 cells were in agreement with
previous independent studies. In conclusion, the applied experimental setups provided appropriate
conditions for the investigation of the cellular energetic capacity and the transcriptional response of
hyperosmotically stressed CHO cells.
6.1.2 Mitochondrial Compartment andCellular Energetic Capacity
Typical properties of hyperosmotically stressedmammalian cells, e. g. cell cycle arrest, increased cell
size and decreased qGlc and qGln, have been anticipated to contribute to the improvement of qP (Han
et al., 2009; Kiehl et al., 2011; Lee et al., 2003a; Ryu et al., 2000, 2001; Shen et al., 2010). Nevertheless,
the extensive characterization of the hyperosmotic phenotype of CHO cells has not revealed the link
between hyperosmolality and enhanced cell specific productivity so far. Despite the fact that recom-
binant protein production represents ametabolic burden for CHO production cell lines, the effect of
hyperosmotic culture conditions on cellular energetic capacity has hardly ever been investigated.
The aforementioned circumstance was the motivation for a strong focus on hyperosmotically
induced changes in qATP and intracellular adenine nucleotide pools as part of this research project. In
this context, the results of a previous diploma thesis (Pfizenmaier, 2011) which investigated resizing
of the mitochondrial compartment upon hyperosmotic stimulus represented the starting point for
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further analysis. Strikingly, significantly reduced mitochondrial fluorescence intensities were
revealed forCHOcells exposed tohyperosmotic stimulus (+ 100mOsmol kg-1, Fig. 3.2), thus assuming
a reduced size of themitochondrial compartment and consequently lessmitochondrial activity.
These results were in contradiction to findings of previous research studies investigating the
effectsofhyperosmolality (Leeetal.,2003a;Linetal., 1999), oxidativestress (Leeetal.,2002a), sodium
butyrate treatment (McMurray-Beaulieu et al., 2009) and CDK1A overexpression (Bi et al., 2004).
Proteomeanalysis of antibodyproducingCHOcells grownat a culture osmolality of 450mOsmol kg-1
revealed increased expression levels for the glycolytic enzymes pyruvate kinase and glyceraldehyde-
3-phosphate dehydrogenase, thus anticipating an increased production of ATP (Lee et al., 2003a).
Lin et al. (1999) investigated energy metabolic fluxes from Glc and Gln in hyperosmotically stressed
murine hybridoma cells, thereby assuming complete oxidation for the consumed Gln compared to
only 5%complete oxidation forGlc. As a result, enhancedqATPwereobservedathyperosmotic culture
conditions and those were subsequently correlated with improved qP (Lin et al., 1999). Furthermore,
the qP enhancing effect of sodiumbutyrate treatmentwas shown to be associatedwith increased cell
specific consumption of O2 as well as elevated nATP for recombinant CHO cells (McMurray-Beaulieu
et al., 2009). An increase inmitochondrialmasswas described for human lung fibroblasts exposed to
oxidative stress on basis ofmitochondrial fluorescence labelingwith 10-n-nonyl-acridine orange and
flow cytometric analysis (Lee et al., 2002a). Likewise, overexpression of CDK1A resulted in increased
mitochondrialmass andmitochondrial dehydrogenase activity in relation toG1-arrest and enhanced
qP (Bi et al., 2004).
While 50%decreasedmitochondrial fluorescence intensities were oncemore described for CHODP-
12 cells exposed to hyperosmotic stimulus (290Ñ 390mOsmol kg-1, Fig. 5.3, P < 0.01, n = 4), the same
experimental setup revealed 20 - 39% enhanced qO2 and qATP as well as 1.2- to 2.1-fold increased nATP
for hyperosmotically stressed cells (Fig. 5.5). Thus, the observed changes in qO2 , qATP and nATP were
in agreement with the aforementioned findings of independent hyperosmolality, oxidative stress,
sodiumbutyrate treatmentandCDK1Aoverexpressionstudies (Bietal.,2004;Leeetal.,2002a,2003a;
Lin et al., 1999; McMurray-Beaulieu et al., 2009) whereas the decrease inmitochondrial fluorescence
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intensity was not. Furthermore, the determined levels for qO2 , qATP and nATP were in a similar range as
values described in literature (Dietmair et al., 2010;Matuszczyk et al., 2015;Miller et al., 1987; Ozturk
and Hu, 2005; Sidorenko et al., 2008; Volmer et al., 2011; Wahl et al., 2008). As a consequence, the
reliability of the anti-TOM22 antibody-basedmitochondrial staining procedure was questioned and
additional analyses were performed (5.1.5).
However, control experiments solely revealed hyperosmotically induced changes in cellular
structure (Fig. 5.7) which may hamper the binding of the anti-TOM22 antibody to its mitochondrial
target. As themitochondrial compartmentwas described as a highly dynamic systemwhich changes
its morphology by fusion and fission of mitochondrial membranes as a function of the cellular state
and requirements, altered energy requirements at hyperosmotic culture conditions may have most
likely affectedmitochondrialmorphology (Campello and Scorrano, 2010; Hock and Kralli, 2009; Per-
nas and Scorrano, 2016; Scheffler, 2001). Pernas and Scorrano (2016) linked enhanced energy
productionwith proliferation of cristae, thus increasing the IMMarea for oxidative phosphorylation.
With respect to elevated qATP and decreased mitochondrial fluorescence one may anticipate that
hyperosmotic culture conditions induced similar changes of the mitochondrial compartment, thus
hampering the interaction of the anti-TOM22 antibody andOMM target TOM22. Furthermore,Mitra
et al. (2009) described themitochondrial morphology during cell cycle as a conversion from a giant,
hyperfused network at G1-S transition to intermediate states of isolated/fragmented elements in S-,
G2-, G2-M- and G1-phase. Regarding the arrest of hyperosmotically stressed CHO DP-12 cells in G1-
phase of cell cycle, morphological changes of themitochondrial compartment seemed to be obvious
according to the description by Mitra et al. (2009). Nevertheless, declining mitochondrial fluores-
cence intensities did not directly correlate with changes in cell cycle distribution. Concluding, mor-
phological changes rather than a reduced size of themitochondrial compartment was anticipated to
be the reason for thedecrease inmitochondrial fluorescence intensity, thus revealing ineptnessof the
antibody-based staining procedure.
Enhanced qATP and nATP were also validated for an osmotic upshift of + 150mOsmol kg-1 35 h after
inoculation (Fig. 5.21). In accordance to sodiumbutyrate treatedCHOcells (McMurray-Beaulieu et al.,
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2009), osmotically stressed CHODP-12 cells (390/430mOsmol kg-1), showed a general increase in in-
tracellular adeninenucleotidepools (nATP Ò, nADP Ò), thusmaintainingATP/ADPratios (e. g. AEC). This
picture of increased nATP, nADP and unchanged AEC at hyperosmotic culture conditions was
refined by analysis of mitochondrial and cytosolic adenine nucleotide pools (Fig. 5.21), thereby
confirming that both cytosolic andmitochondrial pool sizes were significantly elevated upon hyper-
osmotic stimuluswhileATP/ADP ratios (AEC, ATP/ADP) remained rather constant (Fig. 5.21, Fig. 5.22,
Fig. 5.23). Consequently, research results emphasized the importance of conserved cellular distribu-
tions of adenine nucleotides. Strikingly, nATPmit , AECmit andATP/ADPmit of reference and hyperosmot-
ically stressed CHO DP-12 cells were significantly lower than their cytosolic counterparts (Tab. 5.7).
Nevertheless, these findings were in agreement with previous independent studies for CHO cells,
heart myocytes and rat liver (Geisbuhler et al., 1984; Matuszczyk et al., 2015; Schwenke et al., 1981;
Soboll et al., 1978) and probably mirrored the cellular strategy with mitochondria as the energy pro-
ducing "powerhouses" which quickly provide cytosolic processes with the required amounts of ATP.
Inaccordance to independent researchstudies (Alfieri andPetronini, 2007;Burgetal., 2007;Kiehl
et al., 2011; Langet al., 1998), cell size of hyperosmotically stressedCHODP-12 cells increasedwith the
timeofcultivationduetothe inductionofRVI (2.6, Fig. 5.6B, supporting informationFig.A.10B).How-
ever, changes inqATP uponhyperosmotic stimulusout-valuedby far the requiredqATP, + tomaintaincATP
with increasing cell size. Accordingly, elevated cATP were revealed for hyperosmotically stressed CHO
DP-12 cells so that RVI was rejected as a reason for increased intracellular adenine nucleotide pools
(2.6, Fig. 5.6 B, supporting information Fig. A.10 B).
Starting with the hypothesis of a reduced mitochondrial activity for hyperosmotically stressed CHO
DP-12 cells (Pfizenmaier, 2011), further experiments revealed exactly the opposite: enhancement in
qATP, nATP and cATP mirrored the improved energetic capacity of hyperosmotically stressed CHO DP-
12 cells which may have benefited the increase in qP as anticipated by independent research studies
(Bi et al., 2004; Lee et al., 2003a; Lin et al., 1999; McMurray-Beaulieu et al., 2009). Furthermore, the
combination of decelerated cell growth and elevated nATP revealed a surplus in energy supply which
may be utilized to improve cellular productivity even further.
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6.1.3 Cell Line Specificity
CHO production cell lines originate from different parental CHO cell lines with deviating genomic
backgrounds. Thus, the cellular response upon changing culture conditionsmaydiffer fromoneCHO
cell line to another. With respect to the CHO DXB11 origin of the previously discussed CHO DP-12
cell line, the hyperosmotic response of the CHO DG44 derived cell line BIBH1 (kindly provided by
Boehringer-Ingelheim PharmaGmbH& Co. KG, Germany) was investigated.
In general, hyperosmotic culture conditions (435 mOsmol kg-1) induced the same characteristic
effects as described for CHO DP-12 (5.1, 5.3) and other CHO cell lines (Kim and Lee, 2002; Lee et al.,
2003a; Ozturk and Palsson, 1991; Ryu et al., 2000, 2001; Shen et al., 2010). Noteworthy, BIBH1 cells
exposed to hyperosmotic stimulus showed significantly increased qLac, qP and percentages of cells in
G1-phase of cell cycle while µ , qGlc and qGln were decreased (Tab. 5.12, Tab. 5.13, Fig. 5.30). The latter
was contrary to the effect observed for CHO DP-12 cells but was in agreement with findings by Shen
et al. (2010). Despite the similarities in the hyperosmotic response of BIBH1 and CHODP-12 cells the
actual values for specificmetabolite formation rates of BIBH1 cellswere generally 1.4- to 3-foldhigher
(qP, qLac) or lower (qGlc) than those of CHODP-12 cells, thus revealing an enhancedmetabolic activity
forBIBH1 cells. Accordingly, nATP ofBIBH1cellswere significantlyhigher than thoseofCHODP-12 cells
(8 fmolATP cell-1 vs. 3 fmolATP cell-1), while cATP tended to be higher as well (5mMvs. 4mM).
With respect to the effect of hyperosmolality on energetic capacity of BIBH1 cells, significantly
enhanced qATP were observed in the post-shift period day 3 to 4.5 while nATP were not affected at all
(Fig. 5.32). The reason for this difference in hyperosmotic response of CHO DP-12 and BIBH1 cells
may be as simple as the circumstance that the cell line BIBH1 was developed on basis of Boehringer-
Ingelheim's high expression (BI HEXTM) platform, thus holding a potentially better cellular setup to
overcome themetabolic burdenof recombinant proteinproduction than the low-producingCHODP-
12 cell line. As a consequence, BIBH1 cells are most likely capable of utilizing an existing surplus in
energetic capacity directly - a property which seemed to be lacking in CHO DP-12 cells due to the in-
tracellular accumulation of ATP at hyperosmotic culture conditions.
Several cell line engineering approaches focusing on improvement of CHOmetabolism have al-
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ready been described in literature (Chong et al., 2010; Fogolin et al., 2004; Jeong et al., 2001; Kimand
Lee, 2007a,b; Park et al., 2000; Tabuchi and Sugiyama, 2013; Tabuchi et al., 2010; Wlaschin and Hu,
2007b; Zhou et al., 2011). Most of these approaches aimed at reducing the formation of the growth
inhibitingby-products Lac andNH4+ by (over)expressionofMDHII, pyruvate kinase, carbamoyl phos-
phate synthetase I andornithine transcarbamoylase (Chonget al., 2010; Fogolin et al., 2004; Kimand
Lee, 2007b; Park et al., 2000) or downregulation of LDH and pyruvate dehydrogenase kinase (Jeong
et al., 2001; Kim and Lee, 2007a; Zhou et al., 2011). In comparison to qLac of optimized cell lines (4 -
5.6 pmol cell-1 d-1), even lower valuesweredetermined for CHODP-12 cellswhile BIBH1 cells showeda
tendency tohigherqLac. NeverthelessYLac/Glc ofbothcell lineswere inaccordanceto thoseofoptimized
cell lines (Fogolin et al., 2004; Kim and Lee, 2007b), thus indicating that the cellular metabolism of
CHODP-12 and BIBH1 cells has already been optimized regarding in terms of Lac formation. Further-
more, Chong et al. (2010) linked overexpression ofMDH II with 3.3-fold increased intracellular cATP.
Concluding, even one single difference between two cell lines has the potential to cause significant
differences in cellular energymetabolism andmay therefore affect productivity.
In summary, the results of the BIBH1 study revealed a rather similar hyperosmotic stress response
as observed for CHODP-12 cells. Particularly, the confirmation of enhanced qATP upon hyperosmotic
stimuluswas of utmost importance as this result corroborated thehypothesized correlation between
enhanced qATP and improved qP.
6.2 Optimization of the Experimental Setup
6.2.1 TimeofAnalysis and IntensifiedHyperosmotic Stress
Optimization of the experimental setup focused on extending the time between hyperosmotic
stimulus and the occurrence of limiting cGlc levels in order to diminish a potential influence on the
results for cellular energetic capacity. In fact, a 37 h earlier time point for osmotic upshift of
+ 100 mOsmol kg-1 prolonged the time for analysis and revealed elevated nATP for hyperosmotically
stressed CHO DP-12 cells before nATP of reference cells started to decline (Fig. 5.11). Thus, the differ-
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ence in nATP was associated with hyperosmotic stimulus rather than with nutritional limitation of
reference cells. Nevertheless, the differences between reference and hyperosmotic conditions were
not as significant as expected at the first moment. Concluding, the time point of osmotic upshift
did not significantly impact on the intensity of hyperosmotically induced changes of cell growth and
metabolism. In addition, preliminary transcriptome analysis revealed a rather low number of DEGs
upon hyperosmotic stimulus (Tab. 5.4). As a consequence, optimization of the experimental setup
was applied to contribute to an enhancement of hyperosmotically induced effects. Intensification of
hyperosmotic stress was chosen to achieve this aim and in fact hyperosmotic stimuli as high as + 130
or + 150 mOsmol kg-1 resulted in the desired significant difference between reference and hyperos-
motically stressed CHODP-12 cells (5.3). In conclusion, results were in agreement with independent
hyperosmolality studieswhichdescribedmore significant effectswith increasing cultureosmolalities
(Kim and Lee, 2002; Lee et al., 2003a; Ryu et al., 2000, 2001; Shen et al., 2010).
6.2.2 TranscriptomeAnalysis
Preliminary transcriptome analysis was performed in order to test sample preparation, sequencing
quality, edgeR analysis and to receive a first idea of differential mRNA and miRNA expression upon
hyperosmotic stimulus. Although quality and amount of isolated RNA were not affected by culture
osmolality and were in an adequate range for subsequent sequencing, NGS for miRNA expression
analysis resulted inpoordataqualitywithpretty lownumbers for total readcounts. Thus,MFTServices
Tübingenhadtoadjust themiRNAlibrarypreparationaswell as thesubsequent sequencingstep. Asa
result, the quality of miRNA sequencing data was significantly improved and consequently
provided suitable datasets for the analysis of differential miRNA expression upon hyperosmotic
stimulus aspart of themain experiment. However, sample-specific differenceswere stillmore signifi-
cant than those of mRNA samples (Fig. 5.24, Fig. 5.27) and were not completely compensated by
normalization (supporting information Fig. A.17). The miRNA-specific BCV varied between 0.01 and
0.46 and showed amedian BCVof 0.11, thus revealing high sample-specific differences for part of the
miRNAs. This may partially be associated to biological variations but may also be related to the fact
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that miRNAs are even shorter than one read length (∼ 22 nt vs. 61 nt). Therefore, the whole process
of NGS for analysis of miRNA expression, including e. g. library preparation, sequencing, removal of
adapter sequences, is far more critical than for mRNA samples and may most likely affect mapping
efficiency and consequently sample-specificmiRNA expression levels.
In contrast to miRNA datasets, NGS for mRNA expression analysis revealed similarly high total
read counts andmappingefficienciesduring thepreliminary and themainexperiment. Furthermore,
the applied edgeR protocol efficiently normalized mRNA datasets with respect to differences in
library size (supporting informationFig.A.16). Strikingly, preliminary transcriptomeanalysis revealed
a low number of DEGs upon hyperosmotic stimulus, whereby 9 genes were significantly upregulated
and one gene significantly downregulated. Unfortunately, the observed DEGs seemed not to
contribute to the identification of reasonable transcriptional changes with respect to the hyper-
osmotic phenotype. These results were assumed to be related to the moderate osmotic upshift. As
a consequence, a more intense hyperosmotic stimulus was chosen for the main experiment in order
to observemore significant changes inmRNA andmiRNA expression.
Regarding thehighnumberof significantlydifferentially expressedmRNAsuponosmotic upshift
in themainexperiment, adjustmentofhyperosmotic stress level and timeof analysis revealedamore
precisepictureof hyperosmotically induced transcriptional responseof CHODP-12 cells,whereby6of
theaforementioned 10DEGswereagain showntobe significantlyupregulated (CHN1,CITED1,DDIT4,
FIGF, OLFM1, SEMA4D). Thus, optimization of the experimental setup still maintained characteristic
transcriptional changes of CHODP-12 cells.
6.3 Transcriptional Response of CHODP-12 Cells Upon
Hyperosmotic Stimulus
NGS for mRNA andmiRNA expression analysis revealed a total of 558 mRNAs (supporting informa-
tion A.2.7) and 7 miRNAs (Tab. 5.10) with significantly upregulated expression levels during the 8 h
time interval after osmotic upshift (280Ñ 430 mOsmol kg-1). In contrast, 282 mRNAs were signifi-
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cantly downregulated (supporting information A.2.8). However, while miRNAs were significantly
upregulated at both of the analyzed time points after osmotic upshift (4 h, 8 h), a diversity of
expressiondynamicswas revealed for differentially expressedmRNAs (Fig. 5.25, Fig. 5.26, supporting
informationFig.A.18). Strikingly, geneswith similar expressionprofileswerenotnecessarily assigned
to specific biological processes.
6.3.1 ConservedGene Expression Changes
Burg et al. (2007) reviewed the response of mammalian cells to hyperosmotic stresses and summa-
rized characteristic changes in gene and protein expression. A comparison to the statistically
significant gene expression changes of hyperosmotically stressed CHODP-12 cells revealed similarly
elevated mRNA levels for the eight genes ATPase Na+/K+ transporting beta 1 polypeptide (ATP1B1),
aquaporin 1 (AQP1), solute carrier family 38 member 2 (SLC38A2), solute carrier family 6 member 6
(SLC6A6 = TAUT), nuclear factor of activated T-cells 5 (NFAT5), crystallin alpha B (CRYAB),HSP110 and
HSPA4L encoding channel proteins, transporters, transcription factors and chaperones. According to
independent studies (Alfieri and Petronini, 2007; Burg et al., 2007; Lang et al., 1998) the transporters
ATP1B1, SLC38A2andSLC6A6were involved inosmoregulationandRVI (2.6), thusmediating replace-
ment of intracellularly accumulated Na+ with K+ (ATP1B1) or influx of osmolytes, e. g. neutral amino
acids (SLC38A2) or taurine (SLC6A6).
Furthermore, thedifferential expressionof 57genes (upregulated: 28, downregulated: 29)were in
agreementwith themicroarraybased transcriptional responseof anosmotically stressedCHOB0cell
line producing Fc-fusion protein (Shen et al. (2010), Tab. A.2.9). Surprisingly, all geneswhichwere as-
signed to cellmetabolism (Tab. A.2.9), were downregulated although an increasedmetabolic activity
wasobserved inthepresentand inseveral independentstudies (Ryuetal.,2000;Shenetal.,2010;Zhu
et al., 2005). However, noneof these genes encodedaprotein involved in centralmetabolism (2.4). In
contrast, proteins related to cell death (DDIT4, GLCCI1) or cell proliferation (PLK2) were upregulated.
Despite the similarity of gene expression changes for 57 genes, only 16 thereof were significantly dif-
ferentiallyexpressedregardingtheappliedthreshold (log2(FC)¥ |1.0|, P¤0.02)andFDR¤0.02)and
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were consequently defined as CHO specific expression markers for NaCl-induced hyperosmotic cul-
ture conditions (Tab. A.2.9). With respect to a total of 800 significantly up- or downregulated genes
in the present study, the number of conserved gene expression changes was rather low. This might
either be related to cell line specificity as anticipated by Shen et al. (2010) or to the limited number
of genes that is commonly considered by microarray based transcriptome studies. Therefore, future
NGS studiesmay reveal an additional number of CHO specific gene expression changes.
6.3.2 Gene ExpressionDynamics andRelation to theHyperosmotic Phenotype
Analysis ofmRNAexpression revealed a highly dynamic transcriptional response for CHODP-12 cells
exposed to hyperosmotic culture conditions (Fig. 5.24, Fig. 5.25, Fig. 5.26). Unfortunately, mRNAs
with comparable expression patterns were not necessarily assigned to a specific biological process
(Tab. 5.9). However, mRNA expression levels for genes encoding proteins involved in "negative regu-
lation of cellular metabolic process" quickly responded upon osmotic upshift and were significantly
upregulatedat all analyzedpost-shift timepoints. Among thesewasCDK1Awhichhadbeen shown to
induceG1-arrest andenhancement in qP in CHOproducer cell lines (Bi et al., 2004; Fussenegger et al.,
1998). Likewise, independent research studies on qP enhancing culture conditions revealed that cell
cycle arrest upon temperature downshift (37°CÑ 30 - 33°C) or sodium butyrate treatment was asso-
ciated with upregulation of genes encoding CDK inhibitors, e. g. CDK1A, CDKN2C, CDKN2A (Bedoya-
Lópezetal., 2016;Kaufmannetal., 1999;Klausingetal., 2011;Rooboletal., 2011;Trummeretal., 2006;
Yeeetal., 2008). Hence, targetedoverexpressionofCDK1AorupregulationofdifferentCDK-inhibitors
in response to cellular stress conditions were related to the same phenotypic effects which were in-
duced by hyperosmolality. Furthermore, Bi et al. (2004) associated CDK1A overexpression with in-
creasedmitochondrialmassandmitochondrialdehydrogenaseactivityonbasisofMitoTrackerGreen
FM or 3-(4, 5-dimethyliazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) staining and subsequent
flow cytometric analysis. Once more, these results were in agreement with the hyperosmotically in-
duced enhancement of qO2 , qATP and nATP. Thus, it is anticipated that upregulation of CDK1A expres-
sion upon hyperosmotic stimulus plays a central role in the hyperosmotic stress response and for the
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development of the hyperosmotic phenotype of CHODP-12 cells.
Regarding the regulatory network of mammalian cell cycle, mRNA expression levels of CDK1A's
transcriptional activator p53 (He et al., 2005; Poon, 2016) as well as expression of several genes en-
coding related protein kinases, e. g. ATM, CHK1/2, were not affected by hyperosmotic stimuluswhich
might be due to a continuous basal expression to enable a quick activation by phosphorylation if re-
quired (Poon, 2016). In contrast, the components cyclin D and E of the CDK1A inhibited complexes
cyclin D/CDK4 and cyclin E/CDK2 (He et al., 2005; Poon, 2016) showed significantly downregulated
mRNA expression levels 4 h after osmotic upshift (CCND1, log2(FC): -0.6 (2 h), -1.2 (4 h), -1.0 (6 h), -1.1
(8 h)) or declining expression levels (CCNE1, log2(FC): -0.3 (2 h), -0.7 (4 h), -0.8 (6 h), -1.0 (8 h)).
In general, the group of genes with immediate and significant changes in gene expression
levels upon hyperosmotic stimulus were expected to include sensors, inducers and regulators of
major stress response pathways. In deed, themajority of DEGswith exclusively significantly elevated
expression levels 2h after hyperosmotic stimuluswere assigned "cell surface receptor signaling" func-
tion. Strikingly, SPRY2, a predictedmiR-183 target which had been described as negative regulator of
CDK1A by Zhang et al. (2016b) was part of the aforementioned gene group, thus linking SPRY2 gene
expression dynamics to the occurrence of G1-arrest.
Steadily increasingmRNAexpression levelswere characteristic forgenes involved in "cation trans-
port" which finally reached significantly elevated log2(FC) (¥ 1.0) 6 h after osmotic upshift. Accord-
ing to independent research studies (Alfieri and Petronini, 2007; Kwon et al., 1992; Lang et al., 1998;
Zhou et al., 2012), four of the seven genes of this groupwere involved in the process of RVI whichwas
characteristic for CHO DP-12 cells undergoing hyperosmotic treatment. More precisely, the upregu-
lated Na+/myo-inositol transporter SLC5A3, Na+/taurine transporter SLC6A13 and AQP1 were shown
tomediate cellular influx of osmolytes and water while ATP1B1 enabled replacement of Na+ with K+,
thus stabilizing cellular function (Alfieri andPetronini, 2007; Kwonet al., 1992; Lang et al., 1998; Zhou
et al., 2012).
The onlymaSigPro cluster revealing enrichment of genes involved in a specific biological process
was cluster 3 which encompassed several genes related to "regulation of programmed cell death".
Among these was a gene encoding dual specificity phosphatase (DUSP1) which was shown to be in-
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ducedbyp53 in response to cellular stress, e. g. oxidative or nutritional stress (Liu et al., 2008). DUSP1
itself inhibited mitogen-activated protein kinase (MAPK) by phosphorylation, thus hampering cell
growth and proliferation (Liu et al., 2008) similar to the observed effects of hyperosmolality on CHO
DP-12 cells. Likewise, p53-mediated induction was described for the BTG family member 2 (BTG2,
Guardavaccaroetal. (2000))whichwassignificantlyupregulateduponhyperosmotic stimulus inCHO
DP-12 cells. Furthermore, expression of BTG2 in mouse embryo fibroblasts was shown to result in
hypophosphorylated pRb protein, thus inducing G1-arrest accompanied with downregulation of
CCND1proteinexpression (Guardavaccaroetal., 2000). Therefore,hyperosmotically inducedupregu-
lationofBTG2 incombinationwithsignificantlydownregulatedCCND1expressionandG1-arrestwere
in agreement with the aforementioned results of independent research studies.
Transcriptomeanalysis revealed nodirect link betweendifferential gene expression and elevated
nATP and qATP. This may be due to the fact that the transcriptional response was analyzed about two
days before significantly different nATP and qATP were detected for hyperosmotically stressed cells.
Furthermore, metabolic pathways, e. g. glycolysis and TCA cycle, which contribute to the synthesis
of ATP are highly regulated at the level ofmetabolic enzymes andmetabolic flux. nAMP/ATP or nADP/ATP
influence theactivity ofmetabolic enzymesasameasureof cellular energydemand (Berget al., 2003;
Brüseretal., 2012; FentonandHutchinson,2009;Martínez-Costaetal., 2012). Thereby,AMP,ADPand
ATPare commonallosteric effectornucleotidesofmetabolic enzymes, thusenabling responsesof cell
metabolism at the second time scale (turnover rate of 1.5mM s-1 for ATP) whereas the transcriptional
response is several magnitudes slower (Oldiges et al., 2007; Wurm et al., 2010). Consequently, the
identification of a direct link between gene expression and ATP synthesis is anticipated to be rather
difficult.
In conclusion, gene groupswith assigned biological functions contained geneswhich are anticipated
to contribute to the observed hyperosmotic phenotype, e. g. G1-arrest, RVI, of CHO DP-12 cells with
respect to research results of independent studies.
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6.3.3 Correlations BetweenDifferentialmiRNAExpression and the
Hyperosmotic Phenotype of CHODP-12 Cells
Hyperosmoticcultureconditions induced inhibitionofcellgrowthbyG1-arrestwhileqPwas improved.
During the last five years, miRNA-based cell line engineering approaches to enhance qP of CHO cells
applied transient or stable overexpression of a variety of different miRNAs, namely cgr-miR-17,
cgr-miR-19b, cgr-miR-20a, cgr-miR-92a, cgr-miR-2861,mmu-miR-30 family members, hsa-miR-7, hsa-
miR-1287 and hsa-miR-557 (Barron et al., 2011a; Fischer et al., 2015b,c; Jadhav et al., 2014; Loh et al.,
2014; Meleady et al., 2012; Strotbek et al., 2013). Commonly, these approaches achieved 1.2 to 2.5-
fold enhanced qP together with improved or unchanged cell growth, thus resulting in significantly
elevated cP. In contrast, the cell growth inhibiting effect of miR-7 or miR-30 family members in com-
bination with enhanced qP hampered an improvement in final cP (Barron et al., 2011a; Fischer et al.,
2014, 2015b). Besides the enhancement of cellular productivity by overexpression of miRNAs, Kelly
et al. (2015a) andKelly et al. (2015b)were able to improve qP by amiRNAspongemediated functional
inhibitionofmiR-23andmiR-34a, respectively. Anotherapproachachieved increasedVCD,prolonged
viabilityandenhancedqP byutilizinganantagomir to inhibit thepro-apoptotic functionofmmu-miR-
466-5p (Druz et al., 2011, 2013).
Despite the qP enhancing effect of hyperosmotic culture conditions, none of the seven significantly
differentiallyexpressedmiRNAs(Tab.5.10)wasamongthefinallyappliedcell lineengineeringtargets
of theaforementionedresearchstudies. Inaddition, researchstudiesoncharacteristicmiRNAexpres-
sion patterns in relation to µ, low cultivation temperature or histone deacetylase inhibition (Barron
et al., 2011b; Clarke et al., 2012; Fischer et al., 2015c; Gammell et al., 2007) showed no similarities to
the hyperosmotic stress response of CHODP-12 cells. Nevertheless, Strotbek et al. (2013) transiently
transfected an antibody producing CHODG44 cell line with hsa-miR-183 during their miRNA screen-
ing studies, thus revealing significantly enhanced qP in combination with decreased VCD. Strikingly,
these effects of hsa-miR-183were in accordancewith the hyperosmotic phenotype of CHODP-12 cells
and thereforemiR-183was assumed to play an important role in cell cycle arrest and improvement of
cellular productivity. The involvement in cell cycle arrest was corroborated by the fact that the three
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predicted miR-183 targets were shown to be involved in cell proliferation. The most interesting one
in this context was the transcription factor EGR1 which was validated as miR-183 target and was re-
vealed to promote tumor migration (Sarver et al., 2010). Accordingly, Sells et al. (1995) described a
EGR1-mediateddelayof IL-1 inducedG0/G1-arrest inhumanmelanomacellswhileParpaet al. (2009)
inhibited growth of human prostate carcinoma cell lines by downregulation of EGR1. Furthermore,
hepatocytes of mice exposed to carbon tetrachloride required EGR1 for cell cycle entry from G0- to
G1-phase and for G1-S transition (Pritchard et al., 2011). The aforementioned tumor growth enhanc-
ing function of EGR1 was confirmed by other research studies (Scharnhorst et al., 2000; Virolle et al.,
2003).
Concluding, thehyperosmotically induced increase in cgr-miR-183expressiontogetherwithdown-
regulation of EGR1 and G1-arrest depicted exactly the same picture which had been described for
multiple cancer cell lines (Parpa et al., 2009; Pritchard et al., 2011; Sarver et al., 2010; Sells et al., 1995).
In contrast, some other research studies described EGR1 as positive regulator of CDK1A consequently
inducing cell cycle arrest by inhibition of cyclin A/E/CDK2 and cyclin D/CDK4 (He et al., 2005; Poon,
2016; Ragione et al., 2003; Shin et al., 2010), thusbeing contrary to reducedexpression levels forEGR1
and upregulation of CDK1Awhichwere observed in hyperosmotically stressed CHODP-12 cells. How-
ever, a reverse correlation between the expression level of the miR-183 target sprouty RTK signaling
antagonist 2 (SPRY2) and CDK1A expression was described for a colon cancer cell line by Zhang et al.
(2016b). In general, further experiments, e. g. luciferase reporter assays, are required to validate the
proposed interaction of cgr-miR-183 with EGR1 and SPRY2mRNA, respectively. Furthermore, the an-
ticipated correlations between cgr-miR-183 and the hyperosmotic phenotype may be confirmed by
overexpression of miR-183 in CHO DP-12 cells and subsequent analysis of CDK1A expression levels,
cell cycle distribution and qP.
Besides miR-183, all other differentially expressed miRNAs were associated to p53-mediated
tumor suppression or to cell proliferation (Braun et al., 2008; Georges et al., 2008; Jiang et al., 2015;
Khella et al., 2013; Kong et al., 2012; Li et al., 2014; Park et al., 2011; Pichiorri et al., 2010;Wang et al.,
2008, 2012, 2014a). However, depending on the type of cancer cell line miR-132 and miR-182 either
induced suppression of proliferation or promoted tumor progression (Jiang et al., 2015; Kong et al.,
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2012; Li et al., 2014; Park et al., 2011; Wang et al., 2012, 2014a). In contrast, miR-132 and the p53-
induciblemiRNAsmiR-194 andmiR-215 were shown to contribute to elevated gene expression levels
of theG1-arrest inducing protein CDK1A (Braun et al., 2008; Georges et al., 2008; Jiang et al., 2015; Pi-
chiorri et al., 2010)whichwas revealed tobe significantly upregulateduponhyperosmotic stimulus in
this researchstudy. In return,miR-194andmiR-215 functionedas regulatorsofTP53expression (Braun
etal., 2008;Pichiorri et al., 2010). According to independent studies,multipleof thepredictedmiRNA
targets were either associated with tumor suppression, e. g. ARRDC3, FOXP2,MTSS1, RHOBTB1 (Dra-
heimet al., 2010; Gascoyne et al., 2015;Wang et al., 2012; Xu et al., 2012), orwith cancer cell invasion,
proliferationandcell cycleprogression, e. g. SGK3, SNAI2 (Chengetal., 2013;Wangetal., 2014b), thus
illustrating the potential diversity of regulatory changes behind the inhibition of cell growth upon
hyperosmotic stimulus.
6.3.4 Cell Line Engineering Strategies
With respect to the energy consuming process of recombinant protein production, cell line engineer-
ing strategies focus among others on approaches which improve the cellular energy supply in order
to enhance qP. In this context, previous independent studies applied genome reduction (Lieder et al.,
2015; Mizoguchi et al., 2007; Sauer and Mattanovich, 2012), metabolic engineering of ATP consum-
ing or producing pathways (Hara and Kondo, 2015; Seth et al., 2006) or methods to induce cell cycle
arrest (Bi et al., 2004; Fussenegger et al., 1998; Kim et al., 2012; Seth et al., 2006) to optimize cellular
productivity.
The surplus in energetic capacity of hyperosmotically stressed CHO DP-12 cells represents one
starting point for cell line engineering as ATPmay be utilized to improve cellular productivity. Never-
theless, further investigations, e. g. MFA, in vivo enzyme activity assays, metabolome and proteome
analysis, are required to identify possibilities to fuel the surplus in ATP into product synthesis.
Especially, allosteric regulation of enzyme activity by ATP should be considered in this context (2.4).
Enhanced availability of cellular energy seemed to be associated with G1-arrest as hyperosmoti-
cally stressed cells showed even higher qATP although the energetic demand in terms of reduced cell
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proliferation declined. The revealed upregulation of CDK1A is anticipated to play a central role for
the development of the hyperosmotic phenotype of CHODP-12 cells as overexpression of CDK1A has
already been described to induce G1-arrest and to improve qP of CHO producer cell lines (Bi et al.,
2004; Fussenegger et al., 1998). The findingof elevatedqATP in combinationwith the aforementioned
properties may elucidate the reason for CDK1A's qP enhancing function and its suitability as cell line
engineering target. However, the CDK1A-mediated inhibition of cell growth commonly hampers the
improvementof cP and thereforea suitable timepoint andstrategy for the inductionofCDK1Aexpres-
sionwould be required to utilize the qP enhancing effect for an improvement of cP.
Besides CDK1A, the miRNAs cgr-miR-132, cgr-miR-194 and cgr-miR-215 may represent potential
targets for cell line engineering as thesemiRNAs were significantly upregulated upon hyperosmotic
stimulus and were shown to induce CDK1A-mediated G1-arrest in independent research studies
(Braun et al., 2008; Georges et al., 2008; Jiang et al., 2015; Pichiorri et al., 2010). Consequently, over-
expression of the aforementioned miRNAs in recombinant CHO cell lines is assumed to contribute
to an enhancement in cellular productivity in regard of the qP enhancing effect of CDK1A. Another
promising miRNA for cell line engineering is expected to be miR-183 whose qP enhancing effect has
alreadybeendescribedfor transientexpressionofhsa-miR-183 inanantibodyproducingCHOcell line,
thus resulting in significantly enhanced qP and reduced VCD (Strotbek et al., 2013). Furthermore,
several independent research studies refined the involvement of miR-183 and its predicted miRNA
targets EGR1 and SPRY2 in cell cycle arrest or progression.
In contrast to the aforementioned strategies, which focused on overexpression of genes or
miRNAs, genome reduction may also be a suitable strategy to improve the cellular performance of
CHOproducer cell lines. Analysis ofmRNA expression revealed increased expression levels for genes
encodingproteinswithdispensable function in suspensiongrowing cells. Among theseproteinswere
components for a protecting extracellular mucin layer (MUC2, OVGP1), members of the muscle sar-
comere (NEB, TTN) as well as a protein which stimulates proliferation and differentiation of cells of
the immune system(IL15). Regarding thedispensable function, theaforementionedproteins seemed
to be potential candidates to enhance qP by genome reduction. Especially the synthesis of the heavily
O-glycosylated (>50%) proteinsMUC2 andOVGP1 requires a great amount of energy (Hollingsworth
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andSwanson,2004; Lagowetal., 1999). Forexample, consideringanenergydemandof3moleculesof
ATP per peptide bond (Seth et al., 2006), the synthesis of 1 MUC2 molecule consisting of
approximately5100aminoacids (Lagowetal., 1999)wouldconsume∼ 15300molATP. Incontrast, only
3957 molATP are required for 1 mol of IgG1 antibody (∼1320 amino acids). Consequently,
recombinant protein productionmight be hampered by the ATP intense production of proteins with
dispensable function. Previousmicrobial genomereduction studies revealedanoverall improvement
ofcellularperformance includingenhancementof recombinantproteinproduction(Liederetal.,2015;
Mizoguchi et al., 2007; Sauer and Mattanovich, 2012). With respect to the mindset of microbial
producers, deletion of IL15, MUC2, NEB, OVGP1 and TTNmay potentially contribute to an enhance-
ment of the cellular performance of CHODP-12 cells.
6.4 Conclusions and Future Perspectives
The aim of this thesis was to reveal the reason for the qP enhancing effect of hyperosmotic culture
conditions and to utilize the acquired knowledge to identify potential cell line engineering strate-
gies for the improvement of the cellular performance of CHO producer cell lines. For this purpose an
antibody producing CHO DP-12 cell line was cultivated in STRs in batch mode and hyperosmotic
culture conditions were induced by the addition of NaCl-enriched cultivation medium. Strikingly, a
decrease in anti-TOM22mediated mitochondrial fluorescence intensity was observed whereas qATP,
nATP and cATP increased upon hyperosmotic stimulus. With respect to findings of control experiments
and independent research studies (Mitra et al., 2009; Pernas and Scorrano, 2016), the decrease in
mitochondrial fluorescence is assumed to be attributed to sterically hampering structural changes
rather than to a reduced size of the mitochondrial compartment. This may be validated by electron
microscopicanalysisoracombinationofanalternative fluorescencestainingprocedure formitochon-
dria and confocalmicroscopy.
Comparison of the observed hyperosmotic phenotype of CHODP-12 cells to findings of indepen-
dent research studies indicated that the combination of G1-arrest and enhanced energetic capacity
most likely plays the decisive role for the improvement of cell specific productivity in hyperosmoti-
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cally stressed CHODP-12 cells. Although arrested cells are expected to have an alleviated energy de-
mand compared to exponentially growing cells, hyperosmotically stressed CHO DP-12 cells showed
significantly increased qATP that exceeded by far the required ATP formation to compensate for the
hyperosmotically induced RVI. Therefore, it is anticipated that hyperosmotically stressed CHO DP-
12 cells partly utilize the observed surplus in ATP supply for recombinant protein production, thus
improving qP. This hypothesis is corroborated by the fact that stress related enhancement of qp was
frequently associatedwith cell cycle arrest
The hyperosmotically induced G1-arrest of CHO DP-12 cells is most likely mediated by the
significantupregulationofCDK1A. In this context, cgr-miR-132, cgr-miR-194and cgr-miR-215mayhave
superimposed regulatory function as these miRNAs were associated with enhanced CDK1A expres-
sion levels in independent research studies (Braun et al., 2008; Georges et al., 2008; Jiang et al., 2015;
Pichiorri et al., 2010)which in turnwas shown to improveqP ofCHOproducer cell lines (Bi et al., 2004;
Fussenegger et al., 1998). Furthermore, upregulationof cgr-miR-183uponhyperosmotic stimulusmay
alsobeareasonforG1-arrestandtherelatedenhancement inqP as indicatedbyprevious independent
research results (Parpa et al., 2009; Pritchard et al., 2011; Sarver et al., 2010; Scharnhorst et al., 2000;
Sells et al., 1995; Strotbek et al., 2013; Virolle et al., 2003; Zhang et al., 2016b).
Targeted overexpression of the aforementioned miRNAs and subsequent analysis of cell cycle
distribution and CDK1A expression levels may confirm the proposed correlations between miRNAs,
CDK1A and cell cycle arrest. In this context, validation of potential miRNA targets is anticipated to
contribute to amore detailed picture of the regulatory processes behind the observed hyperosmotic
phenotype. These studieswill consequently reveal whether one of themiRNAsmay be a suitable cell
line engineering target to improve the cellular performance of CHOproducer cell lines.
The immediate and long term upregulation of genes encoding proteins with dispensable func-
tion in suspension growing CHO cultures represents another starting point for cell line engineering.
Thus, MUC2, NEB, OVGP1 and TTN are expected to be ideal candidates for genome reduction in or-
der to boost recombinant protein production likewise to approaches for microbial production hosts
(Liederetal., 2015;Mizoguchietal., 2007;SauerandMattanovich,2012). Future researchstudieshave
to show whether deletion of the aforementioned genes contributes to an improvement of cellular
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productivity or availability of energy. Furthermore, analysis of mRNA expression upon hyperosmotic
stimulus should be performed formultiple CHOproducer cell lines in order to investigate if those ex-
hibit conserved differential expression patterns for genes with strictly tissue related function.
Finally, further investigations like in vivo enzyme activity assays or metabolome and proteome
analysis are required in order to reveal potential strategies to boost cellular productivity on basis of
the hyperosmotically induced surplus in ATP supply.
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A.1 Figures andData of Cultivations
Figure A.1: Profiles ofmetabolite concentrations during batch cultivation of CHODP-12 with osmotic shift
(+ 100mOsmol kg-1). NaCl-enriched cultivationmedium (Tab. 4.3) was added 72 h (arrow) after inoculation in
order to induce hyperosmotic conditions (∼ 390 mOsmol kg-1,N4). Osmolality of reference cultures was
∼ 290mOsmol kg-1 (). cglucose and clactate were determined enzymatically by LaboTRACE (TRACEAnalytics)
while cglutamine and cglutamate were analyzed by HPLC (4.2.5). Error bars of Fig. A represent standard deviations
for four biological replicates thereby considering aswell the technical error ofmeasurements (n = 3). Error bars
of Fig. B represent the standarddeviationbasedon twobiological replicatesand three technical replicateseach.
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Figure A.2: Time course of cP for CHO DP-12 cells exposed to hyperosmolality (390 mOsmol kg-1). Hy-
perosmotic culture conditions were induced 72 h after inoculation (arrow) by the addition of NaCl-enriched
cultivation medium (Tab. 4.3, 4.2.2). Osmolality of hyperosmotic cultures was ∼ 390 mOsmol kg-1
(N) compared to ∼ 290 mOsmol kg-1 for reference cultures (). The concentration of the produced
anti-IL-8-IgG1 antibody was determined by ELISA as described in 4.2.5. Error bars combine biological (n = 2)
and technical error (n = 3).
Figure A.3: Profiles for themetabolites asparagine and ammoniumduring batch cultivation of CHODP-12
with osmotic shift (+ 100 mOsmol kg-1). Hyperosmotic culture conditions (∼ 390 mOsmol kg-1,N4) were
induced by the addition of NaCl-enriched medium (Tab. 4.3) 72 h after inoculation of bioreactors (arrow).
An equal volume of standard cultivation medium was added to reference cultures (∼ 290 mOsmol kg-1, 
). casparagine was analyzed by HPLC while LCK303 cuvette test (Hach) was applied for the determination of
cammonium. Error bars combine biological (n = 2) and technical error (n = 3).
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Table A.1: Data of carbon (A) and oxygen (B) balance for hyperosmotically stressed CHO DP-12 cells
(390 mOsmol kg-1). Values were calculated as described in section 4.2.7. Negative values represent car-
bon/oxygen influx while positive values represent carbon/oxygen efflux.
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Figure A.4: Effect of hyperosmotic culture conditions on intracellular ADP-content of CHO DP-12 cells.
NaCl-enriched cultivation medium (Tab. 4.3) was added 72 h after inoculation (arrow) resulting in an os-
molality of ∼ 390 mOsmol kg-1 (N4) for hyperosmotic cultures. The osmolality of reference cultures was
∼ 290 mOsmol kg-1( ). Intracellular ADP-contents were determined by a combination of a fast filtration
approach for 107 cells (4.2.3), methanol/chloroform extraction (4.2.4) and HPLC analysis (4.2.5). Two biologi-
cal replicates with three technical replicates each were analyzed at all time points and were used to calculated
standard deviations represented by error bars.
Figure A.5: Reference measurement of mitochondrial fluorescence directly before osmotic shift
(+ 100 mOsmol kg-1). Intracellular mitochondria of CHO DP-12 cells were labeled by a combination of
an anti-translocase of the outer mitochondrial membrane 22 (TOM22) and a phycoerythrin (PE)-conjugated
isotype-specific anti-IgG2a antibody. The fluorescence intensity of the cells was analyzed by flow cytometry
(4.2.5). The received histograms (fluorescence channel 2 (FL-2), 575 nm) of samples and isotype control were
overlaid. Black histograms correspond to reference cultures while grey histograms represent the results for
hyperosmotic cultures.
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FigureA.6: Effect of osmotic shift (+ 100mOsmol kg-1) on the amount of apoptotic cells. The Annexin V-FITC
kit (BeckmanCoulter)wasused toperform testing for apoptosis according to the specifications of themanufac-
turer. In order todistinguish apoptotic or necrotic cells fromviable cells, different kinds of controlswereused to
adjust flow cytometer settings. Apoptotic cells (positive control) were received by incubation of cells with 1 µM
staurosporine for 6 h at 37°C, 5%CO2 in a humidified shaker incubator (150 rpm, 50mmdisplacement). Viable
cells served as negative control. Control sampleswere either treatedwith both, Annexin V-FITC and propidium
iodide (PI) or with just one of the components. Directly before (0 h) and 24 h after the induction of hyperos-
motic conditions, cells (5 x 105 mL-1) were incubated with Annexin V-FITC and PI for 15 min on ice followed by
flow cytometric analysis. A positive Annexin V-FITC signal indicates apoptosis and in combination with a posi-
tive PI-signal necrosis. black = reference, grey = hyperosmotic
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Figure A.7: Influence of osmolality on the fluorescence intensity of phycoerythrin. The fluorophore phyco-
erythrin was diluted in 0.01M potassium phosphate buffer (pH 7.1) with an osmolality of 294mOsmol kg-1 ()
or 381 mOsmol kg-1 (N). Fluorescence intensity was determined with a SynergyTM microplate reader (BioTek).
λexcitation  485{20,λemission  590{35, RFU = relative fluorescence units.
Figure A.8: Time courses of the lactate concentration (A) and the percentage of CHO DP-12 cells in S- and
G2-phase (B) for cultivations with osmotic shift (+ 120/140mOsmol kg-1). Hyperosmotic conditions were in-
duced 35 h after inoculation (arrow) by the addition of NaCl-enriched cultivation medium (Tab. 4.3, 4.2.2).
Diagrams show data for reference conditions (∼290 mOsmol kg-1,  ), and two different hyperosmotic
conditions (∼410mOsmol kg-1,,∼430mOsmol kg-1,N4 ). clactate was analyzed enzymatically by Labo-
TRACE (TRACEAnalytics) while cell cycle distribution was determined by propidium iodide staining and flow
cytometric analysis (4.2.5).
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Table A.2: Data of carbon (A) and oxygen (B) balance for hyperosmotically stressed CHO DP-12 cells
(430 mOsmol kg-1). Values were calculated as described in section 4.2.7. Negative values represent car-
bon/oxygen influx while positive values represent carbon/oxygen efflux.
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FigureA.9: Influenceof hyperosmotic culture conditions (+ 150mOsmol kg-1) on specific carbondioxide for-
mation (qCO2 ) and oxygen uptake rate (qO2 ).NaCl-enriched cultivationmedium (Tab. 4.3) was added to batch
cultures of CHODP-12 in order to induce hyperosmotic conditions 35 h after inoculation (4.2.2). Osmolality of
reference cultureswas∼280mOsmol kg-1 (n = 3,) compared to∼430mOsmol kg-1 for hyperosmotic cultures
(n = 4,N). The determination of qCO2 and qO2 was based on carbon and oxygen balancing as described in 4.2.7.
Errors represent standard deviations for biological replicates.
Figure A.10: Effect of hyperosmolality (+ 150 mOsmol kg-1) on intracellular ATP-concentration and cell di-
ameter of CHO DP-12. Osmolality was increased 35 h after inoculation by the addition of NaCl-enriched
cultivation medium (arrow). This resulted in an osmolality of ∼ 430 mOsmol kg-1 (N) compared to
∼280mOsmolkg-1 for referencecultures (). CelldiametersweredeterminedbyCedexXScell counter (Roche).
Intracellular ATP-concentrations were analyzed by a combination of a fast filtration approach for 107 cells
(4.2.3), methanol/chloroform extraction (4.2.4), HPLC analysis (4.2.5) and the assumption of spherical cells.
Error bars represent standard deviations for four biological replicates thereby considering aswell the technical
error ofmeasurements (n= 3). Hyperosmotic culture conditions resulted inhighly significantly elevated cATP on
day 5 (P = 0.001).
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TableA.3: Efficiencyofcytosoldepletionandretentionofmitochondria forcompartment-specific fast filtra-
tionapproach. XY = ratio of the amount ofmetabolite Y in cytosol-depleted andwhole cell sample, cis-aco = cis-
aconitate, G6P = glucose-6-phosphate, F6P = fructose-6-phosphate.
X cis-aco XG6P XF6P
t [d] reference hyperosmolal reference hyperosmolal reference hyperosmolal
1.4 0.81 0.81 0.16 0.16 0.23 0.22
3.0 0.83 0.85 0.16 0.17 0.25 0.16
4.0 0.87 0.81 0.16 0.18 0.24 0.14
5.0 0.96 0.82 0.21 0.19 0.13 0.15
Figure A.11: Effect of hyperosmolality on cytosolic andmitochondrial ADP-content. Directly before osmotic
shift (arrow)andoneachof the followingdays of cultivation a compartment-specific fast filtration approach for
2 x 107 cells (4.2.3) was applied to generate whole cell andmitochondrial samples of CHODP-12. Extraction of
metaboliteswasperformedbymethanol/chloroformtreatmentof cell samples (4.2.4) andADP-concentrations
of cell extracts were determined by HPLC (4.2.5). Cytosolic and mitochondrial ADP-contents (ADPcyt, ADPmit)
were calculated in accordance with Eq. 4.17 and Eq. 4.18 (4.2.8). Hyperosmotic cultures (N4) showed osmo-
lalities∼ 430mOsmol kg-1 compared to reference cultures with∼ 280mOsmol kg-1 ().Error bars represent
standard deviations for biological replicates (n = 3). Statistically significant difference between hyperosmotic
and reference conditions (P < 0.05) for ADPcyt on day four and for ADPmit on days four and five.
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Figure A.12: Time course of extracellular asparagine concentration during batch cultivation of CHO DP-12
with osmotic shift (+ 150mOsmol kg-1).Hyperosmotic culture conditions (∼ 430mOsmol kg-1,N4) were in-
ducedbytheadditionofNaCl-enrichedmedium(Tab. 4.3)35hafter inoculationofbioreactors (arrow). Anequal
volume of standard cultivationmediumwas added to reference cultures (∼ 280mOsmol kg-1,). casparagine
was analyzed by HPLC. Error bars represent standard deviations based on three biological replicates for refer-
ence conditions and four biological replicates for hyperosmotic conditions .
Figure A.13: Profile of antibody concentration during cultivation of BIBH1 with osmotic shift
(+ 155 mOsmol kg-1). NaCl-enriched cultivation medium (Tab. 4.3) was added 35 h after inoculation (ar-
row) resulting in an osmolality of ∼ 435 mOsmol kg-1 (N 4) for hyperosmotic cultures. The osmolality of
reference cultures was ∼ 280 mOsmol kg-1( ). The concentration of the produced IgG1 antibody was
determined by ELISA as described in 4.2.5. Error bars represent the standard deviation for four biological
replicates thereby considering as well the technical error ofmeasurements (n = 3).
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Figure A.14: Effect of hyperosmolality on intracellular ADP- and AMP-content of BIBH1. NaCl-enriched
cultivation medium (Tab. 4.3) was added 35 h after inoculation (arrow) resulting in an osmolality
of ∼ 435 mOsmol kg-1 (N 4) for hyperosmotic cultures. The osmolality of reference cultures was
∼ 280 mOsmol kg-1( ). Intracellular ADP- and AMP-contents were determined by a combination of a fast
filtration approach for 107 cells (4.2.3),methanol/chloroformextraction (4.2.4) andHPLC analysis (4.2.5). Error
bars represent standard deviations for four biological replicates thereby considering aswell the technical error
ofmeasurements (n = 3).
213
A Supporting Information
A.2 TranscriptomicAnalysis
A.2.1 Quality Information forNextGeneration Sequencing
Table A.4:Quality of isolatedRNA.Osmolality was increased 35 h (t = 0) after inoculation of CHODP-12 cells.
At given time points after the osmotic shift, RNA was isolated from 2 x 106 cells with miRNeasy kit (Qiagen).
The quality of the isolated RNA was determined with Bioanalyzer 2100 (Agilent). cRNA = RNA concentration,
RIN = RNA integrity number.
sample osmolality time cRNA RIN
[mOsmol kg-1] [h] [ngµL-1]
E14R027a01 290 0 328 9.8
E14R027b01 290 0 716 10
E14R027c01 290 0 939 10
E14R027a02 430 2 291 9.9
E14R027b02 430 2 345 9.9
E14R027c02 430 2 380 9.8
E14R027a03 430 4 626 9.9
E14R027b03 430 4 717 10
E14R027c03 430 4 336 9.9
E14R027a04 430 6 580 9.9
E14R027b04 430 6 286 9.9
E14R027c04 430 6 971 10
E14R027a05 430 8 599 10
E14R027b05 430 8 813 10
E14R027c05 430 8 1215 10
E14R027d01 290 0 986 10
E14R027e01 290 0 270 9.9
E14R027d02 290 2 961 9.9
E14R027e02 290 2 365 9.8
E14R027d03 290 4 313 9.9
E14R027e03 290 4 491 9.7
E14R027d04 290 6 362 9.9
E14R027e04 290 6 309 9.9
E14R027d05 290 8 1067 10
E14R027e05 290 8 455 10
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FigureA.15: Effect of data filtering on the number of counts formRNAdata sets frommain experiments
FigureA.16: Comparison of counts permillion (mRNA) at different timepoints and conditions duringmain
experiments.
FigureA.17: Processing ofmiRNAdata formain experiments. A: Effect of filtering on thenumber of counts.
B: Comparison of counts permillion at different timepoints and conditions
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A.2.2 R Script formRNAExpressionAnalysis
¡ library(edgeR)
¡ targets  read.table("E14R027_targets.txt", header  T, sep  ”zt”q
¡ RawCounts  read.table("E14R027_RawCounts_mRNA.txt", sep  ”zt", col.names  ,1)
¡ rownames(RawCounts)  RawCounts$Identifier
¡ RawCounts  RawCounts[,c(-1)]
¡ all(targets$sampleID  colnames(RawCounts))
¡ keep  rowSums(RawCounts>10) ¡ 12
¡ filtCounts1  RawCounts[keep,]
¡ filtCounts  cpm(filtCounts1)
¡ cpm  cpm(filtCounts1)
¡ keep  rowSums(cpm>1) ¡ 2
¡ filtCounts  filtCounts1[keep,]
¡ dim(filtCounts);dim(filtCounts1)
¡ group = as.factor(targets$group)
¡ DGE  DGEList(counts  filtCounts, group  group, genes  rownames(filtCounts))
¡ dim(DGE)
¡ DGE = calcNormFactors(DGE)
¡ design  model.matrix( ∼ 0+group)
¡ rownames(design)  rownames(DGE$samples)
¡ colnames(design)  levels(group)
¡ contrasts  makeContrasts("hyper_0h-iso_0h", "hyper_2h-iso_2h", "hyper_4h-iso_4h","hyper_
6h-iso_6h", "hyper_8h-iso_8h", "hyper_2h-hyper_0h","hyper_4h-hyper_2h", "hyper_6h-hyper_4h",
"hyper_8h-hyper_6h", "iso_2h-iso_0h", "iso_4h-iso_2h", "iso_6h-iso_4h", "iso_8h-iso_6h", levels 
design)
¡ DGE  estimateGLMCommonDisp(DGE, design)
¡ DGE  estimateGLMTrendedDisp(DGE, design)
¡ DGE  estimateGLMTagwiseDisp(DGE, design)
¡ print(DGE$common.dispersion)
¡ print(summary(DGE$tagwise.dispersion))
¡ fit  glmFit(DGE, design, dispersion  DGE$tagwise.dispersion)
¡ print(fit)
¡ lrt  glmLRT(fit, contrast  as.vector(contrasts[,n]))
¡ tt  topTags(lrt, n  dim(DGE)[1])
¡ print(head(tt$table))
¡ tt  tt$table
¡ print(head(tt$table))
¡ tt=tt$table
¡ DEG  subset(tt, PValue   0.02&FDR   0.02)
¡ DEGUp  subset(DEG, logFC ¡ log2(2))
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¡ DEGDown  subset(DEG,logFC   -log2(2))
A.2.3 R Script formiRNAExpressionAnalysis
¡ library(edgeR)
¡ targets  read.table("E14R027_targets_modified.txt", header  T, sep  ”zt")
¡ RawCounts  read.table("E14R027_RawCounts_miRNA.txt", sep  ”zt", col.names  ,1)
¡ rownames(RawCounts)  RawCounts$Gene
¡ RawCounts  RawCounts[,c(-1)]
¡ all(targets$sampleID  colnames(RawCounts))
¡ keep  rowSums(RawCounts ¡ 10) ¡ 15
¡ filtCounts1  RawCounts[keep,]
¡ cpm  cpm(filtCounts1)
¡ keep  rowSums(cpm ¡ 1) ¡ 2
¡ filtCounts  filtCounts1[keep,]
¡ dim(filtCounts);dim(filtCounts1)
¡ cpmfiltCounts  cpm(filtCounts)
¡ group  as.factor(targets$group1)
¡ DGE  DGEList(counts  filtCounts, group  group, genes  rownames(filtCounts))
¡ dim(DGE)
¡ DGE  calcNormFactors(DGE)
¡ design  model.matrix( ∼ 0+group)
¡ rownames(design)  rownames(DGE$samples)
¡ colnames(design)  levels(group)
¡ contrasts  makeContrasts("hyper_0h-iso_0h", "hyper_4h-iso_4h","hyper_8h-iso_8h", "hyper_4h-
hyper_0h","hyper_8h-hyper_4h","iso_4h-iso_0h","iso_8h-iso_4h", levels  design)
¡ DGE  estimateGLMCommonDisp(DGE, design)
¡ DGE  estimateGLMTrendedDisp(DGE, design)
¡ DGE  estimateGLMTagwiseDisp(DGE, design)
¡ print(DGE$common.dispersion)
¡ print(summary(DGE$tagwise.dispersion))
¡ fit  glmFit(DGE, design, dispersion=DGE$tagwise.dispersion)
¡ lrt  glmLRT(fit, contrast  as.vector(contrasts[,n]))
¡ tt  topTags(lrt, n  dim(DGE)[1])
¡ tt  tt$table
¡ DEG  subset(tt, PValue   0.02& FDR   0.02)
¡ DEGUp  subset(DEG, logFC ¡ log2(2))
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A.2.4 R Script formaSigProAnalysis
¡ library(maSigPro)
¡ design  read.table("edesign.txt", header  T, sep  ”zt")
¡ head(design)
¡ rownames(design)  design$X
¡ head(design)
¡ edesign  design[,c(-1)]
¡ head(edesign)
¡ data  read.table("maSigPro_data.txt", header  T, sep  ”zt")
¡ head(data)
¡ rownames(data)  data$X
¡ head(data)
¡ data  data[,c(-1)]
¡ head(data)
¡ design  make.design.matrix(edesign)
¡ design$groups.vector
¡ fit  p.vector(data, design, Q  0.02,MT.adjust  "BH", counts  TRUE)
¡ fit$i
¡ tstep <- T.fit(fit, step.method  "backward", alfa  0.02)
¡ sigs  get.siggenes(tstep, vars  "all")
¡ names(sigs$sig.genes)
¡ cluster  see.genes(sigs$sig.genes, k  9)
¡ genes.cluster  cluster$cut
¡ head(genes.cluster)
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A.2.5 maSigPro Clusters for SignificantlyUpregulatedGenes
TableA.5:maSigProgeneclusters forsignificantlyupregulatedgenes inresponsetohyperosmotic stimulus.
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A.2.6 maSigPro Clusters for SignificantlyDownregulatedGenes
Figure A.18: Clusters of gene expression dynamics of significantly downregulated mRNAs. Osmolality
was increased during batch cultivation of CHO DP-12 by the addition of NaCl-enriched cultivation medium
(Tab. 4.3, 4.2.2). This resulted in an osmolality of ∼ 425 mOsmol kg-1 for hyperosmotic cultures (n = 3,
N) compared to ∼ 285 mOsmol kg-1 for reference cultures (n = 2, ). Gene expression analysis was based
on next generation sequencing and data were analyzed with edgeR and maSigPro (4.2.10). Diagrams show
medians of the gene expression of clustered genes.
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TableA.6:maSigPro gene clusters for significantly downregulated genes upon to hyperosmotic stimulus.
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A.2.7 SignificantlyUpregulatedGenes
TableA.7:Resultsofgeneexpressionanalysisfor51significantlyupregulatedgenes4,6and8hafterosmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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Table A.8: Results of gene expression analysis for 32 significantly upregulated genes 2, 4, 6 and 8 h after
osmotic shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
TableA.9:Results of gene expression analysis for 1 significantly upregulatedgene2, 4 and8hafter osmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.10: Results of gene expression analysis for 24 significantly upregulated genes 2, 4 and 6 h after os-
motic shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.11:Resultsofgeneexpressionanalysis for88significantlyupregulatedgenes2and4hafterosmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.11 (continued)
TableA.12:Resultsofgeneexpressionanalysis for30significantlyupregulatedgenes6and8hafterosmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
TableA.13:Results of gene expression analysis for 3 significantly upregulated genes 4 and 8h after osmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.14:Resultsofgeneexpressionanalysis for 10significantlyupregulatedgenes4and6hafterosmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
TableA.15:Results of gene expression analysis for 6 significantly upregulated genes 2 and 6h after osmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
TableA.16:Resultsofgeneexpressionanalysis for 39 significantlyupregulatedgenes8hafterosmotic shift.
log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.17:Resultsofgeneexpressionanalysis for23 significantlyupregulatedgenes4hafterosmotic shift.
log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
TableA.18: Results of gene expression analysis for 33 significantly significantly upregulated genes 6 h after
osmotic shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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Table A.19: Results of gene expression analysis for 218 significantly upregulated genes 2 h after osmotic
shift. log2(FC)¥ 1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.19 (continued)
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TableA.19 (continued)
A.2.8 SignificantlyDownregulatedGenes
Table A.20: Results of gene expression analysis for 1 significantly downregulated gene 2, 4, 6 and 8 h after
osmotic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.21: Results of gene expression analysis for 3 significantly downregulated gene 2, 4 and 6 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.22: Results of gene expression analysis for 7 significantly downregulated gene 4, 6 and 8 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.23: Results of gene expression analysis for 14 significantly downregulated gene 6 and 8 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.24: Results of gene expression analysis for 3 significantly downregulated gene 4 and 8 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.25: Results of gene expression analysis for 10 significantly downregulated gene 4 and 6 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
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Table A.26: Results of gene expression analysis for 2 significantly downregulated gene 2 and 6 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.27: Results of gene expression analysis for 5 significantly downregulated gene 2 and 4 h after os-
motic shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.28: Results of gene expression analysis for 33 significantly downregulated gene 8 h after osmotic
shift. log2(FC)¤ -1, P-value and FDR¤0.02, C = cluster (maSigPro)
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Table A.29: Results of gene expression analysis for 23 significantly downregulated gene 6 h after osmotic
shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
Table A.30: Results of gene expression analysis for 29 significantly downregulated gene 4 h after osmotic
shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
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Table A.31: Results of gene expression analysis for 152 significantly downregulated gene 2 h after osmotic
shift. log2(FC)¤ -1, P and FDR¤0.02, C = cluster (maSigPro)
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TableA.31 (continued)
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A.2.9 CHO specific Gene Expression ChangesUponHyperosmotic Stimulus
TableA.32:Geneswith similar changes in differential expressionuponhyperosmotic stimulus as described
byShenet al. (2010).Underlined geneswere defined as significantly differentially expressed (log2(FC)¥ 1.0, P
and FDR¤ 0.02) in the current study. Blue = downregulated, red = upregulated.
cell proliferation/ cellular transporters/ gene expression
cell death response signaling pathway regulation metabolism miscellaneous
DDIT4 CIRBP ATP1B3 ANKRD49 AMDHD2 ACYP
GLCCI1 HERPUD1 ARL4C ARID4B AZIN1 AMOTL2
PLK2 NFIB DUSP1 ARID5B GTPBP3 CKMT1
NQO1 GLMN BCL6 POLA2 CPEB4
NSMCE1 GPRASP1 CREBBP SYNCRIP EFHD2
RALGDS EIF2C2 TK1 FBXW2
SLC1A5 ELF1 UMPS GLIPR2
SLC38A2 HBS1L KLC1
TCIRG1 HES1 KLC2
WSB1 HIPK2 KLC4
MED8 LUC7L
MXD4 MBNL2
SUB1 PAPD4
ZKSCAN1 RBBP6
RG9MTD1
RNF138
RSBN1
TMEM51
ACYP: acylphosphatase, AMDHD2: amidohydrolase domain containing 2, AMOTL2: angiomotin like 2, ANKRD49: ankyrin repeat domain 49, ARID4B: AT-rich interaction domain 4B, ARID5B: AT-
rich interaction domain 5B, ARL4C: ADP ribosylation factor like GTPase 4C, ATP1B3: ATPase Na+/K+ transporting beta 3 polypeptide, AZIN1: antizyme inhibitor 1, BCL6: B cell leukemia/lymphoma 6,
CIRBP: cold inducible RNA binding protein, CKMT1: creatine kinase, mitochondrial 1, CPEB4: cytoplasmic polyadenylation element binding protein 4, CREBBP: CREB (cAMP-response element binding
protein) binding protein, DDIT4: DNA damage inducible transcript 4, DUSP1: dual specificity phosphatase 1, EFHD2: EF-hand domain family member D2, EIF2C2: eukaryotic translation initiation
factor 2C 2, ELF1: E74-like factor 1, FBXW2: F-box andWD repeat domain containing 2, GLCCI1: glucocorticoid induced 1, GLIPR2:GLI pathogenesis-related 2, GLMN: glomulin, FKBP associated protein,
GPRASP1: G protein-coupled receptor associated sorting protein 1, GTPBP3: GTP binding protein 3, HBS1L: HBS1 like translational GTPase, HERPUD1: homocysteine-inducible endoplasmic reticulum
stress-inducible ubiquitin-like domainmember 1,HES1: hes family bHLH transcription factor 1,HIPK2: homeodomain interacting protein kinase 2, KLC1/2/4: kinesin light chain 1/2/4, LUC7L: LUC7-like,
MBNL2:muscleblind-like splicing regulator 2,MED8:mediator complex subunit 8,MXD4:Maxdimerizationprotein4,NFIB:nuclear factor I/B,NQO1:NAD(P)Hdehydrogenase, quinone 1,NSMCE1:non-
SMC element 1 homolog, PAPD4: PAP associated domain containing 4, PLK2: polo-like kinase 2, POLA2: polymerase (DNA directed) alpha 2 accessory subunit, RALGDS: ral guanine nucleotide dissoci-
ation stimulator, RBBP6: retinoblastoma binding protein 6, RG9MTD1: tRNAmethyltransferase 10 homolog C,RNF138: ring finger protein 138 E3 ubiquitin protein ligase, RSBN1: round spermatid basic
protein 1, SLC1A5: solute carrier family 1 (neutral amino acid transporter)member 5, SLC38A2: solute carrier family 38member 2, SUB1: SUB1homolog transcriptional regulator, SYNCRIP: synaptotagmin
binding cytoplasmic RNA interacting protein, TCIRG1: T-cell immune regulator 1 ATPase H+ transporting lysosomal V0 subunit A3, TK1: soluble thymidine kinase 1, TMEM51: transmembrane protein 51,
UMPS: uridinemonophosphate synthetase,WSB1:WD repeat and SOCS box containing 1, ZKSCAN1: zinc finger with KRAB and SCANdomains 1.
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Changes in Intracellular ATP-Content of CHOCells as
Response toHyperosmolality
Jennifer Pfizenmaier, Jens-ChristophMatuszczyk andRalf Takors*
Institute of Biochemical Engineering, University of Stuttgart, 70569 Stuttgart, Germany
*Corresponding author; takors@ibvt.uni-stuttgart.de
A variety of approaches has been published to enhance specific productivity (qp) of recombinant Chinese
hamster ovary (CHO) cells. Changes in culture conditions, e. g. temperature shifts, sodium butyrate treat-
ment and hyperosmolality, were shown to improve qp. In order to contribute to a better understanding of the
correlation between hyperosmolality and enhanced qp, we analyzed cellular kinetics and intracellular adenine
nucleotide pools during osmotic shift periods. Known phenotypes like increased formation rates for lactate and
product (anti-IL-8 antibody; qlactate, qp) as well as increased cell specific uptake rate for glucose (qglucose) were
found - besides inhibition of cell growth and G1 arrest occurred during batch cultivations with osmotic shift.
The analysis of intracellular AXP pools revealed enlarged ATP amounts for cells as response to hyperosmolality
while energy charges remained unchanged. Enhanced ATP-pools coincidedwith severely increased ATP forma-
tion rates (qATP) which outweighed by far the putative requirements attributed to regulatory volume increase.
ThereforeelevatedqATPmirroredan increasedcellulardemandforenergywhile experiencinghyperosmotic shift.
Introduction
The production of biopharmaceuticals is strongly based on mammalian cells, such as Chinese
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hamster ovary (CHO), human embryonic kidney (HEK), baby hamster kidney (BHK) or mouse
myeloma (NS0) cells1,2. Despite the variety of different cell lines, recombinant therapeutic proteins
are predominantly produced in CHO3. While in 1986 maximum product titers did not exceed
∼ 0.05 g L1, improvements in host cell engineering, cultivation media and process engineering
resulted in a twenty- to hundredfold increase in product titer as well as in enhanced specific
productivities (qp)3. Several approaches showed that changes in culture conditions increased qp of
recombinant CHO cells. Reducing the cultivation temperature from 37°C to ∼ 30°C significantly
improved qp of different proteins4-7. This coincided with a reduction of cell growth and prolonged
cultivation periods finally yielding increased product titers6. Comparable effects were achieved by
the addition of sodium butyrate8 as well as in combination with temperature shift9. By analogy, the
addition of cheap salts likeNaCl, resulting in improved qp, is commonly applied aswell10-12. However,
hyperosmolalitywas shown to induce inhibition of cell growth, increase in fractionof cells in S-phase,
cell cycle arrest in G1-phase or even cell death in a dose-dependent manner, the latter
obviously hampering improvement of total product yield10,13-16. While osmolality of cell culture
medium typically shows∼ 290 mOsmol kg-1, hyperosmotic studies encompassed elevated levels of
about 350 – 450 mOsmol kg-1 without severe impacts on cell viability. On the other hand intense
stress was found for osmolalities¥ 500 mOsmol kg-1 even inducing cell death. To prevent negative
consequences of intense osmotic stress, osmoprotective substances like glycinebetainewere added13
or apoptosis inhibiting genes like bcl-2 were overexpressed17. Hyperosmotic effects like G1-phase
arrest15, enhanced glucose and glutamine consumption rates12,15,18 and increased cell size19 were
suspected to improve qp20. Lee at al. anticipated alleviated energy (ATP) availability by observation
of increased expression levels of glycolytic enzymes such as glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and pyruvate kinase11. Likewise, Lin et al. found increased ATP production rates (qATP)
for osmotically stressed cells applying metabolic flux analysis (MFA) for hybridoma cells18.
Motivatedby this findings our studies focused on the effect of hyperosmotic conditions on intracellu-
larAMP,ADPandATP-contents inantibodyproducingCHOcells. Tobeprecise, studies challenged the
hypothesiswhetherhyperosmoticconditionsmaybemirroredby increasingAXPpools inconjunction
with likewise increased ATP formation rates as an indicator of energetic capacity changes.
Materials andMethods
Cell Line,MediumandCultivationwith Shift inOsmolality
An anti-IL-8-producing CHO DP-12 cell line (ATCC® CRL 12445TM) adapted to grow in suspension was
cultivated in TC-42-D medium (Xell, Germany) supplemented with 4 mM L-glutamine and 200 nM
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methotrexate. Cellswere thawedand cultivated in shake flasks (Corning Incorporated,USA) for 3pas-
sages in a humidifiedMinitron incubator shaker (InforsHT, Germany) at 37°C, 5%CO2 and 150 rpmas
inoculum for bioreactor cultivations. Batch cultivations with induction of hyperosmolal conditions
were performed in a fourfold parallel bioreactor system (DS1500ODSS,DASGIP, Germany)withwork-
ing volumes of 0.7 or 1.2 L and viable cell densities of 0.4 x 106 cells mL-1 upon inoculation. Cultiva-
tionparameterswere controlledat 150 rpmagitation speed, 40%dissolvedoxygen (at environmental
pressure), 37°C and pH 7.1. Two quadruplicate experiments (2 x 4) with same inoculum were carried
out and osmolalitywas increased by the addition ofNaCl-enriched in twobioreactors 3 days after in-
oculation. The resulting difference in volumebetween bioreactorswith orwithout shift in osmolality
was compensated by adding an equal volume of TC-42-Dmedium to each control bioreactor. Osmo-
lalitywas∼290mOsmol kg-1 in control reactors andwas increasedby 100mOsmol kg-1 in bioreactors
with osmotic shift.
Sampling
Cell suspension was withdrawn from bioreactor once or twice a day as well as shortly after the rise
in osmolality. A small aliquot was used to analyze viable cell density and the rest was centrifuged at
800g, 4°C for 5 min (Heraeus Megafuge 1.0R). While osmolality was analyzed immediately, the rest
of supernatant was stored at – 70°C in aliquots. Immediately before and on each of the following 4
days, cell samples for determination of cell cycle distribution and intracellular nucleotide pools were
generated. With modifications of a previously published approach21, 107 cells were separated from
cultivationmedium by fast filtration using 47mmborosilicate glass fiber filters type A/Dwith a pore
size of 3 µm (Pall, Germany) and a vacuum of 30 mbar. Afterwards cells were quenched using 30mL
of ice-cold washing buffer (10mMK2HPO4/KH2PO4, 290mOsmol kg-1, pH 7.1), filters with cells were
immediately transferred to 120mL screw cap containers (Carl Roth, Germany), frozen in liquid nitro-
gen and stored at – 70°C. Tenmillion cellswere separated from cultivationmediumby centrifugation
(300g, 4°C, 5 min), washed with 1 x phosphate buffered saline pH 7.4 (PBS), fixed with – 20 °C cold
70%ethanol in PBS and stored at – 20°C until further preparation for cell cycle analysis.
Extraction of intracellularmetabolites
For extraction of intracellular nucleotides, 5 mL ice-cold 70% methanol were added to screw cap
containers with filters followed by a 90-minute incubation at – 20°C in a cryostat (Haake F3 Fisons,
Germany). Cell extract was separated from filter using a vacuum pump. Screw cap container and
filterwere rinsedwith 2mL 50%methanol and0.5mL chloroformwere added to the permeate. After
20 sec of mixing, the methanol-chloroform mixture was centrifuged at 3200g, 0°C for 10 min
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(HeraeusMegafuge 1.0R) and 1mL aliquots of the aqueous phase were transferred to 1.5mL reaction
tubes (Eppendorf, Germany) followed by evaporation (RVC 2-33 IR, Martin Christ GmbH, Germany).
Cell extracts were stored at – 70°C
AnalyticalMethods
Viable cell density and viability were analyzed by Cedex XS cell analyzer (Roche, Germany). Deter-
mination of glucose and lactate concentrationswas performedusing a LaboTRACE (TRACEAnalytics,
Germany). An Osmomat 030 (Gonotec, Germany) was used to analyze osmolality. Antibody concen-
trations were determined by enzyme-linked immunosorbent assay (ELISA) using goat anti-human
IgGF(c) aswell asgoatanti-humankappachainperoxidase conjugatedantibody (Rockland,USA)and
SeramunBlau® (Seramun, Germany) as substrate. Absorption at 450 nm was measured by Infinite®
200 PRO series microplate reader (Tecan, Switzerland). Ion-pair reversed-phase HPLC (RP-HPLC)
based on amodified protocol of a formerly publishedmethod22 was used to quantify AMP, ADP and
ATP concentrations of cell extracts. Analyses were carried out with an Agilent 1200 series appara-
tus equipped with Supelcosil LC 18-T column (15 cm x 4.6 mm, 3 µm) protected by HypersilTM BDS
C18 guard-column. HPLC was performed at 30°C and a flow rate of 1 mL min-1 using two eluents as
mobile phase. Buffer A (pH 6) contained 100mMK2HPO4/KH2PO4 and 4mM tetrabutylammonium
bisulfatewhile buffer B (pH 7.2) consisted of 70%buffer A and 30%methanol. A diode array detector
(DAD) was used for detection of nucleotides at 260 nm. Energy charges were calculated according to
Atkinson et al.23. For determination of cell cycle distribution, ethanol fixed cells were washed and
finally resuspended inPBS.Cellswere incubatedwithRNAseAandpropidiumiodide followedby flow
cytometric analysis of 10,000–20,000eventsat low flowrate (FC500,BeckmanCoulter). Histograms
of FL-3 (620 nm)were analyzed by Cylchred software (Cardiff) to determine the percentage of cells in
G1-, S-, and G2-phase of cell cycle.
Calculation of Specific Rates and Statistics
Specific rates were calculated for the most sensitive time interval day 4 to day 6. More data points
were available for the second run of cultivations than for the first one as sampling frequency was
increased from once to twice a day (six compared to three). Nevertheless calculation methods
resulted in similar results. Logarithm of viable cell density was plotted versus cultivation time in
order to determine specific growth rate (µ). Changes in glucose, lactate and antibody concentration
over time were determined by linear regression (R2 > 0.98) and were divided by arithmetic mean of
viable cell density in order to calculate specific glucose consumption (qglucose), lactate production
(qlactate) andantibodyproduction rate (qP). Standarddeviationswere calculatedbasedon fourbiolog-
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ical replicates. Unpaired student's t test was used to investigate data for statistical significance. The
calculation of oxygen uptake (qO2), carbon dioxide formation (qCO2) and ATP formation rates (qATP)
is summarized in the supplemental file. A P/O ratio of 2.5 was used for calculating qATP according to
literature24,25.
Results andDiscussion
Hyperosmolality, especially the lower, non-lethal range (350 – 450 mOsmol kg-1) is an extensively
studied research field in cell culture. Nevertheless it is not yet completely understood how hyperos-
motic conditions stimulate increase inqp. BasedonMFAwithantibodyproducinghybridomacells Lin
et al. linked increased osmolality with enhanced qATP even anticipating co-stimulation of qP18. Start-
ing from∼290mOsmolkg-1 (reference condition), osmolalitywas increasedbyaddingNaClenriched
medium to four of eight batch cultures three days after inoculation (Figure 1A). Consequently, related
osmolality levels increased to ∼ 390 mOsmol kg-1 maintaining the constant difference of
∼ 100mOsmol kg-1 until the end of the experiment (Figure 1A). Noteworthy, tendencies of osmolal-
ity profiles were fairly similar in the hyperosmotic and the reference batches. Only slight osmolality
increases were observed reflecting the impact of 1 MNa2CO3 titration (Figure 1A). Therefore a statis-
tically sound difference (P < 0.001) in osmolality was given across thewhole time of process.
Figure 1. Profile of osmolality (A), viable cell density and viability (B). During batch cultivations of CHO DP-
12 sodium chloride was added (arrow) to increase osmolality by ∼ 100 mOsmol kg-1 (, l) compared to
reference (, ). A: Measurement of osmolality was based on cryoscopy using Osmomat 030 (Gonotec).
Error bars represent standard deviations based on four biological replicates. B: Viable cell density (, )
and viability (, l) of cultures were determined by trypan blue staining and Cedex XS (Roche). Error bars
represent standard deviations based on four biological replicates.
Profiles of viable cell densities were similar in all cultures until the osmotic shift was performed
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on day 3 (Figure 1B). Thereafter cells exposed to hyperosmolality showed lower viable cell densities
compared to isotonic (reference) batch cultures (Figure 1B). However, discrepancies of viable cell
densities did not result in likewise different cell viabilities. Instead, viability was not influenced by
osmotic shift at all and stayed above 90%until day 8 (Figure 1B). In the post-shift interval day 4 to day
6, cellsexposedtoosmotic shift showedagrowthrateofµ=0.280.04d-1whileµ=0.480.11d-1was
determined for reference cells. Considering these significant growth differences, equally different
viable cell densitiesmight have been expected. However, direct correlation between growth rate and
viable cell density is not fully enabled because of superimposing high inter-culture variances. Never-
theless, imposing hyperosmolality apparently hampered cell growth (P = 0.02, n = 4). This finding is
in agreementwith independent studies11-13,15 although the effect is less pronouncedwhich is presum-
ably due to inter-culture variance and themoderate stress imposed in our experiments. On the other
hand, previously published effects of hyperosmolality on qglucose and qlactate could be verified12,13,15.
Cells grown under hyperosmotic conditions showed increased qglucose (2.09  0.13 vs. 1.55 
0.18 pmol cell-1 d-1, P = 0.002, n = 4) and qlactate (2.29 0.12 vs. 1.64 0.19 pmol cell-1 d-1, P = 0.001,
n = 4) for the time interval day 4 to day 6. Hyperosmotic culture conditions enhanced qP from
3.69 pgmAB cell-1 d-1 under isotonic conditions to 5.55 pgmAB cell-1 d-1 (n = 2) again confirming find-
ings of independent studies11-13,15,17,20.
Figure 2. Time evolution of cells in G1-phase during batch cultivations of CHODP-12 with osmotic shift. Addi-
tion of sodiumchloride resulted in an osmolality of∼ 390mOsmol kg-1 () compared to∼290mOsmol kg-1 in
controlbioreactors (). Ethanol fixedcellswere stainedwithpropidiumiodideandanalyzedby flowcytometry
(FC500, Beckman Coulter). Error bars represent standard deviations based on four biological replicates.
The analysis of population composition with respect to cell cycle mapping revealed significant
differences between hyperosmotic and reference cultures. Directly before the osmotic shift similar
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cell fractions (∼ 40%) were assigned to G1-phase. The post-pulse period revealed the opposite: a
significantly higher fraction of hyperosmotically stimulated cells was observed to be in G1-phase
(P < 0.005, n = 4, Figure 2). This observation was found to be in accordance with previous indepen-
dent studies15. In addition, intracellular AXP pools and energy charges were monitored analyzing
two biological replicates of each condition. The pre-shift period, represented by sample analysis on
the third day of cultivation, disclosed ATP-contents of∼ 3 fmol ATP cell-1 (Figure 3). Noteworthy, this
amountwas almost identical in all cultures. Reference cells unraveled continuousdecline ofATP cell-1
values reaching about 1/3 of their original level on day 7 (Figure 3). Interestingly, hyperosmotically
stimulated cells showed no decrease but rather an increase in intracellular ATP-contents until day
6 (Figure 3). Thereafter intracellular ATP-contents dropped to∼ 1.6 fmol cell-1 (Figure 3). Intracellu-
lar ATP-concentrations, taking real cell volumes into account, showed similar profiles (supplemental
Figure 4).
TheamountofAMPinanalyzedsampleswasbelowdetection limit. Calculationofenergycharges,
disregarding AMP, resulted in no significant difference between hyperosmotic and reference condi-
tions as intracellular ADP-contents tended to be higher for cells undergoing osmotic shift than for
reference cells (Figure 3). Altogether, energy charges were at high level (> 0.9) during the whole
period of analysis and declined only slightly on day 6 and 7 (Figure 3). This correlates as well with the
previously described high cell viability (> 90%) for reference cells and cells exposed to hyperosmo-
lality in the same time interval (Figure 1). In order to determine qATP on a daily basis (day 3 to day 7),
specific carbon dioxide production (qCO2) and oxygen consumption (qO2) rates were calculated based
on carbon and oxygen balancing (supplemental material). Respiratory quotient (RQ 1) as well as
literature values were used as quality standards for the determined rates. For the time interval day
4 to day 7 RQs were close to 1 with an average RQ of 1.08  0.04 for hyperosmolal conditions and
1.07 0.14 for reference state. qO2 and qCO2 ranged from 0.2 – 0.4 pmol cell-1 h-1 which was in con-
currencewith values from literature (0.2 - 0.8 pmol cell-1 h-1)26. A P/O ratio of 2.524,25 was assumed for
the calculation of qATP. Comparable values of∼ 19 pmol ATP cell-1 d-1 were determined for the time
interval day 3 to day 4 (Figure 3) and lay in a comparable range of values published in literature27-29.
Thereafter osmotically stimulated cells showed an increase in qATP of ∼ 21% while qATP of
reference cells remained almost constant (Figure 3). On average, hyperosmotic shift lead to 30%
higherqATP fromday4today7. In this interval, cell volumes increasedaswellduetoregulatoryvolume
increase (RVI) under hyperosmotic culture conditions (supplemental Figure 3)19,30. Nevertheless, the
calculation of the required amount of ATP to compensateRVI (qATP,+) (supplemental) showed that the
increase in qATP was orders ofmagnitude higher than qATP,+ (4910 fmol cell-1 d-1 vs. 0.26 fmol cell-1 d-1).
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Figure 3. Effect of osmotic shift on intracellular ATP-content and energy charge during batch cultivation of
CHODP-12. Addition of sodium chloride (arrow) resulted in an osmolality of∼ 390mOsmol kg-1 (,l, black)
compared to ∼ 290 mOsmol kg-1 in control bioreactors (, , white). Fast filtration was used for cell
sampling followed by methanol/chloroform extraction and RP-HPLC-quantification. Energy charges were
calculated according to Atkinson et al.23. Error bars represent standard deviations based on two biological
replicates as well as three technical replicates each. qATP was calculated as stated in supplemental. A P/O
ratio of 2.5 was assumed24,25.
In conclusion, our studies are in agreement with well-known effects of hyperosmolality, such as
inhibition of cell growth, increased qp and G1-arrest11-13,15,17,20. Besides, increased ATP levels and ATP
formation rates (qATP) which had been determined during the post-shift period confirmed the
hypothesis of Lin et al.18 andLee et al.11. BasedonMFAandgeneexpressionmeasurements, increased
qATP were anticipated in antibody producing hybridoma and CHO, respectively11,18. Increased intra-
cellular ATP-contents have been described before relating to high passage cultivation31, addition of
sodium butyrate32 and changes inmedia composition33. These facts in combination with our results
of an increased intracellular ATP-content together with elevated qATP reveal the connection between
changing culture conditions and the cells’ energetic capacity. On the one hand this could be
interpreted as an effect of an increaseddemand for energy andon the other handhigher intracellular
ATP-contents might mirror the cells’ adaptation to changing culture conditions. Further studies are
required to clarify whether the enhancement of ATP formation could be exploited to boost
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antibody formation even further.
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Abstract
Biopharmaceuticals are predominantly produced by Chinese hamster ovary (CHO) cells cultivated in
fed-batch mode. Hyperosmotic culture conditions (¥ 350 mOsmol kg-1) resulting from feeding of
nutrients may enhance specific product formation rates (qp). As an improved ATP supply was anti-
cipated to enhance qp this study focusedon the identification of suitablemiRNA/mRNA targets to in-
crease ATP levels. Therefor next generation sequencing and a compartment specific metabolomics
approach were applied to analyze the response of an antibody (mAB) producing CHO cell line upon
osmotic shift (280Ñ 430 mOsmol kg-1). Hyperosmotic culture conditions caused a ∼ 2.6-fold in-
crease of specific ATP formation rates together with a∼ 1.7-fold rise in cytosolic and mitochondrial
ATP-pools, thus showing increased ATP supply. mRNA expression analysis identified several genes
encoding glycosylated proteins with strictly tissue related function. In addition, hyperosmotic
culture conditions induced an upregulation of miR-132-3p, miR-132-5p, miR-182, miR-183, miR-194,
miR-215-3p, miR-215-5p which have all been related to cell cycle arrest/proliferation in cancer stud-
ies. In relation to a previous independent CHO study miR-183 may be the most promising target to
enhance qp by stable overexpression. Furthermore, deletion of genes with presumably dispensable
function in suspension growing CHO cellsmay enhancemAB formation by increased ATP levels.
1 Introduction
The annual global biopharmaceuticals market increased from $94 billion in 2007 (1) to $140 billion
in 2013 (2). With Chinese hamster ovary (CHO) cells being the predominant mammalian expression
platform for biopharmaceuticals (2) the importance of a permanent improvement in performance
gets obvious. Thanks to intensive cell and process engineering, productivity of CHO based mono-
clonal antibody (mAB) production has increased about 100-fold during the last two decades
reaching more than 5 g L-1 today (3,4). Such improvements of process performance coincide with
moreandmorechallengingcultivationconditions likehyperosmolality (¥350mOsmolkg-1) asoneof
several putative stress factors.
The impactofhyperosmolalityoncellularperformance is amatterof steady interestoften focusingon
metabolicphenotypes. Accordingtodifferentstudies, osmolalities rangingfrom350–450mOsmolkg-1
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did not severely affect viability of CHO cells. However, further increase in osmolality induced severe
stress conditions finally causing cell death (5–8). The link between hyperosmolality and improved
product formation rate (qp) has not been fully deciphered so far. Increased glucose and glutamine
consumption rates (qglucose, qglutamine) as well as cell cycle arrest and increase in cell size have been
anticipated to contribute to an enhanced qp (6–9). Recently Pfizenmaier et al. (2015) refined this
picture by outlining that hyperosmolality coincides with the increased availability of energy (ATP)
which is supposed to play a crucial role for the improved cellular performance .
Hence metabolic studies have already created a valuable basis to understand the complex
interplay of regulatory schemes occurring in CHO under osmotic stress. However, the picture
necessarily remains incomplete as long as the link to superimposed transcriptional control is
missing. Related studies are comparatively rare which is certainly caused by the ‚late‘ publication of
the CHO K1 genome sequence (10) which opened the door for today's next generation sequencing
(NGS) studies. Prior to that, microarrays from related species likemouse or rat (11–13) were used and
custom-made CHO cDNA microarrays were constructed (14–17). Transcriptomic studies were
applied to investigate apoptotic pathways, variations of growth rate and productivity and to analyze
the effects of process variations, e. g. low cultivation temperature, hyperosmolality and sodium
butyrate treatment (3,8,18–26). Thus correlations between gene expression changes and enhanced
productivity were elucidated and potential targets for cell line engineering were identified. One aim
of cell line engineering is to provide additional energy for the synthesis of recombinant proteins in
order to enhance cellular productivity. This can be realized e. g. by metabolic engineering of ATP
generating or consuming pathways (27,28), genome reduction (29–31) or induction of a state of
cellular senescence (28,32). To identify suitable target genes for these strategies, this study com-
binesanalysisofmRNAandmiRNAexpressionofhyperosmotically stressedcell cultures.Wesuppose
that understanding the transcriptional dynamics and mechanisms behind the characteristic hyper-
osmotic phenotype (enhanced qp, cell cycle arrest and increased ATP formation rates) would
provide a high capability for the identification of suitable targets to improve the energetic capacity of
recombinant CHO cells. In order to get a more precise idea of the hyperosmotic effect on adenine
nucleotide levels as a measure of energetic capacity, this study further applies a novel compartment
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specific approach (33) to distinguish between cytosolic and mitochondrial adenine nucleotide pool
sizes.
2Materials andmethods
2.1 Cell line,medium, andbioreactor cultivationwith osmotic shift
A CHO DP-12 cell line (ATCC®CRL-12445TM) producing anti-IL-8 IgG1 antibody was cultivated in
suspension in TC-42-Dmedium (Xell, Bielefeld, Germany) supplementedwith 4mMglutamine (Carl
Roth, Karlsruhe, Germany) and 200 nM methotrexate (Applichem, Darmstadt, Germany). Cryo
culture was thawed, scaled up in shake flasks (Corning, NY, USA) and used as inoculum for batch
cultivations. Shake flasks were incubated at 37°C, 150 rpm and 5% CO2 in a humidified Minitron
incubator shaker (Infors HAT, Einsbach, Germany). Two series of batch cultivations were performed
in a fourfold parallel DS1500ODSSbioreactor system (DASGIP, Jülich, Germany). Each series included
one or two reference cultivations (∼ 280mOsmol kg-11) as well as two cultivations with osmotic shift
(∼430mOsmolkg-1). Theseedingdensitywas0.4x106 cellsmL-1 (V0 =1.4L).Osmolalitywas increased
by adding NaCl-enriched TC 42 Dmedium 35 h past inoculation. The set point for temperature was
37°C and dissolved oxygen was controlled at 40% (environmental pressure) using a DASGIP®MX4/4
module. pHwas controlled at pH 7.1 by addition of 1MNa2CO3 or sparging of CO2 while the set point
for agitation speedwas 150 rpm.
2.2 Sampling
Over thewhole timeofcultivation, sampleswerewithdrawnfromthebioreactor twiceor three timesa
day to analyze viable cell density, osmolality and concentrations of substrates and products. Directly
before (0) as well as 2, 4, 6 and 8 h after osmotic shift 2 x 106 cells were pelleted by centrifugation,
resuspended in RNAprotect (Qiagen, Hilden, Germany), frozen in liquid nitrogen and stored at 70°C
until isolationofRNA.Whole cell and subcellular cell samples (2 x 107 cells/sample) forquantification
of intracellular metabolite pools were generated by previously described fast filtration
methods (33,34) directly before and 1.5, 2.5 and 3.5 days after osmotic shift. A 47 mm borosilicate
glass fiber filter type A/D with a pore size of 3 µm (Pall, Dreieich, Germany) was used for whole cell
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samplesapplyingavacuumof30mbarand35mLof ice-coldwashingbuffer (10mMK2HPO4/KH2PO4,
290 mOsmol kg-1, pH 7.1). A combination of the aforementioned A/D type filter and a MetrigardTM
glass fiber filter (Pall, Dreieich, Germany) with a pore size of 0.5 µm was applied for subcellular
samples. Vacuumwas increased to 90mbar and digitonin containingwashing-buffer (0.122% (m/v))
was added followed by regular washing buffer. Filters with cells were frozen in liquid nitrogen and
stored at 70°C.
2.3 Extraction of intracellular cellmetabolites
Intracellular metabolites were extracted from cells by a combination of incubation of filters with
methanol at 20°C and treatment of the extract with chloroform as described before (34).
2.4Analytics
Viable cell density and viability (Cedex XS, Roche innovatis, Bielefeld, Germany), glucose and lactate
(LaboTRACE, TRACEAnalytics, Braunschweig, Germany), osmolality (Osmomat 030, Gonotec, Berlin,
Germany) and antibody concentrations as well as intracellular adenine nucleotide pools were
determined as described previously (34). Concentration of ammonium was measured with LCK303
cuvette test (Hach,Düsseldorf,Germany). Reversed-phaseHPLCwithanautomatedpre-columnortho-
phthalaldehyde/9 fluorenylmethyl chloroformatederivatizationwasusedfordeterminationofamino
acidconcentrationswithanAgilent1200seriesapparatusasdescribedbefore [35]. L-norvaline (Sigma-
Aldrich, Taufkirchen, Germany) functioned as internal standard. Hydrophilic interaction liquid
chromatography-electrospray ionization-tandem mass spectrometry (HILIC-ESI-MS/MS) was
performed with high selectivity in multiple reaction monitoring (MRM) mode to quantify intracel-
lular and subcellular pool sizes of cis-aconitate (cis-Aco), glucose-6-phosphate (G6P) and fructose-
6-phosphate (F6P) (33,36). Measurements were acquired with an Agilent 6410B Triple Quad mass
spectrometer (Agilent, Waldbronn, Germany) with ESI ion source in negative ionization mode with
high selectivity based on pre-optimized MRM transitions (36). The Instrument was equipped with
a Sequant ZIC–pHILIC column (150 x 2.1 mm, 5 µm) protected by Sequant ZIC–pHILIC guard column
(20 x 2.1 mm, 5 µm). Elution buffer A consisted of 10% (v/v) aqueous buffer solution
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(10 mM ammonium acetate) and 90% (v/v) acetonitrile while eluent B contained 90% (v/v)
aqueous buffer solution and 10% (v/v) acetonitrile. The pH of both eluents was adjusted to pH 9.2
(with 25% (v/v) ammonium hydroxide). The resulting data sets were analyzed with
MassHunter B.04.00 software. Analysis was based on a previously described isotope dilution mass
spectrometry (IDMS) method [36] using 13C-labeled internal standard which was extracted from
U-13C labeled algal cells (> 99 atom% 13C, lot no. 487945, Sigma-Aldrich, Taufkirchen, Germany) (37).
Internal standard was added to external calibration levels as well as to cell extract samples during
preparation for LC-MSanalysis. Analytepeakareas (12C/13C-ratios)wereplottedagainst 12Cconcentra-
tion levels of the correspondinganalyteand linear regressionwasused toprepareexternal calibration
curves (36).
2.5 Calculation of specific rates, adenine nucleotide content, energy charge and statistics
Specific rates were analyzed for two different time intervals (day 1.5 – 2.5, day 3.0 – 4.0) following
hyperosmotic shifts. Specific growth rate (µ) was determined by plotting the logarithm of viable cell
density vs. time of cultivation. Metabolite concentrations were plotted vs. integrated viable cell
density in order to analyze specific metabolite formation rates (q). Mitochondrial and cytosolic ATP
content were calculated according to equations 1a and 1b (Supporting Information). Amounts of
cis-Aco,G6PandF6Pwereused to correctmeasuredadeninenucleotide contents for lossofmitochon-
drial compartment or remaining cytosol. Adenylate energy charge (AEC) was calculated according to
Atkinson andWalton (38). Specific ATP formation rate (qATP) was determined according to equation
2 (Supporting Information) assuming a P/O ratio of 2.5 (39,40). Standard deviations were calculated
based on three (reference) or four (hyperosmolal) biological replicates. Gaussian error propagation
was applied in order to determine errors of calculated data. Unpaired student's t-test was applied to
determine statistical significance.
2.6RNA samples and sequencing
The cell samples of three biological replicates of cultivations with osmotic shift and two biological
replicates of reference cultivations were chosen for gene expression analysis by NGS. miRNeasy kit
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(Qiagen, Hilden, Germany) was used to isolate RNA. The quality of isolated RNA was determined
with Bioanalyzer 2100 (Agilent, Taufkirchen, Germany). Preparation of samples for sequencing was
performed with TruSeq®RNA Sample Pre Kit v2 (mRNA) and TruSeq® Small RNA Sample Prep Kit
(miRNA) (Illumina,USA). Sampleswere sequencedon IlluminaHiSeq2500platformusingRapidRun
Mode (62 cycles/library) resulting in 7 – 10 million reads per sample. The software FastQC served as
quality control for sequencing (www.bioinformatics.babraham.ac.uk/projects). Cutadapt (41), spliced
transcripts alignment to a reference (STAR) (42) and HTSeq-count (43) were used to prepare the
received NGS data for differential gene expression analysis. CHO K1 genome and miRNA data for
Cricetulus griseus (www.chogenome.org,miRBase (release 21)) functioned as references for STAR.
2.7 Software andTools
RStudio (version 0.98.1103, R version 3.2.1) was used predominantly for data analysis and
visualization. Differential gene expression analysis was performed with the package edgeR
(version 3.10.2) (44). Negativebinomial generalized linearmodel (GLM)method in combinationwith
tagwise dispersion estimation was applied for differential expression analysis. Genes were defined
as significantly up- or downregulated if they showed a log2-fold change¥ |1| and passed the GLM
likelihood ratio test with a P value ¤ 0.02 and a false discovery rate (FDR) ¤ 0.02. VennDiagram
(version 1.6.9) was used for visualization. Gene expression dynamics were analyzed with maSigPro
(version 1.40.0) (45,46). GO-enrichment analyses were performed with GOrilla (47) and MGI Gene
Ontology Term Finder (www.informatics.jax.org).
3Results
3.1 Changes in cell growth,metabolismandproduct formation
Hyperosmotic culture conditions (¥ 350 mOsmol kg-1) can easily be induced by the addition of
common salts like NaCl. Consequently this trigger is typically applied in related studies.
Accordingly, NaCl was as well used to increase osmolality during batch cultivations of an antibody
producing CHO DP-12 cell line in this study. NaCl enriched medium was added to four of seven
cultures 35 h after inoculation (Figure 1).
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Figure 1. Time courses for antibody titer, osmolality, viable cell density and viability. Osmolality was increased
by the addition of NaCl during batch cultivations of CHO DP-12 (arrow). Viable cell density () and via-
bility (l) were analyzed by Cedex XS, osmolality was determined with Osmomat 030 antibody titers were
analyzed by ELISA. Error bars represent standard deviations for four (hyperosmolal, l) or three biological
replicates (reference,) also considering the technical error ofmeasurements (n=3). Osmotic shift induced
significantly higher osmolalities on day 1.5 – 8 (student's t-test, P-value < 0.001), a significantly lower viable cell
densityonday2.5 -8 (student's t-test, Pvalue<0.001)andasignificantlyhigherviabilityonday5–6.5 (student's
t-test, P-value < 0.001).
Osmolality was increased from∼ 280 mOsmol kg-1 (reference condition) to∼ 430 mOsmol kg-1 re-
sulting in a significant difference (P < 0.001) of∼ 150 mOsmol kg-1 (Figure 1). During the first time
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interval (day 1.5 to 2.5), specific growth rate (µ) was slightly lowered (0.60 0.03 vs. 0.68 0.03 d-1)
and lead to a significant difference in viable cell density (VCD) on day 2.5 (P < 0.001) (Figure 1).
From day 3 to 4 µdecreased even further to 0.26 ± 0.04 d-1 compared to 0.83 0.08 d-1 for reference
cultures. Starting on day 2.5, hyperosmotic cultures showed significantly lower VCD (P < 0.001)
reaching a maximal VCD of 4.01  0.34 x 106 cells mL-1 compared to 12.02  1.31 x 106 cells mL-1
(Figure 1). As glucose concentrations reached limiting levels on day 5, reference cultures entered a
phase of declining viability and VCDwhereas the viability of hyperosmotically stressed cells was not
affected at all (Figure 1).
Analysis of product formation rate (qp) revealed no significant difference during the first 24 h after
osmotic shift. Thereafter hyperosmolality resulted in a∼ 1.6-fold higher qp (12.98 0.18 vs. 8.05
0.85 pg cell-1 d-1) and a comparable final antibody titer of 163 17mg L-1 compared to 176 21mg L-1
for reference cultures (Figure 1). Specific metabolite formation rates (q) did not significantly differ
during time interval day 1.5 – 2.5 (Supporting Information Table I). From day 3 to 4, hyperosmotically
stressed cells showed increased consumption of glucose (2.52 0.35 vs. 1.61 0.10 pmol cell-1 d-1,
P-value < 0.05) and production of lactate (2.80 0.77 vs 1.18 0.19 pmol cell-1 d-1, P-value < 0.07).
In the same interval, qasparagine and qglutamatewere not affected by culture conditionswhereas hyperos-
motically stressed cells consumed less glutamine than reference cells (Supporting Information
Table I).
3.2Hyperosmoticstresscausesanincreaseinmitochondrialandcytosolicadeninenucleotidepools
In previous studies, intracellular ATP-contents and qATP of CHODP-12 cells increased after an osmotic
shift from∼290 to∼ 390mOsmol kg-1 onday3of cultivation (34). This study focusedon theeffects of
an1.5dearlierandhigher increase inosmolality (∼280to430mOsmolkg-1)applyingacompartment-
specific approach to analyze the distribution of adenine nucleotide pools in the cell.
Starting fromcomparable cytosolic (2.7 fmol cell-1) ormitochondrial (0.20 fmol cell-1) pool sizes, cyto-
solicATP-content (ATPcyt)ofhyperosmoticcultures increased(3.7 fmolcell-1)whilemitochondrialATP-
content (ATPmit) did not change significantly (Figure 2).
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Figure 2. Effect of hyperosmolality on cytosolic ( ) and mitochondrial ( l) ATP-content and qATP.
Osmolality was increased by addition of NaCl (arrow) resulting in an osmolality of ∼430 mOsmol kg-1
(, l) compared to ∼280 mOsmol kg-1 (, ) for reference cultivations. Cell sampling was
performed by a compartment-specific fast filtration approach and intra- and subcellular meta-
bolites were extracted by methanol/chloroform treatment. ATP was quantified by RP-HPLC. ATP
data were corrected for sampling efficiency based on measurement of cis-aconitate (mitochondrial
marker metabolite), glucose-6-phosphate and fructose-6-phosphate (cytosolic marker metabolite)
using LC-IDMS method. qATP was calculated according to equation 8 (Supporting Information) with an
assumed P/O ratio of 2.5 (42,43). Error bars represent standard deviations for three biological
replicates considering the technical errors (n=3) by Gaussian error propagation. Student's t-test revealed
significantly higher ATPmit (P-Value < 0.05) and ATPcyt (P-Value < 0.001) on days 4 and 5 for hyperosmotically
stressed cells.
Due to decreasing ATPcyt and ATPmit of cells grown under reference conditions, hyperosmolality
resulted in significantly higher ATPcyt (P < 0.001) and ATPmit (P < 0.05) on day 4 and 5 of cultivation.
Comparable results were received for ADP (Supporting Information Figure 1) while AMP levels were
frequently below the reliable detection limit. Noteworthy, the determined intracellular ATP-
concentrations of hyperosmotically stressed cells were also increased compared to reference cells
(Supporting Information Figure 2).
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Analysisof subcellulardistributionofadeninenucleotides revealed13–20-fold lowervalues forATPmit
than for ATPcyt (Table 1). In addition, ATPmit/ADPmit-ratios were 3 – 5-fold smaller than cytosolic ra-
tios (Table 1). Subcellular distributions of adenine nucleotides of hyperosmotically stressed cells did
not significantly differ from reference cells. Before and after osmotic shift, physiological adenylate
energy charges (AEC) were calculated for both conditions (AEC  0.9). AEC was not affected by
osmotic shift and remained at levels of 0.97  0.01 for cytosol or 0.90  0.02 for mitochondrial
compartment (Supporting Information Figure 3). AECmit were significantly lower than AECcyt
(P-value < 0.05).
Table 1. Cytosolic andmitochondrial ratios for adenine nucleotides.
reference hyperosmolal reference hyperosmolal
t [d] ATPcyt/ATPmit ATP/ADPmit ATP/ADPcyt ATP/ADPmit ATP/ADPcyt
1.5 13.9 1.0 13.1 1.2 4.2 1.2 12.4 2.7 4.4 1.6 13.1 4.3
3.0 21.6 2.1 16.9 1.3 3.8 1.2 17.2 4.0 3.8 1.1 14.4 2.6
4.0 16.6 1.9 17.7 1.3 4.3 0.8 16.5 4.6 3.5 0.7 14.3 2.1
5.0 17.0 2.3 19.5 1.3 4.2 1.0 15.9 3.1 3.4 0.7 11.7 3.8
3.3 Correlations betweengene expression dynamics and functional annotation ofDEGs
Changes in mRNA expression were investigated directly before (0) and 2, 4, 6 and 8 h after osmotic
shift from ∼ 280 to ∼ 430mOsmol kg-1. In addition, miRNA expression was analyzed directly
before (0) and at time points 4 and 8 h after increase in osmolality. While no differentially expressed
genes (DEG, P-value¤ 0.02, FDR¤ 0.02) were identified directly before osmotic shift, hyperosmotic
conditions induceddynamicchanges ingeneexpressionwhichwere illustratedbyVenndiagramsand
maSigPro clusters (Figure 3AB, Supporting Information Table II).
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Figure 3. A: Venn diagrams for up- and downregulated genes with respect to the exposure period after
hyperosmotic shift. Osmotic shift was performed by addition of NaCl ∼35 h after inoculation of CHO DP-12
batch cultures. Gene expression analysis based on next generation sequencing (NGS) data was performed
directly before, as well as 2, 4, 6 and 8 h after osmotic shift. NGS data were analyzed with edgeR package in
order to identify significantly differentially expressedgenes (P-value andFDR¤0.02, log2(fold-change)¥ |1|).
B: Clusters of gene expression dynamics of upregulated genes. Genes which were upregulated at some time
point after increase in osmolality from∼280 to∼430 mOsmol kg-1 were analyzed with R package maSigPro
and hierarchically clustered (n = 9).
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About 40% of upregulated and 54% of downregulated genes were exclusively significantly
differentially expressed 2 h after osmotic shift (Figure 3A). The remaining genes showed different
expression dynamics with 32 genes being significantly upregulated and only one gene (EGR1) being
significantly downregulated over the whole time of analysis. Gene ontology (GO) enrichment
analysis for identified groups and clusters showed little relation between gene expression
dynamics and annotation of genes to a specific biological process. Only four groups of the Venn
diagram for upregulated genes aswell as cluster 3 ofmaSigPro analysis encompassed genes enriched
in specific biological processes (Supporting Information Table III). These biological processes were
“cell surface receptor signaling”, “negative regulation of cellular metabolic process”, “cell adhesion”,
“cation transport” and “regulation of programmed cell death” (Supporting Information Table III).
Several genes encoding Na+-transporting proteins (ATP1B1, SLC28A1, SLC5A3 and SLC6A13) were part
of the GO-category “cation transport” and belonged to cluster 5 or 8. This response to elevated Na+-
concentrations due to osmotic shift was a delayed one which enhanced gradually (Supporting
Information Table III, Figure 3B). “Negative regulation of cellular metabolic process” was an
immediate and long term effect of hyperosmolality with almost half of the genes showing dynam-
ics of cluster 2 and the rest of genes being distributed on clusters 3, 4 and 5 (Supporting Information
Table III, Figure 3B). One of the genes of this GO-category was CDK1A which encodes the G1-phase
arrest mediating cyclin dependent kinase inhibitor protein 1A (p21) (48,49). Genes of cell surface
receptor signaling were characterized by an immediate upregulation (¤ 2 h) and a following decline
in expression level (Supporting Information Table IV).
In addition to the upregulated genes of the aforementioned biological processes, hyperosmolality
inducedaswellupregulationofgenesencodingproteinswith tissue related function IL15,MUC2,NEB,
OVGP1 and TTN are exemplary genes with a short time of response and significantly upregulated
expression levels over a time of at least 6 h.
3.4Hyperosmotic stimulus induces upregulation of 7miRNAs
TheanalysisofmiRNAexpressionrevealed7miRNAs(miR-132-3p,miR-132-5p,miR-182,miR-183,miR-
194, miR-215-3p, miR-215-5p) that were significantly upregulated in hyperosmotically stressed cells
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(Table 2). Four hours after osmotic shift, miRNA expression levels were more than 2.5-fold higher
compared to reference cells. After another four hour time interval, a decrease in differential
expression of miR-182 (-7%), miR-183 (-13%), miR-215-5p (-13%), miR194 (-19%) and miR-215-3p
(-43%) was determined. In contrast, the differential expression ofmiR-132-3p stayed constant, while
the osmotically induced upregulation ofmiR-132-5p increased by 23% (Table 2).
Table 2. Significantly upregulatedmiRNAs (P-value¤ 0.02, FDR¤ 0.02).
fold change
miRNA 4h 8h
cgr-miR-132-3p 4.0 4.0
cgr-miR-132-5p 2.5 3.0
cgr-miR-182 5.3 4.9
cgr-miR-183 2.5 2.1
cgr-miR-194 4.9 4.0
cgr-miR-215-3p 4.9 2.8
cgr-miR-215-5p 5.7 4.9
4Discussion
4.1 CHODP-12 cells showwell-knownhyperosmotic effects regarding cell growth andmetabolism
Hyperosmotically stressed cells showedmainly the same characteristics as described in previous in-
dependent studies (6–8,34,9). Cell growth wasmost likely influenced by arrest of CHODP-12 cells in
G1-phase of cell cycle which had been detected in preliminary experiments (data not shown) as well
as for a different experimental setup (34) or cell line (7). Although Shen et al. described an increased
qglutamine for hyperosmotically stressed cells, CHODP-12 showed a contrary effect. This might be due
to the fact that CHODP-12 cells consume asparagine as well in a non-neglectablemanner.
Summarizing, theexperimental setupprovidedappropriateconditions for further investigationscon-
cerning adenine nucleotide pools and gene expression dynamics.
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4.2Hyperosmotic stress provides a surplus inATP supply
Previous independentstudies (50,51)describedacutecell shrinkageuponhyperosmotic shift followed
by an increase in cell volume which commonly exceeded the pre-shift state. This cellular process of
regulatory volume increase (RVI)was shown tobe induceby activationof e. g. Na+/K+-ATPase,Na+/H+
exchange or the uptake of other electrolytes (50). RVI as a putative reason for increased ATP-content
was rejected as hyperosmotically stressed cells showed as well increased cATP (Supporting Informa-
tionFigure2)and36–41%higherqATP (Figure2)whichoutweighedby far the requiredamountofATP
to compensate RVI. In general values for intracellular ATP-contents were in agreement with previous
findings (33,34,52,53). Noteworthy thepossibility todistinguishbetweenmitochondrial and cytosolic
pools significantly refinesourunderstandingof cellular energymanagement. Inaccordancewithpre-
vious independent studies for rat liver or heartmyocytes ATPmit and ATPmit/ADPmit-ratios were lower
than in cytosol highlighting the conservation and importance of the cellular distribution of adenine
nucleotides (33,54–56). In addition, significantly lower AECmit thanAECcyt were in agreementwith in-
dependentmeasurements for CHObatch cultures without hyperosmotic stress (33).
While hyperosmotic culture conditions increased subcellular ATP and ADP pool sizes the subcellular
distribution of ATP and ADP (ATPcyt/ATPmit, ATP/ADP, AEC) was not affected. This findingmay reflect
the cellular strategy with mitochondria serving as ATP provider quickly secreting ATP to the spots of
consumption which are inside the cytosol. Consequently, it seems likely that ATP sensors which are
incorporated in cellular regulation are located in the cytosol and not inmitochondria.
4.3 Conserved gene expression changes amongmammalian andCHOcells
In comparison toasummarized listofgenesandproteinsassociatedwith the responseofmammalian
cells tohyperosmolality (57) CHODP-12 cells showedequal expressionpatterns for eight genes: AQP1,
SLC38A2, SLC6A6, ATP1B1, NFAT5, CRYAB, HSP110 andHSPA4L, comprising the categories channels,
transporters, transcription factors and chaperones, were upregulated due to hyperosmolality (57).
Further, differential changes in the expression of 57 genes (Supporting Information Table V) were in
agreement with the microarray based transcriptomic studies of Shen et al., thus revealing CHO spe-
cific changes uponhyperosmotic treatment (8). Nevertheless only 16 of the aforementioned 57 genes
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passed the threshold for DEGs andmay therefore serve as CHO specific expressionmarkers for NaCl-
inducedhyperosmolality. Asmicroarraybasedexpressionstudiesconsidera limitednumberofgenes,
future NGS studies may reveal higher numbers of conserved gene expression changes for hyperos-
motically stressed CHO cells.
4.4 Identification of suitablemRNA targets to enhance qp
EdgeR and maSigPro analysis revealed that even common changes in culture conditions like hyper-
osmolality resulted in a diversity of gene expression dynamics (Figure 3) not necessarily confirming
the gene affiliation to a specific biological process (Supporting Information Table III). Genes showing
immediate gene expression responsemight bemore relevant for cell line engineering as these genes
are most likely members of the early stress response and may as well be sensors,
regulators or inducers of subsequent stress response pathways. In fact the majority of DEGs at time
point 2 h after osmotic shift were related to cell surface receptor signaling. To the group of genes
showingearlyandlongtermresponse (¥6h)belongedseveralgenesencodingproteinswhichseemed
to have a dispensable function in suspension growing cells. MUC2 and OVGP1 encode heavily
O-glycosylated (>50%)secretoryproteinswhich formepithelialmucin layers toprotect cells e. g. from
microbial attack (58,59). The cultivation of CHO cells in suspension in stirred tank bioreactors most
likely prevents the formation of this protecting mucin layer but nevertheless cells seem to spend a
great amount of energy to synthesize large glycoproteins like MUC2 (∼ 5100 amino acids) (58). As
the formation of one peptide bond was declared to require at least 3 molecules of ATP (28), about
15,300 mol ATP are consumed for the synthesis of 1 mol of MUC2 compared to 3,957 mol ATP for
1 mol of IgG1 antibody (∼ 1320 amino acids). Hence the performance of industrial mAB producing
cell lines, which is supposed to be much more ATP challenging than the one of the DP-12 cells of
our study, might be hampered by this ATP consuming but dispensable expression of genes/proteins.
Following the mindset and findings for microbial producers, genome reduction may enable an
overall improvement in performance (29–31). Therefore the deletion of MUC2 and OVGP1 may
potentially enhance the productivity of recombinant CHO cells. In addition, interleukin 15 which
stimulates proliferation and differentiation of cells of the immune system and components of the
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muscle sarcomere (NEB, TTN), may also be potential targets for genome reduction (60–62). Another
gene of early and long term response was CDK1A. In previous independent studies hyperosmolality
was shown to activate p53, the transcriptional activator of CDK1A encoding a protein that inhibits
cyclin dependent kinase 2 and 4 (CDK4) thus inducing G1-phase arrest (48,49). Nevertheless, the
expression of p53 and several related protein kinases, e. g. ATM, CHK1/2, did not change significantly
in this study which might be due to a steady expression to realize a quick activation by phosphory-
lation if required (49). In contrast the gene encoding cyclin D1 (CCND1) which commonly binds and
activates CDK4was significantly downregulated 4 h after osmotic shift. Overexpression of CDK1A has
already been applied as cell cycle engineering target to enhance qp of recombinant CHO cells (63,64).
4.5 Linkage betweenupregulatedmiRNAs, cell cycle arrest and increase in qp
Recent miRNA studies commonly enhanced qp of recombinant CHO cells by stable overexpression
of miRNAs (cgr-miR-17, cgr-miR-19b, cgr-miR-20a, cgr-miR-92a, cgr-miR-2861, mmu-miR-30 family
members, hsa-miR-7, hsa-miR1287, hsa-miR-557) (65–70). In this context miR-7 and miR-30 had a
negative impact on cell growth (66,69). Kelly et al. (2015) depletedmiR-23 in recombinant CHO cells,
thus increasing mitochondrial activity and qp (71). Druz et al. (2013) improved apoptosis resistance
and productivity of CHO cells by stable inhibition ofmmu-miR-466-5p (72).
None of the seven significantly upregulatedmiRNAs (Table 2) was among the previouslymentioned
qp enhancing miRNA targets of independent studies. Furthermore none of the significantly
differently expressed miRNAs of this study was among the miRNAs related to low cultivation
temperature, cell growth rate, histone deacetylase inhibition, or osmoregulation of mouse collect-
ing duct epithelial cells (25,26,68,73,74). Surprisingly, all seven differentially expressedmiRNAswere
frequently shown to be involved in cell proliferation and p53 mediated tumor suppression in cancer
cells (75–85). p53 was described to induce the expression ofmiR-194 andmiR-215, which in turn were
reported to be positive regulators of p53 (77–80). An either oncogenic or tumor suppressive role in
cancer cells was reported for miR-132, miR-183 and miR-182 (75,76,81–85). Overexpression of miR-
132,miR-194 andmiR-215 resulted in ap53/CDK1Amediated cell cycle arrest inG1-phase (75,77,78,81).
Increased product titers and enhanced qp in combinationwith a decrease in cell growthwas reported
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for recombinantCHOcell lineswhichhadtransientlybeentransfectedwithhumanmiR-183 (70). EGR1
encoding the early growth response protein 1 was significantly downregulated at all analyzed time
points after osmotic shift and was described to be involved in G1/S transition of cell cycle (86–89).
Sarver et al. (2010) validated EGR1 as a target of miR-183 by luciferase reporter assay in different
tumorcell lines (76). Onbasisof theresearchofSarveretal. (2010)andStrotbeketal. (2013), onecould
wonder whether EGR1may potentially be a target ofmiR-183 in CHODP-12 as well andwhether they
might be involved in regulationor inductionofG1-phase arrest, thus resulting in enhancedqp (70,76).
Nevertheless further experiments, e. g. luciferase reporter assay, have to validate these
hypotheses.
4.6 Concluding remarks
In conclusion, we were able to show that hyperosmolality elevated qATP, thus resulting in increased
cytosolic andmitochondrial adenine nucleotide pools while ATP/ADP-ratios remained constant. Our
findings support thehypothesis that increasedATP-content togetherwithdecelerationof cell growth
provides a surplus in ATP supply whichmay be used to boost productivity.
The immediate and long term upregulation ofMUC2, OVGP1, TTN andNEB seemed to be a dispens-
ablebutenergyconsumingstress response for suspensiongrowingcells. Therefore thesegenesmight
be ideal candidates for genomic deletion thus reducing theCHOgenome inorder to enhanceproduc-
tivity as it hasalreadybeenshownformicroorganisms (29–31). Further the significantupregulationof
CDK1A in osmotically stressed CHO cells together with G1-phase arrest,
increased qATP and enhanced qp may elucidate CDK1A's qp enhancing role that had been described
in previous cell cycle engineering studies (63,64). Overexpression of miR-132, miR-194 and miR-215
maypotentially enhanceas thiswas shown to inducep53/CDK1A(p21)mediated cell cycle arrest inG1-
phase (75,77,78,81), thesemiRNAsmay potentially be targets to enhance qp by cell cycle engineering.
The hypothesized regulatory connection between miR-183, EGR1 and cell cycle arrest together with
the qp enhancing effect described by Strotbek et al. (2013) give point tomiR-183 as themost promis-
ing candidate for subsequent cell line engineering studies.
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